<SEC-DOCUMENT>0001493152-15-002955.txt : 20150715
<SEC-HEADER>0001493152-15-002955.hdr.sgml : 20150715
<ACCEPTANCE-DATETIME>20150714202721
ACCESSION NUMBER:		0001493152-15-002955
CONFORMED SUBMISSION TYPE:	8-K12G3
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150714
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150715
DATE AS OF CHANGE:		20150714

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ZAXIS INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000797542
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				680080601
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K12G3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15746
		FILM NUMBER:		15988194

	BUSINESS ADDRESS:	
		STREET 1:		42 BEN ZVI STREET
		CITY:			RAMAT GAN
		STATE:			L3
		ZIP:			5224747
		BUSINESS PHONE:		972525795082

	MAIL ADDRESS:	
		STREET 1:		42 BEN ZVI STREET
		CITY:			RAMAT GAN
		STATE:			L3
		ZIP:			5224747

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INFERGENE CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K12G3
<SEQUENCE>1
<FILENAME>form8-k12g3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 18pt Times New Roman, Times, Serif"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 18pt Times New Roman, Times, Serif"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 12pt Times New Roman, Times, Serif"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 18pt Times New Roman, Times, Serif"><B>FORM
8-K/12G3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CURRENT
REPORT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date
of report (date of earliest event reported): July 14, 2015</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 18pt Times New Roman, Times, Serif"><B><U>ZAXIS
INTERNATIONAL, INC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Exact
Name of Registrant as Specified in its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Commission
File No.: 0-15476</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Delaware</FONT></td>
    <TD STYLE="text-align: center; width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 49%; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">68-0080601</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(State
    of Incorporation)</FONT></td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(I.R.S.
    Employer Identification No.)</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">42
    Ben Zvi Street, Ramat Gan, Israel</FONT></td>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5224747</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Address
    of Principal Executive Offices)</FONT></td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(ZIP
    Code)</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Registrant&rsquo;s
Telephone Number, including area code: (972) 52-579-5082</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">[&nbsp;&nbsp;]<FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">[&nbsp;&nbsp;]<FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">[&nbsp;&nbsp;]<FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">[&nbsp;&nbsp;]<FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white"><B>Item
2.01. Completion of Acquisition or Disposition of Assets.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
March 16, 2015, Zaxis International, Inc., a Delaware corporation (the &ldquo;Registrant&rdquo;) filed a Form 8-K reporting that
it had signed a Share Exchange Agreement (the &ldquo;Share Exchange Agreement&rdquo; or the &ldquo;Agreement&rdquo;) with Emerald
Medical Applications Ltd, a private company organized under the laws of the State of Israel (&ldquo;Emerald&rdquo;), a copy of
which was attached as Exhibit 10.4 to the Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
July 14, 2015, the closing of the Share Exchange Agreement was held (the &ldquo;Closing&rdquo;) and as a result, Emerald became
a wholly-owned subsidiary of the Registrant. Pursuant to the Closing of the Share Exchange Agreement, the Registrant issued 5,474.545
shares of its common stock, par value $0.0001 (the &ldquo;Shares&rdquo; or &ldquo;Common Stock&rdquo;) to Lior Wayn, Emerald&rsquo;s
CEO and the sole holder of Emerald&rsquo;s Ordinary Shares, representing 40.58% of the Registrant&rsquo;s 13,489,905 outstanding
Shares, in exchange for 100% of Emerald&rsquo;s Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">For
the purposes of disclosure in this Form 8-K12G3, the Registrant may sometimes be referred to as &ldquo;Emerald&rdquo; if appropriate.
The following disclosure information constitutes the Registrant&rsquo;s <I>Form 10 Disclosure </I>regarding its wholly-owned operating
subsidiary, Emerald Medical Applications Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Item
1. Description of Business </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Emerald
Medical Applications Ltd (&ldquo;Emerald&rdquo;), a wholly-owned subsidiary of the Registrant effective July 14, 2015, was organized
as a privately-owned company under the laws of the State of Israel on February 17, 2010. Emerald is digital health startup company
engaged in the development, sale and service of imaging solutions utilizing its proprietary DermaCompare software that it developed
for use in derma imaging and analytics (&ldquo;DermaCompare&rdquo;). Emerald believes that its proprietary DermaCompare software
represents an advancement in skin cancer screening that should enable physicians to more readily identify and monitor changes
in their patients&rsquo; skin characteristics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Emerald&rsquo;s
DermaCompare solution allows dermatologists and other medical care professionals, using a set of 25 total body photography (&ldquo;TBP&rdquo;),
to capture sets of skin lesion images with, among other devices, digital cameras, camera-equipped smart phones or tablets. These
images are then transmitted online and are remotely analyzed by professionals using our DermaCompare software.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
sales and marketing plan is to sell licenses for our DermaCompare imaging software to: NHSs, HMOs, health insurance companies,
hospitals and medical clinics through distributers, health care channel partners or directly through independent salespersons
and/or web purchase to dermatologists and other physicians (GPs) that we expect to purchase licenses based on the number of potential
numbers of patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notwithstanding
our belief that DermaCompare represents a significant advance on existing technologies, there are a number of potential difficulties
that we might face, including the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
    may not be able to raise sufficient additional funds to fully implement our business plan;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Competitors
    may develop alternatives that render our DermaCompare software solution redundant or unnecessary;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
    may not obtain and maintain sufficient protection of our intellectual property;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
    DermaCompare software may be shown to have characteristics that indicate it may be ineffective; </FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
    DermaCompare may not be accepted by physicians including dermatologists and the medical community in general; and</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Strict
    government regulations and inappropriate reimbursement policies, especially in emerging economies, may hinder the growth of
    the dermatology device market.</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">During
the quarter ended March 31, 2015, we raised $780,000 in equity capital to fund our business plan and as part of our commitment
to raise $800,000 as a condition to the Closing. The Registrant exceeded that commitment during April and May 2015. We are a start-up
company and we may be expected to require up to an additional $1.5 million<B> </B>in capital during the next 12 months to implement
our business plan and fund our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Overview
of Melanoma</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Melanoma
is a type of skin cancer which forms from melanocytes (pigment-containing cells in the skin), is very aggressive cancer and, at
present, there is no cure for Melanoma.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 123.75pt; width: 177.75pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
women, the most common location is the legs. Melanomas in men are most commonly located on the back. It is particularly common
among Caucasians, especially northern Europeans and northwestern Europeans, as well as those living in sunny climates. Melanoma
rates are higher in Oceania, North America, Europe, Southern Africa, and Latin America. This geographic pattern reflects the primary
cause of Melanoma, ultraviolet light (UV) exposure in conjunction with the amount of skin pigmentation in the population. Melanocytes
produce the dark pigment, melanin, which is responsible for the color of skin. These cells predominantly occur in skin, but are
also found in other parts of the body, including the bowel and the eye. Melanoma can originate in any part of the body that contains
melanocytes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
treatment includes surgical removal of the tumor. If Melanoma is detected early, while it is still relatively small and thin in
depth, and provided that it is timely removed or otherwise treated, the cure rates are very high. The likelihood that the Melanoma
will reoccur or spread depends on how deeply it has penetrated into the layers of the skin. For Melanomas that come back or spread,
treatments include chemo- and immunotherapy and/or radiation therapy. According to National Cancer Institute statistics, the survival
rates in the US after five years are is on average 91%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">While
Melanoma is less common than other types of skin cancer, it is far more serious if it is not detected in its early stages. Melanoma
causes the vast majority of deaths related to skin cancer. Globally, in 2012, that most recent year for which statistics have
been reported, Melanoma occurred in 232,000 people and resulted in 55,000 deaths according to the World Cancer Report 2014 of
the World Health Organization (&ldquo;WHO&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 192pt; width: 282pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">It
is estimated that 420 million people across the globe are at high risk of Melanoma (See RED in Image).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>The Dermatology
Device Market</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Various
devices are used by dermatologists and surgeons to diagnose skin disorders and accurately determine the types of conditions and
the treatments required. At present, the dermatology devices market consists of two segments:(i) diagnostic devices market; and
(ii) treatment devices market. Our Product is part of the diagnostic device market aimed at increasing the speed and accuracy
of skin disorder diagnosis at an early stage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
respected research firm, &ldquo;MarketsandMarkets.com,&rdquo; has forecast that the global market for dermatology devices to grow
from $6.6 billion in 2014 to $11.3 billion by 2019 and the market in North America, a primary market that we hope to compete in,
is expected to reach approximately $5.2 billion by 2019. The key factors expected to drive the forecasted growth are: (i) a rise
in skin disorder incidence; (ii) an increase in awareness of available aesthetic procedures; (iii) advances in technology and
rising prices; and (iv) the recognition by the population of the harmful effects of to exposure to the sun on skin. All of the
forgoing are major contributing factors towards the increasing number of people that become more skin and health conscious.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
global dermatology devices market includes two distinct segments:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Diagnostic
    devices, such as dermatoscopes, microscopes and imaging techniques; and</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#9679;</td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Applications
    of these diagnostic devices, such as imaging processing software, skin cancer diagnosis technology, hair removal and wrinkle
    removal</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Based
on the 2014 MarketsandMarkets.com report, imaging techniques accounted for the largest share of the diagnostic devices segment.
Skin cancer diagnosis technologies represents the largest share of the device applications market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
global dermatology devices market is expected to grow faster due to the increasing number of people suffering from skin-related
disorders and the number of people opting for less invasive cosmetic surgeries. These are important factors contributing to the
increasing demand of dermatology devices, which, in turn, is expected to contribute to demand for our DermaCompare software solution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dermatology
devices and respective applications are rapidly gaining popularity not only due to their major role in aesthetic but also the
rising numbers of skin disorders such as vascular and pigmented lesions, skin cancer, acne problems and others conditions that
vary in different regions of the world.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Geographically,
we plan to cover four major regions including North America, Europe, Australia and the increasing market in major Asian countries
including China, India and Japan, among others. Rising occurrence of skin related ailments along with technological advancements
and higher healthcare expenditures have resulted in North America being the largest market for dermatology devices. This trend
is expected to continue. In Australia, Melanoma is the fourth most common cancer with 1 in 14 males and 1 in 23 females expected
to develop melanomas during their life time. Its incidence has been increasing by approximately 16% in males and approximately
24% in females over the next decade, according to a report by National Health and Medical Research Council (NHMRC) and New Zealand
Guidelines Group (NZGG). The Asian-Pacific market is anticipated to be most profitable due to highly untapped opportunities, rising
public and physician awareness and improvement in healthcare infrastructure. Skin disorders such as acne, Melasma, dermatitis,
skin warts, lesions and moles, especially in China and India, are projected to drive the Asian market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Our
Market Opportunity</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
challenge for dermatologists is the detection of skin cancer in its early stages, which is crucial for patient survival. Approximately
60% of melanomas occur as a result of a new mole, while the remaining 40% are the result of a mole that has changed. Since the
human body dynamically changes over time, dermatologists are still using manual techniques, which are time-consuming and, as a
result, costly, often inaccurate and not readily available for population-wide screening. The most recent innovation in the skin
cancer detection field is Total Body Photography (&ldquo;TBP&rdquo;), typically a set of 25 photos that cover the entire skin
surface of the patient, and was adopted by dermatologists approximately fifteen years ago. At present, dermatologists recommend
doing TBP on a yearly basis, comparing the photographs and detecting the key differences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
believe that the most significant research in skin cancer detection over the last decade has been conducted principally in the
state of Schleswig-Holstein, Germany. This has involved the use of manually taken TBP which, from an efficacy study performed
for the early detection of skin cancer, found a 30% increase in the early discovery of skin cancer, resulting in approximately
90% of melanomas being diagnosed at an early stage and with mortality rates decreasing by approximately 50% of that expected five
years after the study. As a result of the study, since 2008, the country has mandated a nationwide statutory plan for a bi-annual
early screening of skin cancer for citizens aged 35.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Based
on our estimates, there are approximately 420 million people, representing 7% of the total world population, that can be defined
as within the Melanoma high risk group; the majority of which are living in the Western hemisphere. Melanoma patients are more
likely to be found in countries with warm and sunny weather. The disease is, however, also prevalent in other regions such as
China, India and elsewhere in the Far-East.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">It
is estimated that approximately 250,000 new cases of Melanoma are diagnosed worldwide each year. Based upon studies conducted
by the National Institutes of Health (&ldquo;NIH&rdquo;) and the Skin Cancer Foundation, an estimated 74,000 new cases of invasive
Melanoma will be diagnosed in the US in 2015 with detection more frequently in male Caucasians. At present, Melanoma is the sixth
leading cause of cancer mortality in men and the seventh leading cause of cancer fatalities in women. Based on these data, we
believe that skin lesion imaging is expected to continue to be a growing market. We believe that current market potential is over
$1 billion, although there can be no assurance that we will be able to commercially exploit this large and growing demand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">At
present, the most conventional and widely-used visualization method is a standard photograph followed by manual image analysis
and then comparing these images with previously taken photographic images to reach a diagnosis. This traditional method has several
disadvantages, including the fact that only the outermost layer of skin is imaged and subjected to diagnosis, the visual comparison
process is time-consuming, expensive, and often inaccurate because it is dependent on the dermatologists eyes only. The standard
conventional photograph method, although inexpensive, is inefficient and laborious for examination purposes and limits the market
to dermatologists and specialized physicians.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By
revolutionizing the fundamental approach in which skin lesions and/or Melanoma is diagnosed, especially in the early stages, we
reasonably expect that our DermaCompare product should be well-positioned to become one of the leading applications in the market,
although there can be no such assurance. We hope that this will be achievable by replacing the need for manual photo image analysis
with automated image analytics software using advanced algorithms of our DermaCompare process for anchoring, identifying and detecting
changes in the shapes, color and sizes of skin lesions. We also plan to utilize available large data bases together with new &ldquo;computer
learning&rdquo; and &ldquo;artificial intelligence&rdquo; techniques to learn from the &ldquo;wisdom of the crowd&rdquo; and,
based on business analytic tools, we will use as a DSS (Decision Support System) for all range of physicians.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
DermaCompare imaging software solution should provide several benefits including, but not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: left; vertical-align: top">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">shortening
    the physician&rsquo;s diagnostic procedure, which is both time-consuming and limits care only to those with very high expertise;
    </FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">replacing
    manual photo analysis with our DermaCompare application that enables a more in-depth diagnosis; and </FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; vertical-align: top">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">opening
    the market to less experienced physicians in less served markets outside of urban and suburban areas, thereby increasing the
    potential clientele and patient base significantly.</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">With
the rise of the incidences of skin cancer, we believe that the medical community and the general population recognize that it
is not only vital to monitor the skin on a regular basis, but it also important to have new means of diagnosing skin lesions more
rapidly and accurately. One of the best early indicators of Melanoma is a new or changing mole. If detected in its early stage,
Melanoma is almost always treatable. If left untreated for too long, skin Melanoma can become terminal and very difficult or virtually
impossible to treat. In addition, if the skin is not monitored on a regular basis, it may be difficult for the patient or doctor
to detect new moles or identify changes in existing ones.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Total
body photography or TBP, which is part of the procedure used with our DermaCompare technology, is intended for use in detecting
and monitoring skin moles and lesions, particularly for individuals considered at high risk for Melanoma. Early detection improves
treatment and survival and increases the chance of a full recovery. Our DermaCompare application software is designed to assist
dermatologists and other medical practitioners in diagnosing Melanoma quickly and with less effort.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Moreover,
the use of computerized technologies with our DermaCompare provides an opportunity to compile, process and store data, thereby
creating an extensive database for treating physicians as well as medical researchers. Availability of the data in Internet based
SaaS and cloud networks can also provide cross linking between dermatologists, general physicians and/or oncologists.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
believe that this should help to alleviate the relative limited availability or even complete unavailability of suitable data
in certain regions and for certain populations and may shed light on skin lesion development into Melanoma.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Our
DermaCompare Solution</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
DermaCompare imaging solution is provided as a software platform aimed at early detection of Melanoma based on ABCD Rule for classification
of dermatological lesions as published by the National Institute of Health (&ldquo;NIH&rdquo;) for analysis of moles. The ABCD
Rule is defined as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #262626"><B>A
    &#9679; </B>Asymmetry, a benign mole that is not <B><I>asymmetrical</I></B>;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #262626"><B>B
    </B>&#9679; Border, a benign mole has smooth, even <B><I>borders</I></B>, unlike melanomas;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #262626"><B>C
    </B>&#9679; Color. Most benign moles are all one <B><I>color</I></B>, often a single shade of brown; and</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #262626"><B>D
    <I>&#9679; Diameter</I></B>. </FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #262626"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; color: #262626">Benign
moles usually have a smaller diameter than malignant ones. </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our software
processes and analyzes derma images of skin lesions, moles or total body images. Our DermaCompare imaging software solution is
able to read and extract data from those images and in essence turning digital camera, camera-equipped smart phones and tablets
into virtual scanning devices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
imaging software can be installed on any desktop computer, smart phone or tablet with either iOS or Android operating systems.
The software&rsquo;s imaging capabilities include image recognition, repair and optimization, dynamic data extraction and several
image-specific capabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
proprietary DermaCompare software combines our core image character recognition technology with advanced image processing capabilities
that transform a color skin photograph or total body photograph into a digital image of various sizes and resolutions. Photographs
taken by digital cameras or photographs of skin lesions captured by camera-equipped smart phones and tablets are exposed to variable
lighting conditions and various angles and focal distances. Raw photos of skin lesions taken by a camera-equipped smart phone
or tablet may be of an unknown size and resolution and may often be geometrically distorted, skewed or warped. As a result, an
unedited mobile image of a skin lesion may be virtually unusable without the use of our DermaCompare imaging technology.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
DermaCompare software solution uses advanced algorithms designed to identify and correct geometric and optical distortions and
automatically correct each image, zoom in and manipulate both new and old images simultaneously in a corresponding manner to facilitate
correct and timely diagnosis. In addition, our DermaCompare software is designed to enable dermatologists and other medical practitioners
to review the skin lesion images and digital processing results in a graphical and analytic way.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">These
images can then be stored on our managed cloud-based servers and our licensee/users will be able to safely access their patients&rsquo;
images via mobile access or Internet login. We believe that our central image storage solution insures that images and data are
secured and kept confidential. We are compliant with HIPAA, the United States Health Insurance Portability and Accountability
Act, sets the standard for protecting sensitive patient data. Any company that deals with protected health information must ensure
that all the required physical, network, and process security measures are in place and followed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
includes covered entities, anyone who provides treatment, payment and operations in healthcare, and business associates, anyone
with access to patient information and provides support in treatment, payment or operations. Subcontractors, or business associates
of business associates, must also be in compliance. Emerald has recently been as a HIPAA compliant company and also using the
IBM SoftLayer cloud that already HIPAA compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Practice
and Pricing</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
pricing will be based on a fixed-price model, which fees will be charged directly by the App or collected either by the dermatologists,
other physicians or medical centers. The process will start with the dermatologist or medical center charging the patient for
the total body photography and upload the images through the Internet to a secure, company-owned server. We will invoice the dermatologist
or medical center directly on a monthly, per-patient basis. If a patient is to be found to have Melanoma, our pricing model is
to waive the fee for this particular patient. We believe that this should serve to incentivize physicians to use our DermaCompare
software and encourage patient acceptance of its use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
physician/licensees can add new patient accounts to their online account and, at present, our pricing model contemplates that
each patient registration will cost US$95 annually.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
will offer our dermatologist/licensees unlimited access to their patients&rsquo; images during the one-year period. Each registered
patient will also receive a user and password to enable secure access to his/her images through the website or mobile access and
enable any other physician to review the images with that patient&rsquo;s consent (&ldquo;2nd opinion&rdquo; model).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
believe that our pricing strategy should make us competitive and is based on the fact that we do not plan on being directly engaged
with the end-user and taking and transmitting images to the server. Our strategy is to provide imaging software as a service to
dermatologists and medical centers that analyze their own patient&rsquo;s images.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Maintenance
and Product Support </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
plan to provide ongoing software support services to assist our medical professional licensees with answers to technical questions
and will also maintain customer service department for support with respect to DermaCompare software installation and system maintenance.
The majority of the inquiries that we expect to receive will be handled by us via telephone and email. We will maintain our licensees&rsquo;
software largely through online releases via the Internet that may be downloaded by our licensees with technology enhancements
and updated software features. We plan to offer our licensees post-contract support. All of these services are expected to generate
significant recurring revenues and shall be typically offered under contract on an annual basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Maintenance
and support service fees will be deferred and recognized over the contract period on a straight-line basis. Costs incurred by
us to provide maintenance and support services will be charged to cost of revenue as incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Intellectual
Property</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
success will in large part depend upon our ability to protect our proprietary DermaCompare technology. We plan to protect our
intellectual property rights primarily through patents, copyrights, trademarks, trade secrets, employee and third party nondisclosure
agreements and other measures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
we are unable to protect our intellectual property or our intellectual property infringes, for any reason that we do not presently
contemplate, on the intellectual property rights of a third party, our operating results would, in all likelihood be materially,
adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">To
date, we have not filed for domestic and international patents. Further, we have no registered trademarks, but will continue to
evaluate advisability and the costs associated with the registration of trademarks as our management deems appropriate, from time
to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Sales
and Marketing Strategy</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
sales and marketing plan is to sell licenses for our DermaCompare imaging software to: NHSs, HMOs, health insurance companies,
hospitals and medical clinics through distributers, health care channel partners or directly through independent salespersons
and/or web purchase to dermatologists and other physicians (GPs) that we expect to purchase licenses based on the number of potential
numbers of patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Initially,
our marketing strategy for our product is based on a pilot program with worldwide leading dermatologists and medical centers in
Israel and Europe in order to improve our DermaCompare software application further.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subsequently,
we plan to market our product worldwide through channel partners, via the Internet as well as through our direct sales force.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
intent to have an internal marketing group that develops our product marketing strategies and executes marketing plans with the
support of external resources as needed. We will employ a technically oriented sales force that works with management to identify
prospective customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
indirect sales strategy concentrates on distributors and software solution companies that build, integrate and sell software solutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
direct sales strategy will concentrate on health insurance companies, NHS, HMOs, medical centers, dermatologists and other physicians
that want to provide our software to their patients. Our sales process will additionally be supported by a broad range of marketing
programs, including trade shows, public relations and digital advertising.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In addition,
we plan to utilize the following low-cost methods in order to maximize our marketing budget, such as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;Internet
    promotion to support public relationships.</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;Publicity
    adds at pools, golf clubs and beaches.</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;Collaborating
    with leading companies that manufacture sun-screen lotions, swimming-suits, etc. </FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;Taking
    advantage of public awareness at special opportunities through product placements.</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;Social
    networking, utilizing web sites for PR needs.</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;Presentation
    at scientific and medical conferences and highly publicized patient organization meetings.</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Competition</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
market for derma image processing software products is intensely competitive, subject to rapid change, and significantly affected
by new product introductions and other market activities of industry participants. We face direct and indirect competition from
a broad range of competitors who offer a variety of competitive products and solutions to our target markets. Our principal competition
will come from: (i) manufacturers of custom-developed solutions; (ii) companies offering automated derma imaging processing systems;
and (iii) companies offering competing technologies capable of recognizing and analyzing derma images. Many, if not all of these
competing companies will have far greater financial and other resources, established name recognition and lengthy operating histories,
any of which could make it difficult for us to compete effectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">It
is also possible that we will face competition from new industry participants and/or alternative technologies. Moreover, as the
market for derma imaging software further evolves and develops, a number of companies with significantly greater resources than
we have could attempt to enter or increase their presence in our industry, either independently or by acquiring or forming strategic
alliances with our competitors, or otherwise increase their focus on the industry. In addition, current and potential competitors
have established or may establish cooperative relationships among themselves or with third parties to increase the ability of
their products to address the needs of our potential customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
DermaCompare product competes, to various degrees, with products produced by a number of substantial competitors, many of which
have far greater financial and other resources and established operating histories with name recognition. Competition among product
providers in this market generally focuses on price, accuracy, reliability and technical support. We believe our primary competitive
advantages in this market are: (i) flexibility resulting from the ability of our product to operate in Internet based web services
environments; (ii) an architectural software design that allows our product to be more readily modified, improved with added functionality
and configured for new products, thereby allowing our software to be easily upgraded ; and (iii) combined methodologies of &ldquo;Big
Data and wisdom of the crowd&rdquo; (which means <FONT STYLE="color: #0E0E0E">analyzing tens of thousands of electronic medical
records, whereby investigators can uncover new risk factors, novel preventive measures and treatments that are the most effective
for a range of diseases and conditions) </FONT>with machine learning and artificial intelligence together with high end machine
vision capabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
a result, we believe that our DermaCompare software Product should differ substantially from what is currently available in the
market and heretofore has been known as &ldquo;gold standard.&rdquo; Imaging and analytics is a major sector in the medical device
industry and competition is expected to be broad-based and intense. Increased competition may result in price reductions, reduced
gross margins and loss of market share, any of which could have a material adverse effect on our business, operating results and
financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following list of competitors is not intended to be exhaustive, and there are other existing competitors and there likely will
be new potential competitors in the future:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>DermAlert:
</I>The DermAlert software, as presently constituted, is designed to compare images taken by digital camera obtained during a
6 to 12 month period in order to detect new or changing moles through total body photography, by monitoring a specific mole or
moles. We believe that their software, at present, cannot define whether a mole is a new one or not.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Canfield
Scientific:</I> Canfield Scientific provides custom photographic systems, image monitoring and centralized analysis services for
the pharmaceutical, biotechnology and cosmetics industries. Canfield software is a local based installation and is also expensive
to purchase and for this reason is not truly competitive with our DermaCompare software.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>DigitalDerm:
</I>DigitalDerm&rsquo;s MoleMap CD technology is a baseline system for early Melanoma detection. Their technology is unique in
that it combines total body photography and patented software into a CD-based imaging record that runs on any personal computer
with a Windows-based operating system. DigitalDerm&rsquo;s MoleMap CD applies 35 images as a baseline to compare new moles and
moles that are changing or have changed and is based on a local DB, which is considered on older, conventional manually-based
solution, not using the &ldquo;wisdom of the crowd&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>FotoFinder
Systems: </I>FotoFinder Systems&rsquo; Dermoscope is a system for digital dermoscopy, fluorescence diagnosis and standardized
photo documentation in dermatology. We do not believe that any of these technologies are used by or are competitive with our DermaCompare
software</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notwithstanding
our determination that the above-referenced companies are not actual competitors with our DermaCompare technology, they all have
substantially far greater capital, marketing, personnel and other resources, and greater experience in commercializing products
and services than we have.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Government
Regulation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company&rsquo;s DermaCompare software Product and systems are not subject to FDA or other governmental approval. Any change in
current regulatory requirements or related interpretations by or the positions of, governmental agencies, federal or state officials
where we plan to market out product could adversely affect our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Employees</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
Liron Carmel, CEO and director, and Mr. Oded Gilboa, CFO, constitute our Management team. Mr. Yair Fudim is the Chairman of our
board of directors. They are not obligated to contribute any specific number of hours per week to our operations and intend to
devote only as much time as they deem necessary to the Company&rsquo;s affairs until such time that we begin marketing our products
and generate revenues. The Registrant has entered into an employment agreement with Mr. Oded Gilboa, and Emerald has entered into
employment agreements with Lior Wayn and with Oded Gilboa, Emerald&rsquo;s CEO and CFO, respectively. Each of these employment
agreements are attached as exhibits hereto. Reference is made to the disclosure under Item 6. &ldquo;Executive Compensation&rdquo;
which contains a summary of the material terms of the respective employment agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">At present,
Emerald has 10 employees including its CEO, Lior Wayn.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I><U>Summary
of Risk Factors</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">An
investment in our Shares involves substantial risk. Our ability to execute our strategy is also subject to certain risks. The
risks described under the heading &ldquo;Risk Factors&rdquo; included elsewhere in this Current Report may cause us not to realize
the full benefits of our business plan and strategy or may cause us to be unable to successfully execute all or part of our strategy.
Some of the most significant challenges and risks include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
    Independent Registered Public Accounting Firm has expressed substantial doubt as to our ability to continue as a going concern;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
    limited operating history does not afford investors a sufficient history on which to base an investment decision;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
    revenues will be dependent upon acceptance of DermaCompare by the market. The failure of such acceptance will cause us to
    curtail or cease operations;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
    cannot be certain that we will obtain patents for DermaCompare and technology or that such patents will protect us from competitor;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    availability of a large number of authorized but unissued shares of Common Stock may, upon their issuance, lead to dilution
    of existing stockholders; and</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
    Common Stock is thinly traded, sale of your holding may take a considerable amount of time.</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I><U>Our
Filing Status as a &ldquo;Smaller Reporting Company&rdquo;</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
are a &ldquo;smaller reporting company,&rdquo; meaning that we are not an investment company, an asset-backed issuer, or a majority-owned
subsidiary of a parent company that is not a smaller reporting company and have a public float of less than $75 million and annual
revenues of less than $50 million during the most recently completed fiscal year. As a &ldquo;smaller reporting company,&rdquo;
the disclosure we will be required to provide in our SEC filings are less than it would be if we were not considered a &ldquo;smaller
reporting company.&rdquo; Specifically, &ldquo;smaller reporting companies&rdquo; are able to provide simplified executive compensation
disclosures in their filings; are exempt from the provisions of Section 404(b) of the Sarbanes-Oxley Act of 2002 requiring that
independent registered public accounting firms provide an attestation report on the effectiveness of internal control over financial
reporting; are not required to conduct say-on-pay and frequency votes until annual meetings occurring on or after January 21,
2013; and have certain other decreased disclosure obligations in their SEC filings, including, among other things, being permitted
to provide two years of audited financial statements in annual reports rather than three years. Decreased disclosures in our SEC
filings due to our status as a &ldquo;smaller reporting company&rdquo; may make it harder for investors to analyze the Company&rsquo;s
results of operations and financial prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Item
1A. Risk Factors</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">RISK
FACTORS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>The
shares of our Common Stock are highly speculative in nature, involve a high degree of risk and should be purchased only by persons
who can afford to lose their entire amount invested in the Common Stock. Accordingly, prospective investors should carefully consider,
along with other matters referred to herein, the following risk factors in evaluating our business before purchasing any shares
of Common Stocks. If any of the following risks actually occurs, our business, financial condition or operating results could
be materially adversely affected. In such case, you may lose all or part of your investment. You should carefully consider the
risks described below and the other information in this Current Report on Form 8-K before investing in our Common Stock.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Risks
Associated With Our Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Our
Independent Registered Public Accounting Firm has expressed substantial doubt as to our ability to continue as a going concern.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
audited financial statements have been prepared assuming that we will continue as a going concern and do not include any adjustments
that might result if we cease to continue as a going concern. We believe that in order to continue as a going concern, including
the costs of being a public company, we will need approximately $30,000 per year simply to cover the administrative, legal and
accounting fees. We have funded these losses primarily through the sale of restricted shares of our Common Stock and the issuance
of convertible notes, which have subsequently been converted into restricted shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Based
on our financial statements for the years ended December 31, 2014 and 2013, our independent registered public accounting firm
has expressed substantial doubt as to our ability to continue as a going concern. To date we have not generated any revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notwithstanding
our success in raising over $800,000 from the sale of our securities principally during the first quarter of 2015, there can be
no assurance that we will have adequate capital resources or be able to continue to raise equity and/or debt capital to fund planned
operations or that any additional funds will be available to us when needed or at all, or, if available, will be available on
favorable terms or in amounts required by us. If we are unable to obtain adequate capital resources to fund operations, we may
be required to delay, scale back or eliminate some or all of our plan of operations, which may have a material adverse effect
on our business, results of operations and ability to operate as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Our
limited operating history does not afford investors a sufficient history on which to base an investment decision.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Emerald,
our wholly-owned subsidiary, is a private limited liability company incorporated under the laws of the State of Israel on February
17, 2010, and its DermaCompare was only fully launched at the beginning of 2015 and has only recently commenced marketing DermaCompare
and are therefore in the very early stages of our marketing plan for Derma Compare. There can be no assurance at this time that
we will be able to operate profitably or that we will have adequate working capital to meet our obligations as they become due.
Investors must consider the risks and difficulties frequently encountered by early stage companies, particularly in rapidly evolving
markets. Such risks include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">competition;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">need
    for acceptance of our product - there can be no assured market for our product and there is no guarantee of orders or of physicians
    or patient acceptance;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ability
    to develop a brand identity;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ability
    to anticipate and adapt to a competitive market;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ability
    to effectively manage rapidly expanding operations;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">amount
    and timing of operating costs and capital expenditures relating to expansion of our business, operations, and infrastructure;
    and</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">dependence
    upon key personnel to market and sell our product and the loss of one of our key managers may adversely affect the marketing
    of our product.</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
cannot be certain that our business strategy will be successful or that we will successfully address these risks. In the event
that we do not successfully address these risks, our business, prospects, financial condition, and results of operations could
be materially and adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>DermaCompare
may not be accepted in the marketplace. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Uncertainty
exists as to whether our DermaCompare product will be accepted by the market without additional widespread doctor acceptance.
A number of factors may limit the market acceptance of our DermaCompare product, including the availability of alternative products
and the price of our DermaCompare product relative to alternative products. There is a risk that dermatologists or other physicians
will be encouraged to continue to use other products and/or methods instead of ours. We are assuming that, notwithstanding the
fact that our DermaCompare product is new in the market, dermatologists or other physicians will elect to use DermaCompare because
it will permit to safe valuable physician&rsquo;s time and more subjective analysis. While we intend to continue to build and
gather data to demonstrate the benefit of our DermaCompare product, this data gathering may not be conclusive or may be viewed
as insufficient by potential users such as dermatologists and other physicians.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Patients
have to be persuaded that a certain level of intense self-imaging is justified for the anticipated benefit, but there is no assurance
that sufficient numbers of patients will be convinced to enable a successful market to develop for our product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Our
revenues will be dependent upon acceptance of our DermaCompare product by the market. The failure of such acceptance will cause
us to curtail or cease operations.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
revenues are expected to come from the sale of our one DermaCompare product. As a result, we will continue to incur operating
losses until such time as sales of our DermaCompare product reaches a mature level and we are able to generate sufficient revenues
from the sale of our DermaCompare product to meet our operating expenses. There can be no assurance that dermatologists or other
physicians will adopt our DermaCompare product. In the event that we are not able to market and significantly increase the number
of dermatologists or other physicians that purchase our DermaCompare product, or if we are unable to charge the necessary prices,
our financial condition and results of operations will be materially and adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Defects
or malfunctions in our product could hurt our reputation, sales and profitability. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
business and the level of customer acceptance of our DermaCompare product depend upon the effective and reliable operation of
our one DermaCompare product. Our DermaCompare product is complex and is continually being modified and improved, and as such
may contain undetected defects or errors when first introduced or as new versions are released. To the extent that defects or
errors cause our DermaCompare product to malfunction and our customers&rsquo; use of our DermaCompare product is interrupted,
our reputation could suffer and our potential revenues could decline or be delayed while such defects are remedied. We may also
be subject to liability for the defects and malfunctions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">There
can be no assurance that, despite our testing, errors will not be found in our DermaCompare product or new releases, resulting
in loss of future revenues or delay in market acceptance, diversion of development resources, damage to our reputation, adverse
litigation, or increased service and warranty costs, any of which would have a material adverse effect upon our business, operating
results and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Software
failures, breakdowns in the operations of our servers and communications systems or the failure to implement system enhancements
could harm our business.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
success depends on the efficient and uninterrupted operation of our servers and communications systems. A failure of our network
or data gathering procedures could impede the processing of data, delivery of databases and services, client data and day-to-day
management of our business and could result in the corruption or loss of data. While all of our operations will have disaster
recovery plans in place, they might not adequately protect us. Despite any precautions we take, damage from fire, floods, hurricanes,
power loss, telecommunications failures, computer viruses, break-ins and similar events at our computer facilities could result
in interruptions in the flow of data to our servers and from our servers to our clients. In addition, any failure by our computer
environment to provide our required data communications capacity could result in interruptions in our service. In the event of
a server failure, we could be required to transfer our client data collection operations to an alternative provider of server
hosting services. Such a transfer could result in delays in our ability to deliver our products and services to our clients. Additionally,
significant delays in the planned delivery of system enhancements, improvements and inadequate performance of the systems once
they are completed could damage our reputation and harm our business. Long-term disruptions in the infrastructure caused by events
such as natural disasters, the outbreak of war, the escalation of hostilities and acts of terrorism, particularly involving cities
in which we have offices, could adversely affect our businesses. Although, we plan to carry property and business interruption
insurance for our business operations, our coverage might not be adequate to compensate us for all losses that may occur.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>We
face risks related to the storage of customers&rsquo; and their end users&rsquo; confidential and proprietary information. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
DermaCompare product is designed to maintain the confidentiality and security of our customers&rsquo; and their end users&rsquo;
confidential and proprietary data that are stored on our server systems, which may include sensitive personal data. However, any
accidental or willful security breaches or other unauthorized access to these data could expose us to liability for the loss of
such information, time-consuming and expensive litigation and other possible liabilities as well as negative publicity. Techniques
used to obtain unauthorized access or to sabotage systems change frequently and generally are difficult to recognize and react
to. We may be unable to anticipate these techniques or implement adequate preventative or reactionary measures</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>We
might incur substantial expense to further develop our derma DermaCompare product that, once commercialized, may never become
sufficiently successful.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
growth strategy requires the successful launch of our DermaCompare product. Although management will take every precaution to
ensure that our DermaCompare product will, with a high degree of likelihood, achieve commercial success, there can be no assurance
that this will be the case. The causes for failure of our DermaCompare product once commercialized can be numerous, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">market
    demand for our DermaCompare product proves to be smaller than we expect;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">competitive
    products with superior performance either on the market or commercialized at the same time or soon after;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">further
    DermaCompare product development turns out to be more costly than anticipated or takes longer;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">our
    DermaCompare product requires significant adjustment post commercialization, rendering the DermaCompare product uneconomic
    or extending considerably the likely investment return period;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">additional
    regulatory requirements which extend the time to launch our DermaCompare product increase the overall costs of the development;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">patent
    conflicts or unenforceable intellectual property rights; and</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dermatologists
    and other physicians may be unwilling to adopt and/or use our DermaCompare product.</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Compliance
with changing regulations concerning corporate governance and public disclosure may result in additional expenses. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
recent years, there have been several changes in laws, rules, regulations and standards relating to corporate governance and public
disclosure, including the Dodd-Frank Wall Street Reform and Consumer Protection Act (the &ldquo;Dodd-Frank Act&rdquo;), the Sarbanes-Oxley
Act of 2002 (&ldquo;Sarbanes-Oxley&rdquo;) and various other new regulations promulgated by the SEC and rules promulgated by the
national securities exchanges.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Dodd-Frank Act, enacted in July 2010, expands federal regulation of corporate governance matters and imposes requirements on publicly-held
companies, including us, to, among other things, provide stockholders with a periodic advisory vote on executive compensation
and also adds compensation committee reforms and enhanced pay-for-performance disclosures. While some provisions of the Dodd-Frank
Act were effective upon enactment, others will be implemented upon the SEC&rsquo;s adoption of related rules and regulations.
The scope and timing of the adoption of such rules and regulations is uncertain and accordingly, the cost of compliance with the
Dodd-Frank Act is also uncertain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
addition, Sarbanes-Oxley specifically requires, among other things, that we maintain effective internal control over financial
reporting and disclosure of controls and procedures. In particular, we must perform system and process evaluation and testing
of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over
financial reporting, as required by Section 404 of Sarbanes-Oxley Act (&ldquo;Section 404&rdquo;), and our independent registered
public accounting firm is required to attest to our internal control over financial reporting. Our testing, or the subsequent
testing by our independent registered public accounting firm may reveal deficiencies in our internal control over financial reporting
that are deemed to be material weaknesses. Our compliance with Section 404 will require that we incur substantial accounting expenses
and expend significant management efforts. We currently have limited internal audit capabilities and will need to hire additional
accounting and financial staff with appropriate public company experience and technical accounting knowledge. Moreover, if we
are not able to comply with the requirements of Section 404 in a timely manner, or if we or our independent registered public
accounting firm identifies deficiencies in our internal control over financial reporting that are deemed to be material weaknesses,
the market price of our stock could decline, and we could be subject to sanctions or investigations by the SEC or other regulatory
authorities, which would require additional financial and management resources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">These
and other new or changed laws, rules, regulations and standards are, or will be, subject to varying interpretations in many cases
due to their lack of specificity. As a result, their application in practice may evolve over time as new guidance is provided
by regulatory and governing bodies, which could result in continuing uncertainty regarding compliance matters and higher costs
necessitated by ongoing revisions to disclosure and governance practices. Our efforts to comply with evolving laws, regulations
and standards are likely to continue to result in increased general and administrative expenses and a diversion of management
time and attention from revenue-generating activities to compliance activities. Further, compliance with new and existing laws,
rules, regulations and standards may make it more difficult and expensive for us to maintain director and officer liability insurance,
and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. Members of our board
of directors and our principal executive officer and principal financial officer could face an increased risk of personal liability
in connection with the performance of their duties. As a result, we may have difficulty attracting and retaining qualified directors
and executive officers, which could harm our business. We continually evaluate and monitor regulatory developments and cannot
estimate the timing or magnitude of additional costs we may incur as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>We
cannot be certain that we will obtain patents for our DermaCompare product and technology or that such patents will protect us
from competitors.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
believe that our success and competitive position will depend in part on our ability to obtain and maintain patents for our DermaCompare
product, which is both costly and time consuming. We still are in the process to evaluate the patent potentials of our DermaCompare
product. Patent Offices typically requires 12-24 months or more to process a patent application. There can be no assurance that
any of our potential patent applications will be approved. However, we have decided to launch our DermaCompare product without
patent protection. There can be no assurance that any potential patent issued or licensed to us will provide us with protection
against competitive products, protect us against changes in industry trends which we have may not have anticipated or otherwise
protect the commercial viability of our product, or that challenges will not be instituted against the validity or enforceability
of any of our future patents or, if instituted, that such challenges will not be successful. The cost of litigation to uphold
the validity of a patent and enforce it against infringement can be substantial. Even issued patents may later be modified or
revoked by the Patent and Trademark Office or in legal proceedings. Patent applications in the United States are maintained in
secrecy until the patent issues and, since publication of patents tends to lag behind actual discoveries, we cannot be certain
that if we obtain patents for our product, we were the first creator of the inventions covered by a pending patent applications
or the first to file patent applications on such inventions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>DermaCompare
product liability is inherent in the medical devices industry and insurance is expensive and difficult to obtain, we may be exposed
to large lawsuits.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
business exposes us to potential product liability risks, which are inherent in the marketing and sale of medical devices. While
we will take precautions we deem to be appropriate to avoid product liability suits against us, there can be no assurance that
we will be able to avoid significant product liability exposure. DermaCompare product liability insurance for the medical products
industry is generally expensive. We plan to obtain product liability professional indemnity insurance coverage for our DermaCompare
product. There can be no assurance that we will be able to obtain such coverage on acceptable terms, or that any insurance policy
will provide adequate protection against potential claims. A successful product liability claim brought against us may exceed
any insurance coverage secured by us and could have a material adverse effect on our results or ability to continue marketing
our product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
also plan to obtain Directors and Officers Liability Insurance and certain commercial liability and personal property insurance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
may have to establish a reserve funds for potential warranty claims. If we experience warranty claims or if our repair and replacement
costs associated with warranty claims will increase significantly, it would have a material adverse effect on our financial condition
and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>We
may need to raise additional capital to fund continuing operations and an inability to raise the necessary capital or to do so
on acceptable terms could threaten the success of our business. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
currently anticipate that our available capital resources and operating cash flows will be sufficient to meet our expected working
capital and capital expenditure requirements for at least the next 12 months. However, such resources may not be sufficient to
fund the long-term growth of our business. If we determine that it is necessary to raise additional funds, we may choose to do
so through strategic collaborations, licensing arrangements, public or private equity or debt financing, a bank line of credit,
or other arrangements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
cannot be sure that any additional funding, if needed, will be available on terms favorable to us or at all. Furthermore, any
additional equity or equity-related financing may be dilutive to our stockholders, new equity securities may have rights, preferences
or privileges senior to those of existing holders of our shares of common stock, and debt or equity financing, if available, may
subject us to restrictive covenants and significant interest costs. If we obtain funding through a strategic collaboration or
licensing arrangement, we may be required to relinquish our rights to our product or marketing territories. If we are unable to
obtain the financing necessary to support our operations, we may be required to defer, reduce or eliminate certain planned expenditures
or significantly curtail our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>We
will need to increase the size of our organization, and may experience difficulties in managing growth.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">At
present, we are a small company. We expect to experience a period of expansion in headcount, infrastructure and overhead and anticipate
that further expansion will be required to address potential growth and market opportunities. Future growth will impose significant
added responsibilities on members of management, including the need to identify, recruit, maintain and integrate new managers.
Our future financial performance and its ability to compete effectively will depend, in part, on its ability to manage any future
growth effectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>The
loss of key personnel could adversely affect our business. We may not be able to hire and retain qualified personnel to support
our growth.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Emerald&rsquo;s
success depends to a significant extent upon the efforts of Mr. Lior Wayn, its CEO, and other key senior employees and other key
personnel. The loss of the services of such personnel could adversely affect our business and our ability to implement our growth
plan. We cannot assure you that the services of the members of our management team will continue to be available to us, or that
we will be able to find a suitable replacement for any of them. We do not have key man insurance on any members of our management
team. If any member of our management team were to die and we are unable to replace either or both of them for a prolonged period
of time, we may be unable to carry out our long term business plan and our future prospect for growth, and our business, may be
harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Also,
because of the nature of our business, our success is dependent upon our ability to attract, train, manage and retain sales, marketing
and other qualified personnel. There is substantial competition for qualified personnel, and an inability to recruit or retain
qualified personnel may impact our ability to implement our strategy to grow our business and compete effectively in our industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
plan to grant stock options or other forms of equity awards in the future as a method of attracting and retaining employees, motivating
performance and aligning the interests of employees with those of our stockholders. As of July 14, 2015, we had 3,202,935 Class
A Warrants and 2,700,000 Class E Warrants outstanding. There are no other options and/or equity awards outstanding under existing
equity compensation agreements or otherwise. If we are unable to adopt, implement and maintain equity compensation arrangements
that provide sufficient incentives, we may be unable to retain our existing employees and attract additional qualified candidates.
If we are unable to retain our existing employees, including qualified technical personnel, and attract additional qualified candidates,
our business and results of operations could be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Some
of our competitors are more established and better capitalized than we are and we may be unable to establish market share.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Some
of our competitors are well known, more established and better capitalized than we are. As such, they may have at their disposal
greater marketing strength and economies of scale and, as they may have additional products which they sell to the same customers,
have greater presence with these customer. They may also have more resources to expend on research and development to create more
innovative products in competition with ours. Competition will also likely increase as or when the cost benefits of the Company&rsquo;s
DermaCompare product are established and proven. Accordingly, we may not be successful in competing with them for market share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>We
may license or collaborate with third parties in various potential markets.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
believe collaboration will allow us to leverage our resources and to access new markets while avoiding the cost of establishing
or maintaining a direct sales force in each market. We may incur significant costs in the use of third parties to identify and
assist in establishing relationships with potential collaborators. We currently have no direct sales force. We plan to sell our
DermaCompare product first in the dermatology market in Israel, and we intend to slowly later expand geographically in the US
and Europe.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">To
penetrate our target markets, we may need to enter into collaborative agreements to assist in the commercialization of our DermaCompare
product. We may choose to license our DermaCompare product for distribution to a third party as opposed to pursuing commercialization
ourselves. Establishing strategic collaborations is difficult and time-consuming. Potential collaborators may reject collaborations
based upon their assessment of our financial or intellectual property position and our internal capabilities. Discussions with
potential collaborators may not lead to the establishment of collaboration agreements on favorable terms and may have the potential
to provide collaborators with access to our key intellectual property. We may have limited control over the amount and timing
of resources that any future collaborators devote to our DermaCompare product. These collaborators may breach or terminate their
agreements with us or otherwise fail to conduct their collaborative activities successfully and in a timely manner. By entering
into collaboration, we may preclude opportunities to collaborate with other third parties who do not wish to associate with our
existing third party strategic partners. Moreover, in the event of termination of a collaboration agreement, termination negotiations
may result in less favorable terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Our
future sales in international markets will subject us to foreign currency exchange and other risks and costs which could harm
our business.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
expect that a substantial portion of our future revenues will be derived from outside Israel; primarily the US and Europe. We
will be subject to the effects of exchange rate fluctuations. Our functional currency is the Israel Shekel. For the preparation
of our consolidated financial statements, the financial results are translated into U.S. dollars using average exchange rates
during the applicable period. If the U.S. dollar appreciates against the Shekel, as applicable, the revenues we recognize from
sales will be adversely impacted. Foreign exchange gains or losses as a result of exchange rate fluctuations in any given period
could harm our operating results and negatively impact our revenues. Additionally, if the effective price of our products were
to increase as a result of fluctuations in foreign currency exchange rates, demand for our DermaCompare products could decline
and adversely affect our results of operations and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
intend not to use hedging strategies to help offset the effect of fluctuations in foreign currency exchange rates. Movements in
foreign currency exchange rates could impact our financial results positively or negatively in one period and not another, making
it more difficult to compare our financial results from period to period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>The
healthcare industry is subject to changing policies and procedures, we may find it difficult to continue to compete in an uncertain
environment.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
health care industry is subject to changing political, economic and regulatory influences that may affect the procurement practices
and operations of healthcare industry participants. During the past several years government regulation of the healthcare industry
has changed significantly in several countries. Healthcare industry participants may react to new policies by curtailing or deferring
use of new products, including our DermaCompare product. This could substantially impair our ability to successfully market our
DermaCompare product, which would have a material adverse effect on our business prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>The
market success of our DermaCompare product may be dependent in part upon third-party reimbursement policies that are often subject
to change. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
ability to successfully penetrate the market with our DermaCompare product may, to some extent, depend on the availability of
reimbursement to individuals for using our DermaCompare product from third-party payers, such as governmental programs, private
insurance and private health plans. There is no guarantee that users of our DermaCompare product get reimbursed or that a change
in the future of levels of reimbursement to individuals and hospitals, if any, will be high enough to allow us to charge a reasonable
profit margin. If levels of reimbursement are decreased in the future, the demand for our DermaCompare product could diminish
or our ability to sell our DermaCompare products on a profitable basis could be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>We
may not be able to successfully expand our business through acquisitions.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
review corporate and product line acquisition candidates as a part of our growth strategy. If we decided to undertake an acquisition,
we may not be able to successfully integrate it in order to realize the full benefit of such acquisition. Factors which may affect
our ability to grow successfully through acquisitions include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">inability
    to identify suitable targets given the relatively narrow scope of our business;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">inability
    to obtain acquisition or additional working capital financing due to our financial condition;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">difficulties
    and expenses in connection with integrating the acquired companies and achieving the expected benefits;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">diversion
    of management&rsquo;s attention from current operations;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">the
    possibility that we may be adversely affected by risk factors facing the acquired companies;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">acquisitions
    could be dilutive to earnings, or in the event of acquisitions made through the issuance of our common shares to the shareholders
    of the acquired company, dilutive to the percentage of ownership of our existing shareholders;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">potential
    losses resulting from undiscovered liabilities of acquired companies not covered by the indemnification we may obtain from
    the seller; and</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">loss
    of key employees of the acquired companies.</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Risks
Related to Our Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Shell
Company Status</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
may still be deemed a &ldquo;Shell&rdquo; company, as that term is defined in Rule 144(i) promulgated by the SEC under the Securities
Act of 1933, as amended (the &ldquo;Act&rdquo;), because Emerald has had only nominal operations to date. Prior to the Closing,
the Registrant was, in fact, a &ldquo;Shell&rdquo; company with no operations and no assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Reliance
upon Rule 144 for Resales</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Shareholders
who hold shares which are not subject to a registration statement under the Act often rely upon Rule 144 for their resale. Rule
144 is not available for the resale of securities initially issued by Shell companies (other than a business combination related
Shell company) or a Registrant that has been, at any time previously, a reporting or non-reporting Shell company, unless the issuer
meets specified conditions. A security holder may resell securities pursuant to Rule 144&rsquo;s safe harbor if the following
conditions are met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">a)
The issuer of securities that was formerly a reporting or non-reporting Shell company has ceased to be a Shell&#894;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">b)
The issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of
1934 (the &ldquo;Exchange Act&rdquo;)&#894;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">c)
The issuer of the securities has filed all reports and material required to be filed under Section 13 or 15(d) of the Exchange
Act, as applicable, during the preceding 12 months (or for such shorter period that the issuer was required to filed such reports
and materials), other than Form 8K reports&#894; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">d)
At least one year has elapsed from the time the issuer filed current Form 10 type information with the SEC reflecting its status
as an entity that is not a Shell company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Form
8-K Requirements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Form
8-K requires disclosure of transactions involving a reporting Shell company that ceases to be a Shell company, typically involving
a reverse merger or acquisition. The issuer is required to file a report on Form 8-K to report the following: a material definitive
agreement under Item 1.01 of Form 8-K&#894; completion of acquisition or disposition of assets under Item 2.01 of Form 8-K (<I>which
is the purpose of the Registrant filing this Form 8-K</I>)&#894; changes in control under Item 5.01 of Form 8-K&#894; and information
that would be required in a registration statement on Form 10 to register a class of securities under Section 12 of the Exchange
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Form
S-8</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Form
S-8 under the Securities Act prohibits companies who are Shell Companies from using Form S-8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
a company ceases to be a Shell company, it may use Form S-8 sixty calendar days after the company files &ldquo;Form 10 information,&rdquo;
which is information that a company would be required to file in a registration statement on Form 10 if it were registering a
class of securities under Section 12 of the Exchange Act. This information would normally be reported on a current report on Form
8K reporting the completion of a transaction that caused the company to cease being a Shell company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Reduced
Liquidity or Illiquidity of our Common Stock Securities</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
common stock is currently subject to quotation on the OTCBQ market. There is currently no active trading market in our common
stock on the OTCBQ market. Shareholders who invested in our shares of common stock while we are deemed to be a Shell company invested
in securities that are considered to be illiquid and can&rsquo;t be sold pursuant to the exemption provided under Rule 144 as
long as the Company is a Shell company.</FONT><BR>
<BR></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
a result of our classification as a shell company, our investors are not allowed to rely on the &ldquo;safe harbor&rdquo; provisions
of Rule 144, promulgated pursuant to the Securities Act of 1933, so as not to be considered underwriters in connection with the
sale of our securities until one year from the date that we cease to be a shell company. This will likely make it more difficult
for us to attract additional capital through subsequent unregistered offerings because purchasers of securities in such unregistered
offerings will not be able to resell their securities in reliance on Rule 144, a safe harbor on which holders of restricted securities
usually rely to resell securities. Additionally, as we may not register our securities on Form S-8 this may result in our inability
to compensate employees and consultants as cost-effectively as companies that are not Shells, which may then have an adverse affect
on the ongoing operations of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Shares
issuable upon the conversion of warrants may substantially increase the number of Shares available for sale in the public market
and depress the price of our stock.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
of July 14, 2015, we had outstanding: (i) Class A Warrants exercisable to purchase 3,202,935Shares at a weighted average exercise
price of approximately $0.80 per Share for two years; and (ii) Class E Warrants exercisable to purchase 2,700,000 Shares, in three
equal tranches of 900,000 Shares, at an exercise price of $0.0001 per Share. To the extent any of these warrants are exercised
and any additional warrants or options are granted and subsequently exercised, there will be further dilution to stockholders
and investors. Until the options and warrants expire, these holders will have an opportunity to profit from any increase in the
market price of our Shares without assuming the risks of ownership. Holders of options and warrants may convert or exercise these
securities at a time when we could obtain additional capital on terms more favorable than those provided by the options or warrants.
The exercise of the options and warrants will dilute the voting interest of the owners of presently outstanding shares by adding
a substantial number of additional shares of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
have reserved Shares of Common Stock for issuance upon the exercise of the warrants and may increase the Shares reserved for these
purposes in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
shares of our common stock which are issuable upon the exercise of outstanding warrants and options may be sold in the public
market pursuant to Rule 144, if applicable. The sale of our common stock issued or issuable upon the exercise of the warrants
and options described above, or the perception that such sales could occur, may adversely affect the market price of our common
stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>We
are subject to compliance with securities law, which exposes us to potential liabilities, including potential rescission rights.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
have offered and sold our Common Stock to investors pursuant to certain exemptions from the registration requirements of the Securities
Act of 1933, as well as those of various state securities laws. The basis for relying on such exemptions is factual; that is,
the applicability of such exemptions depends upon our conduct and that of those persons contacting prospective investors and making
the offering. We have not received a legal opinion to the effect that any of our prior offerings were exempt from registration
under any federal or state law. Instead, we have relied upon the operative facts as the basis for such exemptions, including information
provided by investors themselves.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
any prior offering did not qualify for such exemption, an investor would have the right to rescind its purchase of the securities
if it so desired. It is possible that if an investor should seek rescission, such investor would succeed. A similar situation
prevails under state law in those states where the securities may be offered without registration in reliance on the partial preemption
from the registration or qualification provisions of such state statutes. If investors were successful in seeking rescission,
we would face severe financial demands that could adversely affect our business and operations. Additionally, if we did not in
fact qualify for the exemptions upon which it has relied, we may become subject to significant fines and penalties imposed by
the SEC and state securities agencies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Our
Executive Officers, Directors and the Chief Executive Officer of Emerald own over 41.96% of our common stock and may be able to
influence the outcome of stockholder votes and their interests may differ from other stockholders.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
of July 14, 2015, our executive officers and the executive officer of Emerald beneficially own 5,660,545 Shares of our Common
Stock representing approximately 41.96% of our outstanding Shares, excluding Shares underlying the Class E Warrants, the exercise
of which are subject to certain Milestones which are not expected to be reached within 60 days. Subject to any fiduciary duties
owed to our other stockholders under Delaware law, these stockholders may be able to exercise significant influence over matters
requiring stockholder approval, including the election of directors and approval of significant corporate transactions, and will
have some control over our management and policies. Some of these persons may have interests that are different from yours. For
example, these stockholders may support proposals and actions with which you may disagree. The concentration of ownership could
delay or prevent a change in control of the Company or otherwise discourage a potential acquirer from attempting to obtain control
of the Company, which in turn could reduce the price of our stock. In addition, these stockholders could use their voting influence
to maintain our existing management and directors in office, delay or prevent changes in control of the Company, or support or
reject other management and board proposals that are subject to stockholder approval, such as amendments to our employee stock
plans and approvals of significant financing transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>The
availability of a large number of authorized but unissued shares of Common Stock may, upon their issuance, lead to dilution of
existing stockholders.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
are authorized to issue 490,000,000 shares of Common Stock, $0.0001 par value per share, of which, as of July 14, 2015, 13,489,905
Shares of Common Stock were issued and outstanding. Additional shares may be issued by our board of directors without further
stockholder approval. The issuance of large numbers of shares, possibly at below market prices, is likely to result in substantial
dilution to the interests of other stockholders. In addition, issuances of large numbers of shares may adversely affect the market
price of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
Certificate of Incorporation authorizes 10,000,000 shares of preferred stock, $0.0001 par value per share of which none were issued
and outstanding as of the date of this Form 8-K. The board of directors is authorized to provide for the issuance of these unissued
shares of preferred stock in one or more series, and to fix the number of shares and to determine the rights, preferences and
privileges thereof. Accordingly, the board of directors may issue preferred stock which may convert into large numbers of shares
of Common Stock and consequently lead to further dilution of other shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>We
have never paid cash dividends and do not anticipate doing so in the foreseeable future.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
have never declared or paid cash dividends on our common shares. We currently plan to retain any earnings to finance the growth
of our business rather than to pay cash dividends. Payments of any cash dividends in the future will depend on our financial condition,
results of operations and capital requirements, as well as other factors deemed relevant by our board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Our
Common Stock is subject to the &ldquo;Penny Stock&rdquo; rules of the SEC and the trading market in our stock is limited, which
makes transactions in our stock cumbersome and may reduce the value of an investment.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Securities and Exchange Commission has adopted Rule 15g-9 which establishes the definition of a &ldquo;penny stock,&rdquo; for
the purposes relevant to us, as any equity security that has a market price of less than $5.00 per share or with an exercise price
of less than $5.00 per share, subject to certain exceptions. For any transaction involving a penny stock, unless exempt, the rules
require:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">That a broker
    or dealer approve a person&rsquo;s account for transactions in penny stocks; and</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    broker or dealer receives from the investor a written agreement to the transaction, setting forth the identity and quantity
    of the penny stock to be purchased.</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In order
to approve a person&rsquo;s account for transactions in penny stocks, the broker or dealer must:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Obtain financial
    information and investment experience objectives of the person; and</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Make
    a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient
    knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the Commission
relating to the penny stock market, which, in highlight form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Sets
    forth the basis on which the broker or dealer made the suitability determination; and</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;That
    the broker or dealer received a signed, written agreement from the investor prior to the transaction.</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Generally,
brokers may be less willing to execute transactions in securities subject to the &ldquo;penny stock&rdquo; rules. This may make
it more difficult for investors to dispose of our Common Stock and cause a decline in the market value of our stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Disclosure
also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the
commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and the
rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to
be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny
stocks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Financial
Industry Regulatory Authority, Inc. (&ldquo;FINRA&rdquo;) sales practice requirements may limit a shareholder&rsquo;s ability
to buy and sell our Common Stock.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
addition to the &ldquo;penny stock&rdquo; rules described above, FINRA has adopted rules that require that in recommending an
investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that
customer. Prior to recommending speculative low priced securities to their non-institutional customers, broker-dealers must make
reasonable efforts to obtain information about the customer&rsquo;s financial status, tax status, investment objectives and other
information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low priced
securities will not be suitable for at least some customers. FINRA requirements make it more difficult for broker-dealers to recommend
that their customers buy our Common Stock, which may limit your ability to buy and sell our stock and have an adverse effect on
the market for our shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Our
stock is thinly traded, sale of your holding may take a considerable amount of time.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
shares of our Common Stock are thinly-traded on the OTCQB Market, meaning that the number of persons interested in purchasing
our Common Stock at or near bid prices at any given time may be relatively small or non-existent. As a consequence, there may
be periods of several days or more when trading activity in our shares is minimal or non-existent, as compared to a seasoned issuer
which has a large and steady volume of trading activity that will generally support continuous sales without an adverse effect
on share price. We cannot give you any assurance that a broader or more active public trading market for our Common Stock will
develop or be sustained, or that current trading levels will be sustained. Due to these conditions, we can give you no assurance
that you will be able to sell your shares at or near bid prices or at all if you need money or otherwise desire to liquidate your
shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Shares
eligible for future sale may adversely affect the market. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">From
time to time, certain of our stockholders may be eligible to sell all or some of their shares of Common Stock by means of ordinary
brokerage transactions in the open market pursuant to Rule 144 promulgated under the Securities Act, subject to certain limitations.
In general, pursuant to amended Rule 144, non-affiliate stockholders may sell freely after six months subject only to the current
public information requirement. Affiliates may sell after six months subject to the Rule 144 volume, manner of sale (for equity
securities), current public information and notice requirements. Any substantial sales of our Common Stock pursuant to Rule 144
may have a material adverse effect on the market price of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>If
we fail to maintain effective internal controls over financial reporting, the price of our Common Stock may be adversely affected.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
internal control over financial reporting may have weaknesses and conditions that could require correction or remediation, the
disclosure of which may have an adverse impact on the price of our Common Stock. We are required to establish and maintain appropriate
internal controls over financial reporting. Failure to establish those controls, or any failure of those controls once established,
could adversely affect our public disclosures regarding our business, prospects, financial condition or results of operations.
In addition, management&rsquo;s assessment of internal controls over financial reporting may identify weaknesses and conditions
that need to be addressed in our internal controls over financial reporting or other matters that may raise concerns for investors.
Any actual or perceived weaknesses and conditions that need to be addressed in our internal control over financial reporting or
disclosure of management&rsquo;s assessment of our internal controls over financial reporting may have an adverse impact on the
price of our Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>We
are required to comply with certain provisions of Section 404 of the Sarbanes-Oxley Act of 2002 and if we fail to comply in a
timely manner, our business could be harmed and our stock price could decline.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Rules
adopted by the SEC pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 require an annual assessment of internal controls
over financial reporting, and for certain issuers an attestation of this assessment by the issuer&rsquo;s independent registered
public accounting firm. The standards that must be met for management to assess the internal controls over financial reporting
as effective are evolving and complex, and require significant documentation, testing, and possible remediation to meet the detailed
standards. We expect to incur expenses and to devote resources to Section 404 compliance on an ongoing basis. It is difficult
for us to predict how long it will take or costly it will be to complete the assessment of the effectiveness of our internal control
over financial reporting for each year and to remediate any deficiencies in our internal control over financial reporting. As
a result, we may not be able to complete the assessment and remediation process on a timely basis. In addition, although attestation
requirements by our independent registered public accounting firm are not presently applicable to us, we could become subject
to these requirements in the future and we may encounter problems or delays in completing the implementation of any resulting
changes to internal controls over financial reporting. In the event that our Chief Executive Officer or Chief Financial Officer
determine that our internal control over financial reporting is not effective as defined under Section 404, we cannot predict
how the market prices of our shares will be affected; however, we believe that there is a risk that investor confidence and share
value may be negatively affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Our
share price could be volatile and our trading volume may fluctuate substantially.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
price of our common shares has been and may in the future continue to be extremely volatile, with the sale price fluctuating from
a low of $0.44 to a high of $2.24 since 2012. Many factors could have a significant impact on the future price of our common shares,
including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">our
    inability to raise additional capital to fund our operations, whether through the issuance of equity securities or debt;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">our
    failure to successfully implement our business objectives and strategic growth plans;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">compliance
    with ongoing regulatory requirements;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">market
    acceptance of our product;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">changes
    in government regulations;</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">general
    economic conditions and other external factors; and</FONT></td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">actual
    or anticipated fluctuations in our quarterly financial and operating results; and the degree of trading liquidity in our common
    shares.</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Our
annual and quarterly results may fluctuated greatly, which may cause substantial fluctuations in our common stock price. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
annual and quarterly operating results may in the future fluctuate significantly depending on factors including the timing of
purchase orders, new product releases by us and other companies, gain or loss of significant customers, price discounting of our
product, the timing of expenditures, product delivery requirements and economic conditions. Revenues related to our product are
required to be recognized upon satisfaction of all applicable revenue recognition criteria. The recognition of revenues from our
product is dependent on a number of factors, including, but not limited to, the terms of any license agreement and the timing
of implementation of our products by our customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any
unfavorable change in these or other factors could have a material adverse effect on our operating results for a particular quarter
or year, which may cause downward pressure on our common stock price. We expect quarterly and annual fluctuations to continue
for the foreseeable future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Delaware
law contains provisions that could discourage, delay or prevent a change in control of our company, prevent attempts to replace
or remove current management and reduce the market price of our stock. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Provisions
in our certificate of incorporation and bylaws may discourage, delay or prevent a merger or acquisition involving us that our
stockholders may consider favorable. For example, our certificate of incorporation authorizes our board of directors to issue
up to ten million shares of &ldquo;blank check&rdquo; preferred stock. As a result, without further stockholder approval, the
board of directors has the authority to attach special rights, including voting and dividend rights, to this preferred stock.
With these rights, preferred stockholders could make it more difficult for a third party to acquire us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
are also subject to the anti-takeover provisions of the DGCL. Under these provisions, if anyone becomes an &ldquo;interested stockholder,&rdquo;
we may not enter into a &ldquo;business combination&rdquo; with that person for three years without special approval, which could
discourage a third party from making a takeover offer and could delay or prevent a change in control of us. An &ldquo;interested
stockholder&rdquo; is, generally, a stockholder who owns 15% or more of our outstanding voting stock or an affiliate of ours who
has owned 15% or more of our outstanding voting stock during the past three years, subject to certain exceptions as described
in the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Management&rsquo;s
Discussion and Analysis of Financial Conditions and Plan of Operations</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>The
following plan of operation provides information which management believes is relevant to an assessment and understanding of our
results of operations and financial condition. The discussion should be read along with our financial statements and notes thereto.
This section includes a number of forward-looking statements that reflect our current views with respect to future events and
financial performance. Forward-looking statements are often identified by words like believe, expect, estimate, anticipate, intend,
project and similar expressions, or words which, by their nature, refer to future events. You should not place undue certainty
on these forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties that could
cause actual results to differ materially from our predictions.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Overview</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
are a digital health startup company engaged in the development, sale and service of imaging solutions utilizing our proprietary
DermaCompare software that we developed for use in derma imaging and analytics (our &ldquo;DermaCompare&rdquo; or &ldquo;Product&rdquo;).
In our development of the DermaCompare technology, we utilized the knowledge learned from advanced military image processing and
data analytics to improve the analysis of medical images for the benefit of patients and the medical community. We believe that
our proprietary DermaCompare software represents an advancement in skin cancer screening that should enable physicians to more
readily identify and monitor changes in their patients&rsquo; skin characteristics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DermaCompare
is Emerald&rsquo;s first application of its technology, which we believe represents an advance in the early detection of skin
cancer. DermaCompare is based on automated image analytics software using advanced algorithms for alignment, anchoring, identifying
and detecting changes in the shapes, colors and sizes of skin lesions, which could potentially become Melanoma. We apply our DermaCompare
technology in image capture, correction and intelligent data extraction in the market for derma imaging products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
DermaCompare solution allows dermatologists and other medical care professionals, using a set of 25 total body photography (&ldquo;TBP&rdquo;),
to capture sets of skin lesion images with, among other devices, digital cameras, camera-equipped smart phones or tablets. These
images are then transmitted online and are remotely analyzed by professionals using our DermaCompare software.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
DermaCompare imaging software has 2 main modules:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">A
    SaaS cloud-based Dr. Module that can be launched on any desktop computer connected to the Internet; or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mobile
    APP for mass population uses can be installed on smart phones or tablets with iOS or Android operating systems. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
future plans also contemplate the use of wearable computing and imaging devices such as Google glasses or other comparable devices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
sales and marketing plan is to sell licenses for our DermaCompare imaging software to: NHSs, HMOs, health insurance companies,
hospitals and medical clinics through distributers, health care channel partners or directly through independent salespersons
and/or web purchase to dermatologists and other physicians (GPs) that we expect to purchase licenses based on the number of potential
numbers of patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">During
the quarter ended March 31, 2015, we raised $780,000 in equity capital to fund our business plan as part of our commitment in
the above-referenced Share Exchange Agreement to raise $800,000 as a condition to Closing, which we satisfied in April and May
2015. We are a start-up company and we may be expected to require up to an additional $1.5 million<B> </B>in capital during the
next 12 months to implement our business plan and fund our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Results
of Operations during the period ended March 31, 2015 as compared to the period ended March 31, 2014</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
have not generated any revenues during the periods ended March 31, 2015 and 2014. We had operating expenses related to general
and administrative expenses, being a public company and interest expenses. During the period ended March 31, 2015, we incurred
$236,947 in net loss due to general and administrative expenses of $43,936, other expense of $190,000 relating to advances made
to Emerald and interest expense of $3,011.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
February 3, 2015 and March 23, 2015, we advanced/loaned to Emerald $90,000 and $100,000, respectively, in contemplation of the
Closing of the Share Exchange Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Results
of Operations during the year ended December 31, 2014</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
have not generated any revenues during the years 2014 and 2013. We had operating expenses related to general and administrative
expenses, being a public company and interest expenses. During the year ended December 31, 2014, we incurred $48,870 in net loss
due to general and administrative expenses of $28,125 and interest expense of $20,745.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
general and administrative expenses decreased by $13,075 or 32% during the year ended December 31, 2014 as compared to the same
period in the prior year mainly due to a decrease in compensation expense. During the twelve months ended December 31, 2014, our
interest expense was $20,745 as compared to $10,200 in the same period in the prior year, which increase by $10,545 or 103% was
mainly due to increased interest expense related to the conversion of advances into convertible notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Liquidity
and Capital Resources</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">At
December 31, 2014, the Registrant had no business operations and no material cash resources or other assets. During the past two
fiscal years, we were dependent upon interim funding provided by management and/or affiliated parties to pay professional fees
and expenses associated with being a reporting public company. The Registrant also had to depend upon services provided by management
and affiliated consultants to fulfill its filing obligations under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Following
the change in control of the Registrant as reported in Forms 8-K filed on November 21, 2014; December 2, 2014; and January 2,
2015, the Registrant determined to proceed with a business combination with Emerald and its prior dependence upon management and
affiliates for funding ceased. The Registrant successfully raised $780,000 from third party investors during the quarter ended
March 31, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">At
March 31, 2015, we had current cash assets of $554,564 and had $157,535 in current liabilities consisting of $36,556 in accrued
interest expenses and $120,979 advance payable to unrelated parties. At the same date, we had long-term liabilities of $37,375
in notes payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
December 31, 2014, we have had current cash assets of $1,000 and had $163,784 in current liabilities consisting of $7,500 in accounts
payable, $35,305 in accrued interest expenses and advances payable to unrelated parties. We had long-term liabilities of $22,375
in notes payable compared to no long-term liabilities at December 31, 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">There
are no limitations in our certificate of incorporation on our ability to borrow funds or raise funds through the issuance of restricted
shares of Common Stock to effect a business combination, which we completed in June 2015 on the Closing of the Share Exchange
Agreement with Emerald Medical Applications Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Additional
financing is necessary for us to fulfill our business plan. Our independent auditors have an unqualified audit opinion for the
year ended December 31, 2014 with an explanatory paragraph on going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Off-Balance
Sheet Arrangements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
of March 31, 2015 and December 31, 2014, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of
Regulation S-K promulgated under the Securities Act of 1934.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Contractual
Obligations and Commitments</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
of March 31, 2015 and December 31, 2014, we did not have any contractual obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Critical
Accounting Policies</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
significant accounting policies are described in the notes to our financial statements for the year ended December 31, 2014, and
are included elsewhere in this annual report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Description
of Properties</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
principal executive office is located at SOSA house, 12 Bar Yochayst, Tel Aviv 665320, Israel, Telephone: (972) 52-579-5082. These
facilities consist of approximately 300 square feet of executive office space, which is provided to us on a rent-free basis. Our
wholly-owned Israeli subsidiary, Emerald, has offices at the same address, SOSA house, 12 Bar Yochayst, Tel Aviv 6653201, Israel,
which it leases from an unaffiliated third party for $1,600 per month. The Registrant believes that the office facilities are
sufficient for the foreseeable future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Security
Ownership of Certain Beneficial Owners and Management</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following table sets forth information regarding the beneficial ownership of our common stock as of July 14, 2015. The information
in this table provides the ownership information for: each person known by us to be the beneficial owner of more than 5% of our
common stock; each of our directors; each of our executive officers; and our executive officers and directors as a group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Name of Beneficial
    Owner</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Common
    Stock Beneficially Owned (1)</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Percentage
    of Common Stock Owned (1)</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Liron Carmel, CEO and Director
    (2)</I></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: right">61,003</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: right">0.45</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">SOSA House, 12 Bar Yochay Street</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Tel-Aviv 6653201, Israel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Oded Gilboa, CFO</I></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.93</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">10 Hayetsira Street</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Raanana, Israel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Yair Fudim, Chairman</I></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">SOSA House, 12 Bar Yochay Street</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Tel-Aviv 6653201, Israel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Lior Wayn (3)</I></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,474,545</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40.58</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">1 Emek Ayalon Street</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Modi&rsquo;in, Israel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Amir Uziel</I></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,031,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.25</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">5 Shira Street</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Rishon Lezion, Israel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Itschak Shrem</I></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,031,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.25</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">21 Ha&rsquo;rba&rsquo;ah Street</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Tel-Aviv, Israel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Lavi Krasney</I></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,031,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.25</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">8 Paamoni Street</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Tel-Aviv, Israel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Directors and Officers (3 persons)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">186,003</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.38</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)
Applicable percentage ownership is based on 13,489,905 Shares of Common Stock outstanding as of July 14, 2015. Beneficial ownership
is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment
power with respect to securities. Shares of common stock that are currently exercisable or exercisable within 60 days of July
14, 2015 are deemed to be beneficially owned by the person holding such securities for the purpose of computing the percentage
of ownership of such person, but are not treated as outstanding for the purpose of computing the percentage ownership of any other
person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)
Mr. Carmel is also the owner of 61,003 Class A Warrants, exercisable for a period of 24 months to purchase 61,103 Share at a price
of $0.80.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(3)
Lior Wayn also is the record and beneficial owner of 2,700,000 Class E Warrants, noe of which are exercisable within 60 days.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Directors,
Executive Officers, Promoters and Control Persons</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
directors were elected to serve until the next annual meeting of shareholders and until his respective successors will have been
elected and will have qualified. The following table sets forth the name, age and position held with respect to our present executive
officers and directors:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 44%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Name</B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Age</B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 44%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Title</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Liron Carmel</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">30</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">CEO and director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Oded Gilboa</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">41</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">CFO</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Yair Fudim, Chairman</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">66</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chairman</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Liron
Carmel, 30,</I> has been CEO and sole director of the Registrant since December 2014. From 2010 through December 2014, Mr. Carmel
served as a senior analyst in the Investment Division of Excellence Group, a leading investment firm in Israel. In such capacity,
Mr. Carmel specialized in risk management and special debt financing including participation in and leading negotiations with
major institutional investors in Israel. From 2009 to 2010, Mr. Carmel was an analytical consultant for Precise Group, an Israeli
financial institution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Oded
Gilboa, 42,</I> a licensed CPA in the United States and Israel, has been the CFO since February 2015. Since December 2013, Mr.
Gilboa has also been serving as CFO of BreedIt Corp., a reporting company under the Exchange Act. Mr. Gilboa has over 18 years
of experience in finance and public accounting, having served as a senior finance executive in the technology and biotech industries
with responsibilities in corporate finance, accounting, strategic planning and operational and financial management. From 2010
through 2012, Mr. Gilboa served as the Revenue Accounting and Finance Manager of Mylan Specialty, a subsidiary of Mylan Inc. (NASDAQ:
MYL), a global company focused on the development, manufacturing and marketing of prescription drug products. From 2007 through
2009, Mr. Gilboa was the Executive Director of Finance and US Controller of Taro Pharmaceuticals (NASDAQ:TAROF), a global pharmaceutical
company. From 1998 through 2007 Mr. Gilboa held various financial positions with IDT Corporation (NYSE:IDT), a world-wide provider
of telecommunications and media services, where in his most recent role he served as Director of Finance. Mr. Gilboa began his
career in public accounting, auditing both public and private companies and holds a B.A in Economics and Accounting from Tel-Aviv
University and an M.B.A. from Recanati Business School at Tel-Aviv University.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Yair
Fudim, 66</I>, Chairman of the Registrant&rsquo;s Board of Directors effective April 30, 2015, has also been serving as Chairman
and CEO of Peregrine Industries, Inc., a public company (OTCQB: PGID) since July 22, 2013. During the past five years, Mr. Fudim
has also served as Chairman of Greenstone Industries Ltd, a public company organized under in Israel and listed on the Tel Aviv
Stock Exchange (&ldquo;TASE&rdquo;) since February 2013, prior to which he served as Greenstone&rsquo;s CEO from February 2010
until March 2013; Since February 2013, Mr. Fudim has also been Chairman of RVB Holdings Ltd, a public company organized under
in Israel (OTCQB: RVBHF); From April 1991 through April 2013, Mr. Fudim served as CEO of Leader Holdings &amp; Investments Ltd
(&ldquo;Leader Holdings&rdquo;), a public company organized in Israel and listed on the TASE; Mr. Fudim also serves as Chairman
of the Board of Leader Capital Markets Ltd., a TASE listed public company organized in Israel and a subsidiary of Leader Holdings.
Mr. Fudim holds a B.A. in Economics and an MBA from the Hebrew University of Jerusalem.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">There
are no agreements with respect to the election of directors. We do not compensate our directors. Officers are appointed annually
by the Board of Directors and each executive officer serves at the discretion of the Board of Directors. We do not have any standing
committees at this time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
director, officers or affiliates have not, within the past five years, filed any bankruptcy petition, been convicted in or been
the subject of any pending criminal proceedings, or is any such person the subject or any order, judgment or decree involving
the violation of any state or federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Section
16(a) Compliance.<B> </B></I>Section 16(a) of the Securities and Exchange Act of 1934 requires the Registrant&rsquo;s directors
and executive officers, and persons who own beneficially more than ten percent (10%) of the Registrant&rsquo;s Common Stock, to
file reports of ownership and changes of ownership with the Securities and Exchange Commission. Copies of all filed reports are
required to be furnished to the Registrant pursuant to Section 16(a). Based solely on the reports received by the Registrant and
on written representations from reporting persons, the Registrant was informed that our CEO has and the CFO and Chairman have
not filed reports as required under Section 16(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>NASDAQ
Rule 4200<B>. </B></I>The NASDAQ Rule 4200, which sets forth several tests to determine whether a director of a listed company
is independent. Rule 4200 provides that a director would not be considered independent if the director or an immediate family
member accepted any compensation from the listed company in excess of $120,000 during any period of 12 consecutive months within
the three years preceding the determination of independence (excluding compensation for board or board committee service, compensation
paid to an immediate family member as a non-executive employee, benefits paid under a tax-qualified retirement plan and non-discretionary
compensation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Director
Independence.<B> </B></I>In determining whether or not our directors are considered independent, the Company used the definition
of independence as defined in NASDAQ Rule 4200. Based on that definition we believe that of our directors, only Yair Fudim is
independent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Directors&rsquo;
Term of Office<B>. </B></I>Our directors are elected to serve until the next annual meeting of shareholders and until their respective
successors will have been elected and will have qualified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Audit
Committee and Financial Expert, Compensation Committee, Nominations Committee.<B> </B></I>We do not have any of the above mentioned
standing committees because our corporate financial affairs and corporate governance are simple in nature at this stage of development
and each financial transaction is approved by our sole officer or director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Code
of Ethics<B>. </B></I>We do not currently have a Code of Ethics applicable to our principal executive officers; however, the Company
plans to implement such a code in the fourth quarter of 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Potential
Conflicts of Interest<B>. </B></I>Since we do not have an audit or compensation committee comprised of independent Directors,
the functions that would have been performed by such committees are performed by our Board of Directors. Thus, there is a potential
conflict of interest in that our Directors have the authority to determine issues concerning management compensation, in essence
their own, and audit issues that may affect management decisions. We are not aware of any other conflicts of interest with any
of our Executives or Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Board&rsquo;s
Role in Risk Oversight. </I>The Board assesses on an ongoing basis the risks faced by the Company. These risks include financial,
technological, competitive, and operational risks. In addition, since the Company does not have an Audit Committee, the Board
is also responsible for the assessment and oversight of the Company&rsquo;s financial risk exposures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Involvement
in Certain Legal Proceedings. </I>We are not aware of any material legal proceedings that have occurred within the past ten years
concerning any Director or control person which involved a criminal conviction, a pending criminal proceeding, a pending or concluded
administrative or civil proceeding limiting one&rsquo;s participation in the securities or banking industries, or a finding of
securities or commodities law violations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Executive
Compensation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following table sets forth information concerning the total compensation that we have paid or that has accrued on behalf of our
chief executive officer and other executive officers during the fiscal years ending December 31, 2014, 2013 and 2012.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="10" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Summary Compensation
    Table </B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="6" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Long Term </B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="10" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Annual
    Compensation </B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Compensation Awards</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Other </B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Restricted </B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Securities </B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Annual </B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Stock </B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Underlying </B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>All Other </B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left"><B>Name and Principal</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Salary </B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Bonus </B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Compensation </B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Award(s) </B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Options </B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Compensation </B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Position
    </B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Year
    </B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>($)</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>($)</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>($)</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>($)
    </B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>($)</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>($)</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Liron Carmel, CEO and Chairman</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">2014</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Oded Gilboa, CFO</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">2014</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Ivo Heiden, former CEO, CFO and Chairman</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">2014</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 37%">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: center">2013</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">24,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">2012</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif"><I>Executive
Employment Agreements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">Emerald
has entered into an employment agreements with Lior Wayn, its CEO, and Oded Gilboa its CFO. In addition, the Registrant has entered
into a separate employment agreement with Oded Gilboa, the Registrant&rsquo;s CFO. Copies of these employment agreements are attached
as exhibits hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">Emerald&rsquo;s
employment agreement with Lior Wayn, dated January 1, 2015, provides for a base annual salary of NIS46,000 which is equivalent
to approximately $12,000 for which Mr. Wayn is required to devote 100% of his business time to the affairs of Emerald. In addition,
Mr. Wayn&rsquo;s agreement also provides for the payment of cash bonuses as follows: (i) a bonus equal to 5% of the monthly revenues
of Emerald during the years ending December 31, 2015 and 2016, payable quarterly; and (ii) a cash bonus equal to 7 months base
salary only in the event that the Registrant raises at least $1,150,000 from: (i) the sale of equity securities at a price of
not less than $0.80 per Share; or (ii) the exercise of warrants at an exercise price of not less than $0.80 per Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
employment agreements between Mr. Gilboa and the Registrant and Emerald, dated March 22, 2015 and February 25, 2015, respectively,
provide as follows: (i) the Registrant shall pay Mr. Gilboa cash compensation for the initial two month period a total of $2,000
following which Mr. Gilboa will be paid at the rate of $3,000 per month and, as additional compensation, the Registrant issued
Mr. Gilboa 125,000 restricted Shares; and (ii) Emerald shall pay Mr. Gilboa cash compensation of NIS13,200 which is equivalent
to approximately $3,450 per month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Option
Grants</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">There
were no individual grants of stock options to purchase our Common Stock made to the executive officers named in the Summary Compensation
Table. However, the Registrant issued Class E Warrants to Lior Wayn at the Closing exercisable to purchase 2,700,000 Shares in
three equal tranches of 900,000 Shares each, at a price of $0.0001 per Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Aggregated
Option Exercises and Fiscal Year-End Option Value</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">There
were no stock options exercised during period ending March 31, 2015 by the executive officers named in the Summary Compensation
Table.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Long-Term
Incentive Plan (&ldquo;LTIP&rdquo;) Awards</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">There
were no awards made to a named executive officers in the last completed fiscal year under any LTIP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Compensation
of Directors</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Directors
are permitted to receive fixed fees and other compensation for their services as directors. The Board of Directors has the authority
to fix the compensation of directors. No amounts have been paid to, or accrued to, directors in such capacity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Outstanding
Warrants</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following table summarizes information of outstanding warrants as of July 14, 2015:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: -0.7pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Warrants</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Warrant
    Term </B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exercise
    Price </B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exercisable</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 41%; text-align: left">Investors - Class A Warrants (1)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">3,202,935</TD><TD STYLE="width: 2%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2
                                         years</FONT></TD><TD STYLE="width: 2%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">0.80</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">3,202,935</TD><TD STYLE="width: 2%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Lior Wayn - Class E Warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2,700,000</FONT></TD><TD STYLE="text-align: left">(2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">(2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.0001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">(2)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)
The Class A Warrants were issued in connection with a private placement in reliance upon Regulation S, pursuant to which the Registrant
sold a total of 3,202,935 units at a price of $0.40 per unit (the &ldquo;Units&rdquo;), each Unit comprised of one Share and one
Class A Warrant exercisable at $0.80 per share with a term 24 months. While all of the Class A Warrants are exercisable within
60 days, in fact, none of these warrants will be exercised for the foreseeable future, based upon the exercise price of $0.80
per Share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)
The Class E Warrants were issued by the Registrant to Lior Wayn in connection with the Closing of the Share Exchange Agreement.
The Class E Warrants are exercisable to purchase a total of 2,700,000 Shares, in three equal tranches of 900,000 Shares each (the
&ldquo;Tranches&rdquo;) at an exercise price of $0.0001 per Share, subject to and within 45 days of the Registrant achieving the
milestones defined in the table below (the &ldquo;Milestones&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1.5pt solid; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Milestone</B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Description</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>First</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Registrant, on a consolidated basis, obtaining five (5) medical service providers (e.g., hospitals, clinics, etc.) as pilot
    customers within two years of Closing. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Second
    </B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Registrant, on a consolidated basis, reaching an agreement with an insurer or medical service provider (e.g., insurance company
    or HMO), insuring or serving at least 300,000 customers, within two years of Closing.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Third
    </B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Registrant, on a consolidated basis,, reaching gross revenue of $1,000,000 within any period of twelve consecutive months
    in which the aggregate gross revenue that may be attributed to the last three months of such period shall not be less than
    $400,000, within three years of Closing. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Certain
Relationships and Related Party Transactions and Director Independence</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Certain
Related Party Transactions</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Mr.
Ivo Heiden, our former CEO, CFO and sole director who resigned on March 24, 2014, provided securities compliance services valued
at $5,250 in 2014 and $18,000 in 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Indebtedness
of Management</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">No
officer, director or security holder known to us to own of record or beneficially more than 5% of our Common Stock or any member
of the immediate family or sharing the household (other than a tenant or employee) of any of the foregoing persons is indebted
to us in the years 2014 and 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Disclosure
of Commission Position on Indemnification of Securities Act Liabilities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
directors and officers are indemnified as provided by the Delaware corporate law and our Bylaws. We have agreed to indemnify each
of our directors and certain officers against certain liabilities, including liabilities under the Securities Act of 1933, as
amended. Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended may be permitted to our
directors, officers and controlling persons pursuant to the provisions described above, or otherwise, we have been advised that
in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities
Act of 1933, as amended and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than our payment of expenses incurred or paid by our director, officer or controlling person in the successful defense
of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to
a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the
Act and will be governed by the final adjudication of such issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
have been advised that in the opinion of the Securities and Exchange Commission indemnification for liabilities arising under
the Act is against public policy as expressed in the Act, and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities is asserted by one of our directors, officers, or controlling persons in connection with the securities
being registered, we will, unless in the opinion of our legal counsel the matter has been settled by controlling precedent, submit
the question of whether such indemnification is against public policy to a court of appropriate jurisdiction. We will then be
governed by the court&rsquo;s decision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item
7.01 Recent Sales of Unregistered Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">The
following tables and information sets forth all securities of the </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Registrant
<FONT STYLE="background-color: white">issued and sold within the past three years which were not registered under the Act. </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
December 16, 2014, the Registrant issued 4,125,000 restricted Shares (adjusted for the 1:4 reverse split effective in February
2015)to five holders of the Registrant&rsquo;s convertible notes in the principal amount of $125,000 (the &ldquo;Notes&rdquo;)
upon their conversion the Notes. The table below sets forth the issuances of restricted Shares made in reliance on Regulation
S promulgated by the SEC under the Act (&ldquo;Reg S&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Name
    of Note Holder</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Basis
    of Issuance</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total
    Notes Converted</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Shares
    Issued (1)</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 34%; text-align: left">Eli Yoresh</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Conversion of Notes</FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">12,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 18%; text-align: right">412,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Kfir Silberman</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Conversion of Notes</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">618,750</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Amir Uziel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Conversion of Notes</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">31,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,031,250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Itschak Shrem</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Conversion of Notes</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">31,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,031,250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Lavi Krasney</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Conversion of Notes</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">31,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">1,031,250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD></TD><TD STYLE="font-weight: bold"><B>&nbsp;</B></TD>
    <TD STYLE="font-weight: bold; text-align: right"><B>Total</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>125,000</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>4,125,000</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)
Adjusted for the 1:4 reverse stock split effective in February 2015. No warrants were issued in connection with the conversion
of these notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">During
the period from January 2015 through May 2015, as set forth in the table below, in private offering of a total of 2,762,500 units
at a price of $0.40, each unit consisting of one Share and one Class A Warrant exercisable to purchase one additional Share of
Common Stock at a price of $0.80 (the &ldquo;Units&rdquo;), the Registrant issued and sold restricted unregistered equity securities
to the subscribers set forth in the table below. The sales were made without registration under the Act in reliance upon the exemptions
provided in Section 4(2) of the Act and Reg S. The certificates evidencing the Shares which were part of the Unit Offering were
not issued until June 30, 2015, immediately prior to the July 14, 2015 Closing of the Share Exchange Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Name
    of Subscriber</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Bases
    for Issuance</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Price
    Per Unit</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Shares
    Issued </B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 34%; text-align: left">Short Trade Ltd (1)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 20%; text-align: center">Subscription Agreement</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">0.40</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 18%; text-align: right">625,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">PropTrade Ltd (2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Subscription Agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">375,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dr. Ben Zion Weiner</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Subscription Agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">RP Holdings (3)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Subscription Agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dr. Tank Siak Khim</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Subscription Agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">250,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Yoel Yogev</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Subscription Agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Universal Link Ltd (4)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Subscription Agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">175,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Avigdor Hakmon</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Subscription Agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">62,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dr. Shmuel Pasternak</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Subscription Agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">62,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Liat Sidi</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Subscription Agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Tzvi Aharonson</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Subscription Agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">137,403</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Estory Giloz Ran</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Subscription Agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">312,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Malca Maimon</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Subscription Agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">87,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Ohad Cohen</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Subscription Agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">150,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Nissim Simhon</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Subscription Agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">NE Solution Ltd (5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Subscription Agreement</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">0.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">162,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: right"><B>Total</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>1,170,000</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>2,925,000</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)
Short Trade Ltd is controlled by Mr. Shlomo Noyman, a resident of Israel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)
Prop Trade Ltd is controlled by Mr. Andrew Philip Dings, a resident of Singapore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(3)
RP Holdings is controlled by Mr. Rubin Zimerman, a resident of Israel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(4)
Universal Link Ltd is controlled by Mr. Ahmad Alimi, a resident of Israel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(5)
NE Solution Ltd is controlled by Mr. Lee Yang Tong, a resident of Singapore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
June 2015, the persons listed in the table below, each a lender to Emerald on or before November 2014, converted their debt owed
by Emerald into Units, each consisting of one restricted Share and one Class A Warrant, at a conversion price of $0.32. Each of
the lenders was a resident of Israel and the issuance was without registration under the Act in reliance upon the exemptions provided
in Section 4(2) of the Act and Reg S.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Name
    of Note Holder</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Bases
    of Issuance</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Debt
    Converted</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Shares
    Issued </B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 34%; text-align: left">David Masasa</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Conversion of Debt</FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">8,788</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 18%; text-align: right">27,463</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Liron Carmel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Conversion of Debt</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">19,521</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61.003</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Yoseph Cohen</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Conversion of Debt</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">15,632</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,850</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Tzvi Aharonson</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Conversion of
    Debt</FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">43,969</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">140,625</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: right; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total</B></FONT></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>87,910</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>274,719</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 17, 2015, the Registrant issued
140,000 restricted Shares to Shira Brand Shiffer, a resident of Israel, at a price of $0.107 per Share, with no warrants attached.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
issuances to Shira Brand Shiffer and Meyda Consulting Services, without registration under the Act, were made in reliance upon
Section 4(2) of the Act and Reg S. The issuance to Lyons Capital, without registration under the Act, was made in reliance upon
Section 4(2) of the Act and Regulation D promulgated by the SEC under the Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item
9.01 Financial Statements and Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ZAXIS
INTERNATIONAL, INC.</B></FONT><BR>
<FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Emerald
Financial Statements for the Period Ended December 31, 2013 and 2013</FONT></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#a_0a1"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Report
    of Independent Registered Public Accounting Firm</FONT></A></TD>
    <TD STYLE="width: 0.1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_001"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Balance
    Sheets</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">31</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_002"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Statement
    of Operation</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">32</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_003"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Statement
    of Comprehensive Income (Loss)</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">33</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_004"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Statement
    of Cash Flows</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">34</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_005"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Statement
    of Changes in Stockholders&rsquo; Deficit</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">35</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_006"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notes
    to Emerald Financial Statement</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">36</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Emerald Financial
    Statements for the Period Ended March 31, 2015</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_007"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Balance
    Sheets</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">44</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_008"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Statement
    of Operations</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">45</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_009"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Statement
    of Comprehensive Income (Loss)</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">46</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_011"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Statement
    of Cash Flow</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">47</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_010"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Statement
    of Changes in Stockholders&rsquo; Deficit</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">48</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_012"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notes
    to Emerald Financial Statements</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">49</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pro Forma Financial
    Statements for the Period Ended December 31, 2014</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_013"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Condensed
    Consolidated Balance Sheet</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">56</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_014"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Condensed
    Consolidated Statement of Operations</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">57</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_015"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notes
    to Pro Forma Financial Statements</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">58</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pro Forma Financial
    Statements for the Period Ended December 31, 2013</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#b_001"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Condensed
    Consolidated Balance Sheet</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">59</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#b_002"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Condensed
    Consolidated Statement of Operations</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">60</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#b_003"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notes
    to Pro Form Financial Statement</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">61</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pro Form Financial
    Statements for the Period Ended March 31, 2015</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_016"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Condensed
    Consolidated Balance Sheets</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">62</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_017"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Condensed
    Consolidated Statement of Operations</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">63</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><A HREF="#a_018"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notes
    to Pro Forma Financial Statements</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">64</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_0a1"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</U></B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">To
the Board of Directors</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Emerald
Medical Applications Ltd.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Petah
Tikva, Israel</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
have audited the accompanying balance sheets of Emerald Medical Applications Ltd. (the Company) as of December 31, 2014 and 2013
and the related statements of operations, stockholders&rsquo; deficit and cash flows for the years then ended. These financial
statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial
statements based on our audits.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
conducted our audits in accordance with standards of the Public Company Accounting Oversight Board (United States). Those standards
require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of
material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over
financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit
procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of
the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining,
on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing
the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis for our opinion.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Emerald
Medical Applications Ltd. as of December 31, 2014 and 2013 and the results of its operations and cash flows for the periods described
above in conformity with accounting principles generally accepted in the United States of America.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed
in Note 1 to the financial statements, the Company suffered a net loss from operations and has a net capital deficiency, which
raises substantial doubt about its ability to continue as a going concern. Management&rsquo;s plans regarding those matters are
also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 50%"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"><I>/s/
    M&amp;K CPAS, PLLC</I></FONT></TD>
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 50%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">&nbsp;www.mkacpas.com</FONT></TD>
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Houston,
    Texas</FONT></TD>
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">July
    14, 2015</FONT></TD>
    <TD STYLE="font: 10pt/115% Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 30; Options: NewSection; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Emerald
Medical Applications Ltd.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_001"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>BALANCE
SHEETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>AS
OF DECEMBER 31, 2014 AND DECEMBER 31, 2013</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2014</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2013</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>$</B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>$</B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ASSETS</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><U>Current Assets</U></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%">Cash</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">14,411</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Due from related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,999</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other receivable</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">6,718</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total current
    assets</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>40,128</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Fixed assets, net of accumulated depreciation of $66 and $0, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">1,390</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL ASSETS</B></FONT></TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>41,518</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LIABILITIES AND SHAREHOLDERS&rsquo;
    DEFICIT</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><U>Current liabilities</U></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,577</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounts payable - related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,439</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accrued interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,013</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Short term notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">68,389</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Short term notes payable - related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,521</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Convertible note payable, net of discount of $9,555 and $0, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,164</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Derivative liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,532</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total current
    liabilities</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>137,635</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL LIABILITIES</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>137,635</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SHAREHOLDERS&rsquo; DEFICIT</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Common stock, ordinary shares par value $0.002638, management shares par value $0.2795, 1,000,000
    ordinary and 2 management shares authorized, 213,000 ordinary shares and 1 management share issued and outstanding at December
    31, 2014, 100,000 ordinary shares and 1 management share issued and outstanding on December 31, 2013.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">562</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">265</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stock receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(297</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(265</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(265</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other comprehensive income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,932</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(105,049</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL SHAREHOLDERS&rsquo;
    DEFICIT</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(96,117</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL LIABILITIES
    AND SHAREHOLDERS&rsquo; DEFICIT</B></FONT></TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>41,518</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
summary of significant accounting policies and notes to financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 31; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Emerald
Medical Applications Ltd.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_002"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>STATEMENTS
OF OPERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FOR
THE TWELVE MONTHS ENDED DEC 31, 2014 AND DECEMBER 31, 2013</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Twelve months ended</B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Twelve months ended</B></FONT></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2014</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2013</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>$</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>$</B></TD><TD STYLE="text-align: center"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 52%; text-align: left; padding-bottom: 1.5pt">General and administrative</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 20%; text-align: right; border-bottom: Black 1.5pt solid">116,929</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 20%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">116,929</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(116,929</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other income (expense):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,605</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Change in fair value of derivative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,385</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other income from grants and awards</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,993</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Gain/(loss) from foreign currency</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">3,877</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total costs and expenses</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(105,049</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(105,049</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(0.90</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(0.00</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Weighted average shares outstanding (basic and diluted)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">116,719</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">100,000</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
summary of significant accounting policies and notes to financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 32; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Emerald
Medical Applications Ltd.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_003"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Statements
of Comprehensive Income (Loss)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>For
the Years Ended December 31, 2014 and December 31, 2013</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Twelve months</B> <B>ended</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Twelve months ended</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2014</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2013</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Foreign
    currency translation gain (loss)</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">8,932</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Total comprehensive
    gain (loss)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(96,117</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
summary of significant accounting policies and notes to financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 33; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Emerald
Medical Applications Ltd.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_004"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>STATEMENTS
OF CHANGES IN STOCKHOLDERS&rsquo; EQUITY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FOR
THE YEARS ENDED DECEMBER 31, 2014 AND 2013</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Common Stock</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt">Additional</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt">Share</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt">Other</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt">Total</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Number</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Par</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Paid-In</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Subscription</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Comprehensive</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Accumulated</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Shareholders&rsquo;</TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">of Shares</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Value</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Capital</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Receivable</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Income</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Deficit</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Deficit</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 17%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Balance at December 31, 2012</B></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">100,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">265</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">(265</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Common stock subscribed</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Balance at December 31, 2013</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">265</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(265</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Common stock subscribed</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">113,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">297</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(297</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other comprehensive income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,932</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,932</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(105,049</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(105,049</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Balance at December 31, 2014</B></FONT></TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">213,001</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">562</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(265</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(297</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">8,932</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(105,049</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(96,117</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
summary of significant accounting policies and notes to financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 34; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Emerald
Medical Applications Ltd.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_005"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>STATEMENTS
OF CASH FLOWS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FOR
THE YEAR ENDED DECEMBER 31, 2014 AND 2013</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>For the year ended</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>For the year ended</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2014</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2013</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Operating Activities:</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 58%; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Net (loss)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 17%; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(105,049</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 17%; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Adjustments to reconcile net (loss) to
    net cash (used in) operating activities:</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Change in fair value of derivative liabilities</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">7,385</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Depreciation expense</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">66</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Amortization of debt discount</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3,592</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Changes in net assets and liabilities:</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Due from related party</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(18,999</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Other receivable</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(6,718</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Accounts payable</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2,577</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Accounts payable - related party</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4,439</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Accrued interest</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2,013</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Net cash used in
    operating activities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(110,694</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Investing Activities:</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Purchase of property
    and equipment</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1,456</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Net cash used in
    investing activities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1,456</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Financing Activities:</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Issuance of short-term notes payable</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">87,910</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Issuance of convertible notes payable</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">29,719</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Net cash provided by financing activities</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">117,629</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Foreign currency adjustment</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">8,932</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Net increase in cash</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5,479</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents
    - beginning of period</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents
    - end of period</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">14,411</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Non cash transactions:</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subscription of common stock for stock
    receivable</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">297</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Discount from convertible note issued
    with embedded derivative</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">13,147</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
summary of significant accounting policies and notes to financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 35; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>EMERALD
MEDICAL APPLICATIONS LTD. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_006"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notes
to the Financial Statements</FONT><BR>
<FONT STYLE="font: 10pt Times New Roman, Times, Serif">December 31, 2014 and 2013</FONT><BR>
<FONT STYLE="font: 10pt Times New Roman, Times, Serif"><U>ZAXIS INTERNATIONAL INC.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
1. The Company and Significant Accounting Policies.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Organizational
Background:</I> Emerald Medical Applications Ltd (&ldquo;Emerald&rdquo;), is a company organized under the laws of the State of
Israel on February 17, 2010. Emerald is digital health Startup Company engaged in the development, sale and service of imaging
solutions utilizing its proprietary DermaCompare software that it developed for use in derma imaging and analytics (&ldquo;DermaCompare&rdquo;).
Emerald believes that its proprietary DermaCompare software represents an advancement in skin cancer screening that should enable
physicians to more readily identify and monitor changes in their patients&rsquo; skin characteristics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Emerald&rsquo;s
DermaCompare solution allows dermatologists and other medical care professionals, using a set of 25 total body photography (&ldquo;TBP&rdquo;),
to capture sets of skin lesion images with, among other devices, digital cameras, camera-equipped smart phones or tablets. These
images are then transmitted online and are remotely analyzed by professionals using our DermaCompare software.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
sales and marketing plan is to sell licenses for our DermaCompare imaging software to: NHSs, HMOs, health insurance companies,
hospitals and medical clinics through distributers, health care channel partners or directly through independent salespersons
and/or web purchase to dermatologists and other physicians (GPs) that we expect to purchase licenses based on the number of potential
numbers of patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Basis
of Presentation and Going Concern: </I>The accompanying financial statements have been prepared in conformity with accounting
principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern.
The Company has not established any source of revenue to cover its operating costs, and as such, has incurred an operating loss
since inception. Further, as of December 31, 2014, the cash resources of the Company were insufficient to meet its current business
plan, and the Company had negative working capital. These and other factors raise substantial doubt about the Company&rsquo;s
ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible
future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result
from the possible inability of the Company to continue as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Significant
Accounting Policies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Use
of Estimates: </I>The preparation of financial statements in conformity with generally accepted accounting principles requires
management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting
period. Actual results could differ from the estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Cash
and Cash Equivalents:</I> For financial statement presentation purposes, the Company considers those short-term, highly liquid
investments with original maturities of three months or less to be cash or cash equivalents. There were no cash equivalents as
of December 31, 2014 and December 31, 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Other
receivables:</I> The company treats VAT refunds claimed resulting from excess VAT paid over VAT received as other receivables,
amount shown as other receivables as of December 31, 2014 were collected in Q2 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Currency
translation and </I>other comprehensive income: balance sheet items are translated using all-current translation method for Self-contained
foreign operations (where functional currency = foreign currency) whereby assets and liabilities are translated using the exchange
rate on the date of the balance sheet. It translates revenues, expenses, and net income using the average exchange rate during
the period. The foreign exchange adjustment that results from applying the all-current method appears in other comprehensive income,
a separate shareholders&rsquo; equity account, and does not affect net income each period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Property
and Equipment:</I> Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the
straight-line method over the estimated useful lives of the assets. The annual depreciation rates are as follows: Computers and
electronic equipment 33%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Valuation
of Long-Lived Assets:</I> We review the recoverability of our long-lived assets including equipment, goodwill and other intangible
assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable.
The assessment of possible impairment is based on our ability to recover the carrying value of the asset from the expected future
pre-tax cash flows (undiscounted and without interest charges) of the related operations. If these cash flows are less than the
carrying value of such asset, an impairment loss is recognized for the difference between estimated fair value and carrying value.
Our primary measure of fair value is based on discounted cash flows. The measurement of impairment requires management to make
estimates of these cash flows related to long-lived assets, as well as other fair value determinations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 36; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Stock
Based Compensation:</I> Stock-based awards are accounted for using the fair value method in accordance with ASC 718, Share-Based
Payments. Our primary type of share-based compensation consists of stock options. We use the Black-Scholes option pricing model
in valuing options. The inputs for the valuation analysis of the options include the market value of the Company&rsquo;s common
stock, the estimated volatility of the Company&rsquo;s common stock, the exercise price of the warrants and the risk free interest
rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Accounting
For Obligations And Instruments Potentially To Be Settled In The Company&rsquo;s Own Stock: We account for obligations and instruments
potentially to be settled in the Company&rsquo;s stock in accordance with FASB ASC 815, Accounting for Derivative Financial Instruments.
This issue addresses the initial balance sheet classification and measurement of contracts that are indexed to, and potentially
settled in, the Company&rsquo;s own stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Fair
Value of Financial Instruments:</I> FASB ASC 825, &ldquo;Financial Instruments,&rdquo; requires entities to disclose the fair
value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is
practicable to estimate fair value. FASB ASC 825 defines fair value of a financial instrument as the amount at which the instrument
could be exchanged in a current transaction between willing parties. At December 31, 2014 and 2013, the carrying value of certain
financial instruments (cash and cash equivalents, accounts payable and accrued expenses.) approximates fair value due to the short-term
nature of the instruments or interest rates, which are comparable with current rates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Fair
Value Measurements:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company adopted the FASB standard related to fair value measurement at inception. The standard defines fair value, establishes
a framework for measuring fair value and expands disclosure of fair value measurements. The standard applies under other accounting
pronouncements that require or permit fair value measurements and, accordingly, does not require any new fair value measurements.
The standard clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid
to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement
that should be determined based on assumptions that market participants would use in pricing an asset or liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
a basis for considering such assumptions, the standard established a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value as follows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level
1. Observable inputs such as quoted prices in active markets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level
2. Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level
3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company values its derivative instruments related to embedded conversion features and warrants from the issuance of convertible
debentures in accordance with the Level 3 guidelines. For the twelve month period ended December 31, 2014, the following table
reconciles the beginning and ending balances for financial instruments that are recognized at fair value in these consolidated
financial statements. The fair value of embedded conversion features that have floating conversion features and tainted common
stock equivalents (warrants and convertible debt) are estimated using a Binomial Lattice model. The key inputs to this valuation
model as of December 31, 2014, were: Volatility of xxx%, inherent term of instruments equal to the remaining contractual term,
quoted closing stock prices on valuation dates, and various settlement scenarios and probability percentages summing to 100%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Fair
Value Measurements at December 31, 2014</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">Level 3 - Derivative liabilities from:</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Balance at<BR>
    December 31, 2013</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">New Issuances</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Settlements</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Change in Fair Value</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Balance at <BR>
    December 31, 2014</TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 27%; text-align: left">Convertible Note</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 16%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 6%; text-align: right; border-bottom: Black 1.5pt solid">13,147</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 6%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid">7,385</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 16%; text-align: right; border-bottom: Black 1.5pt solid">20,532</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Fair
Value Measurements at December 31, 2013</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 27%; text-align: left; border-bottom: Black 1.5pt solid">Level 3 - Derivative liabilities from:</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 16%; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Balance
                                         at</FONT><BR>
                                         <FONT STYLE="font: 10pt Times New Roman, Times, Serif">December 31, 2013</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 6%; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">New
                                         Issuances</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 6%; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Settlements
                                         </FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Change
                                         in Fair Value </FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 16%; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Balance
                                         at</FONT><BR>
                                         <FONT STYLE="font: 10pt Times New Roman, Times, Serif">December 31, 2014</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Convertible Note</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Changes
in the unobservable input values would likely cause material changes in the fair value of the Company&rsquo;s Level 3 financial
instruments. The significant unobservable input used in the fair value measurement is the estimation for probability percentages
assigned to future expected settlement possibilities. A significant increase (decrease) in this distribution of percentages would
result in a higher (lower) fair value measurement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following table presents assets and liabilities that were measured and recognized at fair value as of December 31, 2014 and December
31, 2013 and the year then ended on a recurring basis:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Description</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Fair
Value Measurements at December 31, 2014</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Level 1</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Level 2</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Level 3</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Total Unrealized Loss</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 37%; text-align: left; padding-bottom: 1.5pt">12/31/14 Derivative Liability</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 10%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 10%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 10%; text-align: right; border-bottom: Black 1.5pt solid">20,532</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 17%; text-align: right; border-bottom: Black 1.5pt solid">20,532</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">12/31/13 None</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 38; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balance sheets
as of December 31, 2014 and December 31, 2013:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Fair
Value Measurements at December 31, 2014</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Level
    3</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ASSETS</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total Assets</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: right; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LIABILITIES </B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 78%; text-align: left; padding-bottom: 1.5pt">Derivative liability</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 18%; text-align: right; border-bottom: Black 1.5pt solid">20,532</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total Liabilities</B></FONT></TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">20,532</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Fair
Value Measurements at December 31, 2013</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Level
                                         3</B></FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ASSETS</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 78%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total
    Assets</B></FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 18%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LIABILITIES </B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Derivative liability</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total Liabilities</B></FONT></TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
fair values of our debts are deemed to approximate book value, and are considered Level 2 inputs as defined by ASC Topic 820-10-35.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">There
were no transfers of financial assets or liabilities between Level 1, Level 2 and Level 3 inputs for the twelve months ended December
31, 2014 or the year ended December 31, 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company had no other assets or liabilities valued at fair value on a recurring or non-recurring basis as of December 31, 2014
or December 31, 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Earnings
per Common Share:</I> We compute net income (loss) per share in accordance with <I>ASC 260, Earning per Share</I>. ASC 260 requires
presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by
dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator)
during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury
stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price
for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants.
Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Income
Taxes:</I> We have adopted FASB ASC 740, <I>Accounting for Income Taxes</I>. Pursuant to ASC 740, we are required to compute tax
asset benefits for net operating losses carried forward. The potential benefits of net operating losses have not been recognized
in these financial statements because the Company cannot be assured it is more likely than not it will utilize the net operating
losses carried forward in future years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates
and judgments occur in the calculation of certain tax assets and liabilities, which arise from differences in the timing of recognition
of revenue and expense for tax and financial statement purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Deferred
tax assets and liabilities are determined based on the differences between financial reporting and the tax basis of assets and
liabilities using the tax rates and laws in effect when the differences are expected to reverse. ASC 740 provides for the recognition
of deferred tax assets if realization of such assets is more likely than not to occur. Realization of our net deferred tax assets
is dependent upon our generating sufficient taxable income in future years in appropriate tax jurisdictions to realize benefit
from the reversal of temporary differences and from net operating loss, or NOL, carryforwards. We have determined it more likely
than not that these timing differences will not materialize and have provided a valuation allowance against substantially all
of our net deferred tax asset. Management will continue to evaluate the realizability of the deferred tax asset and its related
valuation allowance. If our assessment of the deferred tax assets or the corresponding valuation allowance were to change, we
would record the related adjustment to income during the period in which we make the determination. Our tax rate may also vary
based on our results and the mix of income or loss in domestic and foreign tax jurisdictions in which we operate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 39; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations.
We recognize liabilities for anticipated tax audit issues in the U.S. and other tax jurisdictions based on our estimate of whether,
and to the extent to which, additional taxes will be due. If we ultimately determine that payment of these amounts is unnecessary,
we will reverse the liability and recognize a tax benefit during the period in which we determine that the liability is no longer
necessary. We will record an additional charge in our provision for taxes in the period in which we determine that the recorded
tax liability is less than we expect the ultimate assessment to be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ASC
740 which requires recognition of estimated income taxes payable or refundable on income tax returns for the current year and
for the estimated future tax effect attributable to temporary differences and carry-forwards. Measurement of deferred income tax
is based on enacted tax laws including tax rates, with the measurement of deferred income tax assets being reduced by available
tax benefits not expected to be realized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Uncertain
Tax Positions:</I> When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination
by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the
position that would be ultimately sustained. In accordance with the guidance of FASB ASC 740-10, <I>Accounting for Uncertain Income
Tax Positions</I>, the benefit of a tax position is recognized in the financial statements in the period during which, based on
all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including
the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.
Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that
is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits
associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for
unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that
would be payable to the taxing authorities upon examination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
federal and state income tax returns are open for fiscal years ending on or after December 31, 2011. We are not under examination
by any jurisdiction for any tax year. At December 31, 2014 we had no material unrecognized tax benefits and no adjustments to
liabilities or operations were required under FIN 48.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Recent
Accounting Pronouncements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
November 2014, The Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-16&mdash;Derivatives
and Hedging (Topic 815): Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share
Is More Akin to Debt or to Equity (a consensus of the FASB Emerging Issues Task Force). The amendments in this Update do not change
the current criteria in GAAP for determining when separation of certain embedded derivative features in a hybrid financial instrument
is required. That is, an entity will continue to evaluate whether the economic characteristics and risks of the embedded derivative
feature are clearly and closely related to those of the host contract, among other relevant criteria. The amendments clarify how
current GAAP should be interpreted in evaluating the economic characteristics and risks of a host contract in a hybrid financial
instrument that is issued in the form of a share. The effects of initially adopting the amendments in this Update should be applied
on a modified retrospective basis to existing hybrid financial instruments issued in the form of a share as of the beginning of
the fiscal year for which the amendments are effective. Retrospective application is permitted to all relevant prior periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
November 2014, The Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-17&mdash;Business Combinations
(Topic 805): Pushdown Accounting (a consensus of the FASB Emerging Issues Task Force). The amendments in this Update provide an
acquired entity with an option to apply pushdown accounting in its separate financial statements upon occurrence of an event in
which an acquirer obtains control of the acquired entity. The amendments in this Update are effective on November 18, 2014. After
the effective date, an acquired entity can make an election to apply the guidance to future change-in-control events or to its
most recent change-in-control event. However, if the financial statements for the period in which the most recent change-in-control
event occurred already have been issued or made available to be issued, the application of this guidance would be a change in
accounting principle.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
August 2014, The Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-15, Presentation of Financial
Statements &ndash; Going Concerns (Subtopic 205-40): Disclosures of Uncertainties about an Entity&rsquo;s Ability to Continue
as a Going Concern. The amendments require management to assess an entity&rsquo;s ability to continue as a going concern by incorporating
and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide
a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide
principles for considering the mitigating effect of management&rsquo;s plans, (4) require certain disclosures when substantial
doubt is alleviated as a result of consideration of management&rsquo;s plans, (5) require an express statement and other disclosures
when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial
statements are issued (or available to be issued). The amendments in this Update are effective for the annual period ending after
December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 40; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
June 2014, the Financial Accounting Standards Board (&ldquo;FASB&rdquo;) issued Accounting Standards Update (&ldquo;ASU&rdquo;)
2014-10, &ldquo;Development Stage Entities&rdquo;. The amendments in this update remove the definition of a development stage
entity from the Master Glossary of the ASC thereby removing the financial reporting distinction between development stage entities
and other reporting entities from U.S. GAAP. In addition, the amendments eliminate the requirements for development stage entities
to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial
statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the
entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior
years it had been in the development stage. The amendments in this update are applied retrospectively. The adoption of ASU 2014-10
removed the development stage entity financial reporting requirements from the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
June 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-12, Compensation
&ndash; Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance
Target Could Be Achieved after the Requisite Service Period. The new guidance requires that share-based compensation that require
a specific performance target to be achieved in order for employees to become eligible to vest in the awards and that could be
achieved after an employee completes the requisite service period be treated as a performance condition. As such, the performance
target should not be reflected in estimating the grant-date fair value of the award. Compensation costs should be recognized in
the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost
attributable to the period(s) for which the requisite service has already been rendered. If the performance target becomes probable
of being achieved before the end of the requisite service period, the remaining unrecognized compensation cost should be recognized
prospectively over the remaining requisite service period. The total amount of compensation cost recognized during and after the
requisite service period should reflect the number of awards that are expected to vest and should be adjusted to reflect those
awards that ultimately vest. The requisite service period ends when the employee can cease rendering service and still be eligible
to vest in the award if the performance target is achieved. This new guidance is effective for fiscal years and interim periods
within those years beginning after December 15, 2015. Early adoption is permitted. Entities may apply the amendments in this Update
either (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with
performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements
and to all new or modified awards thereafter. The adoption of ASU 2014-12 is not expected to have a material impact on our financial
position or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
June 2014, the FASB issued ASU No. 2014-10: Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting
Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation , to improve financial
reporting by reducing the cost and complexity associated with the incremental reporting requirements of development stage entities.
The amendments in this update remove all incremental financial reporting requirements from U.S. GAAP for development stage entities,
thereby improving financial reporting by eliminating the cost and complexity associated with providing that information. The amendments
in this Update also eliminate an exception provided to development stage entities in Topic 810, Consolidation, for determining
whether an entity is a variable interest entity on the basis of the amount of investment equity that is at risk. The amendments
to eliminate that exception simplify U.S. GAAP by reducing avoidable complexity in existing accounting literature and improve
the relevance of information provided to financial statement users by requiring the application of the same consolidation guidance
by all reporting entities. The elimination of the exception may change the consolidation analysis, consolidation decision, and
disclosure requirements for a reporting entity that has an interest in an entity in the development stage. The amendments related
to the elimination of inception-to-date information and the other remaining disclosure requirements of Topic 915 should be applied
retrospectively except for the clarification to Topic 275, which shall be applied prospectively. For public companies, those amendments
are effective for annual reporting periods beginning after December 15, 2014, and interim periods therein. Early adoption is permitted.
The adoption of ASU 2014-10 is not expected to have a material impact on our financial position or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
July 2013, FASB issued ASU No. 2013-11, &ldquo;Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward,
a Similar Tax Loss, or a Tax Credit Carryforward Exists.&rdquo; The provisions of ASU No. 2013-11 require an entity to present
an unrecognized tax benefit, or portion thereof, in the statement of financial position as a reduction to a deferred tax asset
for a net operating loss carryforward or a tax credit carryforward, with certain exceptions related to availability. ASU No. 2013-11
is effective for interim and annual reporting periods beginning after December 15, 2013. The adoption of ASU No. 2013-11 is not
expected to have a material impact on the Company&rsquo;s Consolidated Financial Statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
February 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2013-02, Comprehensive
Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, to improve the transparency
of reporting these reclassifications. Other comprehensive income includes gains and losses that are initially excluded from net
income for an accounting period. Those gains and losses are later reclassified out of accumulated other comprehensive income into
net income. The amendments in the ASU do not change the current requirements for reporting net income or other comprehensive income
in financial statements. All of the information that this ASU requires already is required to be disclosed elsewhere in the financial
statements under U.S. GAAP. The new amendments will require an organization to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 41; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Present
    (either on the face of the statement where net income is presented or in the notes) the effects on the line items of net income
    of significant amounts reclassified out of accumulated other comprehensive income - but only if the item reclassified is required
    under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">&#9679;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Cross-reference
    to other disclosures currently required under U.S. GAAP for other reclassification items (that are not required under U.S.
    GAAP) to be reclassified directly to net income in their entirety in the same reporting period. This would be the case when
    a portion of the amount reclassified out of accumulated other comprehensive income is initially transferred to a balance sheet
    account (e.g., inventory for pension-related amounts) instead of directly to income or expense.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
amendments apply to all public and private companies that report items of other comprehensive income. Public companies are required
to comply with these amendments for all reporting periods (interim and annual). The amendments are effective for reporting periods
beginning after December 15, 2012, for public companies. Early adoption is permitted. The adoption of ASU No. 2013-02 is not expected
to have a material impact on our financial position or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
January 2013, the FASB issued ASU No. 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting
Assets and Liabilities, which clarifies which instruments and transactions are subject to the offsetting disclosure requirements
originally established by ASU 2011-11. The new ASU addresses preparer concerns that the scope of the disclosure requirements under
ASU 2011-11 was overly broad and imposed unintended costs that were not commensurate with estimated benefits to financial statement
users. In choosing to narrow the scope of the offsetting disclosures, the Board determined that it could make them more operable
and cost effective for preparers while still giving financial statement users sufficient information to analyze the most significant
presentation differences between financial statements prepared in accordance with U.S. GAAP and those prepared under IFRSs. Like
ASU 2011-11, the amendments in this update will be effective for fiscal periods beginning on, or after January 1, 2013. The adoption
of ASU 2013-01 is not expected to have a material impact on our financial position or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Going
concern:</I> The accompanying financial statements have been prepared in conformity with accounting principles generally accepted
in the United States of America, which contemplate continuation of the Company as a going concern. The Company has not established
any source of revenue to cover its operating costs, and as such, has incurred an operating loss since inception. Further, as of
December 31, 2014, the cash resources of the Company were insufficient to meet its current business plan, and the Company had
negative working capital. These and other factors raise substantial doubt about the Company&rsquo;s ability to continue as a going
concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability
and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the
Company to continue as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
2. Stockholders&rsquo; Equity.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company has 1,000,000 ordinary and 2 management shares authorized, of these 100,000 ordinary shares were issued on March 7, 2010,
one management share issued on July 25, 2013 and 113,000 ordinary shares issued on November 7, 2014. The ordinary shares have
a par value ILS 0.01 or $0.002638 and management share have a par value 1 ILS or USD $0.2795.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Recent
Issuances of Common Stock</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
July 25, 2013, one management share was issued for ILS 1 or $0.28 and recorded as a stock receivable as of December 31, 2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
issued 113,000 ordinary shares on November 7, 2014 to Mr. Lior Wayn at ILS 1,000 or $297, since Mr. Wayn has not paid for these
shares yet and this amount was recorded as stock receivable as of December 31, 2014</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
3. Related Party transactions not disclosed elsewhere.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
CEO and principal shareholder was issued 1 management share on July 25, 2013 for ILS 1 or $0.28 and 113,000 ordinary shares issued
on November 7, 2014 for ILS 1,000 or $297.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
addition during 2014 our CEO and principal shareholder has withdrawn travel expense advances and other payments resulting in net
amount due to company of $18,999 as of December 31, 2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">During
November 2014 four individuals loaned amount to company, one of them is CEO of Zaxis International Ltd who the company is in merger
discussion with, who on November 16, 2014 loaned the amount of $19,521 with maturity date of November 16, 2015 and bearing an
interest rate of 8% per annum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 42; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">One
consultant who on January 1, 2015 became Emerald&rsquo;s VP of operations was owed $4,439, as of December 31, 2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
4. Notes Payable.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Non-Convertible
Notes Payable</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">During
November 2014 four individuals loaned amount to company, totaling $87,910 with maturity dates of November 16, 2015 and bearing
an interest rate of 8% per annum, and is not convertible to common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">For
the period ended December 31, 2014 the Company has recognized $2,013 in accrued interest expense related to the stated interest
rate on the notes. Interest expense in 2013 was $0.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
5. Derivative Liabilities and Convertible Notes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
July 8, 2014 the company issued a convertible promissory note to Axel Springer Plug &amp; Play Accelerator GmbH (the &ldquo;Holder&rdquo;),
in the amounts of &euro;25,000 (Euros)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Convertible Notes are convertible at the lessor of a market based discounted and a fixed rate derived from a fixed market cap.
The Holders have the right following the Date of Issuance, and until any time until the convertible Promissory Note is fully paid,
to convert any outstanding and unpaid principal portion of the Convertible Promissory Note, and accrued interest, into fully paid
and non&ndash;assessable shares of Common Stock. The Holder was not issued warrants with the Convertible Promissory Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following shows the changes in the derivative liability measured on a recurring basis for the twelve months ended December 31,
2014, and December 31, 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level
    3</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Derivative Liability at December
    31, 2012</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Additions to Derivative
    Liability related to Convertible Debt</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Derivative Liability at December 31, 2013</FONT></TD><TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 80%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Additions
    to Derivative Liability related to Convertible Debt</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">20,532</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Derivative Liability at December
    31, 2014</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">20,532</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">For
the period ended December 31, 2014 the company incurred $7,385 expense relating to change in fair value of derivative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2014 the company has $20,532 derivative liability and $20,164 convertible note payable, net of discount of $9,555.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
accordance to ASC #815, Accounting for Derivative Instruments and Hedging Activities, we evaluated the holder&rsquo;s non-detachable
conversion right provision and liquidated damages clause, contained in the terms governing the Note to determine whether the features
qualify as an embedded derivative instruments at issuance. Such non-detachable conversion right provision and liquidated damages
clause did not need to be accounted for as derivative financial instruments. Additionally, since the conversion price of the two
notes represented the fair market value of the Company&rsquo;s common stock at the time of issuance, no beneficial conversion
feature exists. We believe that the Company&rsquo;s shares of common stock is and have been very thinly traded during the last
3 years and that the fair value of the stock price was deemed not to be a fair value. Management decided that because the Company&rsquo;s
ability to continue as a going concern was in question and that it has no revenue sources that the conversion price was a better
measure of fair market value. Based on that decision, no beneficial conversion feature was reflected in the financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
6. Other Receivables</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2014, the Company had other receivables of $6,718 which represent VAT refunds claimed resulting from excess VAT
paid over VAT received. These claims were subsequently collected during the period ended June 30, 2015.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
7. Income Taxes. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company is not under examination by any jurisdiction for any tax year. Our Israeli income tax returns are open for fiscal years
ending on or after December 31, 2010.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
8. Subsequent Events.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">During
the first and second quarters of 2015, the Company receive additional loans from Zaxis International. Inc., in contemplation of
the Closing of the Share Exchange Agreement. On July 14, 2015, the Closing occurred and the Company became a 100% owned subsidiary
of Zaxis International, Inc. In connection with the Closing, Zaxis International, Inc. acquired all of the shares of Emerald in
exchange for: (i) the issuance of 5,474,545 restricted Shares to Lior Wayn; and (ii) the issuance of Class E Warrants to Lior
Wayn. The Class E Warrants are exercisable to purchase a total of 2,700,000 Shares, in three equal tranches of 900,000 Shares
each (the &ldquo;Tranches&rdquo;) at an exercise price of $0.0001 per Share, subject to and within 45 days of the Registrant achieving
the milestones defined herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 43; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-underline-style: double"><B><U>Emerald
Medical Applications Ltd.</U>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_007"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>BALANCE
SHEETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>AS
OF MARCH 31, 2015 AND DECEMBER 31, 2014</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>March
    31, 2015</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2014</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>$</B></TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>$</B></TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ASSETS</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-decoration: underline; text-align: left">Current Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 62%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">2,162</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">14,411</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Due from related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,276</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,999</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other Receivable</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">25,774</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">6,718</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total current
    assets</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>45,212</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>40,128</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FIXED ASSETS, NET</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Fixed assets, net of accumulated depreciation of $466 and $66, respectively</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">7,947</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">1,390</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL ASSETS
    </B></FONT></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>53,159</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>41,518</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LIABILITIES AND SHAREHOLDERS&rsquo;
    DEFICIT</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Current Liabilities:</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21,725</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,577</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts payable - related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,094</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,439</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Employee Payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,496</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accrued interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,425</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,013</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,531</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Short term notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,187</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">68,389</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Short term notes payable - related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,521</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,521</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Convertible note payable, net of discount of $7,484 and $9,555, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,235</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,164</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Derivative Liability</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">20,165</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">20,532</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL CURRENT
    LIABILITIES </B></FONT></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>339,379</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>137,635</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL LIABILITIES
    </B></FONT></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>339,379</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>137,635</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SHAREHOLDERS&rsquo; DEFICIT </B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Common stock, ordinary shares par value $0.002638, management shares par value $0.2795, 1,000,000
    ordinary and 2 management shares authorized, 213,000 ordinary shares and 1 management share issued and outstanding at March
    31, 2015 and December 31, 2014.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">562</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">562</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(265</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(265</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stock Receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(297</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(297</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other Comprehensive Income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(847</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,932</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accumulated Deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(285,373</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(105,049</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL SHAREHOLDER
    EQUITY </B></FONT></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>(286,220</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>)</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>(96,117</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>)</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total Liabilities
    and Shareholders&rsquo; Deficit </B></FONT></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>53,159</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>41,518</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
summary of significant accounting policies and notes to financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Emerald
Medical Applications Ltd</U></B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_008"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>STATEMENTS
OF OPERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FOR
THE THREE MONTHS ENDED MARCH 31, 2015 AND MARCH 31, 2014</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Three months</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Three months</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ended</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ended</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>March
    31, 2015</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>March
    31, 2014</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>$</B></TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>$</B></TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Revenues</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Research and Development expenses</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">10,305</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">G&amp;A Expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">168,821</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total Operating
    Expenses</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">179,126</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(179,126</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other income (expense):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,483</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Change in fair value of derivative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">367</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Gain/(loss) from foreign currency</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">5,918</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total costs and expenses</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(180,324</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(180,324</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(0.85</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Weighted average shares outstanding (basic and diluted)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">213,001</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">100,001</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">See summary of significant
accounting policies and notes to financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;
&nbsp; &nbsp; &nbsp;</P>


<!-- Field: Page; Sequence: 45; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Emerald
Medical Applications Ltd.&nbsp;</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_009"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Statements
of Comprehensive Income (Loss)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FOR
THE THREE MONTHS ENDED MARCH 31, 2015 AND MARCH 31, 2014</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B>&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Three months</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Three months</TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">ended</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">ended</TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31, 2015</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31, 2014</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left; padding-bottom: 1.5pt">Foreign currency translation gain (loss)</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 14%; text-align: right; border-bottom: Black 1.5pt solid">(9,779</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 14%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total comprehensive gain (loss)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(190,103</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
summary of significant accounting policies and notes to financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Emerald
Medical Applications Ltd.&nbsp;</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_010"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>STATEMENTS
OF CHANGES IN STOCKHOLDERS&rsquo; EQUITY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FOR
THE PERIOD ENDED MARCH 31, 2015 AND YEARS ENDED DECEMBER 31, 2014 AND 2013</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Common Stock</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Additional</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Share</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Other</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Number of</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Par</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Paid-In</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Subscription</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Comprehensive</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Accumulated</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Shareholders&rsquo;</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Shares</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Value</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Capital</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Receivable</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Income</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Deficit</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Deficit</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 34%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Balance at December 31, 2013</B></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">100,001</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">265</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">(265</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Common stock subscribed</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">113,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">297</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(297</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other comprehensive income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,932</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,932</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(105,049</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(105,049</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Balance at December 31, 2014</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">213,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">562</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(265</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(297</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,932</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(105,049</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(96,117</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other comprehensive loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,779</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,779</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(180,324</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(180,324</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Balance at March 31, 2015</B></FONT></TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">213,001</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">562</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(265</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(297</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(847</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(285,373</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">(286,220</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">)</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">See summary of significant
accounting policies and notes to financial statements.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><U>Emerald
Medical Applications Ltd.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_011"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>STATEMENTS
OF CASH FLOWS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FOR
THE THREE MONTHS ENDED MAR 31, 2015 AND DECEMBER 31, 2014</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Three months</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Three months</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ended</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ended</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>March
    31, 2015</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>March
    31, 2014</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 65%; text-align: left">Net (loss)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 2%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">(180,324</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Adjustments to reconcile net (loss) to net cash (used in) operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Change in fair value of derivative liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(367</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Depreciation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">399</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Amortization of debt discount</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,071</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Changes in net assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Due from related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,723</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(19,056</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,148</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounts payable - related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(345</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Employee payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,496</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accrued interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,412</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">34,531</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(127,312</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Investing Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Purchase of property and equipment</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(6,956</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(6,956</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Financing Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Issuance of short-term notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">131,798</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net cash provided by financing activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">131,798</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Foreign currency adjustment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,779</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net increase in cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,470</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents - beginning of period</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">14,411</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents - end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">2,162</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Non cash transactions:</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subscription of common stock for stock
    receivable</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">See summary of significant accounting policies and notes to financial
statements.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>EMERALD
MEDICAL APPLICATIONS LTD. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_012"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notes
to the Financial Statements</FONT><BR>
<FONT STYLE="font: 10pt Times New Roman, Times, Serif">March 31, 2015 and December 31, 2014</FONT><BR><FONT STYLE="font: 10pt Times New Roman, Times, Serif">
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
1. The Company and Significant Accounting Policies.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Organizational
Background:</I> Emerald Medical Applications Ltd (&ldquo;Emerald&rdquo;), is a company organized under the laws of the State of
Israel on February 17, 2010. Emerald is digital health Startup Company engaged in the development, sale and service of imaging
solutions utilizing its proprietary DermaCompare software that it developed for use in derma imaging and analytics (&ldquo;DermaCompare&rdquo;).
Emerald believes that its proprietary DermaCompare software represents an advancement in skin cancer screening that should enable
physicians to more readily identify and monitor changes in their patients&rsquo; skin characteristics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Emerald&rsquo;s
DermaCompare solution allows dermatologists and other medical care professionals, using a set of 25 total body photography (&ldquo;TBP&rdquo;),
to capture sets of skin lesion images with, among other devices, digital cameras, camera-equipped smartphones or tablets. These
images are then transmitted online and are remotely analyzed by professionals using our DermaCompare software.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
sales and marketing plan is to sell licenses for our DermaCompare imaging software to: NHSs, HMOs, health insurance companies,
hospitals and medical clinics through distributers, health care channel partners or directly through independent salespersons
and/or web purchase to dermatologists and other physicians (GPs) that we expect to purchase licenses based on the number of potential
numbers of patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Basis
of Presentation and going concern:</I> The accompanying financial statements have been prepared in conformity with accounting
principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern.
The Company has not established any source of revenue to cover its operating costs, and as such, has incurred an operating loss
since inception. Further, as of March 31, 2015, the cash resources of the Company were insufficient to meet its current business
plan, and the Company had negative working capital. These and other factors raise substantial doubt about the Company&rsquo;s
ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible
future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result
from the possible inability of the Company to continue as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Significant
Accounting Policies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Use
of Estimates:</I> The preparation of financial statements in conformity with generally accepted accounting principles requires
management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting
period. Actual results could differ from the estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Cash
and Cash Equivalents:</I> For financial statement presentation purposes, the Company considers those short-term, highly liquid
investments with original maturities of three months or less to be cash or cash equivalents. There were no cash equivalents as
of March 31, 2015 and December 31, 2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Other
receivables:</I> The company treats VAT refunds claimed resulting from excess VAT paid over VAT received as other receivables,
amount shown as other receivables as of March 31, 2015 and December 31, 2014 were collected in Q2 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Currency
translation and </I>other comprehensive income: balance sheet items are translated using all-current translation method for Self-contained
foreign operations (where functional currency = foreign currency) whereby assets and liabilities are translated using the exchange
rate on the date of the balance sheet. It translates revenues, expenses, and net income using the average exchange rate during
the period. The foreign exchange adjustment that results from applying the all-current method appears in other comprehensive income,
a separate shareholders&rsquo; equity account, and does not affect net income each period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Property
and Equipment:</I> Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the
straight-line method over the estimated useful lives of the assets. The annual depreciation rates are as follows: Computers and
electronic equipment 33%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Valuation
of Long-Lived Assets:</I> We review the recoverability of our long-lived assets including equipment, goodwill and other intangible
assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable.
The assessment of possible impairment is based on our ability to recover the carrying value of the asset from the expected future
pre-tax cash flows (undiscounted and without interest charges) of the related operations. If these cash flows are less than the
carrying value of such asset, an impairment loss is recognized for the difference between estimated fair value and carrying value.
Our primary measure of fair value is based on discounted cash flows. The measurement of impairment requires management to make
estimates of these cash flows related to long-lived assets, as well as other fair value determinations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 49; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Stock
Based Compensation:</I> Stock-based awards are accounted for using the fair value method in accordance with ASC 718, Share-Based
Payments. Our primary type of share-based compensation consists of stock options. We use the Black-Scholes option pricing model
in valuing options. The inputs for the valuation analysis of the options include the market value of the Company&rsquo;s common
stock, the estimated volatility of the Company&rsquo;s common stock, the exercise price of the warrants and the risk free interest
rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Accounting
For Obligations And Instruments Potentially To Be Settled In The Company&rsquo;s Own Stock: We account for obligations and instruments
potentially to be settled in the Company&rsquo;s stock in accordance with FASB ASC 815, Accounting for Derivative Financial Instruments.
This issue addresses the initial balance sheet classification and measurement of contracts that are indexed to, and potentially
settled in, the Company&rsquo;s own stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Fair
Value of Financial Instruments:</I> FASB ASC 825, &ldquo;Financial Instruments,&rdquo; requires entities to disclose the fair
value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is
practicable to estimate fair value. FASB ASC 825 defines fair value of a financial instrument as the amount at which the instrument
could be exchanged in a current transaction between willing parties. At March 31, 2015 and December 31, 2014, the carrying value
of certain financial instruments (cash and cash equivalents, accounts payable and accrued expenses.) approximates fair value due
to the short-term nature of the instruments or interest rates, which are comparable with current rates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Fair
Value Measurements: The Company adopted the FASB standard related to fair value measurement at inception. The standard defines
fair value, establishes a framework for measuring fair value and expands disclosure of fair value measurements. The standard applies
under other accounting pronouncements that require or permit fair value measurements and, accordingly, does not require any new
fair value measurements. The standard clarifies that fair value is an exit price, representing the amount that would be received
to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is
a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset
or liability.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
a basis for considering such assumptions, the standard established a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value as follows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level
1. Observable inputs such as quoted prices in active markets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level
2. Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Level
3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company values its derivative instruments related to embedded conversion features and warrants from the issuance of convertible
debentures in accordance with the Level 3 guidelines. For the three month period ended March 31, 2015 and the twelve months period
ending December 31, 2014, the following table reconciles the beginning and ending balances for financial instruments that are
recognized at fair value in these consolidated financial statements. The fair value of embedded conversion features that have
floating conversion features and tainted common stock equivalents (warrants and convertible debt) are estimated using a Binomial
Lattice model. The key inputs to this valuation model as of December 31, 2014, were: Volatility of 143.9% for the three month
period ended March 31, 2015 and 132.4% for the twelve months period ending December 31, 2014, inherent term of instruments equal
to the remaining contractual term, quoted closing stock prices on valuation dates, and various settlement scenarios and probability
percentages summing to 100%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Fair
Value Measurements at March 31, 2015</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"></TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Balance at<BR>
    December 31, 2014</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">New Issuances</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Settlements</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Change in<BR>
    Fair Value</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Balance at<BR>
    March 31, 2015</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Level 3 - Derivative liabilities from:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 29%; text-align: left; padding-bottom: 1.5pt">Convertible Note</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 16%; text-align: right; border-bottom: Black 1.5pt solid">20,532</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 6%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 6%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid">(367</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 14%; text-align: right; border-bottom: Black 1.5pt solid">20,165</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Fair
Value Measurements at December 31, 2014</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Balance at<BR> December 31, 2013</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">New Issuances</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Settlements</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Change in <BR> Fair Value</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Balance at <BR> March 31, 2015</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Level 3 - Derivative liabilities from:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 29%; text-align: left">Convertible Note</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 16%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 6%; text-align: right; border-bottom: Black 1.5pt solid">13,147</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 6%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid">7,385</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="width: 14%; text-align: right; border-bottom: Black 1.5pt solid">20,532</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Changes
in the unobservable input values would likely cause material changes in the fair value of the Company&rsquo;s Level 3 financial
instruments. The significant unobservable input used in the fair value measurement is the estimation for probability percentages
assigned to future expected settlement possibilities. A significant increase (decrease) in this distribution of percentages would
result in a higher (lower) fair value measurement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following table presents assets and liabilities that were measured and recognized at fair value as of March 31, 2015 and December
31, 2014 and the three months and year then ended on a recurring basis:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Description</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Fair
Value Measurements at March 31, 2015</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Level 1</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Level 2</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Level 3</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Total <BR>
    Unrealized Loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 42%; text-align: left">3/31/15 Derivative Liability</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">20,165</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">20,165</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">12/31/14 Derivative Liability</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">20,532</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">20,532</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 50; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balance sheets
as of March 31, 2015 and December 31, 2014:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Fair
Value Measurements at March 31, 2015</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Level
    3</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center">ASSETS</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: right; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: right; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total
    Assets</B></FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"><B>$</B></TD><TD STYLE="width: 26%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LIABILITIES </B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Derivative liability</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">20,165</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total Liabilities</B></FONT></TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">20,165</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Fair
Value Measurements at December 31, 2014</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Level
    3</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><B>ASSETS</B></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total
    Assets</B></FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"><B>$</B></TD><TD STYLE="width: 26%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LIABILITIES </B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Derivative liability</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">20,532</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total Liabilities</B></FONT></TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">20,532</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
fair values of our debts are deemed to approximate book value, and are considered Level 2 inputs as defined by ASC Topic 820-10-35.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">There
were no transfers of financial assets or liabilities between Level 1, Level 2 and Level 3 inputs for the three months ended March
31, 2015 or the year ended December 31, 2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company had no other assets or liabilities valued at fair value on a recurring or non-recurring basis as of March 31, 2015 or
December 31, 2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Earnings
per Common Share:</I> We compute net income (loss) per share in accordance with <I>ASC 260, Earning per Share</I>. ASC 260 requires
presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by
dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator)
during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury
stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price
for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants.
Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Income
Taxes:</I> We have adopted FASB ASC 740, <I>Accounting for Income Taxes</I>. Pursuant to ASC 740, we are required to compute tax
asset benefits for net operating losses carried forward. The potential benefits of net operating losses have not been recognized
in these financial statements because the Company cannot be assured it is more likely than not it will utilize the net operating
losses carried forward in future years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
must make certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates
and judgments occur in the calculation of certain tax assets and liabilities, which arise from differences in the timing of recognition
of revenue and expense for tax and financial statement purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Deferred
tax assets and liabilities are determined based on the differences between financial reporting and the tax basis of assets and
liabilities using the tax rates and laws in effect when the differences are expected to reverse. ASC 740 provides for the recognition
of deferred tax assets if realization of such assets is more likely than not to occur. Realization of our net deferred tax assets
is dependent upon our generating sufficient taxable income in future years in appropriate tax jurisdictions to realize benefit
from the reversal of temporary differences and from net operating loss, or NOL, carryforwards. We have determined it more likely
than not that these timing differences will not materialize and have provided a valuation allowance against substantially all
of our net deferred tax asset. Management will continue to evaluate the realizability of the deferred tax asset and its related
valuation allowance. If our assessment of the deferred tax assets or the corresponding valuation allowance were to change, we
would record the related adjustment to income during the period in which we make the determination. Our tax rate may also vary
based on our results and the mix of income or loss in domestic and foreign tax jurisdictions in which we operate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 51; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations.
We recognize liabilities for anticipated tax audit issues in the U.S. and other tax jurisdictions based on our estimate of whether,
and to the extent to which, additional taxes will be due. If we ultimately determine that payment of these amounts is unnecessary,
we will reverse the liability and recognize a tax benefit during the period in which we determine that the liability is no longer
necessary. We will record an additional charge in our provision for taxes in the period in which we determine that the recorded
tax liability is less than we expect the ultimate assessment to be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ASC
740 which requires recognition of estimated income taxes payable or refundable on income tax returns for the current year and
for the estimated future tax effect attributable to temporary differences and carry-forwards. Measurement of deferred income tax
is based on enacted tax laws including tax rates, with the measurement of deferred income tax assets being reduced by available
tax benefits not expected to be realized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Uncertain
Tax Positions:</I> When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination
by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the
position that would be ultimately sustained. In accordance with the guidance of FASB ASC 740-10, <I>Accounting for Uncertain Income
Tax Positions</I>, the benefit of a tax position is recognized in the financial statements in the period during which, based on
all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including
the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.
Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that
is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits
associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for
unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that
would be payable to the taxing authorities upon examination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
federal and state income tax returns are open for fiscal years ending on or after December 31, 2011. We are not under examination
by any jurisdiction for any tax year. At March 31, 2015 we had no material unrecognized tax benefits and no adjustments to liabilities
or operations were required under FIN 48.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Recent
Accounting Pronouncements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
November 2014, The Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-16&mdash;Derivatives
and Hedging (Topic 815): Determining Whether the Host Contract in a Hybrid Financial Instrument Issued in the Form of a Share
Is More Akin to Debt or to Equity (a consensus of the FASB Emerging Issues Task Force). The amendments in this Update do not change
the current criteria in GAAP for determining when separation of certain embedded derivative features in a hybrid financial instrument
is required. That is, an entity will continue to evaluate whether the economic characteristics and risks of the embedded derivative
feature are clearly and closely related to those of the host contract, among other relevant criteria. The amendments clarify how
current GAAP should be interpreted in evaluating the economic characteristics and risks of a host contract in a hybrid financial
instrument that is issued in the form of a share. The effects of initially adopting the amendments in this Update should be applied
on a modified retrospective basis to existing hybrid financial instruments issued in the form of a share as of the beginning of
the fiscal year for which the amendments are effective. Retrospective application is permitted to all relevant prior periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
November 2014, The Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-17&mdash;Business Combinations
(Topic 805): Pushdown Accounting (a consensus of the FASB Emerging Issues Task Force). The amendments in this Update provide an
acquired entity with an option to apply pushdown accounting in its separate financial statements upon occurrence of an event in
which an acquirer obtains control of the acquired entity. The amendments in this Update are effective on November 18, 2014. After
the effective date, an acquired entity can make an election to apply the guidance to future change-in-control events or to its
most recent change-in-control event. However, if the financial statements for the period in which the most recent change-in-control
event occurred already have been issued or made available to be issued, the application of this guidance would be a change in
accounting principle.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
August 2014, The Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2014-15, Presentation of Financial
Statements &ndash; Going Concerns (Subtopic 205-40): Disclosures of Uncertainties about an Entity&rsquo;s Ability to Continue
as a Going Concern. The amendments require management to assess an entity&rsquo;s ability to continue as a going concern by incorporating
and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide
a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide
principles for considering the mitigating effect of management&rsquo;s plans, (4) require certain disclosures when substantial
doubt is alleviated as a result of consideration of management&rsquo;s plans, (5) require an express statement and other disclosures
when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial
statements are issued (or available to be issued). The amendments in this Update are effective for the annual period ending after
December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 52; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
June 2014, the Financial Accounting Standards Board (&ldquo;FASB&rdquo;) issued Accounting Standards Update (&ldquo;ASU&rdquo;)
2014-10, &ldquo;Development Stage Entities&rdquo;. The amendments in this update remove the definition of a development stage
entity from the Master Glossary of the ASC thereby removing the financial reporting distinction between development stage entities
and other reporting entities from U.S. GAAP. In addition, the amendments eliminate the requirements for development stage entities
to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial
statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the
entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior
years it had been in the development stage. The amendments in this update are applied retrospectively. The adoption of ASU 2014-10
removed the development stage entity financial reporting requirements from the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
June 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-12, Compensation
&ndash; Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance
Target Could Be Achieved after the Requisite Service Period. The new guidance requires that share-based compensation that require
a specific performance target to be achieved in order for employees to become eligible to vest in the awards and that could be
achieved after an employee completes the requisite service period be treated as a performance condition. As such, the performance
target should not be reflected in estimating the grant-date fair value of the award. Compensation costs should be recognized in
the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost
attributable to the period(s) for which the requisite service has already been rendered. If the performance target becomes probable
of being achieved before the end of the requisite service period, the remaining unrecognized compensation cost should be recognized
prospectively over the remaining requisite service period. The total amount of compensation cost recognized during and after the
requisite service period should reflect the number of awards that are expected to vest and should be adjusted to reflect those
awards that ultimately vest. The requisite service period ends when the employee can cease rendering service and still be eligible
to vest in the award if the performance target is achieved. This new guidance is effective for fiscal years and interim periods
within those years beginning after December 15, 2015. Early adoption is permitted. Entities may apply the amendments in this Update
either (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with
performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements
and to all new or modified awards thereafter. The adoption of ASU 2014-12 is not expected to have a material impact on our financial
position or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
June 2014, the FASB issued ASU No. 2014-10: Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting
Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation , to improve financial
reporting by reducing the cost and complexity associated with the incremental reporting requirements of development stage entities.
The amendments in this update remove all incremental financial reporting requirements from U.S. GAAP for development stage entities,
thereby improving financial reporting by eliminating the cost and complexity associated with providing that information. The amendments
in this Update also eliminate an exception provided to development stage entities in Topic 810, Consolidation, for determining
whether an entity is a variable interest entity on the basis of the amount of investment equity that is at risk. The amendments
to eliminate that exception simplify U.S. GAAP by reducing avoidable complexity in existing accounting literature and improve
the relevance of information provided to financial statement users by requiring the application of the same consolidation guidance
by all reporting entities. The elimination of the exception may change the consolidation analysis, consolidation decision, and
disclosure requirements for a reporting entity that has an interest in an entity in the development stage. The amendments related
to the elimination of inception-to-date information and the other remaining disclosure requirements of Topic 915 should be applied
retrospectively except for the clarification to Topic 275, which shall be applied prospectively. For public companies, those amendments
are effective for annual reporting periods beginning after December 15, 2014, and interim periods therein. Early adoption is permitted.
The adoption of ASU 2014-10 is not expected to have a material impact on our financial position or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
July 2013, FASB issued ASU No. 2013-11, &ldquo;Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward,
a Similar Tax Loss, or a Tax Credit Carryforward Exists.&rdquo; The provisions of ASU No. 2013-11 require an entity to present
an unrecognized tax benefit, or portion thereof, in the statement of financial position as a reduction to a deferred tax asset
for a net operating loss carryforward or a tax credit carryforward, with certain exceptions related to availability. ASU No. 2013-11
is effective for interim and annual reporting periods beginning after December 15, 2013. The adoption of ASU No. 2013-11 is not
expected to have a material impact on the Company&rsquo;s Consolidated Financial Statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
February 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2013-02, Comprehensive
Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, to improve the transparency
of reporting these reclassifications. Other comprehensive income includes gains and losses that are initially excluded from net
income for an accounting period. Those gains and losses are later reclassified out of accumulated other comprehensive income into
net income. The amendments in the ASU do not change the current requirements for reporting net income or other comprehensive income
in financial statements. All of the information that this ASU requires already is required to be disclosed elsewhere in the financial
statements under U.S. GAAP. The new amendments will require an organization to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="padding-top: 0.1pt; padding-bottom: 0.1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">&#9679;</TD>
    <TD STYLE="padding-top: 0.1pt; padding-bottom: 0.1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Present
    (either on the face of the statement where net income is presented or in the notes) the effects on the line items of net income
    of significant amounts reclassified out of accumulated other comprehensive income - but only if the item reclassified is required
    under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-top: 0.1pt; padding-bottom: 0.1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-top: 0.1pt; padding-bottom: 0.1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-top: 0.1pt; padding-bottom: 0.1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0.1pt; padding-bottom: 0.1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Cross-reference
    to other disclosures currently required under U.S. GAAP for other reclassification items (that are not required under U.S.
    GAAP) to be reclassified directly to net income in their entirety in the same reporting period. This would be the case when
    a portion of the amount reclassified out of accumulated other comprehensive income is initially transferred to a balance sheet
    account (e.g., inventory for pension-related amounts) instead of directly to income or expense.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 53; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
amendments apply to all public and private companies that report items of other comprehensive income. Public companies are required
to comply with these amendments for all reporting periods (interim and annual). The amendments are effective for reporting periods
beginning after December 15, 2012, for public companies. Early adoption is permitted. The adoption of ASU No. 2013-02 is not expected
to have a material impact on our financial position or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
January 2013, the FASB issued ASU No. 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting
Assets and Liabilities, which clarifies which instruments and transactions are subject to the offsetting disclosure requirements
originally established by ASU 2011-11. The new ASU addresses preparer concerns that the scope of the disclosure requirements under
ASU 2011-11 was overly broad and imposed unintended costs that were not commensurate with estimated benefits to financial statement
users. In choosing to narrow the scope of the offsetting disclosures, the Board determined that it could make them more operable
and cost effective for preparers while still giving financial statement users sufficient information to analyze the most significant
presentation differences between financial statements prepared in accordance with U.S. GAAP and those prepared under IFRSs. Like
ASU 2011-11, the amendments in this update will be effective for fiscal periods beginning on, or after January 1, 2013. The adoption
of ASU 2013-01 is not expected to have a material impact on our financial position or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Going
concern:</I> The accompanying financial statements have been prepared in conformity with accounting principles generally accepted
in the United States of America, which contemplate continuation of the Company as a going concern. The Company has not established
any source of revenue to cover its operating costs, and as such, has incurred an operating loss since inception. Further, as of
March 31, 2015, the cash resources of the Company were insufficient to meet its current business plan, and the Company had negative
working capital. These and other factors raise substantial doubt about the Company&rsquo;s ability to continue as a going concern.
The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability
and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the
Company to continue as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
2. Stockholders&rsquo; Equity.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
company has 1,000,000 ordinary and 2 management shares authorized, of these 100,000 ordinary shares were issued on March 7, 2010,
1 management share issued on July 25, 2013 and 113,000 ordinary shares issued on November 7, 2014. The ordinary shares have a
par value ILS 0.01 or $0.002638 and management share have a par value 1 ILS or USD $0.2795.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Recent
Issuances of Common Stock</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
July 25, 2013 1 management share was issued for ILS 1 or $0.28 and recorded as a stock receivable as of March 31, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
issued 113,000 ordinary shares issued on November 7, 2014 to Mr. Lior Wayn at ILS 1,000 or $297, since Mr. Wayn has not paid for
these shares yet and this amount was recorded as stock receivable as of March 31, 2015</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
3. Related Party transactions not disclosed elsewhere.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our
CEO and principal shareholder was issued 1 management share on July 25, 2013 for ILS 1 or $0.28 and 113,000 ordinary shares issued
on November 7, 2014 for ILS 1,000 or $297.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
addition during 2014 and 2015 our CEO and principal shareholder has withdrawn travel expense advances and other payments resulting
in net amount due to company of $17,276 as of March 31, 2015 and $18,999 as of December 31, 2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">During
November 2014 four individuals loaned amount to company, one of them is CEO of Zaxis International Ltd who the company is in merger
discussion with, who on November 16, 2014 loaned the amount of $19,521 with maturity date of November 16, 2015 and bearing an
interest rate of 8% per annum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">One
consultant who on January 1, 2015 became Emerald&rsquo;s VP of operations was owed $4,094 and $4,439, as of March 31, 2015 and
December 31, 2014, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
February 5, 2015 Zaxis Intentional Inc. who the company is in merger discussion with, loaned the company an amount of $90,000,
the loan shall bear interest at the rate of one (1%) percent per annum (the &ldquo;Interest Rate&rdquo;) and shall be due and
payable ninety (90) days from the date of the Loan (the &ldquo;Maturity Date&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
4. Notes Payable.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>Non-Convertible
Notes Payable</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">During
November 2014 four individuals loaned amount to company, totaling $87,910 with maturity dates of November 16, 2015 and bearing
an interest rate of 8% per annum, and is not convertible to common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
February 5, 2015 Zaxis Intentional Inc. who the company is in merger discussion with, loaned the company an amount of $90,000,
the loan shall bear interest at the rate of one (1%) percent per annum (the &ldquo;Interest Rate&rdquo;) and shall be due and
payable ninety (90) days from the date of the Loan (the &ldquo;Maturity Date&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
March 31, 2015 Chief Scientist Ministry of Israel loaned the company an amount of $41,798 the loan bears no interest and shall
be due and payable when the company generates sales revenue from product in development.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 54; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">For
the periods ended March 31, 2015 and December 31, 2014 the Company has recognized $7,425 and $2,013, respectively, in accrued
interest expense related to the stated interest rate on the notes. Interest expense for the periods ended March 31, 2015 and March
31, 2014, respectively, were $7,483 and $0, of which $2,071 and $0 are from the amortization of debt discount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
5. Derivative Liabilities and Convertible Notes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">On
July 8, 2014 the company issued a convertible promissory note to Axel Springer Plug &amp; Play Accelerator GmbH (the &ldquo;Holder&rdquo;),
in the amounts of &euro;25,000 (Euros)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Convertible Notes are convertible at the lessor of a market based discounted and a fixed rate derived from a fixed market cap.
The Holders have the right following the Date of Issuance, and until any time until the convertible Promissory Note is fully paid,
to convert any outstanding and unpaid principal portion of the Convertible Promissory Note, and accrued interest, into fully paid
and non&ndash;assessable shares of Common Stock. The Holder was not issued warrants with the Convertible Promissory Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The following
shows the changes in the derivative liability measured on a recurring basis for the twelve months ended March 31, 2015, and December
31, 2014.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Level 3</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Derivative Liability at December 31, 2013</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 71%; text-align: left; padding-bottom: 1.5pt">Additions to Derivative Liability related to Convertible Debt</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 25%; text-align: right; border-bottom: Black 1.5pt solid">20,532</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Derivative Liability at December 31, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,532</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Change in Fair Value of Derivative Liability</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(367</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Derivative Liability at March 31, 2015</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">20,165</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">For
the periods ended March 31, 2015 and December 31, 2014 the Company has recognized $7,425 and $2,013, respectively, in accrued
interest expense related to the stated interest rate on the notes. Interest expense for the periods ended March 31, 2015 and March
31, 2014, respectively, were $7,483 and $0, of which $2,071 and $0 is from the amortization of debt discount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2014 the company has $20,532 derivative liability and $20,164 convertible note payable, net of discount of $9,555.
As of March 31, 2015 the company has $20,165 derivative liability and $22,235 convertible note payable, net of discount of $7,484.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
accordance to ASC #815, Accounting for Derivative Instruments and Hedging Activities, we evaluated the holder&rsquo;s non-detachable
conversion right provision and liquidated damages clause, contained in the terms governing the Note to determine whether the features
qualify as an embedded derivative instruments at issuance. Such non-detachable conversion right provision and liquidated damages
clause did not need to be accounted for as derivative financial instruments. Additionally, since the conversion price of the two
notes represented the fair market value of the Company&rsquo;s common stock at the time of issuance, no beneficial conversion
feature exists. We believe that the Company&rsquo;s shares of common stock is and have been very thinly traded during the last
3 years and that the fair value of the stock price was deemed not to be a fair value. Management decided that because the Company&rsquo;s
ability to continue as a going concern was in question and that it has no revenue sources that the conversion price was a better
measure of fair market value. Based on that decision, no beneficial conversion feature was reflected in the financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
6. Other Receivables</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As
of March 31, 2015, the Company had other receivables of $25,774 which represent VAT refunds claimed resulting from excess VAT
paid over VAT received. These claims were subsequently collected during the period ended June 30, 2015.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
7. Income Taxes. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The Company
is not under examination by any jurisdiction for any tax year. Our Israeli income tax returns are open for fiscal years ending
on or after December 31, 2010.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
8. Subsequent Events.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">During
the second quarter of 2015, the Company receive additional loans from the Registrant in contemplation of the Closing of the Share
Exchange Agreement, in order to fund its operations. On July 14, 2015, the Closing occurred and the Company became a 100% owned
subsidiary of Zaxis International, Inc. In connection with the Closing, Zaxis International, Inc. acquired all of the shares of
Emerald in exchange for: (i) the issuance of 5,474,545 restricted Shares to Lior Wayn; and (ii) the issuance of Class E Warrants
to Lior Wayn. The Class E Warrants are exercisable to purchase a total of 2,700,000 Shares, in three equal tranches of 900,000
Shares each (the &ldquo;Tranches&rdquo;) at an exercise price of $0.0001 per Share, subject to and within 45 days of the Registrant
achieving the milestones defined herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ZAXIS
INTERNATIONAL, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_013"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PRO
FORMA CONDENSED CONSOLIDATED BALANCE SHEETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>AS
OF DECEMBER 31, 2014</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Zaxis International,
    Inc.</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Emerald Medical Applications
    Ltd. </B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pro forma</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pro forma</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2014</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2014</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Adjustments</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Combined</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>$</B></TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ASSETS</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><U>Current Assets</U></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 36%">Cash</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">1,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">14,411</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">15,411</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Due from related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,999</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,999</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other receivable</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">6,718</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">6,718</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total current
    assets</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>1,000</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>40,128</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>41,128</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Fixed assets, net of accumulated depreciation of $66 and $0, respectively</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">1,390</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">1,390</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL ASSETS</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>1,000</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>41,518</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>42,518</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LIABILITIES AND SHAREHOLDERS&rsquo;
    DEFICIT</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><U>Current liabilities</U></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,577</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10,077</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts payable - related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,439</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,439</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accrued interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,305</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,013</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,318</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">120,979</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">120,979</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Short term notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">68,389</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">68,389</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Short term notes payable - related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,521</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,521</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Convertible note payable, net of discount of $7,484 and $9,555, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,164</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,164</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Derivative liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,532</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,532</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total current
    liabilities</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>163,784</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>137,635</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>301,419</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><U>Long-term liabilities</U></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Notes payable</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">22,375</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">22,375</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL LIABILITIES</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>186,159</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>137,635</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>323,794</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SHAREHOLDERS&rsquo; DEFICIT</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Preferred stock, $0.001 par value; 10,000,000 shares authorized; none issued</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued Common stock, $0.0001 par value; 100,000,000
    shares authorized; 10,025,147 issued and outstanding at December 31, 2014</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">455</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">562</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(15)
                                         </FONT></TD><TD STYLE="text-align: left">(a)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,002</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">388,450</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(265</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(282)</FONT></TD><TD STYLE="text-align: left">(a)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">387,903</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stock Receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(297</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">297
                                         </FONT></TD><TD STYLE="text-align: left">(a)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other comprehensive income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,932</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,932</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(574,064</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(105,049</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(679,113</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL SHAREHOLDERS&rsquo;
    DEFICIT</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(185,159</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(96,117</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(281,276</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL LIABILITIES
    AND SHAREHOLDERS&rsquo; DEFICIT</B></FONT></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>1,000</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>41,518</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>42,518</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
summary of significant accounting policies and notes to financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ZAXIS
INTERNATIONAL, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><A NAME="a_014"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PRO
FORMA CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FOR
THE TWELVE MONTHS ENDED DECEMBER 31, 2014</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Zaxis International,
    Inc.</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Emerald Medical Applications
    Ltd. </B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pro forma</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pro forma</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2014</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2014</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Adjustments</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Combined</B></FONT></TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 36%; text-align: left; padding-bottom: 1.5pt">General and administrative</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 16%; text-align: right; border-bottom: Black 1.5pt solid">(28,125</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 16%; text-align: right; border-bottom: Black 1.5pt solid">(116,929</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 8%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 8%; text-align: right; border-bottom: Black 1.5pt solid">(145,054</TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(28,125</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(116,929</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(145,054</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">(Loss) from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(28,125</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(116,929</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(145,054</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other income (expense):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(145,745</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,605</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(151,300</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Change in fair value of derivative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,385</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,385</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other income from grants and awards</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,993</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,993</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gain/(loss) from foreign currency</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,877</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,877</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total costs and expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(173,870</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(105,049</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(278,919</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net loss</TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>(173,870</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>)</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>(105,049</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>)</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>(278,919</B></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><B>)</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Loss per share - basic</TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>&nbsp;</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>$</B></TD><TD STYLE="text-align: right"><B>(0.26</B></TD><TD STYLE="text-align: left"><B>)</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>&nbsp;</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>$</B></TD><TD STYLE="text-align: right"><B>(0.42</B></TD><TD STYLE="text-align: left"><B>)</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Weighted average number of shares outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">661,111</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">661,111</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">See summary of significant
accounting policies and notes to financial statements.</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 57; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ZAXIS
INTERNATIONAL, INC.</B></FONT><BR>
<A NAME="a_015"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notes to Unaudited Pro Forma Condensed Consolidated
Financial Statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
1. The Company and Significant Accounting Policies.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed consolidated statements of operations of Zaxis International, Inc. (the &ldquo;Company&rdquo;) for
the year ended December 31, 2014 give effect to the acquisition of substantially all of the assets of Emerald Medical Applications
Ltd (&ldquo;Emerald&rdquo;), as if the transaction had been completed on January 1, 2013. The unaudited pro forma condensed consolidated
balance sheet as of December 31, 2014 gives effect to the acquisition of substantially all of the assets of Emerald as if the
transaction had occurred on January 1, 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed consolidated statements of operations and unaudited pro forma condensed consolidated balance sheet
were derived by adjusting the Company&rsquo;s historical financial statements for the acquisition of substantially all of the
assets of Emerald. The unaudited pro forma condensed consolidated balance sheet and unaudited pro forma condensed consolidated
statement of operations are provided for informational purposes only and should not be construed to be indicative of the Company&rsquo;s
financial position or results of operations had the transaction been consummated on the dates indicated and do not project the
Company&rsquo;s financial position or results of operations for any future period or date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed consolidated balance sheet and unaudited condensed consolidated statements of operations and accompanying
notes should be read in conjunction with the Company&rsquo;s historical financial statements and related notes, and the Company&rsquo;s
&ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operation&rdquo; contained in the Company&rsquo;s
Annual Report on Form 10-K for the year ended December 31, 2014, and Emerald&rsquo;s financial statements presented herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
2. Significant Accounting Policies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed consolidated financial statements reflects that pursuant to the Share Purchase Agreement, the Company
acquired all of the shares of Emerald in exchange for: (i) the Company&rsquo;s issuance of 5,474,545 shares of its $0.0001 par
value common stock; and (ii) the Company&rsquo;s issuance of Class E Warrants which were issued by the Registrant to Lior Wayn
in connection with the Closing of the Share Exchange Agreement. The Class E Warrants are exercisable to purchase a total of 2,700,000
Shares, in three equal tranches of 900,000 Shares each (the &ldquo;Tranches&rdquo;) at an exercise price of $0.0001 per Share,
subject to and within 45 days of the Registrant achieving the milestones defined in the table below (the &ldquo;Milestones&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 12%; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Milestone</B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 86%; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>First</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Registrant, on a consolidated basis, obtaining five (5) medical service providers (e.g., hospitals, clinics, etc.) as pilot
    customers within two years of Closing. </FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Second
    </B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Registrant, on a consolidated basis, reaching an agreement with an insurer or medical service provider (e.g., insurance Company
    or HMO), insuring or serving at least 300,000 customers, within two years of Closing.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Third
    </B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Registrant, on a consolidated basis,, reaching gross revenue of $1,000,000 within any period of twelve consecutive months
    in which the aggregate gross revenue that may be attributed to the last three months of such period shall not be less than
    $400,000, within three years of Closing. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
3. Pro Forma Adjustments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following pro forma adjustments:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)
Represent the elimination of the subsidiary equity balances as if the transaction had occurred on January 1, 2013 and the issuance
of 5,474,545 Shares to Lior Wayn in connection with the acquisition of Emerald Medical Applications Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 58; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->







<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ZAXIS
INTERNATIONAL INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="b_001"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PRO
FORMA CONDENSED CONSOLIDATED BALANCE SHEETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>AS
OF DECEMBER 31, 2013</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Zaxis&nbsp;International&nbsp;Inc.</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Emerald Medical Applications
    Ltd. </B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pro forma</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pro forma</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2013</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2013</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Adjustments</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Combined</B></FONT></TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><B>$</B></TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ASSETS</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><U>Current Assets</U></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total current assets</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL ASSETS</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LIABILITIES AND SHAREHOLDERS&rsquo;
    DEFICIT</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><U>Current liabilities</U></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 31%; text-align: left">Accrued interest</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">32,050</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;</TD><TD STYLE="width: 3%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">32,050</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Short term notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">161,729</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">161,729</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Convertible notes payable to related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">85,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">85,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total current liabilities</B></FONT></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>278,779</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>-</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>-</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><B>278,779</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL LIABILITIES</B></FONT></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>278,779</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>-</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>-</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>278,779</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SHAREHOLDERS&rsquo; DEFICIT</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Common stock, $0.0001 par value; 100,000,000 shares authorized; 423,782 issued and outstanding at December 31, 2013</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">265</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">282</TD><TD STYLE="text-align: left">(a)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">589</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">121,373</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(265</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(282</TD><TD STYLE="text-align: left">)(a)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">120,826</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(400,194</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(400,194</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL SHAREHOLDERS&rsquo; DEFICIT</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(278,779</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(278,779</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL LIABILITIES AND SHAREHOLDERS&rsquo;
    DEFICIT</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
summary of significant accounting policies and notes to financial statements.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 59; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ZAXIS
INTERNATIONAL INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><A NAME="b_002"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PRO
FORMA CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FOR
THE TWELVE MONTHS ENDED DECEMBER 31, 2013</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Zaxis International Inc.</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Emerald Medical Applications
    Ltd. </B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pro forma</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pro forma</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2013</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>December
    31, 2013</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Adjustments</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Combined</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 34%; text-align: left">General and administrative</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 19%; text-align: right; border-bottom: Black 1.5pt solid">(41,200</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 13%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="width: 9%; text-align: right; border-bottom: Black 1.5pt solid">(41,200</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(41,200</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(41,200</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">(Loss) from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(41,200</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(41,200</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other income (expense):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(10,200</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(10,200</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total costs and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(51,400</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(51,400</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>(51,400</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>)</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>(51,400</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>)</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>&nbsp;</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>&nbsp;</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>&nbsp;</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>&nbsp;</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Loss per share - basic</TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>$</B></TD><TD STYLE="text-align: right"><B>(0.12</B></TD><TD STYLE="text-align: left"><B>)</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>&nbsp;</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>&nbsp;</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>$</B></TD><TD STYLE="text-align: right"><B>(0.12</B></TD><TD STYLE="text-align: left"><B>)</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Weighted average number of shares outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">423,782</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">423,782</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
summary of significant accounting policies and notes to financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 60; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ZAXIS
INTERNATIONAL INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="b_003"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notes
to Unaudited Pro Forma Condensed Consolidated Financial Statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
1. The Company and Significant Accounting Policies.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: justify; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed consolidated statements of operations of Zaxis International Inc. (the &ldquo;Company&rdquo;) for
the year ended December 31, 2013 give effect to the acquisition of substantially all of the assets of Emerald Medical Applications
Ltd (&ldquo;Emerald&rdquo;), as if the transaction had been completed on January 1, 2013. The unaudited pro forma condensed consolidated
balance sheet as of December 31, 2013 gives effect to the acquisition of substantially all of the assets of Emerald as if the
transaction had occurred on January 1, 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed consolidated statements of operations and unaudited pro forma condensed consolidated balance sheet
were derived by adjusting the Company&rsquo;s historical financial statements for the acquisition of substantially all of the
assets of Emerald. The unaudited pro forma condensed consolidated balance sheet and unaudited pro forma condensed consolidated
statement of operations are provided for informational purposes only and should not be construed to be indicative of the Company&rsquo;s
financial position or results of operations had the transaction been consummated on the dates indicated and do not project the
Company&rsquo;s financial position or results of operations for any future period or date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed consolidated balance sheet and unaudited condensed consolidated statements of operations and accompanying
notes should be read in conjunction with the Company&rsquo;s historical financial statements and related notes, and the Company&rsquo;s
&ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operation&rdquo; contained in the Company&rsquo;s
Annual Report on Form 10-K for the year ended December 31, 2013, and Emerald&rsquo;s financial statements presented herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
2. Significant Accounting Policies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed consolidated financial statements reflects that pursuant to the Share Purchase Agreement, the Company
acquired all of the shares of Emerald in exchange for:</FONT> the Company&rsquo;s issuance of 5,474,545 shares of its $0.0001
par value common stock; and the Company&rsquo;s issuance of Class E Warrants which were issued by the Registrant to Lior Wayn
in connection with the Closing of the Share Exchange Agreement. The Class E Warrants are exercisable to purchase a total of 2,700,000
Shares, in three equal tranches of 900,000 Shares each (the &ldquo;Tranches&rdquo;) at an exercise price of $0.0001 per Share,
subject to and within 45 days of the Registrant achieving the milestones defined in the table below (the &ldquo;Milestones&rdquo;).</P>

<P STYLE="font: 10pt Cambria, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; width: 0.5in; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Milestone</B></FONT></TD>
    <TD STYLE="width: 0.1in">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>First</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The Registrant, on a consolidated basis,
    obtaining five (5) medical service providers (e.g., hospitals, clinics, etc.) as pilot customers within two years of Closing.
    </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Second </B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The Registrant, on a consolidated basis,
    reaching an agreement with an insurer or medical service provider (e.g., insurance company or HMO), insuring or serving at
    least 300,000 customers, within two years of Closing.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Third </B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The Registrant, on a consolidated basis,
    reaching gross revenue of $1,000,000 within any period of twelve consecutive months in which the aggregate gross revenue that
    may be attributed to the last three months of such period shall not be less than $400,000, within three years of Closing.
    </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
3. Pro Forma Adjustments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following pro forma adjustments:</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)
Represent the elimination of the subsidiary equity balances as if the transaction had occurred on January 1, 2013 and the issuance
of 5,474,545 Shares to Lior Wayn in connection with the acquisition of Emerald Medical Applications Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 61; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ZAXIS
INTERNATIONAL, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_016"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PRO
FORMA CONDENSED CONSOLIDATED BALANCE SHEETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>AS
OF MARCH 31, 2015</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Zaxis International,
    Inc.</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Emerald Medical Applications
    Ltd. </B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pro forma</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pro forma</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>March
    31, 2015</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>March
    31, 2015</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Adjustments</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Combined</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>$</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ASSETS</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 34%">Cash</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">554,564</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">2,162</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;</TD><TD STYLE="width: 3%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">556,726</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Due from related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,276</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,276</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other receivable</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">25,774</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">25,774</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total current
    assets</B></FONT></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>554,564</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>45,212</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>599,776</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Fixed assets, net of accumulated depreciation of $66 and $0, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">7,947</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">7,947</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL ASSETS</B></FONT></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>554,564</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>53,159</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>607,723</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>LIABILITIES AND SHAREHOLDERS&rsquo;
    DEFICIT</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21,725</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21,725</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounts payable - related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,094</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,094</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Employee Payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,496</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,496</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accrued interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,556</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,425</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,981</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">120,979</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,531</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">155,510</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Short term notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,187</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(90,000</TD><TD STYLE="text-align: left">)(b)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">110,187</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Short term notes payable - related party</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,521</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,521</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Convertible note payable, net of discount of $7,484 and $9,555, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,235</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,235</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Derivative liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,165</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,165</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Total current liabilities</B></FONT></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>157,535</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>339,379</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>(90,000</B></TD><TD STYLE="text-align: left"><B>)</B></TD><TD><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left"><B>&nbsp;</B></TD><TD STYLE="text-align: right"><B>406,914</B></TD><TD STYLE="text-align: left"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Long-term liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Notes payable</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">37,375</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">37,375</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL LIABILITIES</B></FONT></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>194,910</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>339,379</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>(90,000</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>)</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>&nbsp;</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>444,289</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SHAREHOLDERS&rsquo; DEFICIT</B></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Preferred stock, $0.001 par value; 10,000,000 shares authorized; none issued</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued Common stock, $0.0001 par value; 100,000,000
    shares authorized; 10,025,147 shares issued and outstanding at March 31, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">455</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">562</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15</TD><TD STYLE="text-align: left">)(a)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,002</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">390,210</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(265</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(282</TD><TD STYLE="text-align: left">)(a)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">389,663</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Stock Payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">780,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">780,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Stock Receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(297</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">297</TD><TD STYLE="text-align: left">(a)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other comprehensive income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(847</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(847</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(811,011</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(285,373</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,000</TD><TD STYLE="text-align: left">(b)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,006,384</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL SHAREHOLDERS&rsquo;
    DEFICIT</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">359,654</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(286,220</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">90,000</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">163,434</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TOTAL LIABILITIES
    AND SHAREHOLDERS&rsquo; DEFICIT</B></FONT></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>554,564</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>53,159</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>-</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>607,723</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
summary of significant accounting policies and notes to financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 62; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ZAXIS
INTERNATIONAL, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_017"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>PRO
FORMA CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FOR
THE THREE MONTHS ENDED MARCH 31, 2015</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Zaxis International,
    Inc.</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Emerald Medical Applications
    Ltd. </B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pro forma</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Pro forma</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>March
    31, 2015</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>March
    31, 2015</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Adjustments</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Combined</B></FONT></TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 36%; text-align: left">Research and Development expenses</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">(10,305</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">(10,305</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">General and administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(43,936</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(168,821</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(212,757</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other expenses - advances to related parties</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(190,000</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">90,000</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(100,000</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(233,936</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(179,126</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">90,000</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(323,062</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">(Loss) from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(233,936</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(179,126</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(323,062</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other income (expense):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Interest expense</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(3,011</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(7,483</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">(10,494</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Change in fair value of derivative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">367</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">367</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Gain/(loss) from foreign currency</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">5,918</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">5,918</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total costs and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(236,947</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(180,324</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(327,271</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>(236,947</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>)</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>(180,324</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>)</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>90,000</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>(327,271</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>)</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Loss per share - basic</TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>(0.05</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>)</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: right; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: right; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 2.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><B>$</B></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><B>(0.07</B></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><B>)</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Weighted average number of shares outstanding</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">4,549,004</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="text-align: right; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="text-align: right; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">4,549,004</TD><TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">See
summary of significant accounting policies and notes to financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 63; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ZAXIS
INTERNATIONAL, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_018"></A><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notes
to Unaudited Pro Forma Condensed Consolidated Financial Statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
1. The Company and Significant Accounting Policies.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed consolidated statements of operations of Zaxis International, Inc. (the &ldquo;Company&rdquo;) for
the period ended March 31, 2015 give effect to the acquisition of substantially all of the assets of Emerald Medical Applications
Ltd (&ldquo;Emerald&rdquo;), as if the transaction had been completed on January 1, 2013. The unaudited pro forma condensed consolidated
balance sheet as of March 31, 2015 gives effect to the acquisition of substantially all of the assets of Emerald as if the transaction
had occurred on January 1, 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed consolidated statements of operations and unaudited pro forma condensed consolidated balance sheet
were derived by adjusting the Company&rsquo;s historical financial statements for the acquisition of substantially all of the
assets of Emerald. The unaudited pro forma condensed consolidated balance sheet and unaudited pro forma condensed consolidated
statement of operations are provided for informational purposes only and should not be construed to be indicative of the Company&rsquo;s
financial position or results of operations had the transaction been consummated on the dates indicated and do not project the
Company&rsquo;s financial position or results of operations for any future period or date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed consolidated balance sheet and unaudited condensed consolidated statements of operations and accompanying
notes should be read in conjunction with the Company&rsquo;s historical financial statements and related notes, and the Company&rsquo;s
&ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operation&rdquo; contained in the Company&rsquo;s
Annual Report on Form 10-K for the year ended December 31, 2014, and Emerald&rsquo;s financial statements presented herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
2. Significant Accounting Policies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
unaudited pro forma condensed consolidated financial statements reflects that pursuant to the Share Purchase Agreement, the Company
acquired all of the shares of Emerald in exchange for: (i) the issuance of 5,474,545 restricted Shares; and (ii) the issuance
of Class E Warrants to Lior Wayn in connection with the Closing of the Share Exchange Agreement. The Class E Warrants are exercisable
to purchase a total of 2,700,000 Shares, in three equal tranches of 900,000 Shares each (the &ldquo;Tranches&rdquo;) at an exercise
price of $0.0001 per Share, subject to and within 45 days of the Registrant achieving the milestones defined in the table below
(the &ldquo;Milestones&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.7in; font: 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Milestone</B></FONT></TD>
    <TD STYLE="width: 0.1in; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>First</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Registrant, on a consolidated basis, obtaining five (5) medical service providers (e.g., hospitals, clinics, etc.) as pilot
    customers within two years of Closing. </FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Second
    </B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Registrant, on a consolidated basis, reaching an agreement with an insurer or medical service provider (e.g., insurance Company
    or HMO), insuring or serving at least 300,000 customers, within two years of Closing.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Third
    </B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    Registrant, on a consolidated basis,, reaching gross revenue of $1,000,000 within any period of twelve consecutive months
    in which the aggregate gross revenue that may be attributed to the last three months of such period shall not be less than
    $400,000, within three years of Closing. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Note
3. Pro Forma Adjustments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The following
pro forma adjustments:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Represent the
    elimination of the subsidiary equity balances as if the transaction had occurred on January 1, 2013 and the issuance of 5,474,545
    Shares to Lior Wayn in connection with the acquisition of Emerald Medical Applications Ltd. </FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Represent the
    elimination of an intercompany short term note payable </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 64; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item
9.01 Financial Statements and Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
                                         following documents are filed as exhibits to this report on Form 8-K or incorporated
                                         by reference herein. Any document incorporated by reference is identified by a parenthetical
                                         reference to the SEC filing that included such document.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.7in; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
    No.</B></FONT></TD>
    <TD STYLE="width: 0.1in; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Class
    A Warrant Agreement, filed herewith</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Class
    E Warrant Agreement, filed herewith.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Non-Binding
    MOU between the Registrant and Artsys 360 Ltd dated December 2, 2014, filed with Registrant&rsquo;s 8-K on December 2, 2014</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Non-Binding
    MOU between the Registrant and Emerald Medical Applications Ltd dated December 30, 2014 filed with Registrant&rsquo;s 8-K
    on January 2, 2015</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Loan
    Agreement between the Registrant and Emerald dated February 2, 2015, filed with Registrant&rsquo;s 8-K on February 13, 2015</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Corporate
    Advisory Services Agreement between the Registrant and Lyons Capital LC dated February 25, 2015, filed herewith.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.5</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Share
    Exchange Agreement between the Registrant and Emerald dated March 15, 2015 filed with Registrant&rsquo;s 8-K on March 16,
    2015.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.6</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Loan
    Agreement between the Registrant and Emerald dated March 19, 2015 filed with the Registrant&rsquo;s 8-K on March 24, 2015</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.7</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Loan
    Agreement between the Registrant and Emerald Medical Applications Ltd. dated June 2, 2015, filed with Registrant&rsquo;s Form
    8-K on June 6, 2015</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.8</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Employment
    Agreement between Emerald and Lior Wayn dated January 1, 2015, filed herewith.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.9</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Employment
    Agreement between the Registrant and Oded Gilboa dated March 22, 2015, filed herewith.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.10</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Employment
    Agreement between Emerald and Oded Gilboa dated February 25, 2015, filed herewith.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">10.11</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Corporate
    Advisory Services Agreement between the Registrant and ______ dated July 14, 2015, filed herewith.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 65; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Signatures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-bottom: Black 1.5pt solid"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>/s/:
    Liron Carmel</I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; padding-bottom: 1.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>&nbsp;</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Liron Carmel,
    CEO</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Dated: July
    14, 2015</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 66; Value: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>













</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<TEXT>
begin 644 image_001.jpg
M_]C_X``02D9)1@`!`0$`W`#<``#_VP!#``(!`0$!`0(!`0$"`@("`@0#`@("
M`@4$!`,$!@4&!@8%!@8&!PD(!@<)!P8&"`L("0H*"@H*!@@+#`L*#`D*"@K_
MVP!#`0("`@("`@4#`P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P``1"`%Z`A\#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#Z[\+?L[6F
MG:3OL]"M`RCJT0X/KFKUM^SOH8O(KS6-!@97/S%(ACZ]*]?U6#0]8,;:.7A5
M1\^>!FHK[P]J<.VU-X^R3OVQ7R:5&*LHW2]#]%>(Q#=Y2U9YK)\+/A[H^L/X
M>M+6`RF$.T*IR%/`/TSQ69J?P=\+);/!-HBA\Y5@@P*]@L?#1L[P:A-:>9GK
MN%375B[02+)I4>R5L;\=*;C3DM8I?(A8B:V=SRNQ\%>'X_#S:'<6:.`,1>8H
MRM6-*_9VTNUT@ZE<Z9#=H_/[I<E:[VV\(6LA$%HAD8\\#I6UX>M=2T.9["XF
M81,,M'MX`]:5.,)/WXZ#GB*B3LSQZ[^$V@VDT*:AIK;&.(R4Z`TYO`?A'0YU
MBETP$9RK[.37M*:?IMTSQS6K2JN2C%?NFL#5?#UMJCYU.W*L@Q&1P,"E.G!:
MJWW#AB9RT=SS[6?"^DR:4+_1=!=)TP!(L0VGZTGAKP9)<%+378HPLC?,S)@9
M[&O1-/\`!6IP6JR++FW<\(.E3?9K2*86]ZHWJ>"JU#M=2>A3K-JR.+N_A;H%
ME=,]Q=1R%`/+1N<CTIUUX'\*3JDKV4B3%-L(M4W8/J<=!]:[:\LUU-"[^7GH
M"H&,4ZRL=0T6)YA-$87&W=CCITIRG%/;0B-2IR[ZF/X2^']E:Z']E,=K.UQU
M$\?S9[<U+X@^%]UX;T[?=V%J$E4KY2IDG/M5\O*US"EI>!EB'&#@*:VM/T>[
MUM=NIZJ<EOD#'J:TA5C./*D9.=2,KMGDTWPGL=$,5TVD,K.<HS)\N:W(O`V@
M:O;F'76VOL!14CY'_P!:N\N[:6Z/V#5+T!+9_E+?YZ5#;Z5I5Q92&[M_]*9S
MY4P3:A7/%3'D3=BG6J26KU/-7\":1IVI!&T_S4SE?+[UTT/P]\/I9"_-Z8OE
M.ZV/#"NR\/6D*R&PFTV*<X):1.HXR*J:RE[?R-!`T9"<\@`@^E*RC&^XG5E)
MV.(U31FFLC:V(F$<9RP,?!!J?P7\/M)UF26UU*_-JBJ61G3EV["NKTC7C90#
M3+O3E??_`*YRO+#THUJQ>\C&H:9IWDQ(,[3@D5"JQOS;^1HG.W+MYF)J?@[2
M[NPAL##%,""73RP7)!K-LO!7A";4KB*\LY[>%H\!7BW+NQ79^'M8N+.07::=
M')(!]W9QCZU9U#35N],WW4?D2S2;HSCN:U52-171//4B^5GE"^`;_2;Q=2TR
MP;:7)M1C.,=ZENY-=NM:CO=:,F=P#[(]N0.WUKNIX;6TD%D;R6.:!MS$MU^E
M:L-V^IV1MM/TNW.R/DN`22>IR:RC)7LI?J;.;M=HY>SM[?5A.EB98(YF'^ND
MZ>E1V_P]TBS5T(FFN)9?E=CL208ZYKH]+LM&L[R-[J($J,M&6Z-ZUK:Y9Z+?
MR642N+>7.Y9VE^0#O6RFG'6US%N2?NW/-5\#:,=1\C5=+=(T)).TGYA6S+HN
M@7]JEM;QW3%#B-67!3V!':NDOK^QFEN+6>X=I3D+,/NG'I[4^STBP2R6YM["
M:3_GK(#@9[&I3U:B_4'4E:[,72_!FA>"[*2>2U=[@D,CHF[:Y[$U4N]&2&XD
MB>X^2ZCS,9@-X/4X-=;K-@MQ:!HM2`W$&6U5LGMCBL>]\*)K4#7]I.1Y;A3#
M,_S,>^!52G)*T4*,KZR9SNFR6WAZW>PC6.:U*91&&_:<]AZU?30O#^OZ=]J:
M"4`MB3=*`%R>2!]*V_#VA>$+HRVMQ`R2K&,EFQR.U6[;P0MYS::4\<<)Q,TC
MX7GIBHC*I;2S14IQ3ZIF%I7AGP=X>LIK>`LKR#*.(PV".E9E_P##XI?GQ$+C
M=&V"!L!P<=2.U=7<:5X=T=)+9]&EE9UR'\P``_UJN/#UQIF@7%W&]P@D<#R^
MJ'/K43FY:6V[#A)K6^_<J>$/#-UXQM6TS5[Q4@BR82"$QWP#US6QIOA2:/63
M-INCVRM;KM+7/S^:Q/4UF^'=+OI=/GTU-1A`<\&:0)@^QK6\->#_`!#ILDWV
MR]#P!`\@609<'L,]:JE4=HZ7\R:JU>OH9>L_#]-*GDN]+U6RBNY4+2A%&`3U
M`]*I2^#KNZN7NKUFNY44'=:S!0"/<5UAL_"5U9K"VF7`N_M.]BK?*4[Y]:73
M-+L?[8_LMM3\BVD^>3<.5]JOFC)^O]=3-3G;7<YJPT/Q'I\%SJ5OX,68,FV2
M:6($*O8Y]:ET_2[>ZSJ][H$4F$V%0F/+_P!K%=9K%OH]KIS:>VIRS8.YF$Y\
MLC'I63<6?AVYAB-E)<2.L8,T0))/'8T.7*]'^/\`P`4I26J,GQ+X8\`WMY`)
M+&[@N;-Q)9W.G71B60E&7$JCAU^;[I[@'M3[/X<:'-#'J"6]QYS$^9),<@'U
M_G6[X;BAFN1I-IIB&6YB8+]H4!C^/:H-?T+6-)U2'1M6U")48!I)$DRJ@\@$
M^M'M(M<S5R;.,N5.S,-]`N+2^<#6;6TBB=7C=@1YK`X%:VI:7KOC[6;)+G4[
M:[=#Y23("AX'KWJ__9^AVVC?;KVPBN97;:$D?!QG@X]*3^Q+>]WWVB22:=,,
M&"V4Y5CZ@YXJN9WLMGYO_AA<S>O4H1^`/$VA2W5L=:M@ZOM2.>//FG^Z"13;
M;PYJ\09;R6QED:%A<Q2Q@%,'H&KJ-"BU#3HK>\U[4+'S9;@AVO%+-&-I&?IS
M^=.U3PKX4ELY+V^FW!F*_:X)?DSU7"GMQ6MTU=:>39G[5WL_R//+&SGN3)9S
MZO-#&D;(ENZF53D]!Z#WK/MOAW:C5/*GU#S+<D;IXTYB/-=+=6UG82FUTL;Y
MI!M.U<\'OQ6UH5EJ4-H;(^&OLS2_*+F1]H;GO7/!J;2?3U.IU)05T</+X7U#
MPU=I9V&HO<H7\Q8Q(2I`.1G\:NS:*NJRQR>(+AH1,02+6?[N3TX_E71WMK?:
M3JDA_M?3YI'4!S@/N'I5&%M+GNY8HRT<SG`:$;5[@\42E&F^4%*<U<OQ^&])
M\/7<'A[1K^2UAE.^\%ZN4(XZBJ%]X)\3>*KJ]M_"3J^F6V))(U<E&?&,@'Z5
MHV6F06$9N-3^TR6,G$UT>6/N,UF65[:^'KMKS0_$%Q&DTIVLA.5';(ISJQ5D
M]%ZV_I$1C4U<7KYE.RTC6P7TCQ%K%Q&+=/\`1X&&T`?UK5U7PU;:0(;KP5JP
MN[JYM]K+L^8-]3WJY;O9:Y)$-6>XD54(,@;G)Y!R.@]JBL/`\<FIJ-/OB&9_
M]&<,-Q/<<G@T)Z::_/4)-.5V]ON%EN&UKPN-,O@Z&WE`D4.&+,1C`7M60\%O
MX5G\J.VN+G,;;"V[Y>>5-;/B;PIJNB7<<EU?3I,[#S%>+#'_`&LCK^%6?#NC
MVD[NMIK5S]IEX*;00P/UI>VFY<KW&N3EYHZIG*W7A?7K1AXCLKQ8%1PT/DMN
MPS#L/4#O535/"$]W?Q+>E[F=XSL6-F5D[AO>NDU/0XM(UF2Y?5IS%`5$GF':
M=W?'8U+H\%YX@U`&REEMU*-Y<\S@%>>M9N47.UM392DHW.9\->$-?LM1FN[8
M1S7$+!4CNA\CKWP6Y!J#Q'JM_:W?V+5=$C::.4-*BQ*Z$=0,\UU5WX(G@OB+
MC6Y9E,@#2;3\A/))!IFJZ#>*DEIX:UB.5(02S/`$P?J>]1/VBC977SN7"JI3
M3>IQ]KI5EK2&_AM].M"9FDWHVQXCUZC&*IW]XVL%H(7^VW@RLT\N,9[<]QBI
MM2T:[TFWF>]BLKDR<OB0%N#GMTJC+I#RNTUOHRQP[?G6%2=J^IKFEB:G+:VI
MV0I1D[W'Z=+X4T+4;:71X[V345D.Z2"3)Y[>F*2?X9^,]<UB2^>8VZE=]PSS
M@LB$XYQT'M6E;>#=%MK1KNYN=D<D8?='G*^@P._M4EGI=G80N++6YT^T`Y`8
MC<OOS^E$)N7QKY)V+E'E5XO7S5R5_#TGA)+FQN=9TUU,NUTE.0Z@=A_6JZ:?
MI^DQC4O#<KS)(A_T)A*8B<=015_PYIFC:;=1ZIJ&GG55/)B4'<OU.*ZJZ\7S
M>+9HM.&GS:?IEF=MO!:1'<<]`2/>NZG5YEV[+?\`$\^I*49:*_=[?@>#)X?\
M3:I?RV^D:>]L6!>9WD"!N>?O5U'A+P[\1O#[RVR>'58S`&=U(ER!TS^/>O6I
MO!.EZAHAAC\*W3LK9GGO"%V,22-N3TK#U#P+K+>7;W%U<:=;3KNCC;+,P'0\
M=J2H5*?O)ML?UR%1VT1AKX=,D>Q<PMN`(/0UMQZ??RZ>J7%RA2#[C$@9HFM+
MMM/#R6Q"9_UAJ""W6>=8VG9D3JH;J:QC-0=DMSGE>:NV1G3O.+/_`&CR/X`W
M!I9C-%ISPW$3$%/EX[T75M%Y3/8,1*"`!ZUI:/<0K9&/4;621QQR.E5&=Y6V
M$X+EN<?93WMKJ*2V\Q0A\J">U=';:D)Y/M-ZP9RV%D/>E6PTV.4F2R8JS8&1
M]VK<-LENXAL[59%QG!ZTH<\+NXYRC*V@^XU'3M2$=I]G:W91\\B#@U0EMK&X
M;R+NZD*H<_,O6M2PU326N'LM0LG,I7"%```:K"UOXKLV5YIP\J=OE+=<57M+
MZWO_`%U)C&S)H])LK*T\VUOY?G7$:]<?X5GKH6CBZ\V[,DDF/G7'4UI.;S26
MV6<2S*IP8\\BHU::0O=*R1-$,O&[<_K3E*FK70)2OH5633;'2Y)K.V5RQ*B-
MF&0/7%9EM?6S6K07%HS`#A!G'Y5M%;355$MG$5F8_O`0.14:3PV;^88@Y0Y`
M(R"16<I*5FG8M)Q14TN/2(XDFAC5R&&^$C!_*M5[W3KFQFDC15*O\R-P:IW.
MJ6&H3"^&F+#(Q.]5&%('I4ITM&LYK^.T9491@J,C/O2BY+2-A22=KE*6&)W%
MS9.\H'+*5R5]JNW<XFL$>]LSL"_*<8VFI_#UO>NJO!/'TP<^E3>(O,O+0E)(
MD)7[J-PQ]:M74;DNSDD9GA4VDFIF)[KR@RX1M_`-;FN:):^%;@17S)<23QAX
MV(X(/?BN#GEN]/NDEC3!#<-GO6Y!>^(/$S":XB$D:(%:0OT]`!65/$+EY&M3
M2=%\UT]!-6MK"PA#VCB1\9.T9"\UO^%+JQ\1V\>C7]C!`"H7[0S8]ZR(89[&
M1K:WM%E$J;0C=0?6I+BWU*.>&-+<QESE8EZ^E"J.,[V^0W"\+$T^BZ=I][+;
MV:M(P<@JK=O4>M,C07UW_9D-\(UQP\[<#VJY?VDD$D5K?2F!@H9P$P?SJCXM
M30KF$V]MK1_<H,-&/O-Z5I.7)%V7R)C'F:5S1O-`TZXLA>C2(1=6*C<<\3#U
MJA<16-L4U""PQ),"9(D/RJ/:C2-!CU+09-135G0QJJSJ\_S2'T`]*CM+JWMX
M_,"2C`(9PPSQ33<DG:Q7*DVKCCI&E>5'J5G832AWQ*S+@(?K4=IX<$U^MTMD
MB1!,':<@\]>:NQ6FJ7/AAY]+\10A&()MFX=B?;O571++5[P7$-Q+*9+>,_(K
M!0W.,4TXMK3\BE=)ZE?7KJSTO4)+?[+$-@&!M')([>E)H/B2P\QK.>.5(V&0
M&EPN?QJAXEN;+1+]D?27D<8WHYR0<=#FL`^*=)&JQWFJ12)"!DJO4^@KFJ5W
M"IN=5/#.I"]CN;'3](TUWU&YF<-)+E,GA?8U4NRDFHJ]C!%,60.Y1\!,^I[&
MG:2EOXHT9;MK6>WM5<?:)C*2<9X)':L3Q,=#\-:A-9O=[[96_=2HV2<=`<5K
M.JXTU)+0SC0YJG+U+-W=RB_9[+3'4[\,VS(SW_"MQC%K%I&TVN'[2R;C"'V*
M%7IGU]JYG1?B-<:S(+:\N8X+42$C&%+C'&:W-8\7:0T27=BBW)\L+(D*XV#T
M.>]1"K3E%M2^\*M"HI)<IIZ?=S1>3I.GZ+$SW#KO\\@D52\0VLUOJ;Z1=ZB(
M;1Y=LK0GY`W]:QH-0@M;]+6].UI6Q*6#?N2??Z5T$+>'(/-M=2M8B&'EPE!G
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M;?S)+9HPKE@>S=>1VK,TX:2+6Y%K<SP3R1E6M(EW,!_AQ61;>+)=+E:;4`^Z
MX8L]U)#DMW&,].U1I\1M"T?7O/T];B$2D?:;MDSM!ZY^II.M3LG)V+AAZNJ2
MN:'A^PU27Q#/"U\%:*%FRS#<3C('L:A6U.JP-+=:I<S9!:YMU7)09QS]*R]0
M\:Z=%J4]_8ZO#]K\]?*:!OE90,YJI+K6OZG<2>)='A>V<@B\FB/##/(X_E7&
M\32B^5:[[:G6L+4^)Z&YI>F7UY?2:?IFZ4H=\=S(I;8HYQBM""74FMYO.NHY
MFBSAF&#G/85-I@M-)L1K-Q:7$TFU3DP%4=B/:KU_IT&K6L-WK%R+`1_-,1%C
M(8]>!VKK@TH^[N<51OGUV+CKK6L6EL8[6TNV$/[RV#8``XR1[>M4-:T:PN+8
M"W%K:2+C?"ESG><9X'X552#R0T\&KO=PL=B&(_,1VXK8\,3:+<SSQ67AZ\EN
M(@N)G7[@[D^G-:QDIV3_`,S*<'3U6QS4-OJ5I:M)I3H79?O+`=ZJ#V/057L=
M.U:2X:;5GO8XUQ@2$XR:Z.^N-0>_;3K(7-PJ$F2(+C!'4<=:2]T^]U.S\Q-;
MGDNE*A;,(25!..363BN;2^AKS::EV2;P-+:6M@(T0^66FN(%!(8#@$'GJ:HZ
M2/!3W5S]KA5W*@(Y&X9YYQ^7TJWI5A?VJW,ZZ.MR(-L<S2PDG=SP"!P:I1V8
MOS<2VFCR;@^["-M*#O6LISLG9?<904'=)O[R>+4K&:9D2SBAM@V)4*;@!Z+G
MUJM>Z396!.IV2++`\I5(5C/RG`/I6O::?8&WDU9--NTA6,(N)E)SCK@]JNWG
MAW5;+PO_`&E8^((Q%(C;K.=>3)_=&.IQ2Y9.+OZ_UL3*JH272[L<]%K^KZ0D
MMA9VSQ+.OW2.A`ZFIH/"BQVC33)=SLV',\*$*AZGMDG-5;;0O$UW"NL7D3)"
M_68'.SZ@<UIZ5HOVJ%YU\4Q(%4A5BDV[@#W%1!RD_>7I?0J;A%:/U*]AJD7V
M_P"QPVC2,%Y:]4OSC&<GD5EZK88U%H_+FCN<Y>:WA(VKVSBMS5+WQ#IJ`Z:L
M<DRH%'EQ_,R]>@Z_6DM?%&J3JO\`:,%Q'*WS"X.2=GICTXHG9Z2?X!!RC\*_
M$YV7PGJ5R(4M99;EI'X\]2@W=3DMWQ6SIVH76A6BO?Z+B(#9YD<7F*I!Y/UJ
M:\DTW6EFU"35G9HR"43"@DCD@=,UEZ3KT.GW#0V5S/*K9`A8X4C_`&A62<:<
M[I[_`-;&O+*I&S)]=U[2-:T_-YKC"[N7W2YPJHHZ#`'7I7.:C;^'?LH%SKYE
M(&Y5!P#DXP/>NB?=+#<79O+<*&`6RC"GCN0363JNBIJNDR7&E:='-)YGRHS!
M74#TI57.46U9O^O,WHQA!I;(Q/%?_"+C15/A6':7;89)1\Q)Z#KS56_FU'3K
M(V-RGDNX"M"0,D?S((JO?:)/JM_`EY:111I]Z(-@Y7CDYK=U_P"&_A=;>"X/
MB2YW,J*N7R4RO;VS^E<"E4J<THI*WR/14:<'%-_J.CLDU'0GMEV#,.]]C@@@
M+QGT-<QH^D1W:F:X@D6"VA);81PV.!SU_"K-WX5DT.(6=OXG\YHV(55!PPSZ
M]#FM[1/`?BW4+D6MI:I%:L/.9EY''>A2J3DERZKYFLITJ4;\VGW%^TO=0;0[
M&"RB^P0(P6XD?A"W^/M1:VZR>)&A@UI=2(=6")-Y?'UZ4V7PY97<QB;Q(UQ+
MYY:2)$.WC^M:>HV&G6Z*8+N"U14+D108+9[`\_K7HTY3W>RMU/+J.+T77^O4
M+B[\1:IK'VDRM#'`0RN/WJG:?XNQQ4T6KO<:M))K/BE2RQX1D@W8.>0/0506
M72I)HI;F_D>W5.(!\N[GGI_,UHQ>#;6T5;[[,RK,28R[9('I71"<INZU^;_)
M'-*$4[/T,">>\U#3VTZ.X`B/;N*BMM*.GVB`,69!@DMR3[TRXMYX7W02X&<X
M4<5-<W,/V0#S_P!\>V.O^%<BG%OWMQ6TT('N$CCVN@0[LC'6K$L5S8HEQORK
M-N`9N]8^IES<`88CC!'>G&XG,0^V2L7!&Q3GI62J^\T:^S]U&Z=<A2002V$;
MC&68&H-0'E1K<64HCC/+$-DBJ5DB3QL9;4A<\8SS3$F"!DM[`LH!#[NU6ZKE
M'WF3R*^@S4-1MQA[4EY0V1)CK4XU_4+F6-M0N!]T`,.2OY54O/$%E;P*D%FB
MNA^967.:2VOXKHEY8PI<<E>U<ZJ*4_B-E"T=C52TF7-[#J'F"3C`X(_.L]+^
M,WY2^PP)P<"IXM.:TC-W'*\D1&,"H(4N[>Y%_%8*V<G#KG`K23DK:?J*"0ES
M+:B<RZ?<M$!TS3M#L+W4))3<#]V,G?OZGVJ_:VMQKEL\FF:;&!R7);ICK3-+
MM[VTN&L+JW*@$$2,#M/T/>A)74@<K*W4=H^C7>JWGD[0R)DC>PK7BDO;:UDT
MRW@RG1T+<$>M9<EGJEI*9;2=0SMC"-6K9W$JVC27<\)DV;%0GGZUK3;=U:QC
M4U10MK*\MY,854'+[#3+F6R@8P2QNRMRI/:KT%@%MV9\R;N2<\5FWMS(+AK&
MWM/,=1D$'(`HE[D%Y_,F*YY$"Z#82NKW<Z%68GRR>0/6A8[32WS9S/.G4K",
MXQTS5S1Y+"1_/N[,AT;&"O`]J=-K=OI<LD%LB*)"#]WIFHY822EL:IRO;<S1
M?WU_<"ZMI!`8VR.#E1CK5FWFG=UO+6-IY"N&PYX/K5V_U2WTN7S+6R$IGA"R
M*H!4D^AJE`NH6,0DA*QCKL#9/KTJ%!QEK*[_`*^1HW>.Q:.I:[I%^)-6TX2R
M21A"T[Y`STK*UW2KVSLUOEACR[DR!>HJ37-3U/4;=8KH-S(&#;"-Q`XJ8>*[
M98H;&VM&%R\?EW`D7<#[CWJG--N,F5%2232&Z%?6\%HEW)8X>,\'?C/YU8O;
M35M3@:XL5B570M<1IC<.<Y-.TBTL+I9I8(I_,3[J-`2I4?Q"LZXUH:3K$D\]
MM)ME&UVC.,Y'85HV^1<ST)45*;Y=RM:6]\D1N=-U!I&3YI43@)BK%_/;RP)<
M+KK)*J9E=VVY/7:.Y^M01ZQ80V9L0#9RASMF!+>8I/`*CO6/X_%OIMI#"K-.
MK1X21HR`6/<<?I6/.J4&UJ=$82G-)GH$VA^'-0\&(]OXEM[B=T!\MHLL'(Y!
M/7(->3:K*GAF:?2;_P`G>T^'+1[F4#TK8\*^%_$,%FFN:/<Y6-!*\<4@,D:Y
MQG'<US7Q3U+3M1O88_#:++<11$3RQD[I&')8@]#6>)JJ5%5)1LU^/H=6#HN%
M5P4N9/\``LP^+O&.HZ5J2>&?$(BAB0M);>8$\Q%[`'J?:N!T7QK8>(M8FM==
MUR0/*2MO$[E09.GS'M7B?Q.^)'BV;6VTKPS+*MRDQ\M8IB"Y_"J]KXE\3W.G
MGPEXSLIK6]FF)L)U.3(Q^\"1_,U\U4S><Y1M%V7JT_ET/KL-D7+3<I-7?WI=
M_,]O\;VVLV&IVTNA:VL-M(0OE&3>6Q@=>V3SGTKK=!\9Z1X20V'BW=++/N^R
MQPR$;U_A<$]1GFO.]%EUR[T&T@FL'\R`*GSIQ+P#P?SK;\9ZWXFALTN9OAY<
MRN(ECBFNHU*1G&<*!R>!FO5A5BKSLU=*VC=OD<5;!IVCH_FD>O\`A?Q!HES=
MG3M1LYLD8-P[<`8^]CJ:U+C3M)CUH^;/YD*;65XIL_KZUY-X'GO+A8)]?O#%
M>-`);6.!2ZREB`,8Z#MCM7L&CWMO%//#K7B*PTPIY9*"'(*XX89^]]*]##5(
MSCJOR^YGSV+H.A-\O]>A9FF74;F&TT2_NOM#PEMDK`F11UVCKBHKNW\,-<AM
M1UR<R2<)\O`;KR*BBTHV9C\6#Q)%="YR(3$Q1E7/;'2LB73]$EU6YBNM5G>Z
MCEW0QH,J0>:Z).2W2U\SEITHR>C9T>KZT;2R;4M*LK7%O`PBD5"GS`9.<]\5
M'H?C[4=>TRPTCQ%;II\-RY\XQ`"0H23DYZYKRSXBZ_B9]-T'7KJ(,H:Z:1,A
M#[`?>_"N:\5>*=0TF]L[;Q/]HU$/.K;X'VS(NW`4;C[YVXKSJV8NA)OHK7[:
ML]&EEBG%=WMW_P`CW;6O$'@"]2[BBU5$M;.,"!YGR97S@]>1TK@/$/QCUSP8
MR:<MC:26;-OADGC#1,K#Y8RW3W-<S9^.XO"NE7.B:AX/EOUU$+-;FX9#(JYX
MR5)P?:NEUCPS:>(]';Q1>:)IU[;):*JZ*+HHT`8[4R>A8$_6L*N/>+BU%\LE
MY?UH=%#`_5I?O%=/T+6G?#NX\36ZZX^OZ?:(]H)?+TZ97()R3N'8#OZ"O._#
M^K^+-/\`%USX=T[Q3<16LER1;7@C807#`=.>GUIEEHFH^&M3;5O!-GY,EHY2
M\M+Z8*$!'`R3A@>>,>E:?BCQ'XFU^!M$UVU31F>%)[.*'3W$EQA#RF!@#CDY
MYKRZC55*4DXRB^C=GY=$CTZ=)P;5U*+7977RUN=?I'Q,\5Z+<R:#JDEQ+:13
MH9E2+Y?,`Z*P)&!G/6O4/A[\0-$U?6#"]ND@CA.]'/F,V[&>6XXKR/P3X^31
M?#\MQK[Z79NT3-:27<C,=YV@%DC!"G@=?>D\*^/?#$7B`:MJ,LFKW=VSYN=#
MB*0>9A0N!@8P>,>]>CAL;*FX^]>_1[I7^9Y6*RZ-:,K0M;JNOZ'O>I7]Q;2R
M0:)IZ6MA*QDCGE52T<G]U=G.*K2:IXABL8E?5[>"XD9MK)A9)`3SN]1Q6/+-
M>OI2IKFD7EL9XBUO$]V"[N>5X7/..QJK:6&G)`MX^L^=)&J@P3,0?4J.O_UZ
M][VS?_#VM\CP/JT8Q]/F=AI\5E#:QWD_B"-)(R&9[:7&_/WE)]:T;N?POK6C
M^;%K+0W<V%0R/@J,X'('ZUS!L=6BE,ECH%LBW%N%6(R?-R001GO196,-EJ$=
MKKE_]DDEF`:V,1!5>I)8C`%;1K22MRZ'-.DF[\VN^AN6VJQ6>E-96VK7$(:8
MC<"I#-@9..OXU=NKO2[VU2+3M>E-PG_+0VXCVG'3=D<5B7=IX7TC7H7.I"XM
M]V^;+_,.>!Z&MH6NG:U<RW.DVSP0+$'DN9X\JQ[+C/MUJH2E=K0QJ1A&TM5U
MV7XF5>V'BN)XX;E7N(BID"V\P^<G/(([\53TX7[WJVMQK!MY6R5%PY4(?<FM
M;7-/ATVP:22[2TO'<20-#-\KH>>`.GTSWK*U6\BU'3_(,\LX8*)9YK8`@]^?
MPK.::EOJO,TI2=2'KY%W0I[G1K&YDO=9@.)=CVZR#>Z^H/I4XT2";3&U+1A`
MT93,JR,"\1S^!-8,?@RT\I;ZUUX/#DKY3'+C`R25'./>NCT.SMO#L:2W&EK?
M-<J?)DM90QP.3E<9&*=*4I64E9>MR*O+'WD[N_\`78=H3ZY%*(=.6&5'A8*!
MA&]^M0ZUK8LTCTR\L9;251A)BQ#*A/..Q%5M0ET![DZC";JWR3OC=N1QP0<<
M\UEW>IOJ$[7&P[X6`7SG+``=,]<U-6JHKE3+HT>>?,_Z_$M2C2+1)(;JX<QL
MY:-C$,R__7J>QETNXM$&B6T$-Q%$5N&NHP01W//?Z5GQWFGW$,B:H_[SSC(3
M`<#H!Q_A3%U'2+:3?%8R3,^`"Z%5&?6L?:J+OI8Z?9<RMJ;LL^F1Z9Y<^AHP
MCX$Z1J5X'M_6N2U+4=$GVPZ?9*&9V:61ESCGHOX5O1>)])M9'BCLTEE<<0F'
M:B_CWJ"Y$MR?L.E+;M#G=)Y4.68]P.,CFG.?M%:,E^I5*/LWJCGH(4GABMX;
M?;&7.)[I#MSS[4C6$3$V\E^LDH;8QW[@/I[5V%E8^)X$@$EPS6DQ_=QR*H*'
M'3GM5;4K8KJ!NK'1TWP`+\D10G'\7'4FL'AVE=_E^5F;QKW=E;[SG8O`NIWT
M\L=B(W2W&YIB=BX_'J?:MB/0-5TRW4W_`/:,:,H:1[<X1D/7)'M5ZPN]+U*Y
M=[V[NHRZ_,K,"P/;`[U)8^+K;3=$O-+E\2J6!"V\658C)Z$GL/2M(4Z,%J_Q
M_0YZU;$2=DK[="IH]A;W-K)<>'-0CMBKEEDN2HV@?7G.*JG2]>NI?+N;1[QV
MRX-NPQM]P*+&YL+.ZA=(C/!@^:GD'!;ZXYSZUNVVHW=R1J-BMM8^0/W;.ARV
M>-H]:T@HS5F]NQ$I2@VU^/\`5RC)H?AR\M(HH[<B0./.CWJ,\'N.<"G-/H,M
MO!!J/B&[7:2KVZRGC`X(SU%6ET'3M7NHI=1U#?,X,LAB('EC/0CN?:L'4K"7
M3M1<6&NVR13Y(:6(9&#T/H:IN4%=)?UY$P4:CM=_U\BA++(\*0V\:GC+,*:M
MAMD\VX8)D=Q5:26S,ZBPN7VD<,RG'-3S/J%S&;>25'!X"GKBH<K]!*#3U(KV
MZ@AF$<CQN`/E8=<U%<?V?-L>YG8$'Y@!536M-EAVRK*JE5!(W=:ACO+AX!;`
MKM;C=WK)U?>::-U25DTR]$;![_R[?5BD6S(!/>B\E:PMA*6,@?.2I_I533_#
M5Q;S-=S;OF.6XY%7%TE2&D6?S.,!1Z=ZE<\EM83Y$][G-7-S:27AN(P?]9\P
M/>M#2[ZPM[=I%B<KDEU`S@^O-:+:+'<6[K':B-EY!8=:QSK8TY'M!&K%VQR.
MW2N-0G2G>3W.E2C4C9=#=TGQA/-I8TW[(CH')5@F2145SK4YE)>S*`KM*G^=
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M$?/F;UP5P:VYFM(NY"CU:(;K6$?6UEFMC%%M`4HW?UQ3-1U=+/4S+;RM(_F@
M8!R%3'>M*\TB*X4[YK<[0'X;G%9@TZ]:\*A$&[EBQQ\O;/I64HU(R^9M&4'$
MV8M5U&QN%N=/Q>#[R+(@^7C)X]*QXM=O+KQ`VIPZ5_I+9PBK@%N[8[5,\.J^
M%[LW(M,Q%.9(Y-P`/O4\^NZ5J5M//-$EE/';[8Y5)R>^<#UIRDY-7=FNA4$D
M[I7+4>LZY;Z2DMQ.@+@D&,@.`>HK$6\TN67[/KLTRODF/`_B]_2L<321VINK
MK5B%$?R%6]^GUK`U3Q(B*8[UI'63A96'(J7B-%?\36&&YF[?@=9JU]%I.I^9
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M5!!<:JGFPPI:!49/N[5XX)`%>'"E%P4G+E2;ML_O/L<+B)PJ<KAS-I7W7E8\
MFT+]J[QUXOM&TZ]OKC0XY)0C$6(F4*!PX'!#9KTCP=\4?VEOB)X/BU%-;TNY
M@M+T6=@]Q;?Z3<2$$G"*?FPO)..!7EWA/QGH6CR7^GW<\"K/$WV>-M+>>3#M
MT`4'D`\'-<OK>C^*#XBNK30/B'=WD-K*'TVQLH)K2299,AER5RN!UY_.KHRJ
MN7.Y-K;1V]#TZN#HUDX1@H]5=7]3Z[N]$^(W@V^TN^E^,^DP2262><]E!]Q@
M^"F%SDACSZXKH)=3\0I9R6.K>*3K$U[=_P"@3FS8">+=M$H[J">V,U\DZ'J/
MC73/`4/B6VT+4KBSTMY('E'(BE?NK$C>5;]:3PY^T%\6]`O=&T#7M%O;7280
M'LGMH'GN)"#@!B.>2.@KNAB84[VBU\V_GKH>#B,DG4A=2BVF[Z);'VWX#\<W
M<>DR>&?[#:>]4MOP3YEL@."WS<`&M36-0\1SZ+=7NDZ;=M]B0-)>1*&\E5!X
M;9GK7R_X>_:.M_&4]]KOB?4(]#<7<=O"=0E\B4`'IY/WF4_Q$]*ZOPW^V5XR
M@U'4_#]]J-A9Z5=E?.N9V_=A&&`8E7[WJ!TKKCF-.,5&;=MD_P#/L>'4R7$1
MFW!*ZU:^[;N=LFJ/?:A;:%J_A_4;QKUU:X,=N=Z1DY4I[G]:YGQ)XCFT[QW;
MZ/KWA=]3B7=#O^Q,DN6P%)&!\PP!D\9J_P#"OXD^'-&\,W^L3^-3=_VK>.JV
MR7!$\.W_`%>XD9"=QC!KK/#7Q(\/:'H[Z?XB\.MJD$L4SL,>7(P8`@M*^",,
M.N>E<_*L133YDF]=D]%LFO,J\Z$VN2]M.VO6QY_XFU_18-3N/`GA?POJR:PU
MR))[>^NX5CMDV\9);@GTS7,WEU;^&?$4\>O^+-9L;I9E(AA@(M\A>`2I(ZD5
MH:=XM\#Z9<:U=^/L7VE>)'D>TN%F666!@-BJY;G"\'(YXKH?"EIX)U/2'\'>
M'9)+NVEB?;*ELUVEPRX8*`1D,<#Y@>*X?8NI.\9*_;_@+<]#GC"%G%V[_=U?
M8Z>7P]X6\36^EZLOBF^O]0N--66\\^78'D!P%7OTJ#Q/KW_"(6=M9_$*+5)G
M@D1(+.9_GGBW<)&>3^/O7C/C7QU\6-)D@/A_P)-;6(E*V[1LKS+&#@%\?=)]
M&QUI\USXTT/7+SQ]\0_#7B&ZM]"\I8Y=0C:0,7<*4WH2L6W.03P2,5I]9LG"
M,6I=79VMWL*.7NRE*::Z)-7OVTV/6%M1X@\5O=:-\/IBEQ`9(]`U"4K*T2'+
M;2<9P!CFM#4_B9\.?"[:!IUAK%[IC.EQ))IEC&9##*-H2-D<?+DY^;//%<=X
M;^)-[XH6Z\4^%;RWT-;8HMNL%O/=W-T#O$AWLF.`QW#IZ9JA\2X?@8?'.G:`
MOB3Q)K-\+4S:UJ%A9,)(YLC8`LFT`8./:K<9QI.<&KMK5Z7U6UM3)4H^VY)I
MV2>BN[676^A[;I.IP7=S8>+]9^+4TL$D9,MK<3(LUNW.$"YQR>,5H6?Q:OM#
MT[4=+LY8;B2:3$<,D&Z0KG/![8]J\=&IZOX,UN+0OB1X4CM+.XM3_9IN`(Y(
ME?I)(5W$,>,`Y'I6QK'B7Q[X%^'%_J-O<Z:3%H\EY:WUI#^_E<L(U@#/P,\D
M^E=-/$2C&6C5M^ZT\SSZV!C.<8I*2E:W;?R1TW_#8_@GPY)>VOQ&O;K39GLP
MEK(]N\@5D[CCW'M7J7@G]H/2M>\#:5X^UM+.26\3,=S%)O9(`=@+Q*"P'(.?
M?-?$&I?M&3^*]2EU;XG^#;35KF33?LME:S6NV.*3C"],LQ[G\JT_@UIGA_Q/
M\1K/3M%\->)=%C#IYSV*R$0R\[RPDQM4G&%YX7-9X?-J\9)<W-T2LT]6K-]#
MIQ7#F&=+FE%Q:U;O=;;+KV/O#5#I,D+ZE=RP3#*J'@4*.1NZ>N,<5#X;U^4#
M^S+6WU*X,DWS10N0NP5X=\'-"NO"VGP:S>?%**<7$]P+2+6KEU63;*4``(X+
M``AN!@5[A9:IKWGQS6C0V;3V`8S12C`4-R1G'.:]S#XB=:TI+E?9.^_F?*8S
M"0H-QB[KNTT;"Z78-*)]5:>VDG^:U%RVX#G&T[OPQBK1M?$FKS/?S-;BU@D\
ME)&15#$#.`#^%4M'AO\`4K%+21II+TRL;>^O(P5VC!`#9X[\>]:-M#KL6G-I
ME]-!'<Q2-)+'+/@'(XX['OG->C!7[V_K<\IRL]&K_IY&<;2^EN?LNEP^5+*,
M32S2@(,GGIP!6AI%IXC\-_:!$]G(G'GRJ^[`(Z`CIQ5K1M6,NF2_VG?VD,BJ
M#$TL!^8#(V@]/_UU9TZY=;>6ZT_5K!$N3ONF%N=H```4`_6M8TX)IWU^6AA4
MJR;<>73Y_F)##K%\\=NEC)/;,!)&%960#ICWY]ZS;S1M8@U(#2[!K19(M[1,
MZXXX)'-1R!]/NA-;^)8+FR=\$*&&WOC;U`R35K7(=/O;V"UTR\C9A'^\FCD;
M:6/.T9/&*F5IQUWOW7X!"4H2TV?D_P`3.>:VLF4W=E(\I^65I5&T'OC%76LI
MS(45(TD>-3;"2494YR#UJQ':6%PP^RZA=&:!,R-<(H0OG"C!/`QWJOIDGA^)
MIH]<TV*2>2;`*2<H>GKT[U')RNS_`*^9I[6ZO%,HW-Y8Q:A+'K5TDLHPNR!`
M6Z?XT6][/->):R:$T$\Z8BF@WQLR^H'3I5B\\.>&TO&N["\(2%2THCF`D.3Q
M@'J?;TI+MY=4EAACU1IRHS&'`C:-<8`!SBLW%QWM\M;Z];E^TYK)?\,163P6
MTCI/]KPL?^D;IE+Y]/F.*KV<]C:M)<?;+^>((6"6\P#`\]0>>!CI5_4=+U'7
M)TM;S1BY,H&+5E"NHQGGW_+FK%W;:+:0F9-"E@FC&Q(W3>#M[$COZT_9R^2[
MK^D'M(IVZOLSE7LM+$CZE?6\]LLD>8/M*,5<YZYIFC3:-%JCSV.@O-+MS%_$
MJGN2#UKIKFP^VV*7-]J,Y@7&V$R+A,=BIZ#-.^S:&NGMJ"V*(=@`4ON60XP<
M],<UD\.^9-6[['0L1>.J\B+P_J&JLWVO4M7MXV<86":'*A>G&!CMVJ;4DO!,
MG]GZQ9S(JEA;HI92WH!C]*AU%+:TAMHM/\,I*\;J$,;^:LF?4CWJOH&K);7,
MUNGAFZ^T^:2TL3'Y!W&!6\7RV@W\]3G:YKS2^6@J:@]E.VL:EIT$;,PW1/"<
MJ!_$.U95WXAL]7N5@MO#S(8V9C<*22V>V.@%=+=^(-'NT5)]$N)65?GAN9#@
M9]/:J<%@8ITO&T9X(9=QC.PLI_.E*FVK1E===!QE'>4;/U.*GM)9)TCBD",!
M\_-74T>.<-_Q,D&U<D$]3Z4[6M.F`2]FNXR.^.,U!''')<*84#[5W-EN!]:Y
MW>,]47NM"EJEFBH2&RR]$9N<55TZRN;-OMD48)!SACP.?>KVHW$,U\;ACDKQ
MA>_MTJQ,]G,RBYLWM\@$`'.:FT7)V>QIS241FI:_JLN/M$4<9*=NX%)$9FME
MO+*[^<#YT*\&FW,=BDPANR'4G.5/.*GFM((71H)5$3G`4]<57O-MMD*VB2&P
M2WS0^8Y<^82"N.E9,7AFYU;46M5MP">06;@5IWES?6DR&TB.S.T#J*8+/4GN
M6629HF(R2A]:B2C+1IL:<H:WL1:?X1%I=,TNH@+$"/,4YYJ:XAM'0I+?&8'J
M"N,_C4UGIT]FAVR>;GEL-TJQ?6,4T!FMT16*_*@.>:TA3Y862L1*=Y:LKVVM
M7UC$]A;1#[,W+;ASCKUK6+W>I>'FDM[*`;6&W<W7/3BN6U0ZE8RM;7*D.Z9P
M#V[42P:_IT$=T]S&5E'"QR\C\*B-5PNK-HJ5-2L[ZE^\LKM@JWAB2>%`6$0^
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M)`J"37OM6E"&>)U:-L/,HZIZ&L>2YL;*U3[#/*EPY'FJ>$Q[&J^)[*8W<N)(
MFY9(FSD'UI^TG;\QJDKFK<^)+.&"6#2;R1&N./LTD>00.F36=>QZ3#J4']L7
MYDBEA!N$M#DQ^U9GB/4VDOE>VL@`R`1AEZCUXK.O/LFDVYU&VU*1YF8HX;J,
M]<5SU)N<MKI'92HI+M<UM7UW1Y+Y=/T"Q\U)"JQQ/&02>@)S57Q3X9?58S)8
M&`R0NN;&&7DG'.W/I7'_`!0OH-&\/P:IHVLJUY(PCN;&//F0#/#>PKBKSXF^
M)/A_J5O8:GJR/'<380`X=1P<@GI7'5QM.C.49Q;CI=K97V/3P^!E5BG3>OGY
M'=27/@U+R>>\OIK<1A4>&7KG'S_2L'Q7J^A^'])DU.WN-MH`PB66URSMU5=W
MJ0:YV_UNTU>QN]2F@@26ZN)&@N[G4U5$(Z;A@YK@_&OQ(^,WB'0[;PIJ"6=S
MID]SOC:P3?@XP&&`.0/>N"KCU*F[+5[-+SZGIX;+I5)J[LEO=V^XZ^VU2QO-
M+DU76O$;6+\FUB*[O,?'RJ.>3GBN7L/AEXJ\>>'I]<TCQ!%]LE<A[53N<')(
M`&<Y]QQ7$?V]>7/B%-*U>5E6TFV,^>"W3/M7;>+OB'X0?6)[KPQHMOI@LM.A
ML+=1=DO+(,"2YRAZDC@>E<=/EKQ4JFRZ7=WY_(]=X6KA6E#=ZWLFEV7S.$UC
MP1XYTJUN[;Q9<Q1W,#8DA$P\Q2.!CGG\*X[0X_[<N9(=6L-0;5+*]\MH/++H
M4'N.E>J_%/6=#^(%]I6E7.AZM:/`X2XCTVV$LESD']XK<`@\8!_.N<^'NF_%
M+P0_VO24FM1?;TDFEMP6D&<\DY^;W%14PS4K0=X][:_/[SU\+BTJ+E.RGVV7
MWF+9_%C4?AG)J-]X?\"VTMU<6LEM$UVFYH<YY7NK>]<-H=[\0_%=R+W3M-EM
MKYIRTMR]WL9F8\GW'UKZ'N+_`,%)H<MMXH\)!KT*97GA<;G<]?QS7$>*=)T&
MPTJX\<6Z7FD6\!C2-Y&27SI63*H54_*""/F[=Q5>QDHI*=TM;+2QW4,>I)M0
MM)V5WK?MU'V/CRTT[P/9>!-;\':]KEQ:;_/AEOR;5-V276)0,L"<[B37:?LT
M7&F>$_&UE/X6T*W@U2[9EC.O767A`0L)T$@\M%!Z<_A60/')\47=NGAR?P^-
M6MM.D:8'49(V=O+&4!1"@)'(YYKPKQIXEO[:&2'Q/K5VNKQ@I;K81L59&R"I
M<D8QTX'2NIU%1E&5^9+;1+MUW.7ZK+%0G!KEOOJWJ_+L>G_''X<?M$:Q^T[8
M>!?$=KI$@>.XO7\02VZW$4X9"Q?;!G<RAEVH/XL9KI_!>@K\-8K#3O&GA[3K
M^VUR]ALM*U_Q!92VPA028E8Q[<<]F[`\5ROPG_9V^)NK^$!\9X_CWI]MJY@>
M.R\.ZW?O&]Q$W!"[&+`#`8\=A6;+9?M"2Z%IAUC5Y]2$MS+%`&8^5$57+8WC
M.0HX(]JUJJ'(ZC@[O5:WTTW_`!/.:E4?L%->ZK/1K5:W7_#GTW\3/AYINBW^
MH^*OA]I-AIO^B,CVEEYD]LR%.9%WH"O;!'2N<G^+'BW1="A\*ZWX:N+K5Y(A
M'/)<IYL<\#8R\:A>,#CGN17EFM?$/7I#!H_AOQ=>ZA>6UM(;A]2U!/GVC<53
M#$\XP`>3TINE_'GQ.-#T^#XH>+K>+4F2>+3()[2XEO$((D7!3`0$@#)SP>:P
ME64Y7A>*?:UO,XH8&M&*YK2MWO?R]3W&7PK;:II^G:19>$[AK6XCE>738M.B
M!7"DX\S/!P.YSFN2?6_'G@$:K86GB:>QTZV8R:9()$ENE>1!LB:.,]\8)S4/
MP]\;_&F\@NCX/^(_AJ>6VMI9-4@U"=;:X'(WQKYG/F8/!'X5Q$OQ$A>VNO&'
MA+1;BPF:[Q?62JUP&&#B5YFXSN)XP.U;U%'E4H)I_I;6UC*C3G&3IS::_)WN
MKW-[6]/\?1>$K75-3O(LW#37%W'H<P%Y,O#,6AR<(I`^8],DXK(^%_[35_\`
M!OP3)=ZGI\EWHVH7C_VQI^HP2/.Y!#)*C,I79O`!/4$FL_X*?%/Q-X&\?6_C
MN*2WGD,[17<5Y,H22!R%=&/8'.,U[!<:1\*O''BJ+36\2M=:?K4C3CPI9L?L
M5K`@\QD\Q_1]GMR:SHTW.:G&7+)::OTU^?8ZJE2-#]W4AS0>MU^*\FNAX;H_
M[2/BKPU\4'^+GA;Q=#IEZ8I"(I3YMO<AW5?(:,X5=J%B3R2?2O1=1^+/C0W$
MGQ5M].LY+?Q7)%!JMW)&)9HBN"6C0XVKTP`>U8'C[QOIG[.XTCX:^)/!>F:K
M96'B1-3^UPZ?;R1W]GMXADFY;.[@KZ8KTW3O"7@[]HKP=_PEFE_"73-.AV-)
M]DL+PKY&#NR4X)XX^4<`]\U<:,ZDG",[-:VVUZOL.I4IQBINEH].:Z>G16T9
M-X&^)'P(U7Q2-6\0_$'5Y9+^&5;F"YM("2``$3.2JYR?<8%>2?$?6]`T"2>*
MP\3>(UTZ_EDCL[*=1Y4;*ZAHV9OE/RD'Y<X.*DU$?`H^(&U&X\&/;Z7I5DJM
M!ISN6NI5<!B7SA0`?\YKH/&K?"+Q_=Z9-HM_X@;PQ;+)`NCVVK12W!N652Q6
M)T^53CDYR>*YZBG5I.+:NGI:]WM=ZCH4H8>LII/E:UO:RZI(YS6OAU_:?@N,
MS?'WPXPD,$UQI,=S)%+:J#G!VQ,2PX!(_E6_\1/`WC23XCZ=?_#;Q+X;N[.2
MSBN+--'\0NMQ!B-$.YG`\T,6#'J05-<_=_":>U\0PZ)X9OM1@\00XDT31I-/
MBD\^P=&=VN7##<0!CRP#GIFJJMX#^%.K?\)W\9O#KZSIYTR=(;+1-173KF$R
M,V6,,H4[,J`-K'%.%/W;2BHK2[N]+?EZ&M6;E-.,^9ZVC9:W^Y/UN?2_P>\+
MZAJ5PL'C&W\/NNB:?%-<01ZXTEQM9F16P(^IPQQS@?AGT'0I/$LFLNEKJL4=
MC#;_`.C6T=SYT:Q;\``]2>AQ7PAX9TSXA>*]/&K^"+6Z\/VEXYGM;I]7$ES<
M12,JHDOS9;:JG!]2:^^/V>?!<^A)8VGB71]3N&.G)Y&Z52Y8_P`;8.%!P3@]
MA7HX"K[>HH135NOY=#YC.<,L/%SDTV_L]N_4]2M;7Q%<Z#:$>((+:U12R%HR
MQ#L<;0.O;Z"F30W,-\$ENHM2N7!1F288<8SDDXZ?TK%UZQF@U*YDL)98I;><
M;'$X`/'(`)ZYXIEM9Z3))'-J9N6+LK2&"92P7G<#G@&OH).47:WXL^/5.-KI
MZ=K'5Z;<G5XY+?4+'%NL8V);KPI/3<>N,@U94>&+,I;SRM;W2#YT$+.C8/&1
M[UCVFCQB\:YTRXG2W,*.R72\B,C[V>,CGM4>MGQ'%)-::-J45PK*'F>%L@*.
MG)[XJG.<8W<;_C]Q'LXSE9.WX?YE_2;RP$:-=:/"%NG94N)"=J+GD[>O&:H-
M<Z!I&JNRK<O&F1%+&X0[AQG!ZBLR($(U]/J<L*D[2-AP03S@YK<L%TO5[5X;
M6Q%QND7=<7`VR!AV')&#6<?>MK_F$X>S;?1F[I%M;?V=;Z[+/.6NF*2/=Q*8
MAUQWSQ4NN:-/'IWVRVM[$F&-91-;Q[,@]CNX:L+6$N-.TLJ)\1G#",L0OKUZ
M5H6.IQZS;P0:]#<`01C8OVI(U8#H`"!GBNE3A?D:UL<4J52+]HG=7&:7>ZU#
MISWMEHT,3/*6>Z2VWCL,$#[HK,U72$U*9KJPO1,T0'G[4\L9/4@$Y(]ZZ/S]
M?TDRVFA1Q6UE.Q827$P8HF>3WQ6?)K6GI<RKJYTV4<(\L4;,<?WEVXS43I1<
M4K_?^A=*HU)M+[M_G_PY6T;5+GPO>-?W.K(1);8@C6/S,D]`/3IUI&\:>)KO
M58Y;/P^L#H#B0+^\;/7/7(/O52QTBVBU8:CIMG?7!5F,>_Y55<'\L`UI7]_X
M>ATV"ZL7FBGV%)(7E;<'!XYZ`4H\RC;FM;^NI4HP=2_+>_\`6I8U*;4=7ED;
M7]">62,958$"<DXY(]STJGJEGKMEIYMHM-,5J902LT0+*/3([4EOKFIS7HF-
MY=QJB;U)`<D]-PR.1706D+R>$WNKR^EC.PYF$2EGR,XQU(.<527M+VOZZ`VZ
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MBMGR0`5;UK2N;2[FGCLX((_E;=TK`N3=W"_;+1`P!^9@,DC^E1:7XCOYH6:Y
M8K-"[(S("/IC/L:N,X*ZEU&XRO=&]>VEPTWVI+E2%.WRSQS45YI>K068U1;I
M=C<<'FLN2^DV[V=GWG)&.]7(X]4N]/5Y+E8X-^T`GD_A2YH.Z2U)<9+6Y+87
M]QIL9GB5)CCYP><BK>E13S&36AIC/%MSY2J<`^U8EQ%<Z5&M[$XD0GCFFGXB
M:G8VSVEO=%(MN)4C')!I1J1B[3'[.4E[HS4+V>[N9;B6)B&X52>0*R[HWJL(
MG#*#RS$Y(':M&XU2.:U,J6KH^.IZGZU@WWB1X;)IC<*P1L<8W?05C544[MG1
M24GHD;%GIFAM;-=SWK"1CR":O^'O%_A_289[+5=)$K.FV-@^"I]?>O,-5\<V
MZW/E-*H,AX0.`<5SVI_$;4(KK[)I5H9I]^%;=U..@KSJN:T</JO3179W0RVK
M7C9GO-]?ZE]F<EEBACBS"D@P64UB0^++.UOX5@*M)N'FQDY4CWKR2P^/MGJ5
MPVE>,->DM[J)=IA$71!UY]J@\,?$6UA+7>HR^6MRQ%D9.2P!Z_7I4?VQ0J./
M*]^_3U['1')<13@W)?\`!/=+E=;UF1AIUW$L`DW-"S_<R/>LBZUS4?M+VPMS
M*T8PP9<@#L:S/#WBZ^\96<MOI$R_:8(MDA0?/*OH`/YTV/4M<TVW%Y/I+MYK
MF$2%L,".H(Z\5ZL:D9P3C=I]=S@5%TVXR2NBQ=6TD"K-=WBE9!PBC)!]*FO+
M>_MK&"0P,@EC)`<X^4=ZAUBXNGMHVD%O(R1JX\EQN'UQ3_MN@ZK%YFLZM-&R
M0J457X;KD<T*E[S15W9$FFZFMC9P6DEL!F<2V\\S<KV(.>U<WX^U[3Y+UKF2
MQC202;I8]V59@>#@5TVA36-[++++I_F:='C;!<.JR$8X(/3K7$>.]7@UFZNX
M;3P\Q<'&Z)<[`H_V>.G6M)T^6EHRZ-W6.5\2^"]1\2ZG<W'A@6_GWEN)SOG,
M:P;02Q)[\`5\T?%_Q#I,EK%K/Q'^+$:?OBLMGI:[I5[`DG&![\UZYXY\6ZMI
M-O/8V2M<1+`XD*QMD*>O2OECXNWW[.FI(VDZWKVNPZY);-YLJVNZ!#CY%4$C
MC.,FOE<7"-6IRQ5M[WV;_P"'/N\F3@KS\K62;7W[&O'XPTS3)UOO#.O2>(=*
MBV2S6YD+-\O+;O0'BO4OA]\=_%?Q\N;CPO\`#/139B&,R2I$0WV:W&`Y4`=.
M^:^0_A!\'_'GQ`T+7/$GP^\8BS30+1WNVN;CR@Z?W1_>)].]>E?"FP^+GPS\
M9"ULO'&BP7M]HZM`MA=B/SH7&2I(Z-P>M<\*=2BK[)[VMJ?0UJ&&JII6<DM&
M[Z/?5+0^F_%'PT\.WLFGWDVK!Q<PNC:BL>Q%>/J64#."/QK3^$?AS1O&VLRZ
M5X9T.SO5>!;>22>3R=C9'[U<@YZ5Y'X*\?\`CF2PBU#7;"YB7SW8K/ELEAAN
M<=Z[KX>>*](U:XO"]\=-O`H6V&-B2)CD$\8/O753G!UXM0LNOW>9XE:E65*4
M7._9K;[CW?\`:A^%&O>#-)\-:]!XU^V-':8MHHT`,4:8!7>N,X]ZI^"M<T+Q
MMX,TW1WT^PCU&R9VCADRIF)`&.`3DXSZ>]?.<_QG\0W=PVBZ7K^H3HDY4)=G
M*QG(^[G/!P/:O4?!/@W7-7TW5X=5OM-AGL;99[BYFU->6;'[M-G\66'`X&*Z
MX8R%3$-TX:-6:;NKI=^AYD\%6H8:/MZBNGHTK.S?;YF!^TIX/U;0;.QATV_T
MV74K^,RS6>G2&:2WPQ`#X&`>?6O#_$O[.'Q6UB^U'0H]5MHC80++?SQ77F0P
M9Q]YEXRH(SBO6O'WP]\8_#^WGU.+XAVL^I)<>7)9VB,S!>H8/C:XY[&O)O$/
MQI\9>%=-U3P-H]\&BU&(FZFAMR)G)ZID]NU>76FH5VYQ:\D[_P!7/HLL=9T%
M&E-.W5KS6OR6Q%:^!/#VB?$>S^"&H?M(Z-%9S3B/4-4TK3Y6C@C"XW?,J[B3
M@8S[G%2^'OV;?`'C*[UI]/\`VEM.M+K0KEK2*VOX9':\9>\;#Y=IY'7K7FNG
M?`CQ-XYM4\4:1X.UK4IT8OJ%S]D800_-P-^>1R,\=Z]WM?AMX>^%?AFV\,>-
MO@WKNE^)U1;F+4$93;E=P;S-B_,!CU&:[*=+GA=P5M];V]+FN+Q3HR]VJ^;1
M625[K=O3[SE?`WPS^,_PI\6V?C?18/M30$F,'YI!G(#`'IP.]>Q:58_";X@>
M%H=9\0ZOKVGZI:`/?6-WIR%9.S"%E.`#[\\'-7_B)I7CKP3\/H?$<\I2'59E
M*3DE&D8@$K@Y)`'?TKG+_P"/-VVEV^FFSAO2KH9Q-&OE(JGY1QR>^:V]E&DW
M!MVM>S5]^VIY%6O7Q:52,5>]KK31=S@O%/@6XM["XUO2_"6HW4,>YUFTZ++0
M(#P_T^E7/C#\'-5\4_#*R;P/X4\5W&KMI[7%U-JFB>6T0&TH(Y))-P+,>2N0
M<C`KT-_%7['5OX=BU>3X[>)M'\26EE)+_H,*_9IKG[R(..@;L1T%>&>.?VCO
MVH]%T*['AOXLZUJFF:FS6BW%[91;IB5QY<2Y+A``.1@`XHAAZ=*-I>]==&G;
MU[!1KXBO--+EY7U32?\`F<E\.OB'X@\$Z]:ZEI?@S[9?17+6MX^IQM<>?*`5
MVE3QD'\L5[YX0_:'^/.E_#76M26#P/:V"!M0ET^^L1'+,J(T;(6P%`.0-IY)
M(QZUPGP[T/\`:V\;>'CX+N-'T2RL-%L4N9)EM;?[<%,BN9$4,&EE)()YS@&O
M(_BSX8\/ZKJAUWXT?&S5[J5-3C^T:"NFR6DDI/RG&5\I`IP223D*1Q710H27
MO1;2??\`$6)K4JD[3BKI]-7Y'JS?M=_![QGX9MO".L?`)6U.P19'U+1;V(PO
ME<B-U[`DX)W;@>G2KEEXR\/Z/J+7Q^'>H:<D-NGGZ=INO&5H4<!F#M@E0>.,
M'TKYB^)?B_P9\-[#3/#?@.^LKB..Z%](;4F219>AB=R<,%QD$9!W5WWPH_;9
M^)_A&QO#X/?399=49GU"VN-+BED8,,%D+*2,`#CIUK&K3C&:N_FDG_PYU4Z=
MZ;<8Z/HWW_(]>M?%?PD^(FF:QHGBJTUK3-,FN4_LA+F25HY9,`D*X0[#GH2"
M.E8S^)?BI\-[2]\)Z!>:_9+%$0#KH2V22!CM#12A@TC-\HV[<]:Q_P"W/C!X
MP^'K?$@>*O#TFG3,E])IUD\0?",P+-&#E'!.<8Y&#6.L/Q%^/OCO2=-\6>*+
MZ_M+A)9+>*QBDNKJP')RT:CY6)4'`)^4^]9S@Y122UZ6TW+I^[*\FN5;IN]K
M(](\)_LQ_$GQ)X)U'QZEO;ZW9VS0*^CZ;KNRX.YADX<?,"-P&#G</05)X9^/
M5G\(_B;);>$_APOANWD9+2U3Q#&)S"RDB0M*.I+9R<<5Q?B+3/C=X4TB#3-5
MUG4_".BRW+"#6H=*D>;4)T!VVZL@^5V('RDC;SZ5ZUX=N_V4M`_9ZM?#/CW1
MKS6O$.IVUQ?+J\LA:9'P!M82`;5+<''S9.035PPL+1MHUJV^_EH9U<2M>;WH
MR=DH]%Y]-#3\*>/_`!!XE^,S7G@KQOX7.M:7$LUA?6<,D4,<LV0P#/DMM`S\
MW!YP#63^T5\#OBG/JX\1:]\5?#_B$7T+G4)]/F:X\N3=D18:)3$O)/'&0>:U
M_AY\'_#_`(>\-V?Q+M=$N_!UQ<0P#39K"WDO+6X5!AO,E.3YKAF(W*-N,`=Z
MHR_'#Q#XW^(VH?#32/$FLWVE3S,6FM=*:XN9PB;ANBC(SRNWMQDUG4HJ--Q=
M^:3NM>OH8QK2CB%.FERQ5G=+;UM^IZ)\%/@)XREM/"VC1?$#2'LH%%V8=(M2
MT5H[*21))W90I8KVR:^NO!'ARZ5IM.T3Q[+JFI02I%#<QV9^SR2'J#)NYZXR
M0:^'_A;^U.-"\.7WA#2[G5$GMXII$T^'3$AD>/E93R25')RQZ`XS7MO@KXW^
M(;+POX?7P-\089_M<RNUI&"%3S(R78$#)QG9DC[V[TKOP#A15W!WLKZ]M-%<
M^9SBGB<74;4DM=-%ZW>A]%:K\/?$FC:A)I6JZM;ZE<!?-F6RD9FASU&TCUY_
M"K$_A_3'CMK--8MH)`N)MER-DAYP?4-U&#_6O%/AS^TEI5TVJS^(_!_B33([
M6=HKF_M;QY%\S/R$2,!N5L'*GVYKTKPL_AOQIHJW.EIJ\ERRF82LH=9"3@K\
MHR.,<D_A7JTZU&M)J"U[.]SYVIAZ]!?O'MU25K_)GHWA[6-0T[PB^GZGH<>H
M03M)!&LD@:XCQCD#^Z!5+4M#U'2M-DU31K-[:`QJ\:3W*M)MQC)4#]*Q%\1>
M$]$9H;'4]0M;A(/](\Z0`@_*/+4$9;OZ=!52T\1:Q/=KIFBRW-]"SED2"'+C
M'][<,#@#.,UT3J1LHO6W;='%3HS4W-:7=W>]OSL:U\]Q!;Q:7?V=Q+O13L6(
M*'SR.O?![>M6($LM'FALK[0[N)2@<R!#N"L3U!.".*R(_&D=CJ\=CXOEN)$1
M3BU=MKQN>`K?+Z8P!Z]:V]-TZZM[T7&HPWMC'<E?(47)>11@E<@Y&#[_`)5G
M&*G*\?\`AO4TDY)6E_P_H2:^M_';[TLH'28`P1HCC*GHW/K6AIVHWE[8IIM]
M%9*\3A5::Y`8$<97Y>G'K65+X5UV*XN=5.MPWEE9RJ)$GN-G50Q7!XXS@T7'
MBI=4M9K:U\,.AG`%K/`K?(1P1@]0?:M-83;EI^-S)M3BHQUM^'WFGK6B^-7N
M)Y9+I9[*!!YIM[H.$4\@$\?4U#;V>M:OIJV^DI:61,1RHGR90,\L#]T\>HK#
MT;Q'.%70+VW`C:[#W+R.RE\<;2.N/:NSO-%\/ZU$MG8:=&9XQYKK!/L>1`.B
MDYSG.?P-."56[B_O?Y:&$W.@E>WJE^>IA7VC:S96"C4=:2*?S@DEL6.2I&=^
M[.#D59N+&"\C=K*2SM73^%Y&?>>/7^=5O$^FV<=M'<2*8`[J86:Y9BJ@X*_,
M!DX':K2Z'8VMJUWHTJZC$N&#RHR,!ZCL:APM*R7XZFD9WBFWKZ:?Y$MK)#K$
M3S7^LW,=Q$%0R)"#&@YXPO0=*BM-0BT^>"\O6O-L!!_=,'WD'(X.`!TJQ:7E
M^=3?4K"SAL&,(9X)B=LN!UVGBM%->5[%)]?>*"03I_HPC&TQG!9L$\DUK"*6
M[^?_``YSU)OMH^G_``R(=3U33_&$#F<V]BD<9V2S%C(>_0<'TZU1LY;'1XVM
M+SQ#(\P;]RD<K"#G@Y([C]15^P\2'1]6DABTR6_L;B;99Q_9PHQG@9;IR<4_
M5KCP_K6HM!/HLD,>W,IAA)>&0CA<X&<=<8J[<ZO=<WH_TT,D[/EY7R[[K_AS
M+%I+K%X8K;3S-"QX:-`OS#OD]OK6M?Z=J&J6R07&@VD/V;'FW-L,EB1P03V.
M?2HSJ_A)Y([*YL+F.:*-D)MG\L3'L<=C[52\57ES&8SIVI7J^<@`60`Y`YQE
M../>E94XMMW]/^&-%*56HE:UMK_\!G'E==L&=)E60LH"@GM3\Q16XOM3#LVX
MXC'05F7VI7-TV/M!*KT;/>K-MJSK9B)XS+@9;=7&I>^]3LE%V0^%Y[A#-9RJ
MK`$F/N:YW49-3:=GD4[G.&XZUKRWL,N)[9O*`!RF<9K/,MW>*ULT@3!SO8]Z
MBHE))7-*5X.X_3));.6-BN\*P)0]#5B]U"QU2YFNDM/)D(^Z1A3QSBJ5M?)I
M]T7OW,B*/D*<Y-6=1U6RFF_M&VM25\OYX]OZT1:M:_R*D_>O8KP>*HU`L8[1
M=P/S,0*FGN)38!FO`H60D(O-4K:ZB^R/<I8!R5(*E>E.T*ZT2_B>QV,DRN3D
MM@`?C2I*6BD]Q3LM4BOJ6LJEMY4TK[(\E5!IJ7>GOI;7:6X!!Y+'YJSK[^R$
MDGEOM9V'.8P1D5R'C#Q#JNDA?L^KPO',Y$;%L`5G6JQHIR9U4*$JSLC=\1_$
MF>&:.R,VW(V$@=!7+WOB71-9U*;3].U<0SP6[S,LH(5W`^Z,>M<#XN^(_B30
M]8\N*SC=G39@X.<]2":\YDU_X@:_KES#X>MI2QSYHB;!P3T)[5\KB\WG.?)!
M-Z[6_+4^GP&3W]YM+3>YE>(_CU#K?CX^$]2EELKI9BL#*?\`6`G!YJTWQ!FM
M/%MSIO@_Q!Y[6D*JL4LH+>81RP/M7E?QCN_&%AXPM4O/"B?;K(9BFA7#$<Y5
ML=<YZYKF7D\>^%M/@^(EAX+6)$O-ZI=7(5I><%!W->+&G.I.[3OW\S[FE@:*
MHQE&R36UTTSN/%7C#QE;ZQNN=9G>YG?]](,#'/J>HK4\+?&J_P!+BN3JFK&[
M>X;RH\@8B`_N^A]Q7GWQD\9_$5O%6GWNM^$++3'N;426MM:7(D7;C.6QWZ\5
MG:+XE\/ZI<VM_P"-+B'1(U.U;J`'Y\]6QTXQ1+#S]HU8[I4Z$L/%SBGIT/L3
M]GO]IW3-.U*%S%<*H`5I8F\MW(]3R#SVKWS_`(2BU^(^JC4_#?BF&TAE4R2)
M=QA-LI_ASTZ=Z^$]9O\`PW\+M*T_2;+57U&/4";B#5V(V2*<8P1T;GI[UZ7X
M2^*5QX5\#JFN*[37@22VOI6VQQJ<\?[1KW<MQM;")TZVL%K_`):GQ6:9/#$2
M52BK7T1[M9>+]3T35+FXL##*T,K)+O(V,.F<UPOQ)^+5AX,:UN-9U=(8=0N6
M428)12.3@]\>U>0^(_VF="O'^P6UV\JXP"&QYI[MD=*\9^+GQ?\`$'Q/U30]
M`TS2-UEIJS>2%D(R';#/N]>!^5;SS)UFX4W\[^?^1GA.'ZMTZJLNI]<:U^T/
MX.\/ZK:ZK8^*?[315RL4;AEW[<J<?W<\$5Y=\3OVU/%NB:=<:9HMZ(#?7RJ;
MS@;<_?&WTYQGVK@?"GA"WT&RMYM2NY)I'E^9&E!VJ5Y`/<USGQ$_9G\::]K4
M=Q8^+($2Y.Z.2YD+!$P/[IX`K5SQM5.TK+RNO(Z:6`R^A42EKZ^1;G_:P^(7
M@KXQPV$U_8.J0FYN$E(DCG1TP`?08[=C7F?[0'@+X@S63_$ZY\+W0TR_;=:2
MZ?)Y\<"-@J&QSC'?'%9GCOP7K^C_`!(BT:ZE@U::UA,*7EO_`*N8*,?+GTZ5
M6T_QS\4OACJ5Q'#>ZE;1,%=8;HF2)1Z$'@#\*BG'1J:9['LU2E&5*VJ5_-&#
MX.\:ZJGA9_#>EZ)>1&:Y):XM@P,@)X4KT;D<9KN/A#X]M-.OX4;3@+BQE?:+
MF$!O,SU<]3@_E7`VLOB>2Z_MRSU?]^9O.9X)MJB16+`@#H<UT]];ZWJ9MO%D
M,S75Q=LK7,L:`YG+?,-J\DGC\ZXJG,>Q2E3E&TDK'TS>?M0^)K^W7S%L(Y)6
MRT;V:@*3Z#M5_1?C+J]W;0Z3K4%FP6(NLEO9J)&RW1B/S^E>`7^GZK<:U)/J
M]M.\V466VE1HF&U`""AY7GZ5Z3\%+VRL;&\@\<:.\SI%Y=NX?!3/W6S^F*F%
M:ISM2D_F<M;#8;V7-!+Y?H>F>(W\0^'-57Q/X-L[(VES:K))"(TD)7`()&.#
M1\+/'NK6.L+=Z_X<MI-H))>'*D]<X&!6AIWBO2-0T:/1?#VC6]O$ZF"8S2[V
M90Q.5S]WH.:KV?@7Q#>VD[:+J<;?9PR3RK("`#D@XQGH:OE:J*5-^=O/KH>4
MK5*;IU(I=+O>W2YZ1I?Q#\"Z[XCL)]<L`8([8O<V<BA`K!2`N0.<X_6LKQC\
M+/@5KOCF+7?#6I:OI$=Y%)'<7]SIZ3PQ.4XS&N"#U&1]:X#P[H_C>YUAKDQQ
M31$_9EN)&&QOE.,'M46@>/-;M+VZT?[2QS(Q98U+8*GD'ZX_#%=<<0Y*U2":
M>M[=DCEC@IT:C=&=K*S2??OZ'H>L>(/C!\*?#.KRZ"+.]T"2;SE30(C(DF,?
M>5]KQKP,\&O(O#_[4E]!X]_X2KQ-J$^J-=#9<VMQ&9'`Z*@Y!'`P<U>\9>.-
M5MK*:['BF>+RIF3RK.3YF/I@$`]*Y'PY\%/BS\3]9%[91K;0FVDNG>XDCA=D
M0X+-DC!YZ54ZE2?*J3>FMKW^[_(Z:%"C",I5DM=+_P!?F>A^/_B3X_\`C>G]
MH6VFWB:;I4QM$59/,-N&7!&T9YVCK[5<\-?!CX>Z]/:Z)%KD\6G)N:\OQ"5F
MDXR6*MT`Z#BK7[&'A7PE+X7\9)XYU2:U@TZ1'2:*9F,C99<<'''6O0;*;0([
MS5D^%\^D:Y=64<BS65]&J&2(J0206&2,=N0<5Z%"E&5*-:H^9O===&>-B\5.
ME6E0HII1V:VU2W9X5\6O`'P8\#:I;ZC\.M(_M6V5]TT5Y'NDC(S_`*P-W/7C
MBO/[72O&_C77K/3/"MNX:P3RHM-F"L/()RXR!D#\<U[Q\3?#^G^--*N-7TW1
MC#<I;"0Z="K!6=5SM#J6W$]A7%>!_&^C?"WQ;9^))+=FNXRI,2+B1V'#QLC?
ME1.$8U%=6B^WR*IXNJL*^762[N^IROB_P5K_`,$/'\"Z=/>V.GWEJ-[C+)&W
M&[#,<C@YQFNBO_BM>>,M"MOAG+<6$^F38C2;4].C>1V##DR,.O)P,U]+_M.?
MM+_LRZM\#XK&;P'?B\:*`M)=6*%8V?&$R#QGGG.<#D&OAG6O'OPV\/:'J4][
M\)-4UVU:[9;/5[&ZDM+1"2H"@RJ-[`LO05TSH*E6O3G[K7G]QAA,5/&4;U:;
M4EHGIKYGJ'[1/[/O[.F@?!K6OBMK/BO2VUWPW9JBZ)JVG1`WRR1%6"F/8=RY
M0IRWS8).,U\X?`[4?V;I]4L_$/QF^'FJ>%[#49((+2\M9"\<JQ+(\SD,5XD9
M50;3A1GJ:Y#XQ?&[X@_$_?\`"FY@32]$TV&>Z"D_:II20-D4DBG@;MBYS@;@
M37>Z[\!/%GP=\5>"_!/Q$U.]O/"HC@>2_OM-CFM(4E\IGB`$C.I$A(RIQM.=
MO)K5\M22:BDEOI=7^9I%5,/3<9R;E*[5GJEY6-_XNS_L_?"VW2SU^XL-(UA-
M#BN=&_X0N\BU&VFE#;D2\5VX=T(SM)VDX-5M%_:E^)<%Y<>,=1T73;2[\1Z:
MEQI^I6%VMIY<<'RE=B.H'"$;3RQ/O7;_`/!4#X5?L/?"KP#!JGPJ\`%?$.MR
M0/HEWHX6&R6((FYB/,+L6`8X(QD\5X+X$USPK\2O#>A_#[QYID_A/P[9+.RW
M>DVD<D\MZ44)+-.XW)%O*;AR!DD`5E6P\54LI=MO,VPU=2P_,XM_XM_DMSN?
M%'[3GQ`^-?B?0_!/BCQ;XATOPAIN-0T;2FL62!9U)#S[82[XSN^<EC@DUZ-X
M8^$WA?Q+\-1XLFU?3M:BOF\RXNM.\1.LUG$LG,2QRL%?[RDLP7'.!WKBOV4/
MV<?%/Q!\7?8/`_C_`,.6U[I.@R7FGWLNKS6^I7J"\:-Q">4D?#@[#P5`QBOH
M[X/_`+&OP<\4^&Y]"U[5-(UK4[K73%->ZI&(IFA`9?E*."C;VYX;)7VKKP^`
M=2+>C\V_0X,1FM+#ODC>-K727SO\SQ#P9\9O`6@?#_Q=HWBOQKXE>]L5CM_"
M^CP7A^R7DADP\D\B'Y%C4`J!]XYYXKZ%_9!BL3X,D^*/PR\3)H6H/>L[6<FH
M(1&H1HV42R*20025YZG!S7A?Q=_9&\7?LXW5QX-\?^%-5TG3M=ED@BU>TGBN
M$AAY"R-;N2S`C!'*D>M<G^R;X(_:-N[+Q-<?"_0KWQAX=T6ZBBNK&*Y2UDMS
M*"8Y2'.5#",@%=V"".XSG2I1HU8J4;O7IJO/N.M-XK#R=.6C:=VU9[:?,^E?
M%_QQ^*OA3XJZ#X^\;_#C3_$6D6%W)"+^;2K>TO/LHVC[D+KYR9Y).0237&1?
M'OXK2:K+J/P7T6?1+""XD\G[!8^9YCF9B!C;)M(#GC<H`'4UYS\1?CY^UCXX
MT=_#_B7P7HVGZ3HB&S:TUB-;FXMG?[S#<`P;@$;<8P*Q_P!D[5OVLM0\30?#
M_P""?Q?&GFQ>[NKV75=,*6MC&`"91*"Y8-G!!48XZYK.K3<ZUHMM/[[_`'FF
M'I0C0<YI*2T\K+78^C/`W[3'BOP3XJO_``W\=_B%/=:1))'/J.DI*RSN@0NL
M3H$79DA>0QP"!ZU[%X?_`&OO@9I6A6Z?L\>/?$-YKBL@E\(1!I$D0Y8@7)&4
M.W(QGKT]:^%)/#O[7/C'XKW$7B'PS%XPN]:9O-N+('?=A"1E3M!QQ[<"NP^`
M/Q]\??LI>,KW1M<^%UE/MN'$VG70C\RWD"-T+`X!W@<@]!@UPU*U3#5+2T6U
M[7:]'<UGE5#'T^:#3EO9-)/UTV/MC0?VC_#GBF<^(UTN9KMY6=[2_NA)D*HW
M*S'!7G/)KU+P0GQHU72=)U+P?X+^SOKLLRQZE)=X,48_AV$?*."=W.<CI7P[
MX1UE?%GP[_M?Q5X)&FZSJ(2Y\O3+N$)9V#$QK))'G>9V<,YXP1C`&*O3_P#!
M3CXK?"/Q')\,X_B&=3M],PMC>:1;ML0[1D,'4,6SG)X_*L\/CW&3]JV]K623
MWZW\CBQ60UZJY<,HW5[J3NM%T:WU/KO7/"7Q)M_$.JZ7XCU73K;4[=8[B&:Z
MD9GE!?:S*20#MQD^V,=:J>,/CA\7?#FJ-:VFM:=JVFW%HOV6ZL;;RW=%?9O1
M'P>IQD?_`%Z_/[X@?\%//B+\4-4U"W\9[YKK[:!I)5S&ULH`W/@`EF;"Y!X&
M*L6?[6OQA\-Z>_BNY\<Z9K%M!8(-#N[Z81RP.9=[1A`,EBQ88(P0!C%:U<5#
M5PYDN]]?1K8TP_#F)Y8^VY6^UM.FJ=C]&O"^I:?J\&LZA_PD]UJFFV$%NTUT
MZ^4\%S*#F.1=W4,!R,\,*[G3=2T>?0+?4X]7G`>0`1173%+=Q*R,S=<`8_\`
MUU\8?L?_`!LM/B+^S]KNJZ7XNL]/\2VVJR7^H6JPDS3\`%SOD"F,!`<!3R<5
MT_B']M;PIX,T*\T1O'.IWSW=Q#)>2I8VUO:LQ0,V&!W/\V[@#BNBGF%.G!2J
M1T:?9]?O/$Q.28CVTH0U:=MGM9:[6/JK5_"NH30CQ5I/BJVNI6*[EFB(E.<#
M)!&/3\Z72+?^R+N1]?M[@(A()ANPN"!R`P!!_.O$?AS^TS\/=1;^V=4\<V%U
M9+;0NMK=B3SG+?P1JF%<#&">:]!\-?'?PMJNA?\`"-S6JOJ$+I/%;74RP)Y4
MN-JA6(9F&X@@#MG-=5/&X6;YHM+Y_IYGE5LNQ=+W)Q;7I;_(ZS6M;\/LD,]G
M=7\CQ)NCBEG4HCEN0,9X`_.M_0-1U2ZT"WWZ[8"$$X@3`D1@<<@X!Z=,USVD
M>&?"NJQ!]-UR&2Z!4J;<EX>0,C<<'@YSQ2^']4;0M8\J]T:VD\Z5DB9U9D4A
MB-P'?UQ71"4D^:5K/33_`(!P3A%QY8WNM=?^"=#J>L:9JS-'J&LW=S/Y?EB-
MD5`I!YQ@<"F6"^'TTFX@GMKI9T!-LZNK!L\*""..?2KNGZXNCWRVVJFUO3AQ
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M`%SP?U-6M%U2]OK,VE@\+-LZ.>0![U2GS2Y2O9>[S$T^I6TB,EMI1V;MQ4]1
M^-4KW6==DC,-O`HC888D=O2L_5M8U:/S$O%*JJG&P8SZ_6O//'7Q:UCPG;10
MQWD?[TL8E+<G'K6%?$PPT7.;=CKP^$J5Y*,4FSLO%7B:;PM)%%=WJ8V[CLE[
M?XUR6J?$K0WEE-O?R"1I,)'&X))[YKYP_:"^-,WC8Q77AG5?)\N]6+4`DN1@
M=<<BO`?B5^U#K_@;=)X+#[GG*NMW)EN.ZGWQ7D?VE4K56H+W>A])1X>DJ"G/
M?M;;U/N3Q=\1X+'0;F^\2:];V0@3>D<IYD^E>*^+/CO?M8IINGRF8R8)N3EA
MC.>.>*\"T[]J"?XL>!O[!\:./.F92LT;$^3@\BG>"/C+J_@?QPNB6#Z1<JT:
MK`=4;]VB@Y)QG@''->;BI5<34M*35M/^'/<R[+*5"G>45)[KHO(],\5_&MM3
MOH[*/7D<VR$QB7Y2&(^;)-4M/^/*'7[8Z'XI^S"Y@\B^D@Y&[Z_A7GGB;XL>
M&OB?KNJ)XGT/0],0Y'VS2]VUG`/*_4UQ/PV\4Z7X5\=64&@:S#/<+?(;6*[B
MWP[\XRP[CFN..%E";L[^9[:IT/9:QLTMCN/BK\6?$DOB'9HNH27LL3;?/)[#
MH>:Y^/6?$VIVLE]XJU)9)KF;%K;/,V5)/++V%4OBY:>.;[X]W_A>]N=-M]3O
M[A,M"XBMRS@;<<X4>QKEOBGX9^*?PTNX(/$MO>23Q,RQK$Z21-C^)&4FNRCA
MVHMM-V9JJ])0C&+2;70]!ACC\3Z9JIU""_CU3341-,G%PK1S9)!#`]./0UY=
MXEL]?NKHZ5K-Q=0203`/"H+;5[G'./6LC4?&_BS5K0+IUU)`PYE$SE-OO[UD
MZOJFL::UOXCNO$#;ILK,T4F25[]ZTC2;E=*S+C5C%-.5TSW_`,+>+;N/P:/!
M$5Q=:[H%HIN+N1K*0^4^,81@,@@<XZ5DVNH_$C7EG0ZUJ(TFV)6RBO9V+^7D
M#Y5]<8XQ6#\-/VK?B%X*\%W/A3P+XE\C3[UFBFMDB5FE#C!SD$\^M+X>\=ZG
MX9\3A]4U::22UE6X=99\J,@''Z`8]JTJ455@OQV.>%2=.4M%Y?U;<[&WU[PO
MX=CEMM.EN;BZ6#]W+<+L`;N"#7/>,?%\.I3VM_H=]);16U@!)&/E&_<=PX_#
MFNJU#]IO0_B_\4K;Q%J?P?T5=/\`L<=E.)01$SGY3.PCV\\Y_"KO[5O[(NA?
M##1]1\6>&OB6-1TI3;&QO-/T]DMII98]\D(<L<&,X7!Z@YJZ67R2<X:I?(RE
MF5)35.K=.2TZZ]5H3_"']J/0O&EU9^`O'GAW2[9+?3YK>UO9[AHUGE(^1I".
M<Y&,^]=)XC'Q#^"?Q$MI/&]D+_3;J"&5(K!&VK&PW%`S>Q_&ODGP%)X3G\3V
MD7Q,UN^TK38;A?M>H:?9K/+"H/!16/+5W_Q3\8?$3QCK0;PG\8O&6J^#[^%U
MAU7Q':+%)-!#\I"*"1A01T/>N^BY2IOFWZ?UU1YU6E%UK1^%K6_Z/HSU']H3
MXS_`R'XCZ9KGPKEO!IRV:S207J@R13D_,`1@#D=#FLOQ7^T5KGBFZEU/P1H>
MGQ"[L!;7C2V",%R>6PX(+8`.1TYKRRS\*^%-4L+6]\'F/4+^QN?.U/29Y#M>
MT3RR#"V<L[?/N7'':O:?B7^TO^S+XC^$^F_#O0-`N-'U6TNC]G*6HWL'.YQ(
MQ`)^;A<]!5^QE-2G*23[+RZ:`JT*4H0C%R6UWT7=]SBI]%LK[5-(@O\`Q<LM
MFZ//?J(D18Y2Q#*-OWOE`/(')-=GX#\2>#(/$J:[=ZW_`&*-*N8KC1(8=,>X
MB:2#8$\T*1]_:26YZUP,GAOQ7%KD7AR#3/(@NX1]IF**3Y7#<')`..X-=)X+
M\9:?X1\41Q:JK:GIL%S\]A,I590..<<C^E>;+F4KL]=Q4J;4=;H]>\<ZSXH^
M*>JZO\6[_P"R6=WJ]VT\C);>4'<G&4#G(&`.M9MEX;^(T'B"TTK7=2@L(Y-N
MZ\NURL8))!9@#D>O6F^/OC1X'^(=KJDJ_#.YGEDB/D)!J#$6$:D8<X'SD@<Y
M]:=X$\>Z%KOA*XT+QH]S'%!$#I4C$GR6[@_[)%<\U"<VY:WOKJOZN9T'4ITD
MDK):6T;2T2MJ6;36]7@D33@+:]*.R1-"FX.S'DC`Y^M>Y^"_@Q+KO@VV\27%
M@CW-Q`3!!9W+PVQB!P996))8XZ8P*\3\$0>)K37+?7_A[K7G:A!)NL&CB&_(
M')VL"".M='IGQ[^,?P2T^XL[C2XI(I;=[5XM2LB?W9)^5<XZ<XK7"RIT7>46
MU]]CFQ]*I5BH4Y)2];-_Y'3?$*RT/1K)=?\`AYJ1TH6=L/M%G-*9(V=>K+GD
M$GIFN+TZ*#6;F'XC^-/B9I7A?3]2TBXF69;1IO.O8VPL3QHVZ,R>O3V-8FG+
MX@^(L5U<^&[A$A2`/<VHE(*>J_.<GO\`G4GC7X):IHVCQ:A\0_#5[IMQ?I$V
MF0;!#;R*!]]@>22.<C'7--U'-N4(:==[7^15*C"E%0G.TGZ-^FN_J=A\-_C+
MX=T;Q'!XOU/X+Z5KR^4T,D4>L;@ZN"-PC*Y4Y[]:I_%+Q=J7BS5#J=UI9TY'
M#PVFG1,0($ST]6(]3UQ7#>$_!7Q,\-01:Q:>%5L;*UN#)%J1AVQM@_WFX<].
M*D\1V'BNRA_X2;59RZWDV?-D?#8]E/.#5QE5Y;.]M[62_P""14H8>-1335]M
MV_EV1Z'X`\;_``]^&'AJ)+[3]3U"22X9M8M&OEBCG78=H0!2<@]23@],=ZVO
M"V@_`KXR6.J^-YM<'AC4+:VECM]+:^2%I#@E'#R/AU`SGC/`&"37&:I^S+\=
MKCP=;>)KSP-.(+^U,\">8OF-"1G=L!R!CN:\C^*OPC^+MOI7V6\\&7L4*Q@H
M?(8#YCM!!/8GCZUVT98BDES1O'LU^-SSZM#"5IMPG:75IW^5CT#4?B5'X$TU
M]`TWQ=97!T[44W7=GX@`>50PX1&XQD?>'K4?Q)\5:=X@^)-CX=Q8VCW,\<M_
MJEM?17KP%R,,&BY+`'.PL23WKY(U'X:_%B/5Y8;S29!L<AA&=V,9R.,^E>K?
MLUZ4?"7B2QU#6I+"UU%+I7BCU&="DN>`"&X'!/)[XK>FY3DURV3,ITJ5*-T[
MR2?]=CWC]KC]GWX0>%=.M=*\&?M6^)/%7B6=A.-,32E,<:A,C<$D.R3D\'H*
M\`@\`_$6#P_IWB.Y^+5I=IINH&?1?#UY,TSQN-K-,UN&^0$[1DYS7T;\2?[8
M\!>(;V[\*^&M'M]0FM6$ZV#*\.V945A%*'SYNTD')/#G&.WSSXD\/ZC#X[U#
M5H=3:PO55F1YER)$8*FU,`@@9(]L>U=WLJ<IMI6Z:7M]_<\VG6K0I)-W>]W:
M[^26B.;M]$N_&_A_7+RS\>6^@12VS6OBB34R)A?3NVX"!(HQ)&#M'RMD+CJ>
ME/\`"NGZSX96;P;KOQ3TU](DA26**2_DDPX;"@`#<C'@D8'`K@H]-UWQ9XK'
MAOX=:K-+<&<?VE]LF15EG#X#`\8C!8=3U/M7T?\`"[X'^+_A!\-3\4=>TS2;
M[QA;WUS_`&/<0&.:/S(SB59<Y5]H+$$<''%:/#^T=H[+J$<:Z5I3W>R[/[CQ
M;XE?";X@>.+32SKNOW]P08TTT16[W`"?,!@`@C``XP3S[5CS_"[PK\-+YK/X
MG?$;7KS1A"94MM,7[.]Q+DJRD2@^7@#/0D^@KT;Q7^W#XQ^(7Q(T"+PV[6-]
MIUN9KYK*&.%4EA5HXVC*@%<*W(SRQSV%?0G[#7Q6_9\^._CG4_A-\4'\.SWM
MZ@A@N/$T0=I?-=2XVL0/-#;@6SR&['FIPN&]I5Y+V5]V5C,PEAJ#JN%]-D_^
M`?`>@_'35](\6+J_P\;686T7>-`WZL[262EB2P<*`<\Y7`ZUW>D_M*6FO:A,
M_P`0=%\81V<\8,]QI'B<1R>9DG?\\+9Y9CC@^]?9G[:O_!-7]E[X%Z[8?#7P
M/\3+Z?Q)J=]+<M$=)>6+R<*5C58RH(8L>>P!Y]<SP?\`L^^.;KX06_A#X5_"
M?P?XINXM0436\3SKJ+J$*E$+C:R,'SLSPR#WSV5<'4HS:B[^EGVZ'G4<UPF)
MI1G*-K]]/G<\0U#2O@Q\1O#NE>(_#_BOQ!/J5NKR7K^*_$CE;M`R"-2N=J#!
M;_OG'>FW_P"UA8^$?%AU;0/^$BT]YX4&J2:1Y4(:2*-4C5(_N-&-BN&8%OF;
MKUIX\*_$M_B[9?#/PG\%5G\01+>&;1M0TZ'9$%0[B[#"L4`W<XP1BO7OB'X>
M^#?QWU_P[X:^%WAW2/M\6B37.NS6_A`VI\]8QOCW>:[3;64*ORH,L<5Q5.9*
MZT>EE:UV=]"I14E"UXV;;O>R>NOEV.!\"?MN6UU)<3^,O"FF:H=4U*&ZU&;4
M+($3+$KX5BI4Y)?)VCG`!X&*][U?Q%XI\0^"=$\!?L_?!TW*:E9G4-0U2RC6
MTO+J<%#*(49?EB&Y1LS@A0W>O'M4_8P\!:#X$M_&LFN:S>SW*3F?3XO",[QV
M:QR;2)7W1[3G.-I/2MKP!-J7P^^%NM:_I'Q\$.HZ>(4L+`VFH"YMXR%&]'#%
M%4J6!0M_RR'I2I2KTW:IM;NKVW*KK#5DI4^CML[7VV7YG6ZSXZ^,NG_">/2O
M&G@73=+@368=-M?%%UHYAU*Q9&)95=''FL=YR".1CGBO(]$\4>!_!FG3^(K;
M7H/$&N/K\D=YI>I1O(DT$>!'EPQR6?<2O&-HY.:Q_$?ASX[?'C7K?P[KGQ=U
M;68-1N6GL1+#(P>?&-RH<9]"W;BLGQ5^SCXI_9=^)VB>$/CM:ZE83W`MKJ^M
MH8-D\=O(V"Z;CRWIVKDK4:F(?-&+LM+O6QU8:O0PD7&4DI.[LM+H]%\!7-_I
MGQ9E'CW5[:PN=15)99X[4&VA)Y5=VX8"@]AV[UUGQ3^&/P2LO"^MZ]K/COQ9
M)K=NX6>=ELC97+R8436SG:\B8`..HZ$UY?\`&;1O"WA'XE7>AZ%KGB;4/#HA
M$CR^(3!'>R1;-^Y(TY1"2%#GL>F:]>MKCPIX^^%/@_\`X65X>NM-\)V0FBTI
MH2LERK&'>;G>ZMMC\Q4!3'/(&*4<$DVK??<J6.5X2C)Z]%;U]3R>U_8W^(OB
MS11XA\.?$F![&S3S;#6[[3I4CG+D?()%#*K#=SDXXQDUM>/_`-BGXD_##P_I
M/AOQ7_8&IZWK5K->6M[;7\GFVEK%]YAD!"N23D+DXXK5\+_MF:Y^S]\$[[X`
M:7?R78ENTOM/M_(26"]AE+;_`#B063"[`$0C!YKSCX@_'3XS_%O3=(\6>(_$
MD\4FB2F.&^15FDLX@&`MR%`VQC^%3GJ<U:H4'2U3<OP7](N&.QWMM9)13=N[
MTT.]TKX>^/\`X!>'+:XLM<T/6(M2$"S7EA))YT6Y0TD?/"A22"2,$DX)KWW3
MIO\`@G)I<\6L^/+[7]/OO[.1GT_7H'G@N96B!D:-@B!<$X!4D$8KYF\,?'KP
MQJ%[HATGPSJ&OZFJ":_MU<^=\L6T1_+C<F\`["#QD=J]8US_`(*'_%CQSX-N
M]!\4?LI-X@>_0V%G=:QI\BP66,JL=N(D3@+T4G.2<DX%10H*%W9>5U=?\`QQ
MM>I6J0:O?JTTG;3ILS<\*ZKJOC;4M+^$?P*\+6'B/2KVY\RZT_4(U;[#`)&=
M0+A6#1%E7)1<D"NM^!ES=?$7QU/XK^(WB[0+'3O##/;6MF(KE;.ZEB+*BO)G
M>$VJ3G.>1UR:^18?&/C3X?>-(]:\;_`06-K)"WD:79I<:;!@MG?)-$P>1AG'
M7IQ7TS\$?VD/AQ#X)AN?!_C*^\/ZRB+%XJ\/72)-::J/,*J8HV4B$11XY;YF
MY))-<,Z-.G+FJ)*VMGU].AOB>9TG&E[W-I=:V;W;:/M7X&>.O&5AL\/ZIX>L
M[7[:1>HFGHOF(A!'EPLY(*!A@'.?:N_\-ZMJ7C.SU#4I]+N&"7OE63JA:1&`
MSP1QDGK7SW\)?$']HV<>JR^);^X^UDO)<R;2UO:9!CP!U./FXP,8KV_X8:]I
M%Y86>@^'/&=]&US?R!R(E50FX@..=V2`#CU)YKU\#5]I!1OIT3:OJ?#YGAU0
ME*44N;K9/IN;]IXB\2-'>V]_I[M=11AT\]/G@`_B&>E:%C'>Z3JI@UZQLL7:
MJ6NW7*J>N<#[I^M4OB+;0:2U@W]LF27'DR.+8B5\=G^8YQ@"G'[6^D"62R>_
MB*Y=Y5D1=QZ`9ZGWKMYG";C=MK^MD>0DITU+9,UEU#PM):*KVR;VDPS0H$6,
M=-P/))[U1NK]-/>XM]&L_M19=@,BJ[;6^@Q_]>I].TF.RLO[1LM%^T6BJ#.L
MQ#.C*/FPPQQ[5S-_XDT^T:>"Q%Q:^;"/,1.%#%N^>G%*M5<(IRT\_P#(*%)5
M)-1U+NN:4MA$M_=Z3*IE1C*9;<C8_3(QC`].:O>&]"\27-LC:)8K&7^9KF8!
M=O'0'WS4-[\0)(-%ET**1[RYN%VRO<%G_=_PXP<`]*JZ-%KC:;+=-K'V?RY5
M!M8)B-Y(//X5BE2]K[MWZ6W]=C6]94FI66O77\#CDO;6*R82(K%QR3)C)JK;
MP1SR`1295N"2.A^M<UJ>@V7C!%TRZN76..9)D:*=D.Y3D#(/(]0>#6K;V=_H
M\WV$W3%6')8<?6H4G/5K0Z7#ETN3:OI:H"5.X*N&V^E94-[;Z7AW209S@`U?
MCO\`[.7=[X'Y\``9W5GZK)8SRO!*YC782CXS_*J:OK$<9O9CM;UIM=LOLWVF
M.(HA*D+C/!X-?*?[5USK#O#+;VDGG0N1')$V`#V'XU](WMX+"PEFAD!_=DD,
MF>/K7AWQU^)?A"70SI&MVD4<SL5M95'S,_;/MFO)S:FIT4I2L_S\CW<CJNGB
MDXJZ/A"Z^(>J^!_%UQJ7B/33J"I.SS:>TI13G.,UR'B_XEZ#XEU2UM=9\`/;
M()VD#V@=CANBY->Q?'[X6>*+IHKK2]*AN+FY0RR?9E^<#MD=N*\9\5?'#Q#\
M-]%^S:AH]LT[J$42P`-&5Z$\=*\S!4XJ7++9GWE6LI4^:&K*7B7Q]K$BVNCZ
M3X<^R6=I(1`I@$<LN?[Q'6L+QAI_BR"Z7Q7?:M96[A,&W^T!G*>A%7-`UB+X
MW.K77BRWM;^)LX'RAL]?J>@%4OBS\/WC$.A:3<PM=VMI)<:A<^8?]6O`!]#F
MO9^IQ:=G=L\R.-<9)-62'>`[R[\071TZZUF*TBWEGDWX)4`YP:Z'X3Q_#R+Q
M:)]<\3R6C1.3;2CG!)X9L\$>PKS/PGKWARTT&+3WL?.NUN=OFSRD*X/&!5_Q
M[^SS\9OAYI5SK^KFVDTJ6S%S$Z3A_)0D$<CW(%5#+TX<T>AE/,;U>23M<[OQ
M[XSC7QEKHU:>P\0PSN%M]3LR4V.!D.HY.>U8ND>*/%&G:3=MK>KM<1)@PVTD
MI))QP<GGIVKF_A%X;\9^-FN=>TRPM88-$TTWU\]].$650<?*#]XG/2NXT^2;
MXJ;_`+=8Z;IDD-NHB>+Y&FR>K#."/4^U<SP]3FVU.U5Z<8V;32(/A]\1=:\:
M^([31+NQ\/6L<8<+-J=L?*&`>&P03^=8_BL^"[[XM1Z+\0/&^DZ?I3*GFW6D
M6Q\J,=PJY/YUP7QI-_X=\52V.@ZK;RQ)F/SK)OD8\9(K(\`_`3Q?\6'O[]_$
MEAIEK86[3W5UJ=R%PG<JIY8^PKLPN#G5E:6ICBL73I4G)2L>[:1HGPE\(:I/
MXP^'?Q!TO7K/2KTM/I%],8I;J!64`KZEMQX'0`US7Q"\?6?B7X@:[XI\/>"8
MM/M)\RMIFG.[0VZCIRQ)('>OGOPOHNIZOXM;P_X;NY+MO,,4$JJ0)3NP#[>M
M?1LWA#X8^!_A]JGA2/Q==3^+K)K:26[L;T_9G@E7]]&ZD`AHR.>N:ZY98YOW
M4DCSGF].DTIR;E;\&>:+\5-1T4R1:3J$D221_O']\YX].:]%\%_MQ^,]3^'K
M?!GQ#J=UJ.F3,PL-*FD)B2=AM\W;W?GK7=^'_P!FO]EZ7X&:)<^(?%*W7B#5
M;VX)U6XO5CMWC1]N`%.4&&!R0<UX5XH^'GP$\!:O?3)XOUFUU2R99=+DLI4D
MC=@_4$@$`#&".<UVPR><*=^9?>>5/B;#2J\J@VT][?B=9JFE^._#.IRZ?K>F
M2Z=/);_.D]N>5(R#\PZ]_6KNG_M,W=K\/D^%NOV2S0V@>&&60D-"C'+;?QQ6
MG\'OVO=1^*&C2?#7XM-?^);1G9+"]N9HUGMYF',S2[=SG``"L2*J_&7]G3P%
MI.JW>HMXCN(-,N[J"6QU*:0%XK689$S1*O[P#!4D$8(KA66U*;YHO3S_`*V/
M2AG="K-0FM=]#EM!\3!]9AFT:_CLQ'EX)GDQOP>?IFO63I2^/8+?5/$7AVW^
MVH5EEU:USE8@O&\9PW`XKR/Q;\&_^%3ZEIMK%XQM=7T[4-+AU%M1M5R+>*1V
M558=GPH)7MN%>@^%='TS7=!NHT\>2VVGPRB.$*F#.G9G`R1QG\`*XZE"M";B
MUH>M#$T)I2C*]O(^L/V?O@QIOAOP[#\4_B/H<^I^";AUMYYI;G9-%OPOF(%.
M1C&>1TYKZ2T3]BC]BSQEH?B/6]/\7RV\>B6<,FG3W5V527=&97+]SV'%?%'P
M/\>_#_P?X:U"UN/BIXANYYH'CM+&TN<P^8%`#2*ZD%,9&.OTKJ]`^)7D_#Z\
ML;+Q4VFK.QCGTZ5RWG1#!7Y^Q]N!5<]&BDG%2];/\=#GJ4<3BVYQJ.+NMM%:
MZZ?@>A?LE>#/#7C?XK:KI]_X*1],N$E:SMT@8^8L8W*JMU`;&#[&O2OVM/@)
MX?\`@];0^)_!FD:;<>'?$4HNX(91YLFGL3DVY92/DSTSSQ7A?PC_`&G/C#\$
M=4BU?PF]K:BWCWVIFM4E`0]^>O?O74K^VG\>/BOI=[\/]2M-`FTC4YR2)-*3
M?"S2E]R<_)R>O85RTZN$=&5.2?,[M-):?\`TKT,QCBXU8M<BLFKO7SVWV,6T
M^,\.EZ39>&--\&Z7IXCE=Y+V`,975OX"Q)P`/;-=+J'QN\">-HET;5+=UN;.
M)(["9KL2A"!@NRE<-_/WK@_''PYT'PGIFO7E]))+K&FRQJ;/?O\`M`89\U-I
MQMQ^E:7P6^$GQ$T5!XEU3X&ZC>VS1FZFU#58%BM]FWON(^4=<\5PTX5HW2VZ
MZ7/2<<+)<[WZ:VNWYO<@TNY\0P>+GU^SN%N6GN_)M8W&!(0<AC&#V'.#7KGQ
M1^.W@SXNZ.-"^*5I>&[L(5MK>\A8OF0'`D4+@<#(`(QBO!AKMW;R?VC;ZJ4N
MX+LK;K!ATC+'(`/2NMTG6X/!37$OB'PAIFHW,MLZ*FHW3(L$K<>8JQD$LO.`
M>,]:UP]:=%2726]UN<V+PT:KC47Q1VL[,ZS5-=U"_P!%M/!NJZ_</I=F%>"!
ME*LK$\`J21QQZ'UK!\7ZA<Z+XJ@N=$\"S:E!8M$UG97L32K<3,N`2O4Y/0>X
MK8^'6G^$O%GC2:V^(OB6]471>6-XHL*S,C,K9)R`&V\>@K?\&?#5;SX>IXI:
MYOH[Z.6.[N-3A9G%O&&`"H1QE<AB3P*Z:5.5;X/^#I8\^I6CAW[^OE;1M]3S
MKQ3^T7^T-;Z^(9KNYTFZ@C-D())<>4IZH68\`#CZ"GZK\1_%E_HTFF_$S5+7
MQ3<)]FAL=/N_$C00I%DL&VC`<$D8W=/QJ]\1OV0?'7Q$T"[\81>-%-_+"UVD
M4YPMU+O!.-K')(R<8%?+'[3OPY&@^.+>[NO#VJ0RBSB.H6TUX1'(ZA1N#8RL
M>.N#\M>G3P-:*4I-N_=WT//J9AAI?NZ:2:[*SOZGKO@>ZB^+%PEK%\4/#G@K
M4KF9HM.L;>.1[BZXV-&A&$7C/!(SFMQ_V3/`FL7=YX@\:>,_%4FI6$8D$*65
MM!')L^]'MR7R/[W/2OB[X?3WIUJ5;^+[3:K%/]B;[0\:P3,H"3(XYRK;3[@&
MOHCP7XZ\>:G#I_\`PE'CR2=(+8K.&OLR"-6Y9CC(SZG/2FXTZ46G&[]?Q,T\
M16DI*=EZ+[CW3Q1\%_AW>?#4^+]`\4W"V$,RPW<%_.$N"<@!@J'!YP.>1].:
M\PO]5^'4?AW4[3XJ_P#"0306EOOTNPT]HEFNY>!&J3N"8TY#./FX!P!UKD?&
M/Q!L9=>@T7356XMRR,7%JTV]`P.?++8.<8YQG/-=U\./V>O$OQ4M+O6+>\MI
M732Y]6NM-L8!"MI$`QV+&K$J2`3M4<"L/:2<ERK7\#10C"#]I)V_%'C'C7P/
M\'Y/#6D>%_AQXFN[GQ+=3R'6")/+@M(64;5\U@N\[BQ9N@"CK7%>'=4U[29%
M\'_$WQ[J/_"-64CRI!874LBS/C@(1\H)VE0QX&>17TYI/[,.C_%'6SJ&CWEY
M%_8'AH3'R624RE91&%`G^4#YR<$#%<O^U-\%?'=OIA\)ZKK/A6\;P]"JH\>F
M/IVHWLSL2(7'*3E#TV8!R.371"$W#F?RL92K4(S23];[K\"M\)_@II5K\+?#
MOQC\0_#6]Q=:C<:5<7D5W$L=O#(\(M?,C(WR=)1(P*C,BX/&#G?M!_LMZ%X'
M^)%CXE\-W*:9F7RKVVM&907!+1R1[CW4?F*V/"=E\>=+T!?V<OCG:P^$;>XT
MNXG\/W_B":>"/4)5(/V%)5W(K.V""Q`4QC)%<;\5;W]H=?!EM)%J.H:AH5U*
MTEL]_>17DUL8R49`ZG)`W8!(Z8/6NE3ITZ=G%WTW[^AQ*-2M6^)6;>ST:>WW
M'O'P/_:ZLKBQUJ'XR^*+FZO[31H[71-2FF!O;&.,X+(S''_+09!!R!VP*Z+]
MG7]MCX!_#+QC8+>:_?6FHZ=J(O)[U=0S'<%6&`NT,RDJS$#:>5QWKP']GSX:
M_"?XT_#J=_'&G^/UU;;);"Y\.:5)=1SS>8IPYVE54JV-HYRH/`Z\UXFM_AY\
M`_'\=W\-?#4VJRQPO'"?$UD6;>R%2X7``9&Y''!6M%7JQI*3:MTZLYW@\+4K
M2I)._P!RT/>X/VMM!_M#QN_B"WO+76_%=[=W3>)%19;RZ\T_+;;7VK`-F27`
M)#*ORG-8<_[4&G_#+XFVGQ!\-_L\FVTZZTZU\JTGU.;SQ;IE"TDJ=6F/S/P!
MS@8K@?A!<?'?7]&UCQGX0\/VVLII%PEU*%@26[:69F&Y8V^^HPV>.-P]J=!8
MZQXCU6]TCXL:WK>AWI2)(]'O=/,3N2S;`#P!C).#@'(]*XIRJ.*DWZ?\.>C3
MAAXRY4O)I-^1[MKG[8OQ=T_P78ZOX4MW\,V>K27-K<3K=F:"\#J/D>.567**
M3\WWOF7TI=,\5?"ZU\*6=OK'CS5FD:[AFUG35N(]L\80[GA<)R`S`[2W8\=Z
M\<^'_AKX>7>IWGAWXO)++!8W"0V?]H:ZT$+RM,@8E8@3Q&#G!_B![8K(_:JT
M7PW\.=>@^%5C::A<:);7$EWI>M0W0CNFCD4?NM^&5XQM!`9<\9!7)KG52:?-
M)W]=;'7[&F_W4(M+>ZZ_/R/O3X=>$?A/\=]%OM<TWXZZ7I\UIIYMM(DGC@M[
MBWB,2LJJ@V8)D)1B0V[J&S7SO^UOX^\2?'W6[;Q#XIT=M:USP5HG]E:C/86G
MG022*X56=VD&T`#.?FP2<`&OF/2_$^LG1M)L]"O-=ANKQ"LA.J+&)T20E.@Z
M#WP,@XKU4:%^SO<:-<0^-O#OCC2_%NI!;C2%75TDL[T'EVEE?!X*L"H!W$]1
M772Q,ZL;*R[[Z]C@GE\*5;GDW+LM-._R91^&4VL/XSE\:^,O!T7B^.;13#=1
M[K@I86RR97:4(X5A@]>N<\5M:3X`^*?CK3GO_"7Q4L#X%M[F7F><2R6QE">9
M#Y2X.5.T!?\`:^M>K?\`"[OV>G^'7A[X7^*_#FFM?:99G^R#HBFPE:2:<9MK
MEE<-.@0DJ^1ACZ5YQ\<?B)X;\$^#=8LO@9HLFAV=OJ@O]2.JZRL=VZ(T2P1P
MQ9;=+N4NQ?=D'C%:3LHOFE?\[A2<I22A!Q>VNJLG;Y,3Q5\'?@KHGAOPUHEM
M\1GDUJ]TJYU36_M&GF-+&&,2_N5D+!FE^11C!4;NIXK<_9F^'?PTBO[+2]%N
MFU2;6M)>6[L_[3>>!YUED"%ER!%L0)R>Y->$W?[2'Q`^-6M:-X7^(EMIME%8
M:8EIHE]?6S1/%#).9#,>2F6#8)(VX4=.M>P?!+Q]H?@^SA\)_!S5KV+['<NF
MKZU/J-I*CVY=B5B1HPP&6.<D@GH.E<ZKPCLM-+G;+"5YI*<O>Z:Z+YGW7^SK
M#^R;H^B^'TN/#.A>$]D2R7>MVD"+=-<LFV192X.(V^4@[?X^#5:X_:5^#OAJ
MRU[X.:A\1+37++2TN7TNVNX8HQ%-*PE1H9EPS%`=O;/(KY)\4^#/&VL^(E\1
M?#R.;Q7?VMJOG6=O9+<2B&)PJ222+(%8DJ%P%R%``[5Y[\;/B!X]A\4WMS\5
M?AM<Q:I-8)%I\46F26Z6_EJ%C(`49"@')R<GDUURQCC324>W3_(\REE4)U92
MG4;^>J=_/4^\M?\`C78Z?\(/^$B\3^!;7Q'X8CEL[635KDI%=,L:J/\`4L"`
MN%VY!(8@GC.*\U\<>(?V2/BWK,?B+1O@MI`TH66-4UB"]CL9K=^A547Y&D"\
M@E>I'I7P%XK^*OQ%U2%["YGOY+2./?;P7%VX)'KMZ8SGM7JOP`^*7AOQ)X"U
M2SUB+0--U.!,+%KESY44^U"<@'DMQC!X_2N+%5958I-*WG9_<>I@\"J2?+)W
M3W5UH^^I]]_!RV\#^(=#U3Q#\,=0GGT"SL+:"PEU*TVX#8B"%E90T@.,%001
MVKU[X9%]%OH[58H97MSM,BR$*I4X.2O3ZU^>W[,NM>*=)^+%EX9^*'B>\MO#
MMQICWT.B:3<>>9/-C)@954,%R6!!(R%P>.M?6OPS^-.C>%_$MQX0O/&6AZCJ
M^H2Q:?HX\,NPC\LH"%*-P69R=V[)+`YS7E8:O&F_>2CJUOUWV_`PS'`3O)1D
MY75]NGJ?3][J^N>)K\Z1+8Z=8VMMAFNKB10LLC#J)._M1HLWB?1`(-5UA)88
M<RV\4K%TE7D97';`_6N0O_">I^&[&V2^U4O#.T;/$90IC<H"<KT(!R./2NP&
MD:'K6I#2-)6Z8P6I,,MNFXR-VW#.`/I7KTIRJ3;MJO/OZ'QU6$*2M]GT_'\3
M7B77IDD>7Q+;VEI(HD:T".BL6_A]QZG/>N6U_P`%W6L2/OUZ-(?*#%TC)'+!
M<!NI_P#K5T%D;;5M.FU:\>Y\RS!AFCNV5Q$,8W8*^H/2DTK1M*U'1@U]K\L&
MY/D$,8.X\[01G/Y5I5IQJQ46KI^9C1G[&3DG;T7_``#F-'TBXA5;V""Z#0,"
MHN+@+Y[@]A@9[UN2.MK.NJ^))[=X)6.+6*7<P;'4[>>]+,L*6UE9A;B_7(\Q
M9)\*K9R0NWIWYJ<>&[&XN3';;K.-0&:!(3*02.`2>G'-94:5GRQ_$WG5YG>7
M]?Y'C=@([:Y*&!$,?3+=:)==FMYG$T1EWC!R:H7%R;*0QQ@L7Y8LV:YGQ?\`
M$*Q\.63ZCJ-]%$(B?F9L#BLI3C3C>3LCT8T9596BKG53>(;:PB\N2!-XP1A>
MGUKF/&'Q#@LK;SWEB0'[I4CI7B_Q-_:LTU_#4GB+1[E)$#%&\L]2.]?/OBK]
MK.'4]2BCU<N;-LF6**3D$>_:O/K9C=\E%7\SU\)D56JN::LCZ[\2?&V:+06G
M@U.W!1""K$?,/3%?,OQ_\8VNN>(+$ZC?65V=HEE6)PHB&>`<=#7C"_'/2=0\
M1QP>*_%=S:VT]R3`(I>/+!XY]:Z?X)_!.Q_:B@\6ZYX/\:1M=Z5=`6EG+.%:
M=!WZUFJ6(QTHIJ[[7/9H87#9;%RF]%U2[E;QC\9M3T[7+OQ/X;TJ[M;.SMPE
MQLN2ZCMN!/:O(?B#XE\(_%JP?6K^RL,I"?-GN9`O7@=#R>>*Z+QGX6^)_AG7
M/&?A3Q-XE=-0T.TV#38K$21OP.&V\#@YS7QKJ^LZG%="&[,WE7%YM0QMA"`>
M<#\:[Z>75*4TY+]%H:?7*52#4)6M]]CUGX2>$OAS8WFHZG>>-WTR]L2?L6ZW
M\V,]?F('857TP?$35==_X2%KZ"^_M.;R@LLNV.=%/\7]U3BN<%QH?AMH]2\,
MQ7,5W;VK1ZC!>2!Q-N'4#%9ND?&^STC3/LD.C`W$=FT$04<$EN7;WZUZ"H./
MQO3?0X_K#JWY5=[:V.X^.GA<3Z98_$A=-T;0HYKH6JZ=IFHB0-(JY\PKG*@X
MZU6\/S_%/XTS1^'M;\<^7I]O:>7"+F0K"ZKR%..O([UY[IGAK6/%FES>(HK>
M2.TCN0@+/D!CR:]Q^&/B#X1_#CP5=R>,O#,FK6]TL0@N4NBCQR`$D8!P1FLY
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MBAE98^5)R5;^\<GOS773NIZ1T.7$-.@E.2OTN^J.-N];L/`&EVY\.7-W#J$4
MCN+L1C$LBMA70]0,5S-QX@\4>(;Z\U35=<,5U,FZ>6ZEPTF3^M/\::-XVN]1
M$&LW675!Y:JP(`)SP!5'0/#FFW]Z;?5?$GE3"-BJSK@,V,A<]N]=T8IK5'@S
MG*$GK?SW+FEW'CXV,\FA6-S=):QEV$$C.(U.=SA>P/>I+'6H_$%M%J.L6-W<
M?9E(OV4K@==I&?IW[UZ5\.O'6B_!"UE\7>"_$-BFI+9/"UE=8F%QO4JRE3Q_
M$?RKO_%"_#SXH_`S_A.O%WP0\3:%KNI+';Z1J/AW14CTS4'C&7#\J`0F#QDY
M)-=T*4>71Z[]SQ*E;EJ^]'W;VOL_Q/G?3K==+T2/6)+^:`RN6B"-MW<YSQZ9
MZ5V?C7XZ>*KOPWX*2]UAKNWT[3GMT@DDW`>7<.=K`]BI7@UP\G@^^DOX--EN
MWA@ED;R+>5OF4\`C&>.U6=;^%VLZ99_O[]!;P7#>4[-\I5AP?7!*UR.,IW5C
MTXSIP<9-IOH>H:A>Z3XM\,Q^.OAM'<!)95M]7\.L[.8ICE@T(Y)C(P<'D'/:
MNK^!GC+3_#T>I6GB#3K)Y[LQ10RWML7>V(D4ED4]#QCZ5YM^S/J'B+X>^+H/
M&NAZO;1ZAI5_%/;K.HD@D"G!#`\%3WSVKV#]HOQKHWQC\;W'C[1O#5OIFLS1
M+_:=EI*_Z/+(`=TB!1\HP!D>U>=BJ<%%R6DOS_X)[^68BI.2A)7@^O5>OD?<
M7@;Q#\%OBBMI\'=>\#^%[O6)(WD&M6:_9+B-&BW^8?*"CY1T0@DDUYR_P\^%
ML.A:3>C4=1U&X2ZN'UNS@GVK!&CL(U+;<JS!<GT%?('PD\8^*],\76=QH>I3
M65RTX$5UYI!!/&2?2OJBQU:6[,NBZO=Q2?;XE%R^D1#8)0H`R,CN.?4DYKPZ
MLU)6E'7N?1T,/*G+EC-VWM<[GQ'X9\):UX6T^7X5:1-'"EG&/$.IW5YYJ0W#
M%B(T53A$V@9R"<]^:Y&QT[6K%IM0TSQ/INGQ6TVU7$W+L.V%))!]ZYNXUKQN
M+"\M]`U0V=O-'Y-XUEF+S(P1\LB@D'IFN<\!2V7AOQ#,NN1M>VMPSB,[V5E)
M_C!&#GOBN.?L[WM^GY'IT\/-4FG*]OF_Q/<?B;\4M-\7:);S/I-E]IL[..VO
M4TM9LS/@[96&_OGH,``#BN:\1Z*;GX6'Q(O[0MW=RQ6C/J&A$S*+1?X8@6;#
MGKP/2MOX):U\#_"/B+6;O5?#$DEC+H\AM;G4KQFF6YQ\I&WY<DGTXQUKK_A[
M^T)X%\+_`+.7BKX?^)?@QHVJ?\)`DWV+7[[3RMQ#/)\NY9!U5$)PHP,\G/2J
MI4U*=Y223OW>VWWG#B:M6C34:<&VFNRT>^_;R/F+X7M\8?%WA/4/%OAG1KZ[
MT#2YD?5I;?`$>3@#<3_+.*^@;2.S\4Z7'XI\+?"[^Q=/TZ+$YN-5:[EE\UVV
M-(S`<C!'`^M<O\3/$GP>OO!5G:_#7P*=%UJ>SC36+W3WF^QWDH)`E\EAL4G@
M`QA1D55^&5M:SZ1=:%'XOOAJ*PYCM#ITK"X<=0"O"X&3DCM5U8P6D-?Z\UH7
M0E5K4[U%RN_X>=MST/1-9\"66AZC8^(M1NYM<,J+I\4"D1Q+_$S'IT.,5ZMX
M8^,'CKX:?#"&#PIX0M]>TF[M9#=V]MJ3,T<1/S+)'C(.0IXXKPCQ%^SI\=M$
MT?3O&-KX*NVMM6P]K<EE'G*5W`@9S@@@Y]ZKP6/[3'A#1KO6-.LC:VFG.K36
MUW.HCD8L!C:>6SG'YTJ$L11E?E:TZ+7\=S#$4<)57QJ6NS>E]K(W+W_@I-X[
M^&WV31-$AAM+6RN_,6RFL$<;-^XQDL"V.W7\*Y'XD_%S3OVF/%>H?$O7=*M-
M,TY_,2734NC+<QH\9&49@%9=PR0$&,UB:Q\6_'EW;2>)-:\(Z)%JZ22VL=W>
M65O);&V==K1B*1""PZAP<CM7F6I>-_%7@WQ+;?\`"-^)-(-ZZ[E:PM42/&#E
M2K@`Y&>*[X8FNDHJ3?J>;6P&$YN?E2?D_ON>IQ?#GX`7G@III/$(L9]/MXC!
M;&!E%TRJ2RQ[`5E+?+G)!&372>(OCG\`_$7@R'P[X-_9>U206(5[W5X;;R=B
MC!?YQG",3_%G`(K@_#6IZMXBT2VTC5M0.B:+JUV^HI:W.D&UM6O"A2)Q-%)Y
MHCSACEMH/.W&:Y_Q/\6OVA4\.V_[.?BSXL6#6<4XMS$#%$D[RR>2RR7`7,B!
M22"6P%&?2O13?*N9[JVRN_7<\5P<*CY;Z.^[LE\MSI-=^)/AWX>Z[XCL-+T?
MP]9C6K:`260N?M!T^!%618XG<%E<,<-SR00>*ZSP9\3?"-KX5?5?!GC(:/.E
MRQO;N_E>)G@DA*QQ8Y!&58G_`'Z\_P#VL_@G\(OAZMGX/\%>+=/NM4MK>&.^
M675%D6"20%BP:,8DR1DG&`&&:\>\`>$?BEXR\:76@Z-9V_B)-%C^U75O;WZ+
M'-"KA#L+D!R0<#J0#D=*RG0FGRQ29UT:U.K"[=EOK_P3Z&\#?M&QZ;J"6FOZ
MG_:6F()1/9O<S+$JLV-Y,9#8SM;"D=*['Q9\7?BY\4M!T:?0OBUH5VMO<,UC
M?RGSKJ&.-/*C@\J;.#M9BK=<*W.2*Y?4/&.D>'?@G-X/^'O[(7B'3(;VY9O$
MVLZPL5_$LJHK1_99F0M`R[OF&\AE(R*\S\%W%_JRW/B+0]*L))=';[1);MHH
M$]R!E0NR-U#KTW'(QFLXPE3]U7OZ-"G4HUH<S25GUL_R.^^+?BO]K/6_A\NJ
M^/\`XZ6'BO1K77#9W'AJXE@DNXYIVWM)%$$+`,4(WK]W&.,US^E6/QN^$6DZ
M/J;?`]HM*D>7[//KL,MH'+S(P5SORZ@[<$@9_"NQ_P"%(^)_'VE^"?C)\-_C
M?I6M7NHS[/$'AG0K*..YT.%7`</"RY*@/][+Y/)/%/\`VEO%?QX\;:O'\/;S
MXB>(/$%KHVD+?:;;:E:PP_88(XU>%-R1Y=A&Q`'JV>^*TE%N&MV^EF84:D(3
M7+91U;5K?=L8'[+7[0'QQ^#=YJ'P\\`^!=(EU+5)Y"+@ZO?0L@<@G8L-S'$,
M<C<RDX/M7T5\'_V(_"?[3OA`^+-=\8:3X4\1W=T;O^Q-+TZZWQ1?.-BW,\[Q
MG<?G.5ZD<UX;:?&7X\^,+:TO-)^#7@O4K>WTF*SU70IM*^T37D*`'?,YQ(CL
MRER4*G)/..*V='\7?#GQKI>GW^G?!K4_AGJ%V]S!)KOAO7;DV#2HBL%:WN7<
M?+Z(Z_?]JNG!PLFKKL[I&6(O4FYT_=;W:LW\T?37P"_85MO"=MJ6J>&X-:$M
MA$81)<ZE'G?O7<&:,8<?=94'0DGM7IG[1O[%GPR\1_`S3?#_`,0OVB-:M=0N
M;H7]F%\B?%PJ%8Q-(ZEVVY<`!@.?;CXG\&?%_P#:"^'GC'5O#7AK]KNVN[=;
M?<;=9I/(F)V_*RL&7N?FSU[UT5U^UF+FPDT7QU\+/`>I7DUOY9O8II//M]O!
M*AF**3G.=M;NO2IP<902_%?AJ>?#!XRM74XU+V[*S_'0N:I\'?B#I7C#3=3\
M51>"O&EA>:FVDVNJ:S'$5,D,#*WFK&P!;RV0^8.05'.<U4UK]E,:IX<M/"_@
M7PWK@N-6O',T6OVD:Z?$P.U)8)F<L5`W]5P:^>=(^+.N:7\35M?"<Q\M+LB.
MTBD$@=Y&P5RH`)P,<8KZU\?^`_C7XJ^#UA\?;_Q]K6HZ!8P1V5[;7]\ZFQ>0
MG$4+%@=H!^Z3UKR(4_:2DU%M+7?IUW/H)3JX=P3FE?35;OHK(\O\#_!+XF?!
MS3;[XJIX>\/ZGIE@L^G`:QX:74-.D6%R7$XCPT>YLD.3]T^F*N?$+PQ\0[GP
MC8_%#5/@1H.EZ3>6CWEK:^']&^U:0]N-T;W39F>>)R&^ZK*HPIV9R:Y#Q/\`
MMQ>!?A9INJ?#_P`%+J;SV%C-::<EN6ACOY)Y&,PO'W9N$1/+6/[I'S9SFM/Q
M#^T)XO\`CE\#[30M0U+3?`OA3P=I<4UWX3T;6G!URY3#7$H9L*LCH\>8^>5)
M'.<]%/V2CRIN]N_4RE+$RJ*4TDK[M6NO3N<'X<^'^@7GB"X\1>)[W0KK2K*)
M56UE>7,,^TX@",\;E1O7=\W!7@GD5EV.FRV^E:D=6^*MRFK6DD+Z7''H:3VT
MCR;EVR3RMP%B0X^]D#CIFCP9XLT#XD3:Q*GB*QTF\UK6A+!H-SI\N^*W12T2
M((UP0Q.#ZGDU[9H/A;X`_%.VO?AW\:;#3-#N+>[BM[S5IK>ZANK5OLP\A%2.
M0+Y1;_EHR8!?TI.F[I_C_F;RQ$:46G?TM?3[C@/"OPYTGQM\-)]=\2^!)O$>
MK"<+:>((-3DAT^"S4-$+>5$"LI9TW(2V,<`5X_H5TWA#2+VXT[P[9Q103K'O
MEU<F8L#R=F07&01ROXU]5>+_`('?![X)?"#3]>\)_$/XB:7>*TWVRXM8(I-.
MN9HY63]Q<842(K`C<<GG(KS^/]E#6?C%X,M_B/8ZIH\/AV^U![.+5;^8?:OM
M0@1P\YCSMC+9&[8%SW.:T]C*<&K=+DTL52B^=R:5[:W^XR/@W^T3\-_"'@B]
M@U7X:BY\1DM]E\0IJLZ2(G&-T:DJP7'`&#SG)I(_VQ/VC[>6X\80?$K4(=#2
M;["-0CF1VA(&5C16);;D]N.M9GQ._9:^+7[-%UX,\:^-/#-M>Z=KMK!>:?/!
MJ23P7"8!",8SE5(P`#AN#7LWPZ\,_L&ZG\%/&-UX^TZ^M?'NEV=Y-8)';)';
M7-TTC+!`@<,0,%`<_P!TX/-.AI=3=FEI?16%B9PY5.G%N,GJUJ^WW(T_`_P"
M\0_MA^,S86/Q`?4/["N8DTFSUO3UEMKQ)`K2F26((=I8C(#%^H'(H\:?LL?L
ME^"M;UOPY\5+2V\/^)KR;?!]@@N&TG2G4,=BQW,CNT3D8)8[N<C`KAO`/@VW
M_9RN].T?7?VESX66[MK*>S\07.G)=06UV5WSK&&(VB-B5RN0W7H:J_M"_$/X
MF?&C7+ZV\'_M?_\`"R([6QV3ZK<>#/(>=8W*HI*`@`*H(+?E6TU2G0NX^]ZW
M_`Y*'UE8I14WR>2:^][>IT:?$+Q]^SMXD_X6W:^"O!(M=9LGMM&UG2K,BV$3
M%TC>./=A7*X89&,;?2O5_P!GC4O#?CCPK:ZM#XK73KCPOY,'A:ZLM-$-Q>2L
MV9II9`N&;<QV'(.%SBO"M$^$WQ`^&_AM-$\:V^FB;3(+.74;>Y#&9IW*2P0H
MI7(<I)&Y7CY3C(Z5])?`?1O`_CKQA!?V?C2;6)["UAEU.\FT9+6.&8#'E(JD
M[O3<0"2"37R>*A*-5I)Z]'W?7?H?459TU@^:Z]4NBZ/U/L#X'^'[Q=$BU3Q#
MXLOM1M[;Y)YI9UFG=BN6D;S/OC)Y_2O3/#7C34]#U5KK0KA+NV@011R_8-C.
M@Z!L`GIU[USFB^!_#GA;29'U;36C,`C%K=0,WESJV""S<@-@^F*W-%VV=O)?
M>&-=E2XV[8;-XN+C.0Q.W'KP?:OH,/2G2IQ2T?D]?Z\C\UQM2G6G)O5/3;0G
MU"]U'Q#K1_LRT-DMW<!;F57)BC#$8;I]>M0R^"+JU62\77ENI3<2*T4)"[$7
MJWICK5#4+/QIJUDMC;>8KW3>4T:2CS&"]/DX.`.YK?\`#:3^&;0RZYIUQ.8D
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MT=NEU'%#-*`99'X7ZUDZ;X$A\674UKIWB>W^T0*S$/\`*DQ'10>Y->UAJ4VD
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MCF56@U)@%,V0,X`P!WZ5Y=\,KCXC>(OB&FE^!(/M%W/`T45MO!5H\?,ISQC%
M;U(\C<&K^GZ&="K*I!5(NR6KO^IZI\,OA3\<+7P,-8\*C0KNP4M*UO>7T8&<
M$'Y6(R>:\M\4>#_&OAW5+BV\67:(MO,08K></'NZX&WCO77>+_!MW\(=<N]/
M^.-GJ=E+_933:+IUFS+%<2L/D.[^[GK]*S;CXHV'C?X3:1\$+7P)IT=_#JIN
MSX@24_:92R%5B;/&W)S]0*Y:D.5<K5OZ_`Z\/6<I<RM)-[VT]?D4O"7Q,\1>
M%KW[9INF-N15/EK$&7`QU'IZT[X@^(-(\7ZV?&::0UM/)S<6\$>R/S1@Y51T
M'J*S]`T[Q'8ZY+X9T_4ETZY97@N)?.W-*>FT?6I?$WPVU_P"Z:C>ZHDMZ9(U
M:!V^X7]0>O'\Z4(R<;1*JSI0JIRW^>IF6VN#3=5B\3ZQ=F6:.9<0/`0%X/&.
MGI7HEM\=KJ]L8-1O-0F:SLYLRZ7,Y\J8%OF4`=,COUIFM>$?%/QUL-+^%/PP
M\,O+?6FF27UWYC+YEVZ#G:>/E`!P*\A\*&YL/%B^&O&'F16\4C"YBFC(,3#@
MDC&>#7;AX\COT?YGD8Z?UB%^JZ=;'H/[5MU\#OB+XQ@\??LV>`M;\+Z3+9HE
M]I-[,T\270'S^7)Z$Y.#TKB/A-HOP_U#X@Z&?C+_`&C_`,(U-?K!JUSICJ9D
MCSR%ST_'UJ_J?C318=*N/!H\5:C%IES>B3R5?Y$(.#)M''3-:WB%_P!F[3K>
MV@\':KXGOQ;6X:_>Y2...2<\@+U(''6NV=K\Z:_KR/'H\SC[*5];I/=I>I9_
M:QN/V=+GXS1P?LS_``KGT#PMIVGB)3J=Z\TVH2!CFY?+'9D8`4>AJHO[8'Q=
MTSP=;?"K3M9@E\/6UV;JTT^6(2>3,V-VPGD`X&16G\*O@/=?'WQ<FFV>NVFG
MR:K8.^E1W:EA,5?:8UV]P/ZUA^./V?[OX(>/I88?&EEKEI:OY4]UH-SAU;)&
MT!AD'CTS6B]I-.6R?;0YJL<-"<:+?,X][OYW&>'?B%J_Q0UEM&\;:A#8QPSR
MRV[PVBHL#N`&Z+G+84<DX[5SOQ&&E:Y)'%H6N:M/*%,<JWK(5.P#A`@P`#GK
M1X3\"_%F7Q#-=:#H-U/<1.9I-T1D<#[VYE&2<#OBJ6M>&KBQNKF;7-0NK<F(
MRFY-I)MEF)YC]A[UE:<M3H<Z,/=VLM$;7[/GB_PU\/=6FU?6;6>ZNX8@^G1A
MT,*2AN&E5U8,O^SCFOJ[]F7]MOX?^&OC.WQM^+.A6>JZD_G)J+S6,;+>^<`A
MVPA1%&$3``"CI7QK\,?!=_K>NPK;H6M[IO+F)(W(.,G'I7HFA^#_`(66%FK:
MCXEFCO[.\:.[MF3,;1J_WE.>21VQ7'6I^\K.S6OS/5P]7W&FF[I:+L?7$GA;
MX=?M0?$SQ%K/[.7@.RL+*SNTU'4M88FW-M"5VLBQ9V!2QSPOTQ7>>#M$L?A)
MX\NO#6JZ9;ZV(8BL8L9Q(/,P"IXZ\D<'WKYR^'7[2VE?`+QKXRTWX#Z<-=L/
M%.EQV,=WJD#1O;*RCS`D8/+`DJ"?3-:?P_\`VE/'>I-)X3T&V_LV>WD597M%
MV3;UX&YL;B?J?>O"QJ@KRW=]7T/IL#]8E'D:M"RM??9;O?<]7^/D1T7Q_J=A
M\,]%U6*RN&$JZ?>VVV:)V4%XRH]&+`?2O//"][XQ\0ZE#::?H!=WN?*,9(#*
MQ[$'IT_"O5/A;X`^+'B?Q%%XMUKQ/+%-'I]U?Z==W-SB6XNXANRS-DL20>#W
M-=[\2['X):5\+O"OBC7]/6?Q]K%@UZM_H4WD.WF98BXC488`YRQP<=*\WV"J
M1;D[=?RT/46/E0E&FES/1=]>[/-8?AGXHN+":86SO,L\,4T<*[D3>#@,_16!
M[5]->`OV#_$WBOX(0WUY\3(#-#"MUI_A][%7#;C\WS,>2!R5`/0>M><_#3PU
M\9_%>@2:+\*]6BO=,NKQ+XVLT0MS<R"/!9?,Z@990">37HOC?Q[^TGX7TA="
M^)G@C7M(N[>-7L[Y7<O#B,*H\O=M"X`Z#C`KHPT*---S3DK>=OP.7'XK$5G&
M,9*+OY7^YG.I\)?!Z>)]?;Q[J,[7_ABVM!H=DUP)+>:$'+*>GR@L"%&`,GK6
MWKWQ%\+_`!!\;Z[:V_ANP\,Z3?6NV`7%FA:SA5A(XCDP-K-AE!QR&"]*X6/Q
M%\5FO;SQA>WUU'?ZE,TD_G6JH60C._E<`?3%9>K2^,_%CSWNKZ_'>SJPB#SW
M`W/GH.>".,5C5Q,H*T8Z7^_Y[E4J#J_'/6V]]MKV1Z)I?[2T=MH]]\/M.U@W
M5M;.P\.7E\O[ZTA7<?)7!(9&7'!Y!R`>E>4>+OC%X@NH5\)ZW92_8]9N0IF=
ME5HQN*$QLV<;2>W<9J6+P[XF^%'BS3_$FK^$H]0AB`>XE\W="5=2.'7[K`-D
M'U%>=76JZ!J'C>==6M[JQTB\O`(4$S3+9J6R9%))/;/!Y]*J%:_+SMW6RU,Y
M8>,&^1)IV=]-_P#/J=9H>H>`'@E\'?&/2]3A%O=3+9HNV9W9(V97(*G(R$`&
M><UYU<^'_!6LZ7K&FV[&VU*)42Q2[&$N5D+9V)SM*@;^6[8]*]S\0Z+I`\1Z
M=X]T7QQ;:I8RQ-MDN+`&X,8`3+Q@@#@$J.#QDUXI\6M:DU^"6'Q79+'-`28K
MB.!(HT5%9ST&3\O\/<FNU3N[)7_+[SD=-RUO:_X/K9,YK1=4^'JV0\-^*Y$N
M;/3[,_:[C1[M[&\D4.`T9WDI*03P``3CVJ?X9^'VTKQYX=^)WAP168T[6HA%
MJ.O62W%O!,2?)61)`4?:`I((P?2L?PGK/P+T6&WU/[59S>)H=/EU"`Z_:--:
M_:4'[FV2)=R,S,1RXP,'.!77_"OX*>,OC)\+]9E^'/CAEUF,I/<^&8YRT%U$
MD;-+*\;`HVT(1CKEN*ZDG4<;[KM_F<51NFI6>CTNU^AM?'7XC^&M=NM*9_'1
MUKQ,=1-QK]WJVD0'=?G`C4%!\ULF-FS``!;BF>-_'WQ\T[Q!X8\-?''P1I.A
MVE]&'T+Q-+8)&D.G;3B-_(C1I$WA77<01T.<URG[/'[(WQ7_`&@]4UW0_A(U
MFFO:83=1IJ6MVT-E)#'DR@K*<[NA`Y!`;.*Z^/X%_MX:7/9>'?B=\%/^$J\.
M:(LL?V./5HY(P9$!&UX)=V%.U@H.`P`]17H1FW"Z3^6WS/'G'DER73:[NSU[
M&M:?$KQO<>$]7\)SQ7%GH%VL[V)LM165+^94423JLN#'&RH?NKDC:I)ZUYEH
M%]XBT'3-1/AC37\B>W^U7NI_8V9[:&,]&QTC:1HU8X[BO4M'N;\_%Q[*#3+O
M3;.RM+G3]-T?Q;-,Z:=</;^3EYW4C;N`QSC.!G`S7&^.+#]H/X+6-YJ>JVEG
M:V2:7';WLMG<1[;BRN6V\X.6#D\G!/TQ7+*I-O5;'71IP2L[)NSW.=7XES>"
M`MUI$CP:J\K"RU[P[.UO+`KJ<0H5`R26((;(V\`=Z]N^%3_M@?$WP3=Z9\-O
MB-87UU/JZZDVE7(1-8>':D(F,C`1F(?NT(8XYXP:^=M,^)>KZQ::3\//'&C?
MVEX:M[A[NVT>TBCM7\Z0;4<SJ@D;!PP#,1QVR:]M\!^-O$EUXRL/#FF>"M6-
MO)!)I$MBVINOEZ?N5FM]Z9PN\,Y;&`P!/0&L:4DZO_#_`)G3B8<E*UE?>[LU
M]PGAKXW?MA_#?5[OQ9KOPZM9+;3+_P"QZY'?:+#.LKKE6,NQUDVGIU"GZUB)
MX\^/7BO5[CQQX1^&\-CI=_=O<2:':Z"#I+OD,0L4K-M4[3D*PSQ7N?[0'P\_
M90\.>&]#\+_#^_UC2+S4=3>?4[O4M7%\;0FV;)CF0+OB<HB[7#=#@\FMK]@+
MX^^*?A#XVB_9C^.&B2W6E1ZG'?7>G7]N`)898G"M#Q\R'?N'..3W%=KHQE44
M92=N]V['D_7G"BYP@K]K6ND?(/Q&\<>,?%VKR:GX$^#>F>!D=1:>*;G0[:Z2
M%V+AD8QR.P@QC[JD*>N#76:E;>"=$\#SP^(GEFO&AQ<WVENE]"K<`#=Y8,3,
MH)QN/3([U]K^,/"WQ.U_Q!XY\6>#O!,%A\,=2UQ8`H^9[JWA)`1-P^ZI9SN.
M3G`'"UY[XU_:5^!OA+P2_P`-/#_PZD\76MPTEI%9*!&T%R/+2)HQ&V)&9G8<
MCU..N;^K4XJ\Y.SVNKMZ]/(YHYM4NG3AKU2>VG5L^";S7-$LK7RX+6X\NP?S
M;6>)2C&0G!WYYZ8Y[8Z<UTL/[7OCC4_!@\"2P)/H-M#(L]I=WTLJS2,`RN1N
M&&!7@]0,BOJ[]F3X)?#/Q%XXN_BC^T-^QS9V?A1KK[)M@NIKH6US$AREQ$KA
MX]VX/NP0Q3``'%6OVA_!OP2^'OBB3XE^+?V%7O?A,^H1P6/B&&!4CD@#!0@<
M^7*&9F<E@002O4+BL98*,(N3EI^GF=T,V]K)1<+OY;]EYGA_[+%G\(O%OPY\
M9>#OB[!X2T+6ET&*_P!-U/6[4O>O(Q<):PI)&2"^8WWJZ@*W7TX'XM7FD>&?
M!/\`PJ#X;>)[6\N]9NH/-ELHF2./>6,J'>,E\A0"IQL.#5_Q_P#"7X:^)OC'
M/XK\%>'KWP[X9U;RY]&35+H7JK&TA*I.3(7(165"?[J@XK1\3_LP>'/&NKZU
MXR^"_DVFD^&6@ANM1FU8&P%ZV6W6WF!7"N`N%QP=W;%<L9QC>*MIMO>QZ=.G
M*I-5)2:3UL]D]K'#VOPOU?5';5/$_P`0]4_M_2I&022NPC6%5&UDEX!*E2,9
MY&.]=C\)/&_Q<O\`X@S>!=8\0WM]J_B.,64UZD\#M-;M$%&YI%.\;`,<@CC!
MS7?^*[_XO?`OX*:5HD?P/BT.Q:58M3\1G5;B\&K--*6AD",_E&,E'"_*0?FZ
MUPOQ`L_"'PKTBXUKQ5X9MY?$$L'GV,EK)+;-;,^=JD1%2N&W8[\+VHQ-2G&,
M7L_N-,+"I6<ENM;;/8]5_:2\+^//V7/`P^%E_P"&-'O+.2S*66I0VDDUM)))
MMD=9HI&=8[A-V-V`<'BN#^$O[5WCO3/!5_\`#"*UA\/^&KQR-3U1-#:<6,PC
M41`2$%D7*EMH)/([<4SX):-\3?VE-'TSPWKNM^*8],DU5IRFH:^T]O#N8,\B
MI*"Q).\EF)Z5ZO\`M,?L5_#+]G#0M)MO!/[5D^J:CXFAE+>&(;<Q1)#R=\S;
MR#D!L9&>1CBL$ZWLW.&D?7OT-^7#1E"C5:;;OHGTZOHCSSX)_M>^%_%AG\-_
M&'X+Z7XBL;"1&:[D\0W,,D4,8"L\4;R%2VW)V],]J\R^)%]\&?B5\8=3B^%>
ML3:;I$NI>3;MJ$1<1P\!9'`)9N<L3SC/M7M?Q`_X)3>--&\%6>H>$_C5HD.L
MZII<=_%X:O7-O/()HU8JC8PQ^\"<X&RO)+/]G3Q%X,\-:OJG]@Z+8/:P!6BO
MM8*7!);`>,-_K`?Q!QFLYSK*"4TOP_,Z\.L,JDG3;UZ=/N?<S/&A\<IX>LO`
M'B/1H]1\/Z5=,=()\M8P[DJ[JY42,'V@@,?E&,8KU3X.1_M%_#5;'P[\&[[P
M%I2K-]L:^C2*ZE9T.4B>0AM[[L`)Z]JB\":W^V=J?PM_X1WPKX(7Q)X7F!CM
MUOO#L=Y!;RD\2Q2.F$8$8SD@4SP;^SW\5_APCZ[\7?A%K4D$SR26:+"T5HER
M2<,?*X<?*P*9`QTK"=><4FDTOFOQ70UC2HSNKJ_;1W^71GT'I7[,GQ>UG4[/
M0OB3\46\:7Z7Z:I>#P(EHT_F2L=ZS7)5I)-KJGR].,#'%?3OPMT+X3^#O!4U
MEI?@V;_A)]5NF6YOKFV="D$3>6HVR$E78JS-_O8'``KXS^$OBG4-&\2-XG^'
MOA7^R%95A_LJ!75`P;>75CEEPP`ZYK[6^"D'Q#U7PD+[Q1;PF]U6ZAFDO+F`
M1A><+%'N'W1G)QG/>LZ595J_+%7LM]TOO/(S2,Z-).;LKK1:7]4NA[WH>J6O
MB'PI%H<'AQX+-)%>ZO8@SN\@&-I8#;C\.!Q6QI7B'P!/?A-7TJWA:*T$30PJ
MP3<."P.>I'ZU1\.:,?"3Q>&?&^KR.X&;:*VNQ##,K'J'4?-@GN:AU6>W6X>X
MT32+?RF?R[2XB;#(5/+=><GNV:]M-PC?2_56U/BY1ISFTKV>J=]-31@2QD$M
MQHRS+-NS#)&A+(!P`6'3ZT[2Y-=\0M_9T\1FABN&>2)W)8$CGD<X)Y],U+IM
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MW,?8]:]"C;E/3JJSTU]3(UKP[K42K9WMC*DB296&1?\`65D^&_"?COQ;?-8^
M%=/'F&4+YFX*%//\1X%>C>*O'9U7P0ESJF@R#483NANV!SMZ%23VKF/!/CFS
MT[P+=^$-<U#[):ZE=AY[F/F5=N>!WQ_C7J48Q4DKZ'DUZE1TFU!;G)ZGX=^(
M^I>()]+U6\2\FL3LDG%T&1<=@W0U:U$?$%(EU&XU2%V1Q$C"Z4R``<+]*721
M:7NISZ+H<EMMD8".6>7:">0,YK'U;2]?TC5_*N)+>X\MRNU'^3KU!'\Z[/9P
MD[L\OV]1+E2V\NA'X@U3QAKB#2M1N)I!;`NRRR\`=SS5GPKIGBW2;F"ZMHVM
M'F&^RNVD*8QU((K2T%+'6],FT#6--CDN+9O/:XCD.\IW3/>NP\9^$-.O]$L]
M1^'/B1[FUP%MM%U!?](A&/F((X(SGBCEBEO<J4Y7BN6R>_8T!\6?&GQ].G>!
M/C?X]A.G03QP++]D5IX4C!4,&QG`!Z=Z\SU7P]H^E_$"XTOPQ=77]GVMXT4=
MY<<&3!/S<<#/I2S:ZWAV;[9;+$)XG^?(ZM]#7KO[/'Q@^&5MX0U+1/B;X%L]
M;%XDH-I+E'DD<'8ZLHR&5L8/I67/&2M/_/Y&O)4HKFIK3LM/F<)X_P#"6EV-
MSIVLQ0SVUI<QJ?M,;DL7!.YLGOT->M_`#]EK3_VAK;4_$/C_`/:;T30='T/3
MI;A;W4\R2[E4,J%!R<],UY5\:O"'C'P+=6NE^);>2UL)%$]AIQO1+Y<;8.TD
M="017(6NHG3+>XCN97CB<!HK3S3A@>S>O:HC)1E>UUVU_0VJ4G4HQM*TN^CT
MOYG7Z`?$.G>(+CQ;X5^)TJ7>CSK%IMY:,8VE`<@%,]!CG%8'CWQ%INL:Y+XK
MUG5[S4;NZWFZEF"I(9<X()`Y'>NBN_B%\)M4\'1Z1=>`8%NDLP@GM92CK*/^
M6FX'YO7!KSZ]\%W6H65QJ^D-.;*#&Z6Y3;@,<#GH>:VA9*R.5P;ES2TZ+;\S
M9T?P?\%?&/A07EWXKUFSUO=B2T\A&@`SQ\Q.:YKQQX/'@2VMY'OEN[2\4M;2
MQ$@N1V;T(S^M5;_PYXO\(W@T;5-&EAF*B7RV7#E6&0?7!'(^M='I7A[Q1X[T
MBVTVVCENET^*1UM9G"I""1EAD]#Z^U=JFN7EL>/*C)3<U/3S-+X%_'/Q#\/C
MI]OX?CM$N+._-S:WVT&XB8KM\M2>`AZXQUJC!\1]#UCQ;?7/Q+TR34+FXUAY
MI;@7S1&-CU/'#<G]*VO`O[#WQ/\`BS9W>I>#?$_A&*YM[%KG^S;CQ%%#--A@
M/+0.?F?_`&<YXKA9/V>OCC9^,8_A^WP^O)=4N+P6T5K`!(9)20``02#U%;I3
MY5;_`#/,E*BZC3>O5]?O/3M?E^%>E6,?C_X*_&S5]+O(2(KV&Y+I+N8$E@%/
M*<8ZG-=#X+^,_C?4=2LM9\7?%)]>LPHBEL;^(&"6(#(5T]">,]:\`U7X=^/=
M&\9:CX#U;195U/2+A[:[M&(=HY$8AH\@^H(P#5G0K9S+<6>I7QT[ROGDM[<L
M^UMV-N,\'&>]1[25+6QI3PL:K5W?S>KL>E^.$7XA^+-1UWX-?#J2"-+=I=7%
MC`QCM9`[%C'MZ)MV\FJ?@_QJW@W1+J6/P7IU]?/+')#J-Y:>9):LIX*D\<GK
MD'-:?A_XL:7\*+9%^"7Q$\007%S'+!K4H*113PMD%=O)^9>N<UI?!/PWXWUF
MY7QIX?\`A=<:[I4%YON$N('DMY`OS,CD8ZCDUYV(<E+FU;/I<"Z<8.#2MI:^
MC^9Z/\$_`>C?$*]T3Q!\9?AU>O8:Q-)/J7B&QOVBDFS*VXB-?E4CH``!Q7O_
M`(^_9Q_9"^$?A>PU3X&^.=5O/$&L73R1P7]W'((HN2$8`!MP..3UKRO5?V@?
M%?Q@A\.^#[?PK8:%::6?L5K:VF;6U@WMU)8G').>WM6)\=_B7X_E\8:?H]]H
MVD64WA0&V\[2@/WI#;@\DB\2'&/FQTKQJV(AR2@E=.VK6M^I[6'PU:<XMR::
MOHGI;H>R>(?&WBSP1:Q6UUK,9F:SDMU\N`@('7YF!SQCC\:X[P_X5T+4=>AL
M+KQ7?W$K;)&1"`@CV@D$]CDD`>U<S8?'.7X@6EP?&VHSRW5S*6C*1;@I/).2
M>,L<X`KZ!_9F\"_`VSTVWU#XV:S?:9)<9D@-O`%,ZL"$8.1]W(P>W%>5-*51
M13MZ]#U^94*;DXMM=E=LV_"MWJNCZ?%9>%/$.II8PQX\NZE#>6IZ[3CY>?3%
M=%XP^(OQ9ETZ"VU'X@Z[>V<8"VZ7ETS@$]5#')(_PKKO"'A_X,>";JT\6:[X
MBCU3172X-QIXN8V$S+AHHR1RN5(Y..17&Z/XQ^&FM^)IM9\0>++>PM+2Y<:9
MIJ1;RH#81F&<$#KUS@5HXN"7O)-^?](XX5(56Y<C=NMNOW'L7PB^)=KH_P`-
M-1G\4Z2L^L>6L,*W=ON"J_RXV]N,D$5<\6?"/X(2:);_`!+T'PSJTD3PM%<:
M+>`[QJ`7<R[5.X1\@CVKYS\1?';4;S4H'OO$T,=NU\C2N@*@*B_)P.HKI_AY
M^V9\1K[QN)M(T:QUBZD@\F![J)HS$XX$H*$$D#IFMZ.-HM*G45TM%HG\SEKY
M;B8-U:>E]79M*VFA/IT6H_#NV;4?!/C0/=7D6_4-,7,@/)^0*X()'0#KQ6)\
M8/"?P^\0?"<^)M/MI!=2([PS6]J(_LS9`^=5^\,9.1QS6UK/A75/%WCPOJ6I
M+'JU^S3R16$8B7S>1L1<\DD'\:X_XE>!O%=O:ZII7A.V@O(7N'L/L,^IO!/Y
MZY_>&,=E;@Y`%.46WHM-OZ0^;EY;RUT;].USE/#7B+3)?#T6CZ!XVO-.T^,R
M!X=4N5"2D@?O```1N`(X)->0^.OB7IGB?Q/=:!JMQ=2Z;:K+'I9$B,YW')!8
M*"V[I\Q.!76>*/@%\<]!@35/%?PRUR_L[^&=6LM!`EW"+AY$X;(5@,M@#@UX
MYK.@Z[X2N'LKZPD5[Q5:W-PR[[<EAC=C\`>E5"$H+5;^5C13A4U33^YC+_PM
M\*]0U*WB\-S:G8F*T$VIWNJJN(I5&2(PAY!/KS7H7@+P"EI\-Y_'[^+]3MM2
M@,?]B1:&(\OU!+G<"@_`DUI>#?!'@'PQINJ:3\2-.\/Z],-%N_*OK/Q&J2QR
MR0LD>Y=I#A697QUX_+I;?4O@GX`T>P\->&[N**^TN-6^V0XD%T7B(=9.O&>!
M@\9KK4E%7NKGG5)3G[MG:^Y'\,OV?_AS?ZH=2^*,&OP6\L3M>:EHFKQD>8R;
M@6R,G&<E1Z$9K9T7]F/P_K,=S#HGQ#UE734FL].-PA6&X^8*K*<`EL'\Z].\
M(_$3X8:7\)-3U"P\%+=>(;G2/LUOL8B.<R$I)O4?>78<XSV-<AX>\3ZE:>-;
M>TUN6^70;>43PVT<6T6Q1@<@GA!QCGV%;JK%1]VSO^!P^QE)MRNK:>OHCDOB
MO\+/CE\$?B9KG[/MOXPU#6;/2=0$=S';W$DZ-E5+(@4\Y!PP%:OQ,U^VA^'E
MEX8OM5;0KN&(V[:9KOA6"[9?,4H7#,I=<*1@MRI.1@\UWNK:UX)\0^&$\8WO
MACQ7IFIZG?/+!>W%JMS9O,6RTJ,`'R0!WXS7/VFOZ+XD\6QZ#K'C:\_LZ<2J
M'N-(YC9E4+(SD[L$CU.W&?6L9.;=T[7V]/F:QE%)<RNUOI^.AX?-X<T7P[?_
M`-K26.IW5OI<"2SW*6#2->3(5/`52`@!Z$X`!JI/\:/BQJ5VOQ)\$WMGIL=A
M-)$7@E2W:02Y+1E`0S9`P2!Z<UZWX?UAK+5)]./Q.3P_J&B32QQRQ:G(EO?V
MZJX)5U)(8D#@#YMW-+\//CO^RW<>')M"^)OPD'BC6)9+B6_O+JR08E;"1O'.
M@,BHN69AP"=O7%--)*\K?C^0W4NW[KE_P?4\F\.?&O5O#7A6[TWQQ!#K!O(H
MU@L]0@\R!'W\.`1@D*S@9R1G(KZ&\!ZC+^T7XEN?%,DFA^`&U&W@T_0M3O[B
M[O'T^&*.0^3`@<!(7<KGS"VW'R@#(/E7AKX'6_Q1L;KQMX(^`^L7>G&^A%A>
MB[FBTZ$`N7`)!)W*8V!W*`$8D\@5[_\`!CP+\./"WPDUKX?^*=)^.&A>)51H
MKJP\&WINM-O"5W"XQMD&,%?NG/)YXK>A[2<TW\/3?]#CQCP].G:*]Z^MK:?(
M^>OB[\=_V_?".O3_``"\7^-[_7].T2VDMAINEZAFUFB<-&#&$(X`<@;<'GJ>
MM>;0>(/VI_$FH:+)X.T>30Q:7\6GZ)96D\<+VL\C8WAF;>K,R?-(3P`.>E>J
M_';X$?#3XC>(X_#OP<N/%<FKWTB13P^(GBM`LD8)=F+1H<_4ELYSTKDI/V>]
M*L]0MO"4'ABYUS7-!@D_MOPM)]OFN).4\N026S[/*=I/D"X(P<GI6J34[?=J
M_P!42I8;V:<4KVUT_%J_4T?#O[)G[55YXG\4ZCJGB@0W/A2.>_UI[7Q-YD@F
MAR3)Y@8*[`Y&58GBFZ[\3?CYX\\$67ACQ+\8_&/B71H8DN7M?$UR9;"*9>#L
MW,=V/,X.<DD'%</XMF_9[TO2]/GECUFTN+JY\K7_``SINJ72/9"-L/"6N`59
MI,]2?DQWK2T)/A7XIFA_MWQUXQT:&SN1#;:3-;-J45A8D,4197(4M\J`*NW(
M)QTJIJ\>ES.DH\ZE*]NFG],W?#5SJ?C"[U#P]JFBS7%RDX$IMX2!91)@%058
MY!R2>3P!7VAJ'[,'P;T/X"0^.=/_`&BO^$AUF72+6UM-"CC&;9\;'C:"1?F*
M1LX5LY%?.WPE\,S:UXCA^&W@C2M,T6QM;N4IJVMVHL+R[W`,5E+,>`>BL21^
ME?3'@3P-X5^$?BK3]0>ULM:UPB.:U%S="XABFWXS(N-N.IQZ,#7GTI2E*2LK
M;7>Z]#NQ4U3491DT][*VJ\[[(\,\1?##XZ-XFT?PIHS7,WA&V,2:=)XN#Q1Y
MB#*J.@)`\L.P'5N>V:?XC_9,\)1^&+NW\3ZO:ZAJC@S7VH_;`8K="WR1QH>3
MR,DL<]!BOJ?7+?Q+X3U>]\3:P//U>:62*S6S>.>U0R#]YY:G<#E2/F`!!`YK
MS/4OAAXAN]*MO&&H7EI:P7U[+'$F4,LLD94DF/J5W$8)X)#>]15PT%=)-^O3
M8>&S'WD[J*\NK/BGQ_\`M/\`Q+^!/CG2H_#?B2%;;0K406(CMP!M7.%?C+?-
MDX/K4'@S]K>\^,^L#2?B38VU]J-W=1/#K6JW?S6\WFEF9!M`.1A0KDJHZ8XQ
M[A^T=_P3)\9>,[33O&>O?$GP]H0UL7$UHVIW'F,[)R=QBRL98D`!\=<UX/J'
M_!//X]1^*]:\$>`O#,>KW/A2R2ZUF^2Z*FSA8*RNT;;67<6X!!)!R..:<*%1
M4?-]/^`=SQ>#JSYDU?OMU/LCQ)H7@+X;:WIUYX5_:%?Q1?VMPKVVFQZ:S2VL
MA0$D.&`50QP,$@X--^*'P7\'^([.WN_BE//'KNI6B7<LD<8+31R1@HH"$JH^
M[@;<YW$T_P#9H_9V7X>_LUVOCKQOHUW>:Q=7`9[O3KB&001+F,1$B3>K.V<@
MH>`ISS77ZQX0GT":!99;Z+6+RT68R[L;`X+*F,`K\N.,@8YK!TYM-R2MO;6R
M_P""S!8RE&:4)-M75]+OR]$>=^)_C3^T)X"^%]O\"_!LVN:;X,TW_1+F&&2&
MTD<OEU,HV&0@^8<]`0:U/V2?CE\6_!_BYDO]7M[[3[%1-<Z5IUQY=J413@SL
M!TP2N%Y.>M:_CS]AOX_:=K-E\2]1M-)GT`6JWU_%K%X0DZCYL2`."01T`.31
M#\%M=T'39O$TFM>&]"@U=HWN+6QRMI%'(%V#*[L$`YVG)&#7#76*BTVFFMK]
MOGT/0I3P52FU%I\V[7?K>VMSW7X6P7WQ+O7\:^$/#.DV]S'(PNK:VL(S:685
M`2H$@X8,<9YR3UKV#P7XHUSQ'';0WFLW=Q>H!!8H+I<6RC`;*D>G`QZ5\/>'
M-3U'PUXQ2U\)?M2Z!+:DN\6GQ)/Y=XX.UF"@#S"#D8QD5]:?#+XF>#=:\-27
MX\2V<VJ06Z?V3K%I;NGG%#M"E<8Z#J1GUK;"U'%VFN5]=4T_^">3F&&OK%\R
MZ:.Z];GJNB0>&=6MFM_$VLWJK`C"W;*NV03QTK3@N-)\,I$=J7BRKQ&25*DC
MJ2.!]*YCP3"_B/06U"]U2V/V;<SH[%2S$]!Z]S7;^'O%>LVEE'9:%`JRJFZ2
M2&%"%#<=QV]Z[XOF2?W-:L^>JKD;2U[K9&WH>J:GXS6>6TU.2!`Q6.&&++1K
MZ#;P`2>:CTWQ#8>&[N>\N+"XEN]DB>>XP`2,*P],&GVW@B]U*P_M>,/:!E_=
MP+&4A<9/);W]ZI1:]H-O;SV]_;"6Y81C,AY&T_,OX\<]:ZK2BHN3L][OK\CB
MM3GS):KLNGS)$BT2ZT^)M2ORF^]CV[^6*DX8`8Z]?TK5\0V7AFP@33+>QOI7
M0[XYX=RHZGU#<9^E<WJMSXK\77%K;Z9X<@AMH[L,DMK#N<]PF['(]2?2NM\/
M6^MQV[BY\0VT$RKAX+HY,8R.,-P.?2B"52\;?.W^9C47(U)OY7_R/F'XA6>C
MBUW:3<31R'.]LD5\A_MF?">/QIX6O+ZU643PQ%F\L9W8]>]?:FM6=MJ&GM:R
MIY3`$EV')KS7Q=\*[S5+*XATVW2\\^%A)"IR2/3%<&.H3KP3BO/[O(^ARS%?
M5JR;/QMUE?%OA%W^VSM(BR%=D@WJ?P-9^M^'?#$WA&TU6WNYH=9GN29(`!Y:
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M@CQ-'?2S2F-K.!\W2C!P=O?\*\]UC1K_`$B\NK+6X)K2Y1SO@N8BLG//(-=C
MJ1DKV."G1J*5G*_YG6:-X7@M[X:DGBI(EE8HLMG%N'<<_6N[\)_LXZQXF\-W
MNO\`@7X@R7UQHT9FN;%5*2Q1#[S+D]O2O&=+UJ\LXO*M;AP"<@!CP>O%;:>.
M/B#ISM=6.K7-N+A=LCP2%2ZGL<5E&:NTT;U*-2R<):^AZC\7/V9?A';?#^V\
M<>"_C))J6JQ6"3ZSI5]8^48Y22'56SSCCZYKC_`/@G2_#EA<ZOXVT75Y?M=D
MZZ'+I<BA?.R`&8D'@?UJ:R\1V6N)83:G$%*7$:7LS#=YBD_Q+T-==J-_XC\%
MZQ?R?!K6&N=&1T)6>$?+MP_`;/&5[5,J\(RT7]?,FE0KJGRRE=M_TKHSO'?@
M2VU?X.Z5KG]IZC+KXUO[!-93X9%B,98,">2<C&.E5/#/PT\-^*[MOA=XD6VM
MM6U)8X[/4[]O*6WDSW8=%/O3?&GQ:\5^/I4U#4--M4OV=&EFM8=A)4$`@#@9
MSS5WP]^R%\?_`(D:&/BKI6@M_9L]P8DO[R^2,;P-QQN;/`!_*E2Q%.,G97_K
MJ9U\%7G&-Y<O]="EXG^`^E_!+QA;^!?B#I<%_P#9+\K>W^GWGF0W*CG",.-I
M'>NK_:0\9_!Z^^%^E:=X(,$$[ZA';M8Q`[UMXANWGVW''/7'M47A[X9&ZO\`
M5/#'Q6\=0Z<+'2GEM9A;M<_:YU_U<<97^\<C=]:YKQ7\!+BZFMK237K)!):+
M<2SRG9Y((SL)]>.E*GC91;6B3?W#K9?&KRN<G>*Z7LS$^+?QKTGQGXAC\2:#
MX7B:^FTA=.OXQ;A(_+C5%1UQR'X.6SS7CDWB'4(+HRVKO`5&/D8\CT/K7N7P
MRTOX&:'8W\7CSP]K>HW`FC2*:QO1%M&[Y@!CG(J7]K;X*>"?"_CB#QE\-_"U
MU9^!O$`/]ARS7@EDBD5$$L4K``!E8[L>C5Z<*JJQYF[GBU:*I3Y%%KUZ^6YY
M`FL:E>:<'%QY4H"F.8/M8X]QW_\`K5T7P]^./Q2^&_B?0_'GA[Q%<P75AJ):
M&>1BQ+`#DEN"0&(JAJ?PF\6:):Z/>:>J7B:Z9!801-EV5'*\@^N,UD:KX)\2
M:9=RZ-J[?9&AG4F"3<6&X#D#M6\5)JZT.*I[*;Y96?\`5CH?C+XCCU#QGK.M
M>$M1,@NKMY[B=Y,O*93O8\\_>)KEO#&G.[_-<^5),<%W^ZV[MDU[9\'?V0HO
MBUX`\3>)]#\2O>77AE(I[]8XUP("I+N"3\VT\8KQ2/1;HWRWD<4\EF;PQ?:'
M0X<C!QZ9P1QVS64Y3W9V4*-%VC![63\CT.+X6^#8?!\5[=ZI=2:I>WBPQ>05
M*(%(WLP'48SC'6O1_`_CGQ#HMO'X,T+4HO[/L1MBEV;">.6Q_>SD<U2\,V/P
M<TSP38Z_?:??7^JM?N(]-EN6$/D;`$)88();).*[3P_X`CUN_36]0\#:=IT5
MW:">TCCD*PNJ#:$!R3N.,G/))SWKR<1BI3O&Y[-#!P@U+5KSMOY'H7[._@'P
ME\4_&&E^#?B)KLD6F:K<30F_(RUG(Q7]X`.`<XZU1^/W['GB;X6?$Z?3+?Q5
M#KOAMW8Z5XCL/FBN8U.W)!Z$'@Y]*I_!_P`8:SI]W]O\/^#K:WEM;DI&`A;9
MP`3ALY.1FO8=-L_$OC>:U-[?RS-&ZQ66GQ*H(9N?N`<\GD^]>1.49Q<%'WNY
MZ]+VE&:GS6CU7ZGF'P]_9TL[?5/M=SK=N+*UO8H9[I-IY?!8I_>VC<?PKZ&^
M-$/P;\.V&CV?@WXF0^.);#2_*C%YHK+%:*HS'&"6&3DDG`X-/O?V<+?P[J$.
M@ZQXBL9;VZLXKF:SLOF$$DA.4D;H&``)`]:]A\!_L]^#]1TN/0;OPAH\MO%9
M.7FCN4%QG=]__:^G844,+.JI1LD^_4SQ&94J=2,W)M*^BV:^9\Q_#SQ/HVCO
MI\]QIC74"L'U.*Z7]WNS]U5[CIUK0\<:_P"#]0UG[5)X2L$BGD9HQ;6GE&$$
MG`(0@'KUQ7L>O_LC:?X9GEETV)[K3IF=HUMT;S85RW+)SE1CJ,]*\TU'PAX;
MMS<VMO=1W*(QC$JG(/?@UQU\-5I+EEI^IW8;'X6O[U.[-_X8:A^S5J%I,?&'
MA18M4@F06NKQP)-$T2Q[3&ULPP6)Y#GD'G-,U+0/A-X7N3/\,_&MS!J*1I)'
M<^0JHCD9*$J#@`]ZX2YLKO2I[J*RT0*C;=NT?<&,9I_@OPH][?R/=ZC+!:%L
MR9!VR=\&HI3G\/*GYG1.,8MS4W;M>Z-2V\7^)H-8_P"$BD\2DSVN5CO8;@A\
MYZCN#DYXK"%KK7B;6KW5=:^*%KI)BB8RW%T96W28)4[D4Y)(`S[\UU'CCP,N
MA6;W2:C;VUO:6XNEEF4A9\_=4>Y/`^AKG]6\'^!=3M]!LXISJ$VJ!YM1M;>3
MRWAACZON;@%CD`9[5TI23Y7_`%]S..K.BX<RZ]EV/*_"W[2/QP^%/CG3]=TS
MXC:G,EFQB6U74Y4C,3,=R'##:K;B3C'7-=%X-3Q+\7/&-UJ_A;P7ILTWV^6]
M.JS3"WCBA57WQQB0D2+@;@<$Y'J:U_B'\/\`]EI]'-QIM[>Z;J&E,(Y+:607
M5W?W#DLB1Q'@!1@$G@[A63X._9\^(E_X"G^/OAF]NK*V\.HCVLEPGE[)(]LB
MLAY5FW$<`$'.#UKT*5*;=KWMKI^/H>54Q-*,')+E;TU7W>IWE]\"]&\4>(GO
M]2FTJ-;:,&25X893*RJ"\FS:"R=>2#G%:/[8WPB\$_V3X>O_``Y8>";#7KNU
M"WNG>&]#:T-N$Z-*0Q5]RKO+*,8(Q7@$/B#]IG0OVADUR^U?4KK4;TBX9[&+
M)N8Y@6:/8@QA@S`ICGIBNO\`C]\5/%M]>VUW#J<316=O]FL[BTMC:RVJ'<'@
M*C!4C>RGUZ5K-QIW4H[_`/#G+"&(JU(M3323_$W?@O;^`X?"&JGQ)\1-0T[5
M3:9T:RTO3_/\YB.1(Y($:\`5WG@OX?\`Q'G\(WWQ2T*]MO%GAO3HX6\5:/>+
M]GG/F/ZH=Q0;`2P(QZ8S7B7@GQ18VND[-!NFANR`)_.F'W<'<!D');/3VJ+3
M?C!\6?A_J=W8Z1XAN[73M0_<NB3@1W$1^8I(`<,.`<&N15(+6WW'6Z%62W[;
M_I;4^ROAY\;[?2(E^(7A3X577A;4;#5[2VT>WTJV.HQD-MBV(EP73S,$D`+G
MYO09JKX\\;WFIVWC;Q/XXUK1=^D3>2EIXC\*VR7EQ)(&(B`M0-SDACD`A`.H
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M1V"\XQS7+^'?#7P?^#OQ`EFUN_UK5[&RMU:.XTC4DLI1=;F"LI^\FS!;IG@9
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MFT_5+9-'OOC!K/AWX&'Q)<W6BRWZ1.;F\\I06D94)RN]`VX@,&'')J3XN:M+
M!^T98^._'7C_`,)?$[2+;3E6*Y\/J+=0L<8BMWE0;5:=%8LJ9R2H[4SQA^TS
M\-O@OXWA_P"$`OX'2[TLVMW%<3PW$!(=09R+<-MD(SP>?D#=ZY?1/&WPK^-G
MCRZ^('Q8\>:9#91ZQ%;6GABTT26"*XL(8L@FX3,BKNPN#\S$DDXJZLX^SY;J
M]]_Z9CAZ-?VO-)/EM\]?U/?]-_:+_9>\'>&5\#>#/A3I&OZ_EH;76=6TO9<Q
M._#RRELB5^Y)Z$^U=UX'\0P:2\OC""R&IW*(S--;0[8;5CM"DX&T#=QM'7(K
MYG^%?PL^#>KZ-K/Q9\)>))AK-C<7%U+X)\.6IN396*!F\PSSY2-%&T99BQ)/
MM69X'_:@\3>(O"::'9"]O-1O%,]M#-<[(XK=`VU<`C<Q/3C@CWKRY3JTYJ4E
M==+;(]&.&H5HN,6[WUOY_H?0/QO_`&E?!?P^D@U+Q5J1N_M&R:]:W7#&0_\`
M+-!T4#`SCK7F>M?\%$_'OB;Q5+XH\*_#ZW;2_#]O%8:.8;</'I\)4L%V-U9F
MWDD@Y)/M7-_''X<>+?CEIUEK$=Y80Z?X=\/6KS:BN^&>*[,;DVL@/S"50K\$
M`'`/>K?@+]ECXB:O\*]*\.^!/CM)'=6<YN;G2$M8S_9RRD,KO+&VYW<L?E;)
M`P,`"E)5JM32377M^)K2H82E33LGT=[Z?(XGQ3\?[7XIQ:EXL\<ZIJ.@ZMY]
MJRZ1IH:/3-1MUD7='-"F`KD*"2,9P>>E,U_]HSX>3?$+7]:^&][JVDW/B.XC
MGN_L-L+>&-RB^9``6+-$IZ!NO6NJUM/COHOQ$_L#6_%>G:]+!#%#=ZF^G!H(
M%^Z!-E"5&<D\<]>:]7\,?M.?!#1?@UJ7@GQ-^Q/H%EXAL5EMV\2:-:1-#='`
M;SE25"^-J#+*W&\],UK&+E%W;7RO=_(55TJ3CR1YKVT3M9:=S;_9K^-?@;Q-
MX530O$W@GQ#XBOU@W1KIEQ+N)0`"=\$_=`/`P!FO>;+Q7XV^+-C;?$+P]\$+
MN[\.(MOI\4%C8J/M4EJ%&7;!WN1D-CD]\XKX<\<_\%#-%@O]1&C^!8?#T=Q<
MK]KTK3+;[/'Y"8_<-MP=A/7GD<&O4?@5_P`%G/%/P\^#%I\,_`O@^'3F@O)=
M0:^M4\VY>0R.S$1M\JJ%90,_W:F%91DHS;Y5U22=^GJ88G+Z\X>TI07,WLV[
M)6U>FW0]W\7:C=_$G7[+P_)XQTC1-/U+5H8/['1)6^P$M@B12`JA>X7`KD_V
MF_A[\$O#$>G^%;3X]Q7]S;([ZFEMJ*>79.)FC!AC#;BPVJ<<D`YKC;7]K;Q5
M^T:VEW^E>$]-MI/^$=-C>W^L16K27ER[CSKZ5A@*VYP`Q'&>#UKRK]H;]F.U
M^'.GQ:GX^OO#%C?HA,NF6'B]?[5GVRX)^SJ&568'(!P=O-<[E*O4D^7F\W=>
M>B.G#X=X=0527*^B5G\V[%[XA^$/V;?@MXCT[Q+IWQEEU<:N@O)5_LW=<6<Y
M=L[LG!+%0Q!.<'G.:]A_9T^(/A77-2CU?P?X4UW4[%I2NHZC?1)!9P[\X$(&
M!N'J2>F<&O)/!7[-_@S5=`TZQ\(R7=W=%6NI]-\7Z(X:#:`LI5BP1E!]1GY:
M]_\`#/P<\<-X!LD&FZ+I&A6$L+"[T]UCGNR2=A=0YR3R0`ON37EXVI5<K<NV
MNBTTMW/;4<.L/K*[>EV[/[EN?3GPQ\>OXBTZ"'P[9&VMKFV@L[J>\2,$.`%!
M^4`+P!SCZ\UZWK2-#X?A3R[B-+8>7!+:6"K&YSCYI!RV>O)[UY1X+\/W7PX\
M*1IJ-E97<=Y#&]O=13AMK$*0=JG[P''(]:]$TSQ)<>*].MK2YU=[6UC@#2B>
MZP'?')5>@&?:O;PCE&ARS?O-+R/A,PA%U>:FO=3_`*_R.@LM0TW2V?3-EY>Z
M=Y8:6.9I`(CWRN0HY-9GG:-XBU$QV.FPVA<A8RK%4&/XNM1R^)+FYTU/#"ZD
M[QJVRX\H_(Z@]B.3FM+^UM9TR\2XBTR:*.5T,7V9"F]L<=NIQ^-=3E&2LMO0
MX.1P]?4S]-UG7/#-[";*[64QMG&,KD\=#6MK=_JE_<H^MP`,P&^*`J2>"02>
M?6HI/$VM2W,EWJ>G3HTI$<TCQ?<C)`()(XS23V?AW396"ZX!.(QAVD!0Y.<^
MW'&/6H3LW9NW9Z?@-[W:5_ZZGDVJ:=<3H1/,N5Y)!S@5BW-I9V,RZA!?&-@<
MLRM74W=H;^0VRQB,$$*ZM@>O-<G>6%[I+.MW!$\;9",2"#VSBB53E=TCHI1Y
MM#ROXW^!/#'Q&:::ZL2TDJ%`Y7OC@GVK\[_VU/@+XP\"7C:D;$2VO(CEC3A5
M^E?JMJ-@]Q:/#%;1KE>>._8UYA\6OA/9_$7P!JOA_7M+B,P@?RIW/(?!Q@_T
MKAQ&%C*7M(_%OMH?0Y9FDZ$E3EK';?;S/Q;N;R^U">+3K[2E9,`!U3GTJ#_A
M6<OC+78M,T=4CD56!-P^`Q`X%>R_'3]G[Q7\.YM9BN[8^:K^=8O;1'YU+<@G
MMQD_A7C5OH'C"-CJ,]YY`YQC@Y]/K2HUXI*70^KE'VL/<ZD?PY^'.N:=XZA@
MB\2-8RV]S\UU:SA6CV]2I/I6SXZ32/B+\5;J^U[6KS5H_LGDB^U"4&7<JX!)
M&!P:Y^'0O-/FPZJ\4L>2>>#71^"_#MQ:W"W#W<"/YZE8KR,YF!ZGZ5UQQ<59
MV.6I@Y6;;UMIH9#>$],L_#+V$NB+OB!-GJ5F@8LV>DA[5)=^!(;'2K:6=+R(
M2QCS9I5R"QY.*]:M/@-\1M9\02:7H;644&J6XN)")MD(C7D@9_SFCQ;^SIXC
MT;3TGLKR+4+=Y`1)%+O"R=-H/I45<=&+NR:>#DTE<\BT_P"'WVNP^RI;20,9
MEWET(ZYPU=C\.M0LO#-[)X6E\`VFO72'=NF=V3&.<A>O%=;HOPN\>>%K@:7J
MFO+;I=!)7@659&D7/Z8KUWX0>(O@_P#"_P`77'C6QOGAUC3K?;:0RV8=;@D?
M,&X[\BN*>,C*6LK'8L-*$6DK^7F>>:%H_@?XB23GQ)\.4M)XXE6Q@T5!$AQD
M$L?Q!)]JK^/OV>_'_@'0+*=+B2^M;\[K=X)RT<)SC:W]T_SKV_P?XMF^(/BJ
M*[\$^`[.P>]O2B6ZJ61BQR3R/T]Z]/NM%UGPBU_HFH^`5N;*ZP+N-(R@51RS
M#CUKE]NW=WOYV.>K:G:+2OV;7X'S1X1\(1P"")M)M=2E80^>DS@ER@/'MC-;
MG@O]G:^UK5KV#Q-X4:6QN;>3]PDH"YSD$,WIQTKZ03X0_!!/`:>-=&U:\;4C
M$!+IT4(1H&S@,.,,,8K'TFPT^3P<UA'J.;N4D6Z7"$&`!^2I!QSWIJM9IRDN
M^C_K4YW7A4B^2+5G;5?B?.MS^P9#KR:AXJ\!+`OV*:/R=-EN,SN2"2R@#YL$
M5S'Q*^%'QAL?AIJGPZ\8?#C4-0T?4+HW5O>PQ;Q;787[X*@X^4<CK@5]6>"?
M#^I6&JW4\LE_$EL`99-/).T?[1'W1C//O47BK6_AXSW6D^'Q<6]N^GEFCO;E
M]US<<[E4@X7.>I'(KT:&)C&G=.S]=S@JQG5KN+7,E9[;?,_*34(O%?@?7;2Y
MTN\N&DTLB2U)4LBX.3P>V:KZCXG^(/C76+_59;%)I=1DS<"*(89B?X1V/TKZ
M^G^%_C2^AU?XCZ`]I;Z1IQCLKG1FND2XO!-(5,87JZ$CYCV%<S\=/"_A*P$]
M[\+_``]IV@6-W+&VH>&VF6XGM;A./-C?&8XV)("[NQKT*6825+<)Y?0G4T@K
M]^VSLSQS3=+^,GPS\*W>EZGX4U/3[F]L9)#+$&CWPGABX4\ISCGBO/YG\2Z/
M9Q:++<R+%%<?:!`00H=E'S`$=<8'Y5]!Z?X?\2^`-2G\.Z[HDMIJUQ9F26XN
MT\]/LS)NW!5SNXR1VK'\177@CQ)8:3XD?2=2N=3T[5#_`&_?ZI+NANH691$$
M3^`J`1@<8QZ41Q:FM6:PPE.G+2'S\SD/A'INN:MJ<2J\,J)-YGV6YG"JYZDM
MD\`5]H^`?AOX9L;S0T^.7B#2;V".Q63^Q-%N$C(B0KL5I!P&D4GY^6P!FO'(
M/B!X$O\`7VG\2?#;1YK>5Y)+>ZMK%48L<8+,O.%!'RUTVE>,/#^M7&G>$/`'
MPDTEI;2[EDDU7[0T<EYD8"N7;:JKUP.:\^M.*G[OY?\`!.MQJ3BN967E;\SW
MW4?AA\`X-?NO$OP]L)/#ME*^^WTZXU(W3!<#@L0#Z\]\U4EU?PMIES;GP>^H
MIK8E"6[6C$M*Y.`5`Y!Y/`JO:_##Q+X+UV7P?\5-9T:WO5TFWU)%L[D2[DE7
M<B*P.-P!Y'8UL_!/Q'\+/"GQ%@\;Z[J!B&@!)1$ZMYL\P<DLN!MP%(7VZBL9
M5$VDTHW>K(4+0<DW*RT7?M?N7]'\"^*FE@.FWFI6DK221ZY<ZE-##;P2*1E2
M[-G(R`<_Q&MSPE\-?BG87BWGB>]DTZQFC66+670RV[1L,HQ>/(`/'7UKG_BQ
M\7/"6JZ9XJ\::GLV>)WO7\U+@M),[2,Z#;G']W/'45\ZZ%\4/$27]FE]XBUZ
M+2H=.0/'>7;B.3_91!@%2PX'M0IQC4]Q.7SLOF3"C.K3?-:/JD_N/K?Q!XP\
M4Z)/#HFD_%V6\-O$!;7-E._E094-C=WY."M><^(;]-;UPR:KXLMK34)Y#YT;
M0[8Y&+$LS!1U)[UUGP3_`&I-&U[7[K3K+X21:EH68X;+3IX#O+E!&)`R_,7!
M!<#UKAOC=#XCT'QW>_VE\0;&\MOLRB&Y^;(C9054G&=P&%.>1CFM:ZC5IJ:[
MVMK^K)PUZ57V?+RNU[Z:_<6D\(_'K2-$OKKP_P"%M6GTFY=%U.X1ALF0-P>Y
MV[NGK67X@U_X@^"K2UOW\)W$5I<+)DS0,4E&,,V1P<>M=Q\!_P!HJ>W\.:C\
M.5\7W<=M>QQQ7*:?</)"'`Y?YP<'GL1UKW6;X*_%#QYH-GIW@;XG))#%;$#1
M]0ABMXHH'&YDB>4E0Q#C`XY/6BCAH587A>]M;6W"IC:F&J6G%6>S=U='P-KO
MB[6[R[N6UBZU+,<!%G'*^8RZ\J"3Z<@#WKSBX\;?%GPQ?!=)TVXADF@/S18E
MWH/F);!X`Y//:O7_`(]_$#QQ%KC:YXO.FWEQ>6XL+&QO+(!I[<$Q*4VC"%1D
M@]03GFN9\(_`K4OC(+GP_P##WQG';3Z?=1@V-QM6,O(Q0;9"!M'"KANI/O11
MPJO;6_RN=$L4G%/1+KO8H:CX,^(/CSPI%\4+_5M+CU62W-S;6<5SBXD2%@A(
M4?Q8!(!QPM<YH>N_%GQ9X8A\*^&_&VH+!9ZA')'X>2]E(:;<3O2('`*]>`*Z
M67X1?$^S"0MXCGEU2&>2RM]+C2-+A9D)#1^7DD]R.YQQGBN1M+2Z^%FM.UIX
MED?4)=JK';28>(ME9-Q7IG./H372HJ"=EMW9C-0FU=I]59'6Z'\2OVC=%UE]
M6U2_N;*ZG;S?[4O[91<XV[<QR,-V.,9'IUKN)O#?@76?AM=Z[XJ\27FJ:M?D
M"#[)<[Y+.17`8S1X.[>TB!3D<YZU+XC^!OQ*\.^!-/\`B'KOP]U75+36]-N`
MMQ;6I*1F%0Q9'#'>$&"PP,#-:OPU\>?`OPA\%$\077AOQ#>>*;#Q%#=[DTYQ
M8O#&"SP'!`)8%3DCY=M4HN3YJCZ=?T./VD8*U-;NSMZ]3A==^`][IMA/?:+X
MO@W6VEQWALM57[#/,C,%`A$G$IR2<`Y(%4OB3\+-0\!Z=IFG>-/!VIZ;<E?-
MO+I-2M[F"2)X@R8$;'8Q)[GVZBO1;KXF^"_VFOB;_P`(!X4TC5;72M>$%G)>
MW4'G7%O*Q+^4A(^1=P`^4AF5,#&XU+^T]^SMI7P-T@^!O#_ASQ3K.DZ)=QZA
MJ'BUO#KP6\4<K+"D<[E/E)Y&,L-V,<DTWAZ-2+G!:$_6JM.HH-ZOI_P3S'1_
MAYX-U+3=.U3PU^T)H=K)<S&)M,U>TN%ELP%R6<K&R[?H:V]1\%_$3P'\,[&>
MZUCPV-'\1:\;"PUR"$>?<2KM,NQG4,D*[E!D4<L`,]:YZ3P5X5U?Q/I/@WP[
M8I875T\9EU2[O5D@*N=H8J@&P#.2",C`XJW\5=9\>ZW)H'P4\4^*U?2_!=Y<
M10WMJWFP6:2RCS)57C))QUZXQVKEY'%[?=<WE5DY)*7F[I;>5O,[>^^-GQGN
M_!VC?LB^!O%_AS4]#TW6!?W^M6YWKIOGND9WRLBF.,.ZY.<,S+UP,>#_`!#_
M`&=_B!\//BM#X`U_38;4W%R&MU@?']H0G!WQ2-G*L,[3TS7L'P<_9(7QUIOQ
M#\6?#SXCWD.D^&K*WG$S0P.^J3-,OE1O%YNXC<2WR!L;1D5R?QPT35;+4(O%
M&N>)[O7]?M?W$1M%\^&$-&Q:$[7W(8P"/[J]N5KO@H.*<E?Y_H<;J.,W&+76
M^FMVEJ=9\/[Q?`/P#\0>-O!FD6^C7GAW7DC@BO[^%KB>WE"KY4UN5_T@;M@+
MCGD<8!(\O;QA8Z;X1U"S\2KMF\2(]Y<0OH%O-Y9P?),,KY>%2S-N((^ZO!K-
M\17]E+XRF?QC83:->?8(GT<QW!G1)&`Q([.=P!#%LC."`*[*S\=KX8^&&J^&
M?!7CN\>W\0:*MAXJN;I89FGVS^8L,&`76-@D9)XR5QT&*TY8REH[&=JE-)R5
M[M?U?R,;QAH?PYTW1-#\4>(_`-]%8W6GK'9WEEJI-S?706-O,?=N5$VL?E7D
M<9QFC68?V>/%.H65U80^+B8;?_BHF?4;=O,E!<*(25&Y%79DMU(->C:A\,[B
MU^!,?QST/0-%DFDGL=)TK3K5(XYK9HU;%S*IP^YG"_,#R<DD@5N_%_7)/&OA
M?5M,\>_!G09I_"]C%!%JOA778K2YE&U(I)FC9B9QN4AL$_-C'&`:5+6S]=D9
MU<4DTU?1M/7_`#/$[#QK^SOX$NIM-\/:3J-U<7ND2*-0N=,CF>RG;(S&@<J1
MMP,L"<L3V%9G@_Q]!]HLM`T>SCC$[R!;[`C=N3M.T$G(W$XP.WI7I/Q-L/@7
M\+OBO8Z((9]!L]0\(6]X8;?3TN3%>"(M%',O/S$_,Q':0'![][X(_87_`&T_
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M\U:S\:7>FS1S"*RM](S%!-L7:K.V0W.,YZ\UX[\.=<T_Q-X@TKPIX$L]7O\`
M4KB?;>6T-RQ6]48(C\M,9X!SUKZ`\$>%OBU\0-5UOX=_`.`QZ44LS=OK#A;>
MTN9TVQH1\P#J=Z@=0.<#-<51.I55H_\`!-*2A2I2YI6_37]3/^)'PBA^%/BW
M1+KQG^T8?#^IW]YY^H#3+HL;6#&\9?+;V88`'(['TKZ#U?QK\*OA/^RMH]C'
M\<?%>L^+[W3;J71M.\*%;JTC%Y)O:.82+Y8<C&Y8UX.0:^"OCS^SA^T-\*/$
MEYJ'Q$T6YN(X[@`:_:0R36$H)(&RXV[,$@@=*U/`UA^T!I'A>QN])U*ZCB\2
M2FWTIM.NHP;AXWP5+[ALP>?F^OO77[=4ERJ-M/\`+74PG@E649J:>M^R]!_Q
MWTFY\>ZE"S331ZA=.EK;PS6,27-U,2/E*Q?*OWAZ'`''2NM^#/[-/C"YEU?5
M_A!XQ\.W3:5J(TB6UU'Q!#:7US+*VP>4C`DJ6R,@CJ*[5?B_\*O`OAOP1X0^
M,_AJ^FU/PW9SF58-6AEFBG,\KM*H0<98HP9B3A/3&/G'QKXVT[QIJ=C#J&H:
MA'8:7=L[W81/M3AI-S%649)'^T3@FL9*DK7=WV.JF\3.ZBN5+KNG\CZ:^,OP
MLLOA'\9(?"%Y;K_:IT.%[CPZ^ES6[6FH2[?W+M<`M<`C#[P2A)R.`*Z;PAX=
M_:DGT"/5]'^,ABL=-@5?(L9((&57+GR"T:!V;`;[QSC\*\9^'_Q`^&7Q>O=+
MT3QUXR\2PV]M;M;V=]J"^<2$4K&S!`TC$`*I([`8KUOXNZ9\,_A]\#M+TK5?
MA!X/UK5M7!DT_P`5>%]4N)[D&,)@S0RMN3@E<8P2#CI44Y>R<IVLO7\/,J=)
M3482?-)V[?>M?O/;YIOCS^T9;V/A+6?"-E))86S36MM+L6>21FVEPX/)8C<0
MQYP2:WOA'\*-6\"_%R;P:WQ#TW4]:T^Q:YUA]/ORZVT^,21@YP9$'`"^E?.G
M[.^A>&KZQM;OXFZ59V$FGS%K70GLS#/=%@=PE;@@<`!<\;J^ROV9O"6AW>MS
MZKXF*:-:WSMNMK")9?+B4!8T0X[[<%O>O*J5(XRJHK>ZU;U27Y&F)B\%0=_A
MMHDNK[:]CV/PU?PZ]J$$FMPV[ND@GNKW:S-.Y(X;)P,\GBO498Y$F7Q+HVJV
M<#!6^S6;Q1$)&HX+\;<GL.M><^'YTT)?[+\->&&O78*\ANK0L00=QQD=,8KJ
MV\1#5;..%_"6E)<7(^1+2-MR<=2,X'K7NT9*":>_Z^O4^*Q,7.2:6GRV]"UX
M6U769M4N)]`TZ.>ZF8&6Y:+(B.X$/M`PHSQZ<UK6'B>ZN-:^P^+[MYA$K*OE
M("T4QZ$`_P`0_,5D06NKZ5IMRFE:;)'&8RLLPN%#.IZ@;3\PXSCFGP>#[BZB
M"W-Y'!<[E#)-<@$[B,'&.>H/%)NI%*V_X&#C!MN5OU$O->UA-2DT&6WD_?3A
MII&3YKA0=PR!6O<F.^L)//TF.*=V5I)(X`S\<8'(`%/T[PAJ&B6^V35+-O.P
M6<QE@F`<`M_#GM]:HZQI6HPW>V_U2U>)B1')YH8''IC)'XBJ5.I!/FZ^FAG*
M=*;2C_PYY)KL4T146(D+L.I/'X5!:7SK(FG3VGF''R[NO3K5D+=0_O#*54`@
M`FK-K<36LS.MH'+?,)&6N2,K.^QWMVB8U_'$JM!=6SJSMM''2L?5O#MLHW"9
M\9PV1D5W%Q;W%W*)KP1/D9*^E9>JZ.D[B&V,29_A5N/PK>UXW,%4][0^?/B%
M\`]+\2/-+?V-O/;N_P!V2/K_`("OFGXH_P#!.L75E=:WX<">6A9C#_<STQZD
M5]_W-JELK6K6ZJ5/$KQYW5B:CX(:*RDE75(6W@,$`ZG-<%3!0;O&_P!_^9[6
M$SC$4&E?3S/RIUO]D#5_"K&TL;>.ZGN4_>2S1%?)YZ#/>J-]\,/%$_V:/5O#
MRRRV7R?:8EVG:!@#TK].=0^"\NJNWVK189E<<,ZC!/Y5DQ?`?2M'O)([_1[:
M1=I'DM@A<]P:\^5#$Q=[.Q]!3SZ@X>]'7U/D?X-?LU^)_&MK%?\`B'5GM]/C
M091FPVW'"#O^%?0WA_\`9^^&%SX:.F1V]]T`!C0;1QC.#7H'A[X;VT,JP68C
M#`Y6!5P#^/2NOTK2H[,"W6U\J-L!U5,A?:NG"X?W;U%^IY.,S>I.I>#LEM8^
M&?B%^Q/>:9XW7Q#832-;-(%_VE)R1D=Q[UU>@?L@^#]1MXUUXS1J#EWC7YLX
MZ\C_`#BOLA-`T&>Y,,/AW[2'0>;-*,G.>WI4D7@N!K:]&G^'XFC\D^;YRC]V
MH[@GO3GE2<^:,M.UB5Q'B.11>C[GS#\,?@C)X$\0K:Z?>7%UI=E=F2U'E!6#
MD8W9['_"O5]*T6);V2;4C)>%P3MN,LH8\<_Y[5W4?P[N[>PB5H$M89VWQL6Y
M(&>U7="^'>L7%C<II5DMQM(!XY*GC(S[UI1P+@K6\_\`ACDKYF\1/GF_(\<U
M#PSIDT]Q-J$$>G6\$A\M[1PK,N>0/7I7,>(?"W@+Q))-<>')Y;:X=4$%O,,F
M4Y^9B>Q/&,5Z;XA\&PV-W)IVL:5<":W<@QN"`V>M<U=6GV>]B6PL%M[:*;>(
MGB`<=OO$<UY-?F@[-+?MKO\`H=^'KIPNF[_A_P`$\JNX/^$*U/4;6?PN()YX
M"BPR7+@#/0_>Y[U3\&6&@)J\6EZWI2WD&HR)$8%N?)PY)`?<>ZYSBO4/C(?"
MNH:?!JFOV"Q7YQMFM9EW!!T#)_>([FOF[XLPZ;K>I20^'M:O(+99`8)+R,@A
M@.<E>G/>FZJIRLG>VQ[&$A]:C:SC?=^G8I?&W]BNXO?BHOA/P7X@ACOM6$UW
M#'_::+MC0L-KG(P20>>F*\B'P[^%_@359O!/QC\':S<32WMN+^?0[H3&%`26
M^5>&)!&.>*U?&.D_$*>ZM!=W#BT*2;-7A1I$\O(WE6')()&1[US'C#X:S_#7
MPU_PGNA?%"VOI=0:2!K/3KETN[7:XVR3*1T91D8/!X-=U&JY7:BEUU:\CM>'
M4$HRE?IHNO>_0Y;Q!XJ\.^$HCIG@C7+Y;-;MWMXKB+9+LW%<,1R"5`!4\5/X
MS^+7PS\9>`[W1-;\`0IKUQY4EKKME(R-&%R"CQH-KY&.O(QUKI_A1H7@[XCZ
M)?\`AC6+6-=1BLVN-+G6$27$]T#G$A8C@@$'ZUTG@OX^^)9-''PGC\'^'-#B
MD98+_4M/T.'[3)&1M$?F;203D[CUXKJIU8OWI.R\E<RJ4W%*,5=IIZNWSVU/
M!/%GA3Q3INF6OB'P"U]=:*((TGU1K-H(Q<L,O"N3\Y4=2.QKK_AKID\=C;^&
M/%<EI;_;8%NK20QAI)2&(V!\_(<UZ3XA-X][;>"?%<L<.F>&%:VLVT]DB28$
MG]ZW'SL1@;L9P,5YEX]L],^)?Q*+>'KG4%B:>.VM;1;I-[9`7.<#DMCDCISF
MB+C.=D:2E*4+25EW_+L=!XV\0:?X>O;CPCJ8U6RN7A1[&2?D12*V,;CRR%?3
MC-85SX]NK1)OLVH.S#<DGF*58<GJ/I@5?^*_P[\3_#RYT7Q5X[\#:[>6\+>4
M&U2>26V1(R-L(E''9N`>AKT3X=7OPO\`C'X_\2:K;?"[2/"FBZCHLLNGZ<;K
M>ZW,,`.$GFR<EQO*C&<XS55,/"3Y7H81K^SA>S:[JWW;GC>D?$+6K>YCU"_2
M[O&B<!+>(%@(R,-R<A6]*Z?Q=X]\>>*?#5SJ\-EJ$6D?:(H+6V-@SB,!<(AF
M5<$@#ID9YXKH+S1/A[XS\&I%#>Q:!-8*L+VJW#1IJ$H^^WF,-I8XS@D#K[5Q
M6N>*+SP=J%AI.@^*+;5K:#3XKEXK6X>6.V>1=QC8,,&1`<,1D`]#25)4XV3W
M^\:KQK._+:W<[_P?XW^/5AX4\/\`A_1_#NIQ)'")=-:XM_LZO@OMD#X#$AV;
M:3QQ[5T_[2GA+XT?"GPMIE[XV^'^I1V]]$CV&JVVHQWULQ`_>"1UW;6))8C/
M<UP7PD_:O^(OACQ!)J&AW.F:MY7[JULM659#&64X,:L#]WD\=,YKU4_\%@]=
MNYM:D\:?"?2KZ*^THZ?#I;3*T$<FT?ODCQ@'<,Y%=E"A2<'SR:[;,\_$8G$4
MZJY(J2ZZV?D>+?"_6M8M-5O9KDSVRW<1$;1LR$2=B,=_K7H'A7]JGXD>$?$"
M:OI_C.34X+92C6E\F80K`(0RG(Y4#ISQQ7"Z+^TCX=\27]X]QH%[81S6\NT6
M]RG[N9@=K$D`D$X!6M/3-#M/&GADR0^+-(MY]/MXWCM&)5;K<P!#<?*P')SP
M`*RITE":<7K]QM6FZRM4A9>98^+'QGU+]IG1;/3O%.IZ38S^%M(/]D%P%ENX
MT((MA(`-S#+%=Q[8ST%<IX6U3Q5\)-2C\2>`/%S//E)56>$1L3D,`R$G<0P!
M'7&*S/$GA;Q);Z]<17/A]+!KJY66"TBD!C"28=%4@G(*L,5T?AGPY\1+K4KO
M4)/!\3-IZDW-MYJJ6"Y!V\GGV'7%6W)M77^9*C&,&HVMVTL;VDV/A;QEH]]X
MJ\7>+K>'7+8"=;9)Y!>7D[DEFWC)8]3GC!Z^M<S8>#[S3YK77]-D2WE6=9(;
MFZ<;6=&!49;@@8&>V.M>T?$WPYX*\9_"FW\2^&_"FIZ?_9=NBVZZG(8S/&X?
M<\0P"R*X'S=\]!7#RZ%X9G^&<JQ>%[FXN;2\53KN6,0#`#9P,*1@G&>:56R5
MG;;S%0?-"]FM=G;^K$EQ\;OB3XCO;K6+^^TBX:TO+B>XTR"[6!292%=8U5AO
M1F4$A/7T-:/Q+^+O[0?B2ST'PA\0="M--T06Z2VNA:1H\5OYJA=HED*IOD8@
M$98D\FN9\!_$;QY\)_#GB+PEI/A6R=/$-I']I:\L`Y$4<@E&&(.W)`XXZ5LZ
MW\3/&/C:.TO[+P--?7EI&]IXAO88V*33M)YB!$0#RBO`&/2L5-RCN_/[RG",
M9_"O)]M$=G/XQ\->'OA9#!9_!CQ9I6MPZDMY=6T6@NUE=6P&U&>4$2!E+2$'
MIEO;%8?QM\?^/]-\.7GA.^U#QMH.FW=Q:SZIX?U.29;*#(+0+()$5B<"1U#9
M![9Q7F^J?&[QO;^+I=0\3ZL38Q*8VTNYD,JW`*',;X8'H<$]<]:YWQ5XWOO&
M5JF@:5#J/]D7,RO_`&>\KR&2500&.,EMBEL$]`36G/S+EZ_(Y_86E=[?/]3T
M#QE\1-,A31;&T^+8\3^';5T>]BTO1_L$]O(RC,2EB7(;D;L]B<#BO.O$7Q5L
MEL;_`,&>%%O-.TS6M12>[6>[9MR(S&)6Q]]5W%N<\UH^"_ASXDUNX5_"-Y'I
MMJ"[++<7(CE=\XP".21D\\8'6NZ\(?LG>*=4\3:/?>"=&TJ_N-:N'L[."XMI
M)H)9(E#R/O8%`NWYB<\`5<8SJ2M%"<L/0C><OZWU.5T#P+IGCLCPQX`UN"YE
M**&LX[MA]I=2=\S%E14B"AF)9P%')Z5>OO&5_IEO:6MQJ$Q?3+EHM0TH;'TV
MX.]0$B,+?,AV*2,\D9!YKM_&W@[Q'\)/$WV/XV?![0I-FFBQLK.U1(8U/#"7
M;%AG."P\PY!SU/%4?'OPXT35=2O;GP_X,T'1YG,=U]@LM=+"$.%"1()#\Q`)
M9N>-V3T-7-."<'H_N,8N-6:DG>/3KZF(VD_#_3M`NO$FL?##5E34[,+;:SK4
M#&UM[D3QL/(;:1LV;DVG)VMQT-<SKWQH\)?\+4;XA0_"W2+FUM?(']D"T:*U
MNV08)=002&[D8/TKZ)^'_@:3PE\,KQO$6J^+#X,OM%N;#Q9)#!]ILS)'`)D*
M$ED\U"/EQC(8'-?/WQ\UKP-XG\6WUC\+(=0UNUENS'HKW^E[+Q(%"K&IVDB3
M*CIU'K6D9\L4F]?Z\D90<9SE&S:[WT_X##XK?&OP9\3K.?0/`'[-J^%O$.M7
M\7D6_A37[V:%X@NTQFU8L&9F)(.>,D8K6\%_'/\`:F\!^)-(\!1^)[/P_J>D
MV!M=+75KK3V6S1G63+KL8QON0'+X8'J1S7GNEZS\>_@7K^G:_P"&]#GTC5]1
MMI+*WOT*S/.&56>+`R%<+)%E3\RY7('%=?%^RY:RZCHI^-WC]-+U+6=<CTS6
M(M2E,`TMY6#":XDP6D7#%C@<=.U=5.G.I>2NGU;T1SU9T*:496:Z;MWZ_([7
MP?<?%KPUI-_X%\'>./A7J&KM=#6M>UC6M6MUO))C((A;QSR*';)<YBBR"#NI
MNB?"+]L8_%+Q!X8\5_L]V$@DT_\`M&[^S6PM[=8"&A6:WD$D>^,L"I9,@L.:
M9\3_`-GKQCX)\-VOAGP/X*\(S:'9>+9I?^$LT?43.)"C0(JM.`0JJ,.">OF-
MUQBO5?VEO'7BSXZ^)+WQ?#9>)K#7M)\,^1:3>&KJ35-/U1(/)7R4A4+)""5=
M_F3;NY/%=D*"M:2;MM;\CR*V)N[4[:WU>ZV/F[XV_#S4O`_Q<L_#7Q8^&?B#
MPI>:;I44=T-4\0_;&+!"5D0Y8HK?+M4'`&*W-!^#_A;P=IUGK/C7Q%HO]J/<
MI?6.EZSHUQ<+<HP1N9,>6^<N&7/6,\]*\6\8_%_Q+XU\01P>(+?47^S?NHH[
MPG>A`V\CC!X`(]J])\">)_BOI'P^;PQ<7&H'0[:^^VQ:7J%CYMHTI7;O964X
MX/';DUPUK0FW8]G#^TJ48QO;O_6INZ?\0O$'B3Q5XB\>^&X]*T;Q.+M;R*XT
M/2A8VUC:11!%BA,`VQAE)!SC/&3DUN_#GX[_`!?^#&B6FL_#SX@V]TLL#:E<
M:=YBFVDFN"F8W$NW?("B@A=QR.#WJPG@GQ9\1_A8?'6NZ7HGAO289G=19Z-Y
M,]^&C8(L0C3#*7@(P.^3G&:T/$&G_#[P5X9\!:[XTU9]<T5[62YDL[ZY$1PK
M';;@(VY/EVOGLQV_PFN1Q<GS7\[]=SLC.DH<K2?2V^R.Q^*?[1OQ]_:<T6PL
M?B-K^E3:I<VRP6]I9ZC'9V6D1PE6(C@A?'F$'#%PV<D+S7E_C/PAI7P^T[3]
M'\9:G=_V.IN#I6HC2D>TN;@-\\L.XKO`^0;CU],5PWC_`.+=G;^,+WQ+\+M(
MNM+T@Z@TFG)J,_F2I&>BE_XLC'%8?PR^)?B_X@_%J'Q)XKU&SO(],0M9Q7\4
M8@5(P7"C@`],<^PH24FW+5]_^'+ITI4X+E5H]CUSX<_LTF[@3XZZ`FJZUX?B
MUD64,T3P)=23!-PVPY;:H)48/KCO7J?Q,^&'[.7PQ.G+X[\"_$72-1_LV.^N
M!J>D?V:ET[<NT32Q?.H^Z`!@D$YKR+XI^)M>T_P#HV@Z-KVL2W%^S7FIZ7%;
MN83<3JKD*JG)9\C/'W=M<I'^TW^TW<^!]6\$:A\8]7M_#NE/%#_8FJ:R[2.%
ME($*)(=WR$G*K@`=11&/(^:*N_D7*52K%1;LK^:9[Y\(/VZOAAX#^'VF>#-'
M^'T&F7'VN;^W_&N$CO?)DD+".%4Y9R",L<`X`XKS']H#]I7XB?$CXJ"W\#?%
MCQ;JGAVRN/+\*SZS<R[X+8'(())";G!)`.!Z\5ZUX._:;_9WUC3=+%S\6-4L
M]1M_#<%[K&JW=BBP7>JHO%G%;HI`1`-H8K@GGBO+[GX\ZUXUU8VNI>'WM[FU
M:<02VLBI:O;NQ95^SR92/!8G"^IXI8J=Z7ON]O+86"A%8FZ@T^[?<]M_9^'[
M1_C*YN=1^*GB/5/%.GZ'(_VBY6\.H1Q3N,1D2990&8@;P<'M7W'\'K[4_%D$
M,NF1.D%K"'N/(??'8AOO)N'+;"0/7(KYB^&]W\3M6^'_`(6M/'^G^78BV$NE
M:!96L45M(@48FF"`%S@JPW>H/>OL'X?3ZU<^!;73O#-BYFBMHX)6L+9D41@?
M=)`Q[UXF&C3GB9<J:LKVZOLC3.*L_913M?96V2Z_,[G2/%^G:3YLNC33!V8(
M][-DR3`8!?).1TSC/?%;&C^'M0U.::X;7V@>W*O##'&S`ACDGCY0<8)YJ[HG
M@+Q#9?#K[?)%-B)!//8;T5#'M&U\$ALX.<BL[1M7U58+R6X,J).I$ADE*LWH
M!D'.*]U0E%QY]F?&NI":DX-73MW+M]X@O+>Y_L_6?$2W)\AA;K`@=5SP<<\'
M'M5FWM]#UBZCCN-6G1E14\V;!"G/7`Z"N;\.>$KC4-=>\TU[F\DBA9V#X58U
M')/Z=37:W%II>@:?/+J=B%N+A'5!YB2LC=,,`<J?J.*(2T<GMYW9E5<8M16_
ME_D79M*T_3+:73]1U>^BG,0,<"L'6X_N_,#]VJ%^+'2X1;Z99O<.6QEHQDCK
MFF6ESJ_BB&&YG\*1V\=F@\TD+$P`&,LWZU)>7FO7T2Z_=BVLH8XUC2:*'>/0
M9`[D=ZU]HIK16[:'.H33W]=3S>X-M>>7+:V;`J1N!Z&D=$N6:%)6#$9`)P%J
M.W@NTMQ<J[=>G>I8YH9289G\MF7D]P/:N&.JOW.R7D0>5=-\B2!RPQ^%/LK*
M![EH'MBSD\'>/E-`:.`;M.D=P.A(QU'6I8I)"X=%#/GC/!(K:#Y9&<D^Q1U%
M;V*XDM_[/!CD.U"PSGFJ5_X?O7B4,P"_\\P<[16]?:KJET3:?9<K&>%5.`?K
M59$N(@4F"J6/`D/(K1N-KZLB+E?70S]+L8#.-.U35@L9.TEESM']*Q-8\)AY
M;F);QIPDF('"?>&>_I73"TME8$LQ=/FW>7D'VJQ?^(`+-;2#3P`Y#.57A\<U
MG+E<;2Z%QG*,KH\]L_!VIPRM"TFQW'`;C;[UL:3HVH6C&W\^*01.&)W;LX]Z
MT[T3WL_VV.!MA)#)UQ^-2:=:K<`P,[(=OR@*<L?2L*<(1EH;U*DI1U"\O=9@
MVQR62[0^U9(TXQUJK>:A:7.DM8I9.+II2&D#8R..,5L#3XPJP:G]I6$H2/+X
MRW:H9;.SL6@B59)I%CRRLG#'VKKDIO=Z'+&4>QBP:)?WL\<5S>H2"!R^=@-2
MO'/9R2VT6H2.B$J6C)P4QR1BM6-]+LK1[B2WDCF!W`L,H_L:RSK<ME(^H26"
M'SCQ'Z#UQ6:Y8(:<IO0R--TB^UM[B&34(#"4=RUP-S'`XY[&O/O$G@;4VU5M
M&M-2MQ'C=]J!/EH.XS[5W^H^)K?3K>>RMHWA2Y`+N3@8'.,&O)]7\5ZU>7MU
MH_@^\:ZNQ"\Q@6,DD`$DYSZ9KQ\QJX:*BI*[?;?TMYGLX"E6J2?+HOP]3".E
MZ7IWBZ47VKZ9%#:[<7UW;M)&<CGC&>WZUXK^T)XI?7+2^_L:Q@MYY6?8=)4!
M9$`/[PKU5CV]L^E:GC/6]4M=,CO/$/B)$>[E;;;/D<$]2?TQ7F]CXB\'VGCV
MRO\`Q[J%V]@+DC6K.W9E.`<#81UR.:\*-1SERI6C?S/NL%A'27.W=I=/+_,\
MO\(?$[6_!.K6<WB&SEO[*Q+JEE>.YC3>02<=LL`<U0\5_%CQ!K7Q"L;N^>WN
MM)`++I%OAAM:1LH5ZECD]?6ND^(?Q`^'GB77-8TOPU9;]$MKZ2+0C=Q$RQ1.
MP+-O)&X@]`:G\+?LWRW?@G5?B+'XDTB8VVG^9ID[7&TW39^:(8X$BY^G'&:]
M"FII\L7>QWR=.RDU:_Z_J<OX[O\`X>?#7Q!J*Z?\-?M.EZW"SZ?::K))!=V+
M$8(W+C@'D'D$8KDOA/K,&E:E/.^FV]_'-&ZK9RLY\K/1@P[CKFNY^`X^&7CC
MQ=>67QT\4R3-:`_9K&^N&$4I08V"3:2!CTXJU?>"-+C^+>J67P2U&&WTB'=<
M33LA:.UB(7*\99E7)&[T&:ZG>4;W5[[=?^&.>T%)QL]%OT_X<\]\;Z'\4;C0
MCXQ/A^[@T^YN3:PSW$;!?E]&88./:J7PB\+2^'O'=M?^*+VSAT^XF\JYN+YW
M"+GOE`3D=1BO:?&_Q,^-GB#4$\">,[JRU72/[-F-C-H5L+FVB1EP[>6%&&Q@
MMQD;LUYE\7O@7:^`[6/Q)X6^*4?B'2U9$N[>:VDL[NV8JIQY,HW%.2`XSP,]
MZVA"R<X+:V_7[B%5>E.I97[:_H9O[4WQ#^(T%KH5EXD^/=GXCM[NS>1M)TF[
M=ETU-Y18I!@+O9%#8&>",X-<KI7QOUG5]-M/#GVNUCM+:'R8E,0+*.,G@=3@
M<]36?+H]MK&JS7.A^&XWBEN3%;_;9OW:;AA5=F_]"-=U\.?CQX1^%^DW/B'0
MO#.BV'B[3ITM(-&;1A/%/""YFF:1B=KC(4``YSUXKOHI5E=NWI_P3AQ2>'@E
M&/-;T5KC=(\5_$`^#[CP[!;WNJZ)=71DDTNQM9?-C=4(68_+A5()&[ZUR>J7
M>@V]Q:ZA9>$]2L?*6,3R6Q8$'A9!R,9(S^=?5EE^V/\`%CXLZC:7'PQLH=52
M]TRWTV33O[/2V@.UY,Q>6/OG,GW@>GTKSGXDZ7\2=6\1W?@KQ!<P^"EN;F>_
MOK2]O(6B0J`R11QQY,))R!G&<CTKH<*4%>#?S/,A5KU6U4@EZ/\`2QXU:^+=
M:^&_Q!A\<VO@&W@M=@AM(Y;/B2-0$W2KT$C@9;&/F)QBO37\1_`CQ3#9:EHG
MP7N8-8F.$EL\0+Y@4*JQH2RO\P!).,Y(KN_AUHO[2&A?#O\`XG\D6M^"93)<
M06VL6ZRVMP_*$A@"P)Y`;IN[Y%96H:IX0D\9R1^&/`FKZ38Q3X32[>1)6M7R
M0WSO@CG@9'1?K24XP5]4WTM^)7(ZSLEMI=/\&4?$7PC^']QK(\,>!O#FI6+:
M9,T&KVFJW"+>K,F7E9H5!**F&&>GRUV'POF_X5Y?ZAJ/@GQU!H]P?W,<NY9?
M-AYW9'.\8`[&L+3_``A8Z_/<>)KJ:>W21-BR26323",MN,KE1@<,,GWI'\&/
M;ZE8Z:WBJSMFO[T6\E](S_NH&(_?`%1@`9X'/%83JRE.\6OR_P`CJITER.,[
MO3U]35\3ZEI][+IVE:Q>_:%NKYIH[^PB6&W$(?:CR*B;@PZC<`/2NMTSP[X5
M^$EO'XTG^(]I9:DMEY[6&@7&^XDDDX`Y.U0`2&4<CM7EVF_#_P`.2?$T6`UO
M4+G2XKAR_P#HGF3W:G<04CSM1<``EF&,YK1A^$_C'Q=IC7.CV]W"HU8VLMM=
M0%5BR#Y:!P"-V%P03U(QFJ<JE166O_`.6<*4=FTNOS/0O!ML?'VFZGXH\8W]
MA>)Y<[1V5](7%K&5^62,AMI<'G81QC..*Y?3+Z>#[8D/B_P[;P6,,C6MMJA*
M+<-Y@7Y5"D>9WZ],C-2>-_AAKNF2KIEI<:?HUJ]L&OK+3+R2Y\A3M`24@867
MD@@X->?:OXR\-?!99I]2\&Q:U!>6LUO:RZI:DQAV.U9EY^8@\\?2L^5R?*UL
M;QLH-IZ.UE^AF^,=5\9QZ7:1Z?J%UJ<<5T)3IM@[/$NTY^ZN2,X[UYOK7QMO
M]7\7SC6[>?P^%<QB*VNF5QR<L^<DMC@YP>*](TSX@?!5_!<EK?6UXFLW5Z%0
M6TK>7Y&.6=3\IPV,#W-9WQ!^!OP_\5:E9>&?"^K^&FAM3&U_KT,SVJOYN,*[
M2`8VX;G;VJL/23]S>_W&=>M%*[35OO.=U;Q=\,);73]337[KQ#?&)#=K++\L
M`W$>4YVC+$`=,]>M=AX4_:(U7PQX3ET2+3I;I+R1!;6D<[1K"G(D0!`#AUPI
MYY&:Z+2?`?[(O@+]FW4-$\->,?$7_"<:M?"UU;3%6&2RDBBF$@*3@LLBJR#E
M><G\*S/AE\)-$O\`QU&GA/6-=DLK#3A=:QJNG:69Y;$$@,ZQDK@`'KGWK2I!
M0J*--W?DG_D<T*].<'*HG9;7.:7]H!;2*ZL+FU_LRROCY.J&WLE9X(]X;$&[
M)C.54%N2>GK7M?@2#P+XY\-0_%;]B_XZ76A^,/"6CR'7/#?B2Z-Q)>QE6$DU
MFOEXV[`JNK``9ZXKQ_XJ?LV>!-4\;Q^&]!^.$D4<L;)%=:IX2GM$\SD@RE6<
M;0/F9QG`!.#7$:E^RG\3O"WB?4-.^&32^.?[,*B[O_!VFW=[:A3C<Q>*,X3E
M1API.1\M=M"C4CI9-]NO_`/.Q,\-6DG&7+ZK3MK?0]*\1?&#5?BSXIO/B)\9
M+RX>\CQ'>66AA(#<R[3M*K]U,X4G"]%)ZUYXGQ>T'P3?/=:YHY2X:\,UG;SW
M6]6B)R!)P,\=^,U1>[UKP?X8CTW6OAGKLBO/YS78L)HXR<-C;N08QAOR/I7*
M?%JWT/Q-H>F>(M%T62UG4.+B<07,A=<Y#'<-H5?NY4]NE)8;GG>2=_0Z55A3
MBHK2.VCT_P"`?27@G]O,ZCX8OO!UWX'T*6UO)9YE^R:?'OMP8]B1ER"6CSAM
MISRH-=?I&M?#+7M*MKBXU"&TAL[":>)+A%CVLQB1E26-=[$MYFP#D!>HKY.^
M`OPD\;?$+71IOA)K!$2.0O>:C<&&!I%C+[/,9>'8!@JG!)X%=WJ&A>-+'Q39
M^`9?#.I:1J8M5%T-9#P1QHQRDN)%!6,JP()X.011*G4IRLMF96P\F[2LUJ_\
MSKK#Q=IWP]^+7AOX]:GK":IJEKJ[7MOHFHR^>TYC=?+5B22H.`,OC('>NA_:
ME_:/T[XJR:=XGU7P!:>$_$=OKDU_?Z%!8&,3`0*$N-[XPK%L!%)S@M_=KE]$
M_9-^-'Q*N+BU\&6&AWTMF9/M6K-XJLXK9$CP3ODF=5`)^[W8C@'%8]U^SW\8
M[NVFG\7^&[+4;:5A!L;7H7NDE!5`L>TEMPW+\O3#`XQ6M*=>'N[)_<<U6&#J
M24^9-K3?4RY?VX?&$FF/X7O?#=C.I@6W2:.(H3$'+LC^61Y@)Q][GY5]*U;#
M5/C%J,VE_$_1M'O=9T43QP-'%>;D@EF8_P"CEE;>@<\#(R>0"<''FGC?]F+X
MV:#XL_X0_1_`5_/?^:D;65C=PW#*[`E8V:)RHDX/R?>]JTG^%W[6OPL\/ZAI
M7BKX4>(-/TRWMTN;^.[B,:QJ&`60\]B<=R,UTP=2,=4V93P^#YO<:N_/>Y]^
M_`;]I?PSJUEJ?PR\9_\`!.'P#I1@U"*35?\`A+4EMA]I6W5/+1)4WQ.ZQ;@2
MRJ6R>YK,^+?C7]F;3_AAJ.I>"%M$TV]\5Q75SI&F:Y'#/9(D@06SV[N?/0J'
M96`.TM\W%?$6N?M%_%OQSX3@L=3>]UNZLXA#%J6I!Y9HH0"!#Y@P64$\;R<8
M`&*PX/&=UI6E6=EK?A[3;`P2;WG12990V!\_S$L!C...2:RK2JU%RI-^NHL/
MA(49.I*=O)/M\[GUE\0/B!INAW7A[Q)\*_#=_/X=U!M3N?"NE1:LES>P*7:`
M0W*1K^Z*GS'4'&Y901Q7AGQ,^`WQP\6Z]=^(_%6F6FG+HT$2W&G)>PR72JP&
MTB&)B3QR>^`21P:]*\1>#_AMXH^`$GC.Y^.$=G%;6RW">&])N$E+.`BF5H78
M$$H6/RD\J0<5Q&@_%KXE6NA#P5\/+J&\\)7DFF3>(=.TX_8%N"=\44,\I/[J
M1T!+$-@[N3Q6+PTJ3]]7NKZ'31QL*BO2:33L[K7?NSJO$G[(GA_P_P"#=,\'
M:[=WT/B&XT"VU750VI1?9]/\\;XA/&I=E8H0`.&&06"@UYEX>^'=Q87G_"/:
M+8QOK%Y</IJ:1<WNZY2=C\K"-%S@_=]R:ZCQ%+\1/`OQ,:[T'X=ZKIEI8SYU
MK3]$FCU&+RRPV*]TIECE8J-N>VWIUKE?%'QNET!;OQ9HME'I_B>.]6XT[4F!
M6:*-0RLH55"`G=]X`'*]JS:O9<MOENCMHSJ*[<N9/SZ^:OL>WG_@F+^TMHFJ
MK<:[\6?AWI6HF"*5+/5/&!MY?F7<JXD0<XVX/0G`!-;'@WX,?M%Z=IC_`+-W
MCW]G[2O&&GZW.UO8ZUH<UO=7$5P^=HBG8@#YPW?DANPKY8\-?M8_$KQ"PT;X
MG:Q)J^G2W)DF-U@W41(P72;&]6`Z')QZ5]!?"G]IGX(^%%_M#X2_#3QM)K^I
M".UO)[C66U"1D(PT:'9N0,V<$$'!Q72XX>E'F2L^R;N_S1R.>8U*G+))K=.U
MK=NIQ'CC_@GO^T]\,/%>HZ#XO^#FKQ0Z"!+J\T$8G2RC;A7D,1;Y3_>&0<'!
M.*[_`."OPP\!3:-'?>'M&F\7:Z52.;2K5;F&WLFDR%DEN&PB@';@'J<CM7K7
MB\_&WXVO9>-;OX3V7A34M!ADBTTZ_P"+K<7%VL1$#0FSF<DC<'.W;C<6(KM_
MV>_V'O'WBO2CKD?Q.T72[?4&_?:!(;D)$XR5=MJ;#U.W+''/2O#Q59<W)2C=
MZ[M?\#4^AH5.6ASUI)-6V[];V/;_`-FSX"WFG>'[V7XF>)],FUS3K6*%;'3[
MDW4$1&-T,<W*MM&,D$C/':OI--4MI'TS0/#82..PM$BL;6VCRSNP^9V*]3S^
M0KS/X7_"=OA=HL=M+K4=^(RT<,MC*%6<JVTM\WS`'K[UZ%:^&M2TJ%&M=)N[
M8RG$[-"<+DDD!NX'%3A:4J<?ALWOUZW6I\SCJ\:]9RE*_;HNVQV"S>(+VU-I
MXK\4"<VNQ$LH)0'#=`H`X.`!G'2B[U14T>:TOM8EW,-C6\@R20?O$D<>GK4,
MN@:-9:?;73^*$E9XC))'"AS$PX"GU/O5N6ZEUK27O)K:V(B4DQHH$@3^_P"I
M]\\UV\S5TUK;O<\7W;Z;7[6#1X;1=$=]`,NI2RIMGMXH)-T1(ZY';-):PZA:
MV,VNRL([E@=LUU)@OD8^4'[QSQFJEI;2VT'GV&H$O,,,(Y&^4?[7;I6S->6F
MKZ?+97$OV6WM(S+%`WS%W"CH.@R>:SC)NW1VT[%R=F^J'W6N_P!LW$>F:FD-
MM>!S]IO(Y<[QZMZFK[WUW9W`M=.UP7D4:@J+.T+$<8YXJG9:?J;V\>M:5HRZ
M?YA8RWGEC"H3@LBGG@>F:FTE=>L;J>30/$K+#E0;H1<MD$X([5T4G+F3:U?7
MJ<[47\/3^NS.!#S01&2"`DIRP]:5#_:J_N[14F0Y9FX[4DL$AC46SL2WW@1@
M&B#3-<@G$=\BJ&.Y-KCD>]8<SYE9:&CM;4BATV?3HB+N\)?.5`6L^_=FU)-B
MNN.A)`_2NDCL0[Q23VY"'@D')/UJIXFTB]L[E`]MPWW2#VK24)*%UL2JJ<M2
MO;Q:M9@73;2CCE#U;TJIJ<6HW=TEP(2WEH0JA<XJ]]ENKFW#Q7(VJ!PPZ5*D
M]Q:F)!/#P.QR?QK.W,K/;U!2=[I%6YU+5+>R2V-D</CGR\,:JW4-YL$<L*HK
MJ0/,'/\`]:N@AN;F999!*LC`91FZ``]JJ7^L7NH1"^>WBW1G&?8<5I*,6M6R
M8RE?1(QX+2WLK5W25B<X_P`BB>WN&>&>:Y**H^4JO#"K4VKVT:L4B1F(PZ..
M"3W%1W7B2Y&GFQ-HI#8\OY?N^M9?NX]33WWT+<VMI8P/&\(GC9`8V0YVD'K]
M:%U-?$$)F):.X1`MKM@^4@#G)[5E0:S;W+"V?YW.>57`4U;M+BYE<FUD^SE>
MKYR`/:M%-R>^G8Q<.5;:F?9XO;L6>J1!CN;Y1QG'`X]ZBU*TTNZM39B-X)$S
MM/8'W[TL7AF]CNQJ\VJ>678[)3G)'-/U'3[9[1G.J*[?=&U#EN_)K.'-;WD;
MW@VG%G$>,O#:WD"0B^,DKH-Z8X3_`&L]Q7A6O^`/%'AOQA-JFCZ[&H@LY/.G
MD+1K(.?D!')R,?G7T?<:59R6A4:CY4N&+%HB2/88KSSQ9\/]:\56-QIB>(+>
MT@(9U>6)BV_&%&1TS^E>%FF$]HU.$;R]?S/>RK&*E/E<K)Z.Z/C'XM77C^6\
MMM)U^.ZA@C!33TL`LK,=V2#W'WCVKR[XA:I9VK?V;=>&;NWU"U1O.\]7#S%N
M`7W8VX]*]2^*WA#X@:)\4)$T^X2W?2"LD\L,ID+R!S@@=\<'CUKA/%7B+XDZ
MGXUN/%7B[49VDU,_OY7MU)D484\-RHP*\>BO<U/TR@TX+EM:W33\#D=.T;PA
MK_A*/4O%U\T5U"[0PVEKA8E4<AV[DGI3?`_C-O"EZNCQZ5<ZC9W$8C:-H7"I
MGA@B]\=C[UM^)M&\+>(%GU'0@^DVVG/#OD:)6DF9F`8QKQNQUJ*3P;XQ\3:+
M<^.+OQKI>I00YBCB_M98KI2O`7RSC@Y'3->A&3MO_F9RA![Z&7XN\`?\)3*/
M$&EZ`_A^UMII()KS4+ORQN"!V`0Y;)7'08Y`S6?I-Q/\+)([SPEX^%O=7]HQ
MDGM$'SP,,,A)R`Q'&T\U5\3+X^T'2D36!=6<$J;()!^\CG(/(W9()Z#\!5FW
M^('Q$\.Z5<^']<\-V4VE:A:1EY=0M$!VC.-I(W9!/&*TC).5[,)1?+;<NP>-
M_#WP^NM,N/"-V+A2GGOJ=Q<GS;;>IWVP`/3)!+8YY`KU'3?B'?\`B/PQ/JOB
MJ0S>']7@D@O;Y+1'ED(B"HBLX)`RJ`D<@=*X_P"'7@#]E_Q-X'F7Q]8ZOIVL
MM,[#5;*^+1R#JL8BVX`&>236UX*^$K+IIT'4];N5CT\`NEJ=RKGE3CH<C!R,
MXK2=25&THR^Z^ARJ%*?,I1M;JUOZ'DGB?PS+I\A>+PL;:-("MO'-$,C<<@D$
M?-]:\VU6^TF]LY;F3P?:/J\M\8))U0Q+"@550@J0"3CI^/>ONNU^"&B^(O`5
MZ)+V74-3D@#6*M`"8V+#&6/3(`X]Z^?_`(@_LI:_>ZM;>#_"6M_:=4UB;R&T
M<PK&8Y0Q'WB0`1CJ<5UX/$5(:=&<-=T*S>NL?7[SS#P'X`\4W]C,\'A34I!!
M<>2DEI>[0DN<'"<$MVX/%>A1?#WQG#9GP]X<\*WZQZ@(+F?^T%$<\JC)!.3R
MI.3N[UQR>']$^'MEJ6A>-M'U0:U9W*Q:?'%J80V^QB)"R*.23T)(]LUZI\(O
M'/@/3-=TK0_$MEJ^@V-R,:SJ5E.;N:Y@;#*FV1E!*C`&#CFNJ5Y2OMW.>5K=
M_D=#\(+CX^_%&RLO",?@R[FTOP\IM8_[/LP(=W5!+*["/[Q[G/I2:CX8\/>*
M/%`MK[X@SZ?8,$CU26\LVA=7#!7"J.9#DLP]AUKN=1\/VN=)\#>'II-)%TJR
M3/%J+V\=Y#+AHI74`J9-GUQ6#XW^&W@?3=5M(=0UJ=].EO7-YJ,4JR26ZQG#
M'G;NR1P>,@T2E9Z+UN_T,:4;.U[)[61;T[X!:1XBUS78OA;XY-]HVG:;+=2W
MUOIYM9-A490!F7>-Q`QR3UZ"N+OM.T4K)::OK;7P#;$N)V8^6<<XQGIZ>U7[
M;QSJ?A/2+_1/AAXHN187\7^G,\6QYESC8G4]\$],5T_PA^"5I9&V\2?$C01?
MZ))"[SVMIK,2SHQ4E=T9R5`VY/J"/6L[JI+W5;OV_P`S=-TDW-W[+9L[2?\`
M:!\&>%/@1;>%+"TLQKT,<`L_[/TZ#R)57.6E;`=9`"O/S`[3WJCXC_:(L](^
M`</@?P[%:Q-<W9;4+M[E;N?SY-OF3<@/&22QW#/I7EOC[1O"/A6[O_!UFC"_
MO+Q&TZY:57CMHR<[92ORMD%>01MP<UE>+KGQ/)JVF_"F?P9:07EG(+5KVPB(
M>\=R",&0J,?,H]JVC5J)/WNEOZZG/]4I73:ZW/1-*\=6UCX?U[2-.U*#4CJ]
MUY4JSF5"'"@J[\$,HP<?-DGM7COQ+^!6J^-/"^JZE:>*A!'HEL#Y/F%EF;()
MV\\'GICK7H%Y\._&G@_7;6Q\5^%;N26^B%MINFK;;9"TG$0C`.68E@"3DXK5
MT>QL_A3X&U*7X@7<^HW]_).T5E:ZC;3A#Y;*7D3=NB>-BK=!G;@D5=/F^WI;
M^MA5.6"O#6^NG4^,[GPQJN@W(LM7MIHI8P1B6(@C'KGWQ6>VG:A-ISPV>J/Y
MEQ+MFM,':ZY[MW_`5])^&/`GQP^*OQ&O/A?\+O`6FI<>(EC,%OX@NK>W80(N
MWS#+.^(E?[Q(/0Y''-<9XETRZM_B)'X9U7P=H^COH%^UG>W&D7+SJ]RA*DH5
MR96RN!MPI]1G-;QI2NG%/[C%UZ;DU.UTKV37RN>8Z!X,UKPS&^L7=T+="N^+
M=&3O8'A%/8GCZ5Z9\`_B=\0OAGXZ_P"$WT;1=,NU2W/VR37K=9;0)D-APQP#
ME,#)!.<=Z]>NOA+\'O#O[/5]XF\4^)-(UC78)!+I^B76MR07UK#O&'`4&`2,
MQ`:)CN`4G=7A-CXG^)4OA;7_``%I^F:A;6?B*1!+;I&6B=5;Y1Y@X8;L>N2`
M0:VGAW!J2>N^F_X'G_6Z==2C;2]M=O.QM_%+]N/QGX\UF"[O-%TZ_>SOUG@M
MC8QFWB`!!C6/'*$'H36K\"OVPM;^'/Q#;5/!OCV\\#VNMI(FK7%D)F@@#;3N
MCAC/!X*@\XS7C/CC]G[XG_"Z,3^)/"-_!).F\"2`MLC!P7PN20.^,X[U?^%'
M[/\`!\4+N\M'^/7A+19X;-I;:VUU[NV%RX(Q$K^0RAN2<-M''6M\/&K&7-?[
M]/S.;%4\&XV>UNFOX'V+!\0?V'_%OAD:/XD^(?B>VUR?3UNH/B!H4L\BQW4A
M97M[V"=@KJ`Q&8\_?)KQ_P"-GA;]JKX*^!;J[\"ZG<^)?A];6)EC\2:-*)[*
M"VED6++QD;X49V"_-QN/7->/>!?A-\2=-UVXTVTTU;]K3EVTC4H)UD&<Y5-P
M9^@S@<#KBNFUGXH7FL:M:^"?"=LJ6(3R]2CN4%O!*\A4%)0SE`H=01DXW#/%
M=CQ+<>5K7NM/QZGE+`RA-2A*\=VGK_PQT?[%5_\`#[1/'$WB?]I+Q-JBZ3-8
M->06]A<.1]HCD0J3&F06*;U7(`R1DCK5SX@_'^W\=_$OQ'XDT2TFC_X2+699
MTUC6A+=3?9D(%O",$L``N.,\GVK@_%7PT\=V6DP>)_"O@G7="%X7MI]4^RLF
MGW*9(.V4':5XY(R/ES7-_"S3/C%X\MY=`T[P$==T[36!OF>1$AME#E4\R1F`
M1=[\%B,D\9HHQGSJ+7X:_>575)PE54M=%:ZLOD7]5_:!AL+O4='O=4DM[N,E
M;0V:-MD8M\V_.">"0..*L:O^VE/:27R0>%+"ZO+FPEM6N[J!7D02>4"XXQN"
MQ[0`!@$XZU]'>%_^#=S]M/XE^%HOBQXFM_!7A31[M%DMUCUHW,S!B/D,2*0O
MR@MRPST!R17B_P`;O^"<%C\!?%#Z!\0/VA/"FGK;QS;$NI3%=$(H95EA7>8R
MY^503D8YKHG@YI<RT7JE^IRT<?@JDE2;N_)7_)%WX"?M6_`G3M!U#P1^T/ID
MVK:#/IT\MB=+M,78OYC"`5^95P@C)Y/&YNN:ZVV\??#+PS\*-3@U&TE-WHKP
M7.B6C^(TN8;RSN/G!>#)5W`8(^W!7&>N<?'WQ!\,:5\/O'4FA:?XRTW6H+?:
M\>HZ)*TD#@J&P"ZJ<@G!R.H/6K][\5-.NX7L+?3I4BD$3`7,_F9=%*DY(R`<
M@[1QQ6,'--WM^?XG;4P4':46]=>WX'Z,>)/^"H/[*=CX`\+>"_AKX7O]$T`1
M0/X[\/7'AFW?S9XU;YK65?FC4E(P<GG(..#7C?BC_@H-^SSXRUR;_A(OA;%J
MVCK;M'9:3<:5"K8*E1OF`W`KPW`Y)[5\U?!_PO=>)O%D5WK\8FTQSY;F$!P&
M(+*A4$$]>IX'?I6KX\\._"'0H%T+P]X?NI[_`.ULPNG(96B8`^7A,@2*<@XZ
MC!K2-2I#6[.*.#H2J.#O?R?ZGO5Y^TA^RGI/P0U#4_!?P0LSXMFMO(L;W,86
MP)B*-^Z=6W@[R=V,9[@XKQC0/$GA[P%X576+>+2+U]>5)-7LB[LD"JT@$)(D
M&UAMSL(_NGO7#G7]`@\:V.G7?@&(6&GPA;C39)Y4:X8\@NX(()ZC'M7TMX&^
M/^D_"/PG::IX$_8_\`M92).OF:_HTM_<W!D'[P&61C]T$`<`J"#[UG*K*<N:
M?3LCMI8.&&2C!-\SUN_N1Y5\*_VMOC1\%+;6#\"-4U'P]I>HD#47LWDDB^4L
M`&'W6.&')SU[5K7WQ/T7Q;X\L=5L/B#)XFU*^@D&I7/B?2X[2U4-O=H@FYLJ
M<GG@Y)QUKG/$>F^,K/P'!K'AKQ;97&G:C>7+WW@VRBE9]*`D!4R!T"%&SP59
ML!1NQQ7+WW@JU6^L[J.^,-O+"KEV7A<=<8[Y!XKBG44%S(]NCAX54TDDW=>?
MS/KOXQ^!O@1\.O"'@W5OC-\)_`%W+XZ\--/;W/@K4;FWET*-)Q$)9(SN224J
MKG:.2:]#^$'P6\$?#[P'??%?X>?$35-%^&6HZRUO:$:W%%J&IJH_=[K5%9PX
M.`2<*-V1P*^7O!WAS3OB3_9NA^`?A5KFN3[1#+?Z@RY+`#.PY"HO4C)XS[U]
M&_!'X#+XJ\6Z%;>`O!*V"Z/$PO+R>Z?_`$B8MDM)ER@*9VY7@[<UYN-Q;W6O
M96N=&'P;H1]^3MU;VMZ'NW[//[*<GQ\UY_C?X[^)J7FN%+BY$NH0LJRHC,$Y
M`"AR`.,=3GO7U'X5\&>'M&\+6^FZ3I$MQJORHLEO(?*C7&3QMZU1^%?PXT;P
M/X7'AV.\M-1:*),21F1$#`!GQE?FY)&3UP<=:]`\,V?B+2XWGN]!N/,1(S!&
MD6`@/S`XZX(P<U%&G",$Y1]YK5K7_/7T/#QV*G4JN*E[J>BVT^0_2-$U7PA:
M1V-WI<6Z^53(971\)GK\I)6NY\(V7VK4Y]0U%M5U!$B:+S+>V<J,#!*]\`8K
M`T5H-L4OB*VO%%S<D^<BDC9CA5!ZXJYI/B..SAEL=(EG:1G(%PI*_+Z5T0E&
MZET70\BJY2NNO<FT]=/U/5Q::W`%B@&Q2Z>6SX[M_A4NJ'P[!;F&QLU>=DVF
M3)*@'N.>35>]6^`7S[E8FBP7"C+8)YW']:V?#]W8P1'5[G2()U7"K&-H(`]%
M!R234*3E)Q?WVU_I$M\JYE]Q0LI["&V%KI'VHW1+"4[058YXP!R.*7[!JMC<
M+'!+GSL@[9"NT>^[^5-U"]O9;F75K.PFME:<R+-Y1').>".@I6CM-1MI=<GU
M>>&ZB52D4ZLPN&!^;D#%2^62:[?+0J[6O?YEI-$UW1-3LVENYD22#<[%/F2/
M)!P#U&*L^&6FT_595TFTG\R8EX%EG6)0G/4L0"<5E32WOB&Y?4(F2#=@.5X4
M`?PBKMS+X5TQ(7DBNK_:#O,DC(,G_9`X_.KA.*?,M$OZ[":;5MVSF$O=.%FD
M!=F?G)]ZB0C8;F>=F./D53FI)(DMH(WGLB"P^4D=:JSZM#80[I;4LJXW;!4R
M=GJ2HWV+#W>I36BI;Y##DLW05(+Z?:ZZA'),Q7"GL&]J@TK5K'4F-P&:*-3C
M&.?I5O4XQ)JD3Z7>M)&\>)4=>=WM3C\/,G_7H)VYK-&<YO+F;[&4(7&"1W]J
M<NF7>A1RR&!)'*Y7S'`(_.FWTDUE=O:D,TA?`*GD"KEQ8WR6RE[9'W@-M,GS
M?C41LWYKJ6W9>0RU@>ZM4$Y$3%.54\G/O5=],(SMU!6!;!C/8#O4<UW-,8[>
MVA*LK#+;LU/!;Q;VDG+F0'HPX:M.6,F2FXA))`"KBVMV\LY+$#KCIBL:[FN)
M=4\FUM5CB(!;!X/J?:M2:SLI?WJ6TCR9W$*<;?85"FESSWN(XFR!DQAAD#WJ
M'&4C6#BE<K"PM+*))V@'S,02&R35Q=.N;?S!IENRQ7!`4/(,^]27-O;Q8M;V
MS9'"_)AL4EE8WL(S,98\K^[/<G-4D]K&<FK7N6-%TS04BN(==,X95(4=0I]<
M=ZR8;G1P\<4R%Q$Y_=YP&].>U:EVMYI5P(9XV^90P.1R/>JNH10:AJ4"6.G1
M(P;.1PN>.I]*M[62U7D91>MV96L6$[W7GMI.Q,?((EW`>QQ]*YW6[G4+I9_)
MTI'\QP'3:%R>BBN[FL?$$T[H")(5/[S[,XQTKE[CP[=:OJBZ>RK;KO\`]8YZ
M9]2.]9UX<T;*^ITT*BYM>A\E_M)^#([&XU8ZE??8-0GLG7[1':[XX_G!`)4Y
M#G&,]J^7/B)IJ:QI]O:^(_'NK+K>D"."UM)[`&#RW?)/F*<[5!)YZDU]U?'K
MX+:L%O;VPOWN(YG:.0129888<\^O:OG[QO\`LT:%K$J6\!N())GR]Q=3[G8`
M=.PZBOCJJJ8>K*,HV_'1^9^G9/CL//#QO/5?H?/$G@5K?5/LNH^)!?Q^3FWE
ML9AL`'\0!`/?IUK,70K/1=:;PZ]QLM?.S#=3IMW'=GDMT)]*Z_7_``CXR\!Z
MQ/X<MM`EW,NZ-MNYF4'.1C/'>J\'CB#7-/FT#5?#<+,Z+'%+-A624,<LH[G!
M-*$XVNSZ'2:NM4_ZN3^,?B#ID-O<>#/%'B?P[<1Z6^ZQM[B4LCO\K$IY2D'=
MM"YKF[KX6^*_CX\MQH?BFPA5&EFBTJ2X,:1&-%)1#+@]"<9ZD&M2X\$>$+&S
MU2TM/`MU<ZFMA'*VI7$Q"V@+#`C'1B3GZ9I/#7@;XF>*/$MOXB\-1/>7MK)'
M#'I]J!YJ''#%/XAC.375&LO=6[.=TI6;CI;J]C!T3PAHGA/PM=:%KOB75H+V
MY=/L=JVF#RI$8_.6D8\@=MM?1?[._P`'?!WB_P`+6%S#J5Z-17/VI;BY`1XU
M!)VC&<X[&HOAC\,O%7BZ*VU3X@VFF:AH\=Y<6]I;ZI.2;69AEL)'R!NR0>A-
M?1'PZ_9[T'1=`AU_1?%<<J!ROV5H"A51P"`3T_6M(0J8BI:"3\FUMW/&S/'T
MJ%%Q<K2[K5>A5'@3P^FF0Z=IE_+%&47$]Q"<*@/&=O7&*\$_;+^%FA:_<&]T
M;QK&MU:V[3236%C*ANIL_=SR=QYY&!7UQJ_PZ.K.L&B:N&,D661D9`7'4#K7
MAW[2>DZQX(\*WT]B/L5_;IF-Y2`4<#KG^5>G7IRH4U>"2TU[_H?+Y?BE/%JT
MFV^G^>A^>-QXWU?5/$$_A8>`7U6ZDE+.GE,UVVQ,;<CYB`!D_2NY^&WB7X7^
M'O#&H-\6O@EXGAN+RZ6'2-820LFFG`#8A<#S,X9NN>*YO5M:L_#?B=?&'B'5
MIX]2><B2XTEE69(F8EGC8X!;!QSV)KCO&?Q;^).J06D]WXQDN[47;W*VV$7Y
MD&T$_@<8]S75A7%T]'^7ZGT.(A.322M\VCU#_A<^A:7KUO86GVS6+&+<EO=/
M&T#&1E'\#$E2#V!I]O\`$?Q-K`O=!TJP1]^&GAE4,^$Y/WNG>O%5^-#:IXOM
M=<L-,\G5X[KS8GML%%)P,!,$$#CCVJ;3/&?C#P3K*^)=)D\V+YM\MP`0X;((
M*GJI]*NIAT_>C>QE2E)>Y+?[]3ZT^#7Q(\)7>O/XI^(7@9+>V6%;:*"/36-M
M<<JNR0J=T9PN[<H)SGBM*Y\6>&[NPBT"YL)=&\-'6-LWB2(333SQQH?E5`%&
MPD9RV#TSWKYR\'^,?'ESHCZ\GBJ:XMY&CFO8(9&"P,&VKD'C/^-=MJ7QK\7^
M`[ZQMM"NY;Z*1DN=4L)8P5D;<=J^K`AN1CN17+*?+*SV-GAVU>^OKM8Z#P7\
M1?"EYXVE6_TO5KNU49B,14R+M&7;)&`,Y(^M=+H'Q>U&Y\3"VOK&.\MKW,4%
MMXFEC=)5#A]COU0L44ELCD=0*;K/[5W@[XO:5/X+T#PKI/P^:36WO+J]L;<M
M=;9`OF1%B,!=P=A\N!NQCBO*/`NF>"O%'Q+0ZAK=W%H9N6>\>:Y'FNJL>5R`
MNXJ5XSU!IM<MN67X6_X(J:=1-S5OG<]0UCQM:?&7QUH?A'QGKM]8QZ?<M:K+
M'>AQ;H68YA).T'H`<^G-9G[7O[+GAC]GW6K'1;?Q==ZI)*0U_/#;'=""BOA2
M>)"`2"1@9Q@\U@:M9Z?>^$-+\2:5X!OYTMWD1]46_P!WG`R$*LB+Q$`FT#N2
M"3Q5_4_B--\7/$;PZCHMS96-EHY^P1W=RTH@(78I`:0%@SA><\`D]JUA43BT
MU=Z69A4IS4TX.T5>ZT^3,;QA#+\2-.T_6_A+\9[R]UC3=$,.JP/I?V2X2,GR
MUCRTI^T.0R@;.<9P.*X'P3I_A;X0:\FM?%R6YN96B:==.C+!I'^;:CK(A')P
M21S@]<UR>E^/;GP)XXBU^"%IY(KHM&8+UXN5)`(=#U&>*]G^(,/[.GC7X7:;
MKYU[QGIS6UHT2:&\,-\+%F^<M%*^T[2ZY.2"`V!NKNP\W)W5KKU.#$TO9OW[
M\K[6_,XF#XC?`+4_":0ZMH>J:)XB&HYN;A)C<VM_"[X<-$QW1LJG*A>"1SCB
MI?"?QF\?_LP^-]8MO@YXCGU+04FECTR_U322D5U"P*K)Y$ZD*P!XSG!'':LF
MUT/X*?#?4W^(&A>/M5NKG3?(FL(-3T>%9#>!E+K)&68;%^8@\YP,CFJGCGXT
M7_CG0WO-?\3IJH<F:=+I60I("`B@!<$LN3Z=<FM)RG-V;U75=#"%"E#X$VI=
M'_D>N>`=1_:/UVXTF:]N?#MO=I9W&I:9JVO^+(=-FM8RX9_WDC`-NW<1D-N!
M/&!7F7QDT+QWXH:^\4?$ZSTZ[U3Q84O+?5]`\3V4J&=3C]]'!NVD+G*X4@'.
M*\OO_%FL>-=1L_M5U+,+95BM;>$#:%'\(`__`%UUOBKP5=:)X2L=5L-(GFDU
MD>;INIW'[M"D9/F0J2=I8'!.<$8]ZTC.7)9+\S">&C2J*4FE?RM^IO:K^R-^
MTM\'/%4GA9=1LKO5+:T@NA%H.L+.WD30^;E&!`)"%<J/F^;&#BG_``I@T#PS
MJ%ZOB#PA8ZM&UUY37EY#+*B.`S`D(0>2F,=>#TYK1^`'Q@^'^ERIXGUZ_P!0
MC\56%]OMK624?9I/W8`.%&\]"#@C:<'GI7.WOQ7T#6;O6+VYN+SP[XAO-2+V
M&N63[K2?=\I2XA//`9SYB9;YCD&NRC2A)*26O6USS,16K1<H-:::VM^NQO>.
M/VE?BA\1_@Q9_#'XBW.L6E[X?UC;H\3N=L4."&CVL-Z`9XYY!`(XKD;?QCIF
MFR:;I.H:1JNDMJADL[O6]"O6AEOHS)O_`'T;#RY"I(7L",=^:\YUKQYXHT?X
MAWEYK?B6T,MU:DS3PNTR7$JGA\D'YFP.>GKBLG7/'?BJ\L;6YO99O(@:1K.6
M3=WP"4'3(V]N]=+E&R5CFI8:I*$FK)7;^_L?=*_M@_&'X$^`M(\.VWBX^-M-
MUO2A#?VM]J%Q97>GRM=S>4R)O5%E,2J"23T[9Y\%MOVAO@3X^^)#:E^T-\.?
M$7B*&RF*`MXB03A"PW*6"8?!#X)8GD<G%>&:1\1?$/C;QI!'JVIHC21+"LMQ
M-@(0?ODMU/4U[=\#==_9TT/PMXT\(^(O!-IX@N=:OE$&H7.HP17-K:1`EC;E
M\(KM)SD')7C!K11NE9V_'\#S8T8X=-\K<NZ;3U>NJ+>I?$/]E[5/CC;O\+?`
M5KH6AV^BRV^FG7!'<,]P64B2=0&608R,9ZL>:O?M/Z3\'-7^)6A^%-'\!Z9!
M)>:"KR+X>ABMX\,799"_.&(?)RN1M`&>I\F^*VD^"?#FNZ:/"FOG78'M59(1
M:I!<0.R@F!PC.KA6X#@@MUVCBM;X6?$+P=\/_&-MXH^+O@#45N)#=VXN'L]T
M=L!&BHJQ,5+,C$LV2"=R_B1J05TWNU=V_1'34A6<%4CS.R=E?5OYG<Z5^QI9
M>%/#(N/$OQIN=#TZ6=9+G4K2RN+I(I?+W"+R1$DCD;@ID4[,GD`8)Y6/X3>+
M4T'Q%ID'C?3[^PT('4C)=R/IEQ]J*",",2KF1\''E@_-C(J33/B7:>"/%KWV
MH_$V_O\`P]>W+RL(%974'Y2'4ES&&!49!/?TK)G\4_#^3Q?K7Q"TXW%QH%M?
M[]"\+ZC=NTEX<'!DD51N1"!D'!(./6M*DJ=ME<G"1Q;OS-M;[=>Q2U7]G3XU
M^!=5^W7-MIEY.ZJ\ATO7;>[$/R>9B1XW98V"_P`+$'C&,BMW3M=^+&FW#:?X
MT\.ZU<JT*%+.X@DC7$@&UN@(##;T^]@5J?"SQQX!\=^.)O$'Q5U6#1M2O+E%
M2U-J196<;*1^[@1-JCE1N)&!D\U[W\<OVBKSPNEW\,I+_3O%=YJ%E;Q1:AJE
MXLLMO;!4\I6>/Y,)L;;\^0&&0*\K$R@DVI;=%_P3W<)6KMQISA=OKL<;\*]0
M^)OA;Q#I\_B+PU=3#4;6:VMK*+1V22[B,@62)69%+=U+?,037J.I_L)7&M6$
M_P`4D^'QT?PCJ,S-::)::KY\]H5CP$=F^8$N,G([X%=5^S/=>.=`L--\*P>'
M!JFHR:PL\'B$:ZEX;>(`2F*&1780Q`L&;:"<J<G/%?;^M?#2'6="LO\`A(=1
M\&7'VIE!?2;Y[B;(8DLQ5!GKR?85X4IRK.44[-;+3?U/2J8CZE.,N5:[M=5Z
M?J?"OPC_`&*_!FO^$X-)?PQ>6UX\WFWLL]PVY"!CRQSM8$@L&'(W8Q7W9^S;
M^SEH/P^\+Q`^%;J&WM4"J!;A8R>F'<XYZ_C79^&]$\'>%;.#1=#>UFMY)E:6
M2/3O](C&`3AB>><]Z[3PGX8T_4;&35]<\1.2+PM]CEER64G.]P#SGT%.AA6J
MBE-\S^5D>5C\VJXB#@O=C?S,O3M.2\NI8-'NRL$;;C;+'N/4#`*C!KIM3DCE
M@BG_`+;-S(T,9$CJ59%VCC.>W3'Z4E]9SVDK0:%<V&9K@B+[+N5U7C\`.G!-
M68?#0MGF2&_MKQHT9FRV`'4X('9CWZ]*ZG>+<;7_`*Z:GCMIM.Y0:SMKM[1+
M&ZO6=3F5II`L1..=@X.*[?3M<\*V?AH:7I^FV:W(`9V.X3>8.1M/((SSVZUB
M^&[37=4A:XFLOM`5L[24W'`X`!(R*EN[=KRZ$0\'7-M<N/W3QG:CMG).#G^E
M$+TX\R6_D9U5&HU%]/,?K=MJ>JW<M[XCN'624`R?(1NXX!;H.E5=$UF72)$N
M])M=TXW?O%YP/H>E:(TKQ%-9F:;45GM@Q\^*-RS*!U)!_'FKFB:OX(TV2'4I
M))`5A9);=)-K%N2K#@YST(J7&\U*_+YL:?+&R5_)%"S\2ZM+)!9:Y</]GC;S
M2CGKW%2V7B'488)+2U=3'M)1RX*`$],$?A5&PAMM67BU9V=_E+S\D=E]!5AV
MTN;3X=,@N98;N"0[XI`,,<@84^OUXI7<=6_0'R-[&G!+!8:6=.U"SMA+;LPE
MD9Q\P/\`=`Z^N<U0G?1+YVOK:_-G+$-JJ0Q63G'`YQ@5)H'AV'Q'=R22ZS'`
M(DS'%./FG(/0$<"H=?TO3C,;32DN1,&Q+$LH9N.^1P1]*NTY0O96Z=_P(349
M6OKU.:FO8+Z6.*.[8A!@!N@-4KW2[XD$K\I)"E3Q5]IM/G,\=KIS!O\`EF5&
M3FJHU`3EHIYC'(H^09J914MW^A46UL@LK.&6,PPF-94RP!;&:;)#?6Z[Y6^3
M/)4G(J&*>.WF+SQ%L'&?6I(M1BAB8B(`DY&\\5#4+6*]ZY5O;^PCQ<Q/)YH;
M#%ASFG6FIK<$&6\5&8X^<]:DN]2@*R16=HCF0#YRO"YK.-O<:9.+>>*(;AG>
MPR`/PK&S4M&;I)QVU+MOINL7%\84N8]@.\,#U]JMVU_!&GDM*N]6&0QR14(U
M!;J1%%H<JF`(SC=V'-6+*P@T:X6>\LX6$XW#8=Q'UK2+L_=,G9[EBQU9%#&=
M$$;<9(Z#UJC)J=E9W6='NI7?D22,ORCT'O4T-PD&YHK9!&P.TR=<5&UY8-9F
M*W14?!*[T&,GU%4Y-1M<A*SO8?+?RZK=K*S(\Q&-Q'W:EAAU::]VB^C!4X1W
M?`/L#4&CV]]IZB>1(VW+M#E?E)Q^E0:AJ!CB8`J74XR#QCI34[1O+<S<6W:)
M+J$&IF1O-;<5.)&W9`Q[TEFNI28C$@!9QY:*F2PQUJM#)-?:>9K:Y$:H?G5V
M^\:ECGM5:)XKXAAC<`.GTJ8SOK^I4HM(G;2=:CN+FUM%,,\8S*CN!N![#W.:
MY:]N-=LHY]+N3(L4DH\T%<'<.G/:NHUN(%([FSOFW-D3,>"367+#)?*+&R>2
M21VW-O(PWO3JJ?-H_P#@_(N@^K.9U#PV'MDN`6GAY+$2<C\*Y/Q-\,]-\8O-
M+H.B;#:PAY&F8#/J03U/L*])*7>FJ5:)#@?=*TMA?BY'V*73(YHT_>.(XOF*
MYR02.U<]3#4<0K27X'93Q56C[T3YD\<_!'5H]1@\3>'KB*.]B(4S0R;7"@'Y
M!GJ.37DOBO\`9F\<^--=CAN=(B-S',0)0L<8B#'ACTSUZFON#7/".C:AK"2V
M,R6EO=2<?:6R(OQ[BJ?B/X9V2*VJV.KV=W,IV/Y6X,RC@-R*\JKDZYFXRT72
MY]'@^)<1AX)-)]FT?&VA_LR>)([>^\-^,O%47[BY_<PPP!]V/ESO'1>O^%=9
MX7_8;UO2)(_$7@7Q)';WQFR)8)F6Y8;?F8'T`/XU]!1?#S3TL;B\U:)8Y'4>
M4'0Y;GKD5=M]"M].@A^TW;""%`H-N<Y!'.#V-11RIWM/;UV-:W$>)J:PE;NK
M*QYA\.?@=I?AR%(+S5I+Z>0GSG$>S!W=3ZYYKTVP\-:)9[+?3;K:\?*AXC\P
MXX.._:MW0;O0[*SD">%XI87)Q-.6+]>#D5I-8Z#J.E02:>B02B4^=)GYMI''
MU_\`KU[>%P=.A'W4K_F?-8O'3Q,W*;9SD&F:XL4NIVHB@(96C4OAF(]/3O7-
M?$[X/VWQJ\&W<.M:Y`VHHBGR98R6N`!C&[HN!C@UWEM8W-G`\T]S;O;LNQQ*
M-Q&1V`Z&G1>&6F3[+X>U0L]Y^[2-U"@DDC:S9XZ#\ZZW"-:/+-7757.:GB9T
M9J<79K9GY:?M-_LGR_#S69X-;T6YM;FSFS_QZDF%6)/W.`0!@_C7BZ?!WX5^
M+-<TK2_$5O=:3<&"=+^:9V6*YDP6C=,#*C!4%>O)K]:?C;\.K3Q>[3>)],2>
MXMH46Z<R%WVC@`L3S@8'':OG+QO^Q3X1U749M9\*VUQ";U/F2^`\O/JF.<YR
M,XKR7"MAJC4=>W70^SPF;T,112J.TNKZ'QXO[._PM\-V%]K=KX=2UFLX08U.
ML2`SG:`SQAAT!Y&#R>,5@>*_@EHFD?">*)[2>77?/DEN9[C5]JP6PVE/W!3.
M90X*MN(QGBOH7QQ^R'X_\*:PUUI_A^TU58BK6<,TYF5RI!Y.>%P?NU8\=?LH
M>,?B7XW98)=-TZVD8+)#96HCB8``Q@#G9P1D=C6LL9-QLU9G32=)2YO:7COO
M^!\O^"O"/Q!^'FC6/C+Q-X!N=1\,W>HF/'VDHEPT0#/%E#G(#`Y]Z]+^%^N?
M#$?$:'QO\0M`>QT^"2&XM-(0LIG"'<HWEL@$CKG\*]NM_P#@GWX4TK21:^)?
M%>H7NJ6L[,EC`A*`_P!TD$8[@X';O7-?&O\`8V\3R:2U[8P65K<1(%'VR3)\
ML``!<`D$#UKFJ59JSM^IU4L1A:[<>;5Z=BQXON?@5^T[H%OH>BZA8^"O%=OX
M8D7RI+!(+?45A\QPHD!+2S.=HW'YBW'2OG/P+;>*O$D)^&VF>%X);V?44LD5
M1LN`XR77+=,!6R3TQ6-X\\%_%[X4>)4\/>)-+N[.[LIU:Q=\CRT/S(ZG'((P
M01ZU+\._"GQ?;Q?'X\T;P_?2YN9=E^D1822&,AB`>,A2<UT2J*:3ENOR'3H2
MI1:C*\7MUU_R.[G.EWNB7'PNO_#]U'+:ZJ?[/O[>ZQ'"ID"X<CY91C.&'/-=
M)\8_@1\1=-\)R)XI\$_9;GPW9L\FNQZL&46W6&+]WGY^N`3STKS2S\$_%A5;
M2KG0+J..UF_>R?8VW`9ZEE''8BM+4=3\>:_X9'A>?2=1E(4Q27TUW(RN`>-R
M9QP.AP:CVD(:&<E)S5GIU_`\VUKP5->:2FK6*SQS0R-Y=E=:?,CS1*A:699`
MI0JI7D$AN1QUK8TCXT?%)?AU)X$TC1-)2WB`9K[5+-!,B,&&0S_>'S9X!(XK
MNO'>CW_C3PC!XDU;Q/;VDMA.;:ZTIP^-A0`3J!@$,1M8`=<$GFO,=5U&'1FM
M/#VH7ZSV08.UHL[LDG'W3CIC/;@5UX>M3<DUOZF>)C.=)II/Y',R1^,]2T+5
MWOM*EU6)IH9I];,3".$*60$%@."7QT[>U>A?"'Q+;3:II&A:AX(M=40M!%:7
MATSS-Z9R490I!ZYR>>,<`UZY\!_VQO"GA/X-:K\&-`U^R\/ZM>ZC%]FM[CPG
M#J%I?QE\"WFD>12@#.6!8,HP.]1ZW\,-!^#?Q#\5_P#"T_B/:>%/$EE(%M=$
MTOPRSP2K(%>38RS+"A\H@JZG!)X(KVJ?LDTXM^?0^9KXBK*,HN/*UM:[>RU.
M2N(/V5=#^(>M:!\3-.^>%&CLM0\.'[$UI,#CS`J,ZOC.2O?&,C-6O#&E>$KK
MX&S^`]4^(NIF.VUHW%FUHZMJ%NSQDJT-E*0)(W.%=TD1L<[6QBMOX)_";]AC
MXS?$FTUSXGZAJFEZ5J,LEQ<W>BWL=M]D*P$LDD$C/B,N`?,64MU^2O5?B_\`
ML'_L97^G3>-/V;?B[KVMZ?I,T4=Y8-XJMA>NI#,1;!T!<@#/'';))`/3"FJG
MO*2OYW3M^IYM3&0B^6HY=-6KJZ[=C\]=7T37K35KGQ4=.$L,5Z(99&<HT,G!
MR\>2P##(R>,YP<BN4\<:R;_6QK.C714M'F9(H/+6,XV[5`/S<?Q'&:^NOBI^
MR;\-_%/A6#Q)J7Q(\0>'[_1K;48]<E\56J^3=+;8:WMX/LZ$F6175<R$_,<]
M!FN3^%_[,W[)]_HWC31/C1\4=?\`"WBRTM+:?P9I=O9"\BNR[J61VC4F1C&<
MC;M`(Y/I<*<Z<DD]^_ZF\L5A\33<I-W6FB]/O7<XWX7?"*^_::@FMO!ECINE
M+I&G0O)/K-]:V<ER55@Z6\;$&:0GGEA@<GJ*=\,+!O#USJFJWVHZ5J=AX7M]
ML6FZYJ<;NTC2986L8/[PF13DKD8.36;\0?@Y9?#S3X4\32>)-.U2>[C>UT>[
MT]69M/Y#7#/O`#EBBK&`0><L.`>=\;_#2_T#Q@]G9Z?K$I9V^QR#0Y;>99@J
MD1F)_N\LN<$]:<N9RU6J^\4(*,.6$KQ>VGWZGMNL+X$\6_#*T;P+\$-!37];
MC_LFYU#68V-];$,\DUXD*96-,30H)&P?E`53R:T/#_[(O@<_"NS\<?%/Q7IU
MY-%9?8K./19&5[.X65T6*8Q1MF0JI8[N>._->%1?%/XUW^K76J3^([F.Z?31
M8SR2YBD>",J=G09Q@>IXK/D^*'Q`Q):6\UY;/*ZI>&%W_P!(.259ATW#GGJ>
M?>MH5YK5QO;37_(X*F#J-<L9VN[Z:O[V?3NN_L6?LI>$=.O/%NE_M:+#JMC:
MQO8>'K>!1>27DD6Z-1YA4E$<$2/U`QC).*Y7]K?]G'4?V<?&NG:EXJ\5:-XI
MTVWTRUO+CQ%X6UXRG5+F\4R@F*X)973"H^Q=OR`DY(KP=M<\4W%W;M::3.+C
MS2J7*0.9)GX[\G/(_2NLM/#?Q6U*W71M<CNH1=W"E;7491%'N5BH9]QR`K9&
M#P.:YIXA\S;@EZ:6_0[Z.6XFT6ZG-W3MMY6,GQQKM_XY\Q9)]1L;&60?8;>X
MMP3-N(&&DX#!<9&?_KUZQ^SM^R;\(OV@=0U61/BA=^#[/P]H\!N(]<ECEDO[
MWGSC$8U"1PKCC<2>1R>WIFG?$:7PWX?TKPUXR^./A8PZ/"L$.CZ9\/QJ42I.
M&6:1Y)O*7?'QCKU&",5RVN^"?V9?$GBTZ3X1^(>L^'M,L='6U@UNQ\*/,=2O
M./GGABF.P/ESP3@*O%8RQ,(V>C;Z.VOW,ZJ>'J2DX*\;+1J[_0P_BC^S5X`\
M,>(K;2M(^+$<]Z+189YI;F.ZWL)#ESY()C41F/"X8GGZ#HOAE\(?@WI?C^VT
MS0+KQ#XRMXXK=+^[ATQ;/S[ASF:.-)MQ*(I50Q4$MN.,8S:\)?LR^*]."O/H
M.D)]IMV-L\NJHMS<1AQ'O^SLYD4D\A2`>IZ"OI?]EO\`8J^(7A.2+QSIVE&W
M2$$W6HW=RJX/]P;R!GCMSQ7@XW,K-J$?>\E<]BAA%2I7JSNE?JEK^9U/P*^!
MWAV/QA)XBEU35Y?+RLNFWJJHM(LX2`.%7<P48)V*/2OLSP[X;\`ZAI]I-X$\
M/ZO:/%"L;+=R"2+/S;SD<CJN`!CK7%?"OX+^(+O0U\175_;)`92]U+-.AGF?
M/.!G+#'(]><5Z[X3TG5DTZ2?0O$$+6\,OER1L1$2`!SC//.?IBN7!*JVZDU\
M7DK_`/`/%Q^)C5GRQEI'3K_D&D:#I&E6D&I:78W9G#Y+.A((!QTQBM1%%W>W
M%PT,=N,AF80LI!(_NCKS5_1O#[:K&EIH0FFEC7S9G,P\F)>ZG=@`YR>#T-6=
M#T'Q`=2^RZ5=6LEQ)(8PHD&UE!/(+#'7WKU.2<VK+3R_I'BNHE=MZD6EVPM[
M"Y,.FO(\H^2[F4(L8_J3QTJYI>CZ-]F5!J?FR%@9$CE"!1P6!#`9/7O5C7=.
MNM"*:7?Z=-]M5A+<A)U>(IDX&5)QQBL"YA2)7NVWKYAP(D!)!]*QJWI.UMNX
MH/VG7<Z&6]TZ+4##X=^TLCDG=<'_`%?3J13FU>YBM7LY-5=VFP`=Q&T`\X]*
MH:!XAUN*:.+P]IR(S':J.5R_&23N]:FU+4S?+#9W%JXEMR2^X@_,>V0!Q1&I
MSQO^FGR$Z=G9_P#!-"X\5:MX6!M?M-M./*"H1&&#+@\9ZC[WYU4BNCJ-Y;SZ
MEI@CM(,>?]AMQD+@`G)XS]:5]5@U":(:I;63F*$C<8Q&1[G'WF'O3=1F:(B2
MUOY)8'(8OM(X/<CI3LVVU+3L-)*.VI>2704!MGO;F.XW%PL=J%#YP5'48[YX
MIE[H^BW+1W=SK4EMYF>)PKD$=!\O/-1Z/<7%W.%T^)99Y3M42H"2.F.>E$.B
MK>S`3(8Y2W'S`*C9X_E5\C<=KDJ7O;V(K<Z;;AA<&Z:3=A(XY=AQ^1[U#-?:
M9;PO]B@OV?/R0>>..>I*CTJQ!%IMK8.FH7S+=R$_+@`KZ8/I4HT7PSII#Q>,
M8IB1AT>R?!/LPSG_`.M41C/I;SV_4MRC?6_XG$-KFR5X89RH/3!YJ`0W,O[Z
M"1<@<[VR<>M074UNX^TPVV'8]>QJ;2);&,9N=ZN!ECCK[5E'5^\;\O*M";3S
M>7<BPM&7WGC%6UTR_2Z$5W%Y2H?OMSCBHFNK6W>.XL9'5E.2".G/2GS:AJEZ
M=TKE(F)=_,ZGZ522V,I7OH/:)/,4R70=#_"!C'O4<T11L2%I4(Z'],TEDZ2L
M(IK8J2.:F6W2:3-LLB\$$9IQ5U=";=QUN+TVC?8=/'R\D=ZAFOKZ^2*U$449
M`^:0<&I[6233XQ);W95AGEJ2[L+620:@DK8<*'9?NIZFAP;1*E9ZH8YGBB6W
M%PDRLV<%<D8ZU!?+HL5Q_H\K22`+N$8.,]\U/>VKSS11V5L44(<REL9XY-1Q
M68ME-QI]LSER5?-8R4E+R_K8M-=26">."/R+>5I0PZ'H&_\`K5!+IMN(EN8#
MN[2PN,_K5G3H89=14O:ON2,-Y`.-Y]:-/FDFF\FV@;*N6DW=O:KC&]DR+I7L
M9@-U/`]H\H@7/`VX]ZO6,6EV<+7,<0E<@;@QP%J6^C62Y\IXU;=DDYZ&FV[:
M6A"W,:MD_P"K)P3Q23Y96&WS(D_X22RDN-]SI\'E@'[Z%N^?_K5&]YHLTK36
MMHZM(>`.-O-236,<,9F@5#$^/W8P6'?IWJ*ZM8V@:ZLH9,+@$,,5?[SJ[B_=
MWT)]9\+QV1^U0SAT"KO97R48C.#_`(U1BAMK9&O;$PJZ`!XRW,@[_45<MY[9
M+9DO$(3@.`3\WZ\5/):Z1I4PODTX3QACNCE.<C''2MDX/5:&3<EHSF-:TF#4
MRUQ;X.'.ZV3^'Z>U0V*M<3Q6E]+Y$>,%XX]Q&/4#K75V>FM=VPO=*T1RL#$N
MP4L6STZ>E5YKB'3KA[^XM%AN0=RIY6/T]ZET?>YWL_N9M&LK<AA36MAS`1).
M[-LC)7@C/I4,&G#1KN:.ZL(2?,!\M_N`_3OQ6O;:\DT>=5TY)PI+LJG:4R>.
M12P6EB(5OI;02>86Q'N.5&>"3^?Y4E9VY64YRBK-%2XU.UM[*2.STZ)]\F9%
M,&0,>AXP/:K%KJ5F+(Q3Z%;!-O7RR&SD]ZO6-A<S)Y]O/&@B4^=%(1@J>.*L
M7<NF6;[KNRG>-L+&6VDJ!SQCCTK>$6O>;.:<K^ZD8^GZBUE9W5I;Z/#+#*O.
MZ#+CZ>GUK*OIA-;+:V]BL<._+.TFTG'8UT$NIZI;W$L^D2-&I0J^1R4/K@<5
M71++7BT=[?Q+M&1"T.`7],CN?7I4R?,U&_\`D$79W:.9@\/:']J6^NWFG,C9
ME`4%1SUYZ\51O?#7AW4;D/=_NXHSQA,9'8$#O[BNXN=$TZS@2!;%[>18_G#/
M][!/(SUXK*L-$M[];HM;-,L>0@C3)SV^GUJ^7DM%I%QJ7N[GGFN>$8M(*6\>
MF6K,1N69$#!P??K_`"J"X\(+>N=3T[PS;KYQ=KHB+"H<\%1U`KLO$5GJ-I*(
M'TPQQ`X+8R4!]34VC0VMPH75M4N)5C&T00+M#+GH6[=3GBL'"$I-/1'2JLU%
M-,X=/`WA6\NEMYYI;+"E9+B!2Z[NV1G.">N*HWOPWT:ZGMQK_ABX>(#;-)]H
M<)+Z,#@D?3%>G:-IF@:7<3SZGI$D]O-"Z#YL;&/W3GGGK5VST>SO=2:PN_&:
MK9Q0K*IAB<YE(QM`P.??I35"G)J]M?0E8JK#5-Z?UT/F7XB?L]_##Q1?3R:E
MH]W)'$I6SA$GF^5@`+\S\[>^*PK#]FGPSIMJL>I1RQQKS;V\``5@3USGY1CT
MY-?5>I>'WU-5TM_#27:6H*M)#!L>3)R&+8SG'K6%JOA/3]#MKBSU7PK&=Z$`
MF8AXSD?,,'J!VZ<UA5P,+WMIZ:'?2SK$J"@I/[S@/A)HGACP]X?G\,V^CP2)
M>2K'.+@+M)SPS%U.5%4_B!^RUX7U<RN;/2+N_FE86L&CQ!$C0+PS':I(R1V]
M:]$@\*>'XK!=5M-`N+NP+@RN)#%)$N1@9Z-]<5GZCX?MIKEYK.^N(6"?Z/"6
M\QFYP%)X[>U=4*<%14))-?UMW.=X[$*LY1DTWN?+WQP_9WT'4;6ZTI_`^D6D
ML:*1]EC^^RXP"V3G)Z^]?%_QF^%7P>O=2B\,Z':WVB>(Q?0P.VL:BL=D4^;>
M=Q0&(DC`S\H[U^I7CCP3KL-K*)GMH)D(8?:/EDSG(Z]:^(_VWOV:?$FJ2P_$
M?4-3TR2'4YS*\<+N9@5./F/W0"3DCKQ7G23H5N;IYVV/H<NQD\33=.4M>CU/
MG'XZ?#O]F/PS\/K==(L_'&D>*H=3>*6:6Y@NM+>-2!A)$`#DD$AU?!W]/EY\
MQUC4O[:U41W7C"XU:9&5()+S+@E0`!G/S+QQGL!7KMQXOUGX;^![OX*:UXM^
MV>%KK4%OI+%;2*6!7QM)C#@NDG&,Y'3IS2Z%KW[!\WA^;0M;^&WBC1-4,_F6
M/BV*^^VID*W[J6S.P,K-M&58$#)P>!7K0Q4*R25M.MO\A?5IT+N=Y7?373OJ
M>,6&M+X75M*U#2IIO,RV4G54!'0A<'(R/7I6OI7Q9\86FHVWBL:I+97NG7:R
MVL]MPZNI!5L=."!@UZ)X^U70-0\+:7/K_P`&_"A\-VK3VVG:WX:C,#SLZ;1)
M<MN,OF*5#"-P%Y89Q6%;^'/A1XK^'<,/@[PI>Z7?V%XD.O:_=^(_-BND<N08
M+7RP5`"9)+G&!ZBM?:.-M=16H5HOFAIM?>QSOQ,^.GB?XC:W`/B#JTNH63ZB
ME]>W,;[&GE6,+RH)&:Z?_A,=9^+UY>ZUHWPFGBU*^N8K;1=>TN=+.*PBC0C[
M.0W[L[QAG<D'Y>*T9-5_84\.V]CX1U+X<>(=:,<C7.JZI;:ND$TG[I4C@1RC
M!`'+N3L.<*.QK8\#_LS>.OCMX5U/Q!\+K9=$\+Z5*DNGW'B74<-),["..VBV
M*#/,Y=`"(P.I)45O3KRO9._5I7_-Z')+"T8KF<'%+1-Z+5]D>=?$'X*_'VR\
M*0?$CQ-:,UE-/+I@\01ZH+N&YF@897S49@H7`V]%.W@UYU-KWCZRU^+4/$OB
MK5H&F3SH[[[4TDCMGB0,QS@D=1Z5[!X6\8>%_@WK(L=>\6>);O0##+::_9V(
MCMGF<HZRVT8D$BC#@#S"O3.!D\<GI>B^'O$FL:C\1/!G@:Q;2M$/GR>'/$&L
M^8]Q;LZ((T^X974N"0HZ$G``I1EL^O\`7R-HQCRM26FR:5D^RU_,L>`OVC[&
M#PY#\./B?IMWJ6G1>8^E:M9R+#=Z=+*VZ20'_EMNPH(<]!@8KLS^TVE]X#EL
MO%7BR^U$66H*-/NK30H8TN-K;E$DX(9"H);&UNIP:Y'XX:=X%^(\5MXZ^'^C
M^'O#MC?78BD\*:/:2>?9,L9&YW?EPQ#$X/&5J7X-?`+X>>/VU7PQXH_:#'A>
MVM-/^V_\3#P_,T$K+P5'S@E_FPN`<\\COM&O)/26FVMOQ,'@Z-2'-)<KO>UF
MWYVMW)[KXR>&8!;^(['5-9OM;AE:Z%Z]TJQ).64@J@'8+CGK@5SOCF_\7>-+
MJ/QAXGM+QFOC)+?:C>P^6TK`@OC!.[[PYP.M>F?#C]F?3=*TZQO]0\;VDMYJ
MEJ<03:5Y@M4#`+(6WCR_E()8C(Y&#7J/@/\`8<\>_$KQ9_;'B#XF1PQWCM'I
M6I&PEN5U`Q.8PD`X#KN4#ID=2,5Y=?$-RY7K]Q[.%HX>G'FB[)7WO^!XQ\*?
M#^HZ]-.^EZ9IXL[FSCCMX7O$>>9B#CY6.[MD\<=Z^E?@O^ROXJ2RM+#6]5T3
M342[29[.&4S*[E%*R-Y:,.AVX[<C'6KGAC]@_P`4:C\6X(=7\2:;<:I)=`W=
MK9VTEM+:;&V8D4KM0G&XX;&#TK[?\#_L_P#AKX11+H?B353<WB1AU?3W5Q*.
M0/F(..1W&:\R:JUJEEI%;^3^0\5C</A::<6G-^73YGG/PL_8*\-6T</Q&U7Q
MII27<$UQ+!;&)D*!0A&T!3MW;SC/]T]*](\->"4OWNIM`M)H;5,,WF_,7Z`G
MCKSSTZ&NIT;2AJ96W,<KHLA,<38))/3)`&1P*ZN$6]K:VHN[>2"8EXII4D`1
MT&-H`'0CG]*F>%C4LUHEZW?^1\_5Q]6H_?=WTV5OEU,_P/XEN=%TVXTC6M/M
MIWEA\J$WMKO,0SD%.F#SWK:T>T\-6-N;6WN)%N(RYCEE7='.2>%P/N]^?>MK
M3O#&D_8O[6LEN)KVWD4-;NGFJT>/O!^-OX@BM+2918Z:;9-"MI/,/)DC5GSG
M.1GI6M.A*-E)Z+;2_P`CAG7C)MQ6^^MC%L]0"@VMS(UM"[@3(DI`(!STS@UL
M6'BN+3IH8O#EM=DJ[;KB63AP1@*%'3'/?GVJ5P+2Y>#5-)CASP8Y8`&`/.1D
M86MQ]=E;389;+PW:""'A?*4"3=G.\MW-==-\M_>U]-3GJ-2M[OXZ$>F7VMG3
M+HV[6T43\7!G=2[>P[GI53S;'1]46\L9Y+EY`%/FQ`,K$<D+VZX'_P!>JEI?
M+?:FS:K#$(6=F;+$<G//R\\>E;MGX(TC4+G^TM,UB46_W9)6(<[P,G@<JN>!
MUZ<T*4ZC5M?5ZF:2A=O0HPM97MY<3WD-Q'.@"PBWB49P<<CUP!R*N?9Y;R\>
MWM=">-;B9(PLN,J^/[QYSWJ]8^&-4U22>\T766D-B-D8FF6)_+['!X(Y]:Q;
MBTU:?76MKZ:X5E<^:5;<V>Y!K2TX1VW9"<9R=GL5!I<=E?,M]=Q32I(0L2$G
M)![$#&/K6II5SKU_YLUQ;.(XG6/,<>Y%QR%]JS-4U?\`L07-A:6$13(.]AF0
M@>_/>K'@J7Q3N#VRSQR2-OWPD_(V<].A_&HIM*:@EKY&E1-PYF=!-K:6PBB7
M3K.>`$`LUL!(,8/4?SK`U>Z$VJMJ^GLMLDDC+%:AB^T[<9YJUJ<=].KZU>7,
M:,"%9"PWN3U('%9;3Z?=8$L$[R,V!(D@!&1@<8Y]:=6H^;E9%&"3N6IUTY[Y
M'D@8OLQAY]S9`^\?]G/05%JFIW-]$BW(6&'I&=F`<>F*JVTITSSUN[%'=QM5
MS*VX8[XS6CI\=O-`]O<"W"1-G-T_R9/H/6LHRYFXK2YHTUJSE;*>VFM4MQ;!
MO+.``.2?6H+Z20W8@CM_)^3!)Z_6@6<EO%\]V(PS?*XHU&;2VD9DGEF95^8A
MN,X_E3?P&UO>(H8X!;(DMR\C(H#.>K8[GW-23:W;7$:6[H2R-RV>@INCOI5N
MK1W<<LK,N%C5L=?>GQZ;8Z9=-)=0ED88/MGVK-<UM/F.T;ZERUU+3;F3R(YI
M`ZKP0N1FF1/J;0RSVS@@#'*\FI(;;P\)U:SNY(@,98K^?%07FHK;12K97!+G
M<%8#&1S6EK*[?W&>\M%]Y$EVUQM$SJ<?>W&EU..\D@6.#5E%MD#8O?O6"FH:
M@\[IY2R,5P&SP/>MF&QNX;%)GNDV'DQXR<D5A&?-K8Z'2Y;:EJ.WF3""^\Q`
MN%..@J1Q>6S>3#=!D"[A@]#WXJ?1K5(-XEU$(KK@MY>>/2GC3H]/!O1=*<DJ
MC,,UNH*4;_J<TG:5C)L=7U.VU=[@2.)%7"X':M"QTO4[N-KU)PI8\1J>6IVG
MS:=%=36EY<^9'(@,A2/!#8Z`FIQ#_9L:RVM^I*\JHXQ^-1&G%/5W1,Y7V1'_
M`&:BP&>\F(+#=\ASCV(HTYM(^=XK;;)$F5E89#GW%0WT]ZC^>0"DG+,>AI8[
MS4;2/%O$!&6!)'/-%XQEHA<LY1U9<TZ\OY3)!:6RAV/.Y0&`_I4EQ<6]V@^V
M'R=HX:,<%O<5-:ZG=RSF[O-)622=-I=P1D]L55:*TW"*7Y7W')Y)^GM6[=HZ
M/[S%_%L5[NQD:Y1`&)D.50CD$]Z2-KRPG-I<W"O'EAM/W0<>U:KW>GW4QLM0
M5H"J_NI$SG(Z$UE2Z'?V]V'\K<C?,K%C@U,HV=XZE1:>C%M/$NL^&[KRM%NI
M"N`69%(5?Q/6I]0U^_U>3^T+NV>2\DDXG>/@C'"@?A39/$%RL#V]U:*RDX!V
M].G`J2>_NM0D@=8MI6/:A)QSZ\4O:?9BV#A]IHS[/2+O4[B1[FR"+)(2SD;1
MN],_TJ_!!]EG\N+4K142/#9!8'-.CCN$MO(EU&;>S[EB1QMQZFEE30XTFM9+
MOY@1\_EY#G'KV_\`K4X6BKH3DY.Q5BT@W$C75IJ,8CY^;..?H?>ITL)X!&^F
MZA!<R."L\1!S&>."3P?J*S4TP3Q>?:@LP;Y47DX[UHV6CS30F6TQ:J#\S.Y+
MXQSQQFE"4GT'**2W,[4M*UN&Y\NY@%O%)@^6'^\.N<]J@D>SN=3F?P[I6](U
M#X=N<`<D]NH-:RZ=<7J,ZW37:QY#JSX(4=\5!I]RNE9B(C8`_-$R8'YCKUH2
M]Z[T3^?XE7TL58=6DUFV$E\641J0JJF=C=<>U1:1:ZU:.X@61(I@?,.2H*D\
M$UH121R7?G6,20%Y"T\8.U"V>/PQ6I:W$L%W).=4C1R"C;%W(1C'Y54.6;5W
M>Q,FX:)&+)X1OY+*>:#7+7:H"RQ"0DOG\.:CU;PQ!%/%'<6]O;L553]GX1^/
MO'DX)]JTM36SOI2;-(8G4_O)(G(20GT4]*HZO9+8$*)Y@4'SAP#@]\&JG*%G
MIH0G4NM?P*>I:2OAUEO+S2F,4X*Q1N2T9`[YSSC^M+IBP3301:3I[V]PB9E=
M0S(V.^,<8]:ETWQ3<V%PMP^GK=!05Q=?.NT_P@=*V]!76()VU/29`A\L[K=6
MRZJ>NT=Q44Y1G/0JHY1CKN<Q=:OK_P!H+2SR1RR/DLX[^Y^E0:SI41M$O]3O
M89I3(OF1VTNY@N./8DXK;UG4(`HCU&[=1O)9A'DCKG/K7.:UK%W(=FD6D(B^
M4O)'!@C`ZGN":F4W!O6Y=-.232L/L[O3;:<SW'AQGM6?F*29QQGV.*B@L/#$
M-K]HDT:>63<=DCS85L]!@="*Z#PO_;\^AQRVUW"^R3(@EM]WF84DDYZX%1ZK
M;1>7+<W.H0OYK;A%%`$"N?;/'U%==.[IJ3_)&$I6FX_JS@_&%II-[9K::_X;
MD>,R?)<1RMYB+SP"<@XST]J\,^-_P5MKGP_=7L$9OM'AF98X;B3$AZ'#*K<'
MGM7T/XA;4(#)_9-Q+*5P5#P9`&>IZ]\5PS>'+&\FDBU[59T1GWL+>W#,<]?O
M$<UP8RC&L[6U[Z?GV/4P=>6&:FF?F9\4?A]\"[?Q//H'B7P)XIM76Y+K-H-[
M'N@@Z,-DZ-YAR<CYACFO.?%W[/GPPFTZYUOP-XU\1PPVUP%9O$6FPJY+NJJ`
M()&RV"S'('"G%?H!^T7^SUX4\236FM6"W<=[9S`O!"BD7JDC*LQ^[Q['/2OD
M/XV_#FWTO6KZW&GW6F22,\TJV]KDDY)R,,`0,CL,9KAI5Y8?W)._HE^>Y]CA
MZD<;!3I.W=/_`"/.]1^`'_"G]-\.^)[;6-"\?VNHW?F7NA17M];,R@$F)U*I
MD8PQ9"<8QFG>'/V:_&OB'1O^$CL/%'@/1;?4&G9K.^\6Q1RVZ;PNTQLP/`;@
M$\@&JMQOL-(T;6/"OCO7[KQ&D[8M;^&.W@@0D;3'(7.[)X(VCM47BCX>?$&Q
MT67QKX^L$N)KB?R5B62,!W+9W.%.6&6'(`R<5Z4<1"6ME^A*P]9:7M?JUKZ6
M#Q/^S5=?#VYF\)K9Z;K][8RK/<^(O#NL+>67ER1D10G8"JMYA'?.>,5K_#K5
M[W2-"TV.\^/LFGQ-+Y\NE)ITCSVLL8DV2+EDC.WLP8$;^`<5CZ!K'QFM$7P[
MHVE.MHQC)2,>7$S1[L2-U!(+<$]\5T]M\*K:PTZ\\*_&F1H7\.WL5X\.CK`+
MJ^CN(BRE;B7A8P`.-AY/:B,_>;2T_#_,<XR]FH2>OR;?R9P/C[X*6L&N6WC&
MY\<.NCZK?2R66I-;!Y9420B25XRY*MNQP3DA@>E=!X*^'_[/MY\.+R]U?Q!X
MI_MH:Q$MG+#-!'9>4W,C']TSES@D<@`#O6KX1_9S^$?Q=T"#4/`WQTET;4KR
MZDC/A[Q#9M*4!5S&RSQ_*<L$3&T'+YZ"L'QW\'/C1\.M"@T[QCH(M6:>>TC)
M<&:,P?+('C!W)P1C(&00152KRIP35K?)_?<J%%5O=OJO*W_#G8Z#^S7\/?VB
M?!>K^)_"-UKMAJ-E,+33(;S4K'9J$GF,3++(_D[$2$*.`S.S=@#GS'3?AH;2
MUTRPOO$U[#>6D]S%JML;3S(X`K#8R2!MKAOPY%=]\.$U'P_X"3PQ:VDEW#K.
M#-IIA+A@AR)25.5P>I/%6_`/@GQ3HFLL=5^(EQH>ERQ.T<EK8F:&5RQ(ADYP
MB$\;MIQZ&HEB8SBE]^Q4</.$Y.3TNK*VWYG,:9KGB+18EN])@NVN8GQ;3VZJ
M@*]!E>2>GKBOH7]FG4?VF?BMHEE\+1'?Z3X7L]06ZGU5X"&B<G):(\8<Y/0U
MH7'C#X5:G;Z?H7BOX=+I%VZA;K4M#3;<HH8$RMD[&W)D;2`.<BO;O`/C'5=.
MM]'\-_"/QM)XDT2Y4)<VU_HSVEQ:R%0``P#HX]&ROTKR*E92F^ODM&=E9NG0
MNH)/NUIZKL=K\+/A5X4\">.;NS\!>)-7U2&[AC>_UC6#^^,Y^\O&,G^0ZU])
M^&M/L=&TE1J*V;RR2JV][(/(ZX(QN).!R#TP<5Q?PR\%6FFPK%?Z=<->,=SV
M\,.XJQQG+8YYSR*]6\&^!_%VO"0:)';,L*;FC=U!7.>#N[UZN!A.-._+J^BZ
M?(^"S"O[6I>3VZOJ4]-L;%K26>#28XY-A_?F(*$3U&"-S=NE;GANWT/2=.N;
M>2>S=[J'$CWEKO((Y&WTR1U%0:UH]WICP6EY:3AV4,5V[0W/)4=^013HM`B0
MB9;2\24_,5GA+1CN<'`QVXK=N2D>??F6KT&77BNZCF-GI:&$,OECRF."GH>.
M1_A5K3=!N[BV%[YT(E0$O&C$N%QU';]:2'6=,LK:#3K;1D:7SBS7)0@MQW]A
MUK?OT\'3^&K633$EAU%/^/F4'Y9<DYX]?IVIQBI7;=]/3[A2J<MDHV_KJ,T.
MTT+7K2X@U=KR:Y,:BWGN)OE0[L<`=>/RJM=3V%A%+H\>G+YV_P`G?'(VT$'&
M\C/>H;,WD<PCTN27<I((D08&35K2V:WG*ZE=R>7N9W-O$K-N/UZU"<9)*UO.
MP/36_P`BUI'PUNYQ/&FI1O+'(J^2K(=X8=1N(R,_RJ&[L!X3GEM[_P`/3^:A
M(WM<#`.>#A>#3_$,ND74]G/X6L;A=LFR:60\S/UQ@?TI]YK]O?ZO+<7.AI:6
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M80D<4A/0GDD#UXJE<6TD\4:V6G-;!VPNX_(3T)!//6K5LD]U>)#8ZN#"[`/&
MD0#,HZ%@#@GVJ#4\OJJVVEK*\B,24\K9DCGH33UDKOTZ?\..*:=D$_A:VLYH
MQ>7Y1W4!RT'"G/.TY(/'.<U%/964(%LE\+AF8^:K#'3H<C.:OI?ZG-&MK>W4
M`B==_P`S`]CQCL?:JOF>&8+H75[L9<XE@`VC.#R/QIN$4DUHO,%*>SU.#EO!
M.-HA*QG.-_-5OLJ163QP.ZL1T(X(_&M6>"TOK<+*X$JL,,HP*K3FVMV-M-$S
M-C#$'BN5Q74]",DW9$%C;.+<75O+N;=\P[YJ];:NBW6VZM69>C;SFL34;RST
MRT:ZCE=9-WRJG]:V-#U=+BT&^P4I*N&9QDYJ8-<R5[?B5.#Y;LO0W-K%"UU8
MF/&0"C+S]!23QPWULUQ/$J;CCT/X4266FLBI!)@OC:0<!6]ZCN-,$.H_9Y+L
M/Y:C;ALAC6TFTK',N5/3<@M['288FB5)/,R3O/`ZU=MM+B2,2Q3Y+=$QD@5/
MI1TB6Y>WU%,;G`Y'05:E&EV)D\B[8(4.PA1G-$8QM>Z)G.5[:E22.2SM1<2V
MXV2Y`8']:K+;M/('60M&!G:IZGTI]XXGM5\N67:!@!N@X[52DMIA%$T4@</(
M=\49^:LY2UT'"-UJRS9:?>W6H3QVUN=Q;[@.=H`J2ZTZ]2/8A!P.I/`_QJ[I
M\4"6!N(K[R)(B"Z,,%L]ZCN([S5V#6:`(!\Y4<?4U3C'EMNR>9N1F7%OJEW8
MM;F93&&`PS8/0]*KZ6=8M2\04J@!QOY_&NE_L&S?3PSZDK3;@%CVX^M1?8XK
M&R\R\!8/D)L?)XJ/86L[VT[E>V335B&UU*]\I$DD:947=R<;#[>E/MM6?SS/
M'"5E)P'=>@QUY[U'I4K0.Z1KY:D<OMR?UJK-!;?9)I9I9I)`"%V_+@GH:+R5
MK,S:BS;OKMY+D33^2P6,!2G<?_KJ*QO999F:^(DA+#="7QD>U.T&UT83Q6M]
M:C+83S)92`/4FHM0)T&^>"!4F20'RI1R",G!%;<TK<S>ABDK\J19GEMDND1M
M,F,$<Y8C=DD<<=.OO2RP).[^5&L=O-E@)#ED%5[74IK9=QD9W<Y)#=ZMK&E[
M:O<V]E)N5<R%6P%![U2<9?G_`%8331FPBQM)#/-<!UZ!`V"`./UJQ?:WX<O(
M4LK?0A%^\#2R;R2>/TK+&J65C=[Y8EEYVG<"`#6T=:\/WL3(ELD;GD2*!Q@8
MQQ6=.:::4DOD7*#C9M-E33=4M='>29-+:6W(*J6!##CN1VJVD%E<V;7$Q=_*
M.X,LG#`_7ICI5>T>YO[`B%<VT#!97<]\^G>D31H[58UU&1FCD!,1@<``$=Q]
M:<)-/35!)*WF-`M8'1XE8LXR,C`!]/<5;EEM-5M)+FXCBBG3@OP`ZCMC^OO5
M:42;3!809\J/+-)@]^U(L,L.G-JKWT$,JL$6V,6=P/\`%S5N7+IT)LW8HZ;J
MMO!?2*L."Z[`VP9`/7CUK1OM$:TMX)HI72*=<J)!WZ'./QK+OM4"HH@2-G:4
MDDIR?RJ^-5O]1TMK:*$?N<,8P"0H`QD$\_A6$*D4G'<TG!NS%?1O+DEGENX@
MJ_*`3M)R.H7THL])U$:>\]I?1N[YCV#J<CD<^U5XM/U!;-KRZ\N7>X&WS,.G
MIQ]*HVAOK4F>>:12S[TC,F-OXBGSQ5KQW)4&UN7;O=<);+J5G'#Y:`X"E?-]
M\COVITKP7%]]LTH3Q-&HV*TV2A`]<=,]*CNHKJV:XO+>U0ER=Y$GF+&#CE>3
M^=21Z2PMX]3M]5*.PWQ1-&RKU[']:2E*^W];;E.,6KD%XFE:]*S:A)=Q3M#E
MGQY@DDQT(XP#T[XIS:J=)T^3PT]E"4EE1W?:"QXX`8=N>E0Q3M/=&6]BE4QY
M.$[]\Y[YK467PIK%JRC09X)E*F*:)R0N`<Y4@[LG'>J@W*6CL_S%)6W5T4M'
MOWM;B-\>7&DA$@1=PD0CGY<\Y_"H+O1+^^ADU.1H4B1MPC4`,%R<84G..*+K
M[3%<!6B?=C$;!>_I5R#Q%H5K#')<>'//NX6+*\K_`"N<C&X=QVQ[UO"<>5J3
M,G!\R<4<Q<3VUBYD2\NF:0;9!``H*^F3FLRQ_L5I=FI69N2)BT1:(,57.<$\
M!O3FNVET?[5.RZ[;1PQO.IE6!%#`$Y.W\#4&H^#](BC,NA[_`##+LC8X*@'@
M,3U#>W2E[*5^:_R-55@E9G!^(M'\-ZI>37.H>&EB9R!$VG`1A5`'.T@C/^->
M(_&?]F+2_BK93V=O.D&HR1.+:>4!`_&1&S`<;NF:^E'M98;&X\.W=I_IDESN
MG=XOF0`'`SGH<YK%O_!]H5N+/5-1GW*"%^R(KC<#UR>U3/#TZJLU?_,Z</C*
MN'J*4'9H_*'XQ?LM3:;XBN[&TM)+-;.-#%)=(_EVTB'E%)/\1P#V&:\Y7PUO
MT&9-9\1FU$TT,<<"VYGEW^:"[9!^4!,MGIQCK7ZN_%GX'>'?B/I,[ZUK.R=K
M<_91/:@F=@V-K%3\O'.3Z5\2?'#]D#XI>#KVX?P=96^HV5^JB$6,BEX22<[\
MC(P*\:K"MA:FJNNA]Q@<RH8VG:<N67];,\8L=6\-3:AI.AV5["\=Y%.A'GAE
M\P($5BCX`5AW.0#SC-8&O_!CQ=<_$W_A"KK6'F.I0I%</)=@)%&C-Y4?F[MA
MR!W^G6MOQ#\$?$FF:Y9_#U?AO?V^HP,TLUS!`3<)D;@IR.5X!QZ58TSX5?$#
MQ1:W3:UININ]S.L;>>Y0+$IPA[#*G)Q5/&VA;Y>:/1IX*'/[1-=_)^9UW@'P
MYX?TRRM-2T[PA<6_B;0K)+;31<J9K>YD\P_.@C&%*K@@MG.#FNH\+_!3QG^T
M!XXU-/B-XB%E=R!FBU&ZG0P3,NWS%\PLJKD8&><G':NI^&'P$UO3+=9+F]EA
M>T91;;9P<*0,\Y)(Y/3I7NFB_"K1M0\(CPM<R:?&J)+(PN5=U8L`,`*,[NI]
M/6N18AU)JZO;SM\NQEB*U/"K1ZOYV_X!\]:O\&_V>_A+I,-GH^M>/;G6)[::
MTU#3;9[;<LIY#(T:'=%N"#:<D@Y!K@?"_@WP;IFJ:@GBKQ%K]M$UBJM#901`
M@C^!O,4X(/7CC^7U,W[,.OZ-8PW^@>-K.(3-AI8RWF9#!EW`CH".,=Q5+QG^
MR'K?CJ_EU#Q-XHTS[7$ZF"\TN"14E.>7N`1\S8[C`/O1*M6<K\J_#^F*EBL,
MHV<KWZ]3D_@S\"O@UXXO8K#0_%VJP7<>E--<W]\J.1+N3RD&U@&55W%B%S\P
MP*]Y^`GPKU+PAXPNH]-U:>]"A52ZMG8VTJ'[K#('(&<Y&036)X,_9FN](U=]
M2'BVSDO'7;]JL[5U9P,#H1@#`'%?2?@/3[CPM9P^3=1PHD<:A[:`%0<<@\C!
MQUJ\)1G7J\TXV47>ZMKY:'DYKF*C3<*4^9-;/H=!8:?)X#_TZ^G,M])!&RF*
M9E:!V8G_`(%E0,_[U:>F:I,K_:!;3K/EC*WFX#'.>1CGJ:FT?PC)K%C)XAB\
M20O=(R[8)EW&1BX5>IP.*OZGH%E;W2W&IZR@?<!<I`IWENXQD@GW'!KZ-.27
MNZ+IM_5SXB4H3=GO\PO?$-A<)!]GBE:^$Q=YD?Y4'&U%7TSDD]\UL3>*_%^G
M1KJ%W)(L"`"<(W#@C.UO3(KE!<:;')L.[:'($F<,O<9]:OF_TC40+6TT^Z(*
MC[5.UP>@'8=`">>>U9QK.[5]1.C'330T#J!>TVVCVTPE!EXM@/L^X`E`W4\Y
M'X59T+Q;I>FPJDVDQS,D>#YGS8;LP_ND#C]:KZ7'H\.F>3<:=$9$R&*7#B20
MGIT^7`%1:=IVFVD\ED]C]IFD<+&Q8_)GID].M7>::DG;\2'R---&@=<AU+3#
MI]P?,D65C%*44,A8Y/(&2.>^:BM['4;)A9Q:.E[%L+EL'?M')(P>*75[.?29
MQ';V8BR@0^<X^9L9)&.U1V-IKRM-?+$RK;KMDEAD4$9';)YHE)7LT[BC%;JU
MC$UK6`EW'-$9(@+C=Y(D^;./O`\5LQR0W]DM[KVJR-)YA=+:,*>"`2S-GKD"
MH-6:]N]-C2\\/I+#$NR!Y2-RD]1\O)Y_*JUAIMC-?)IMQ+'MD901!'C9^)_^
MO6*YX3;6M^^ATODG!+:WS-&X\7:J;98K9#!:R?*T<:X5P/7UIE[XEL]9ACLK
MLQ*L0/EANS'U(ZCBGP^(=-.C_P#"-RVKRD*5$KW+>6N3UVC&*J:/I+/-]IT[
M38VMHQ^\,J[B0.I!/&3Z53E4DU9WON2HPBG=6[$@U_1;B\A-CHZ"Z1`)5492
M1R>%"]A4SZ@\<-WJUW86\DR2>5/;-;[@%/'&.A':LH?V`MU]OMK6;+OO"$[-
MN"<`8/I@Y]ZA@O=81I8[>ZEA@DEWR,C;\DC./KTYJ'.6S=_3\RO91O=?B/O]
M<TG3M6AU/0TNH%&TF.;^]U(]<=NM:[^(M1U>Y\U4MX4=5P)H@Y./0]:H?;K*
MX9;9!->3``1JZ\I[XYSSVJ2[?4M4O(K"VT)ENXHB9O)7;P/FSCMQ50;6\K^2
M[CFD[77S98GT+2H%>6*Z+7D!#F"<*(GXR0.<]^*YB22YM;F>\DL78(07B`P!
MG@>];=WIJ>6;K5-9B0DGY8R&*D=!6+K-W?>()A;637-Q*$"RNB@9"].G6IK6
MDE96?2Q=%/U11NGLHY#)*V<X(4>M-^UZ0F3-$WW"%"GH<=:D@%OJ$S0Q6#-(
M!@;00:J7$4T<OD2Q8",<[^F?2CWDKLTBXO0R[K3?.3SEN492<@'J*UM/:YM[
M*)+CRUC4X'J?>H(M3TR42_:X45FCV(JC`'O]:+:VCE=;223]U)PC,<X%8Z)^
MZ;2DVK,UX&T5T$+.[\]00.:F6VLX"[1R,_&.!DBJUCI*6EO*2\>4.`Y/7FG6
MZ2V[.;:=6)YZ5LN9)72.6;3;LRS/86"Q^>S2><6SM/8?XU9"S26T7G1JT3G#
M`]?QJF\EWSY[@.Y&01V]:=+?V-E>J(+@S`H-ROP,^E--;[&;OU$+L\_V>7'V
M>(CB/M45_'IEC?+-8:C(0Z[B$&,'THU"Z*D75HJ@,><#CZ4U=3$Z)!<6\9RW
M!"]*B3W147?4MV]K:7\J/?7NP2#E\Y^E-&H3Z)(]M;.9$+8!7H?>GLKVL3->
M:2H3'RN!P,]Z?;II^H(+.UM\RJA^<N1GOGVHY'?LR'-?(ANI'F`G$K#(R1C@
M5529_+`#,26^ZJ$X-:MO-;6Z_9YH\JZX?/\`#]#5'4&FTHK<07&<\Q[3D4IQ
M]V]_4<'=V&Q:S.(7DAB?>K9+^GU%6CXGMKV)X=?TR.66[=!',GR[-O?CKQ5/
M3/$=U;V<Y2U0F1<$M'NP35&Q"7&H)]L52MO'ECNP23V_+^=*,VDN5_>:>SCK
M=&]?1V$ASI:RM&0&9IF^Z<\@>U$]KIJO"IOF+-]["G$8J(VME<W"K9F1(O+R
M^&W`>]"PW5JH=9!(CD[@G)'N:N[ET,K>9;6YTRU'D,PDR?\`6(0..]0W&M/"
MROI:@(O+8'+57@L[9KB*XDB+X?+QGN*OSWMG.BRZ3(5E5B/):,!53Z]S0I2:
M[!:*?<QIEFNX#:ZEI'S,^_S0,.!CUJG#92VB^==LP0\`KC;Q_6KVMS7+12"3
M5"LP?Y[=H\-C^E4-,O-(*+!J#3S*[Y9(V[$]*YI-.?*SJC%\ET:EA=I<F0K'
M-*OF`_(@5#QTXK5T6*/5K_\`LZVA,+$9423\*<<DYJEYUG#,IT^^,<(&WR9&
MSM(]>.E5#H'B36-146]U"H"DDPL00,]375!RBDTN9_(P<%)O6Q/?&=]5DT^V
MO`YC;`,?1B#CJ.M4))+R"]\FZF9L\8QGFMFWM[_3H([..&'$P(;RY!N<+T;V
MK!OI+^RN<B.01S*#YDD><+G_`!'6LJJ:]YWN7#7W4:SZ0FFZN+&\TB8HRKOC
M,X5H\CJ2.V3G%6M,TJ"6SE:RU4+/L</$PXP.>#^%5XK-I[/[:+R=L('D'E=?
M4[C532#9WA86]])#\VUB4SQGGFM(\L6KK?\`K<P:<KZ[&E/I5JM@;T2RO*JY
MF4.`,>HQWK,FM(6LU^T"3=N`B!4X(]SZ5;U>+^SH`L$JLY'!4YS[_C3-/UG5
M[MX]VE,4639&YR0G4[!GWYJ9.//R_P#!*@I<O-T'07TNC3QPPLH?>KL0F0<<
MCCH13-2GN0XE5?\`1]P9X4;C&>1[9-:@75WO&LEM(UECY5KG!*D<8'^%4K^Y
MNH[H2:I:VV,CS,1`8`.#P/QJY1LK7)4DY;%=[^\TR\AN;:&++1?*CJ&(Y//3
M^?-7UNHS:"Y@MY1+&N9`J9##^]GUHU&UT:SDL[;PU=-J&]4EE:8<1-U*CM@C
M\>*B?3+M;AY;V[DCMX?O+9C<5)Y"X)Y&<4XJ4?-"]V5GL5H?$>Z"XTR2""19
M8]J%XN8V[.".A!J&#3[6VDN(/$,)E+VS/;312@$2$94GU&>HK/NA<V;&YM+I
M\AAY@8`<9Z8K;U?Q;8>(8TA71;*!$BVJJH=P;^^2"*R4W)OF>O0V<7!+E6C*
MMS:BYN8I(-8_</&,K.V'!QT./TJW:6]@]S;V-X\MM"^XO(I&,XX/-1Z:Z:0T
M>I6TQ$J$-&Q0,H(/0YI)M2N[C4VG22.9G0;@HPN/0UT0ERN[W.><6].A'>:/
MIC2R3V5]=2-&1AI(\[^>G'M3+^.YT^^WSZ(4CW`D#".1CDAOI5^+5=2U1C:2
M6UL%'RL_E@$?B*CO%M+C3/LTCW#LDC$.C8"Y&!C(/&>:ZXS4E=?U\CG]Y.TC
MAM?\(7NLW,MS;L%AA0R2,1N=4SDL0,`X[XQ7&Z]\+=0\432Q6EPA7RC(A`"L
MZ@C)Z\'K_A7IUY#]F(+W$QD;IY;`*5[YXI]C:>'-)N(-972II70L9H_M.TL2
M#C!`&,&N:K2C53C+;K_2.VG7G3LXOT/GV'X)^$-/U=]<LKB2RU*/[MV-QDER
M"I5FZXP:JZ9\';*PA_L[4[);VVG=GEAG;(&X\D'L?I7N-Q+>7$Y@.D6KR22!
ME::$%O8DGDFK$.@FU>6^N)[>6;YC(D<2[D;IP,8Q_*O->!ISEHK6/3CFF)BK
M.7XGE=O\!_"&EZ&NJ>$Y8E6($W%A+D-$.,!3D[A^M7]&^'E_?B,Z5ID@.TAV
MC4$_@!S7J6H:3IIMT;0[G[2LI"I$\05QA023CJ,\4B:'H6B222ZKK$B3"!#;
MI#$0?,+#*Y]`NXY[G%;K`T%*Z5EY&7U^K45I-M^>IP>D^#=+L-2^RW^ESS,?
ME,0)5]V.,9'7.#6E8_"O6IM:&CZC8M"[*97224(S*!GD]CBNSAU;36U2.YDM
MH[PQH41+N,E03_$<<DCKUZT[4](F^U&ZTSSF7C:T[C).!D=<XK3ZM22]W5)[
M$_6:E^S:,_2O#.G/8I#=:&EA!`Q0WBAGDD)Y`ZX)XK9.@:!I%G(D,S7$CJHB
M)<@`G^+'X8Y]:@TV:]@L"MW>Q22M*1Y,B%F3GDYZ9KH]2^(EEX>T7^S#H]G-
M*5`-P\`9\?4UM"5)1?3Y7.2I*LY*VOS.<LK=[34D@GG5#D$@]![UT>E1Z3:F
M2?4CYVY#Y**^,$G[W3D>WO5'3-86[CEO]4TJ!WO0@1A&%VHIX&`.#ZU=M[K3
MHF:YN],,I"#:@&Q1ST]Z4;15T_P,IRE+H(?#<5]*=3V)%"7/S;SCCHIJ6P>V
ML5+W-LYMI"5"JV"<=_SJ6WU))XK@7.CQ!&(9%5,!2!P/6K=AH4VL0O=VMJBQ
M)\YB$GW?IDTXPC>\=V9NHTK3V+%GX:M-<,%SI&JFUBE<AOM;J&W`=..WO@5!
MKITW2;\Z>T]PIVIYPE`/SXZY'4'CI4<]SI;,0FER2-#F-'BW*CMGAB`>OL*?
MJUAX2M[!]0DDNO,*@*LJ;"&]1U!7K[U53X=+7ZL4%[VM[#+:\U2*XCL[>P$\
M<JGR_.B#J0>"03]#R/2FO:7EI<N(;U92)0SPQ`MSU(Z=NAJK!XEO-5L1ID&I
MO%'&/W69,8`[=,]2>!ZUI66DW>@B"ZN;^X@\X!OMENHD4*?7W]JRI^^[K5?E
MZ&DDHK71B6JWFNPSIYL<*JA_>28&WOV%8\*DS+%;P^82N,N/S.:M:U:F^EN)
M=*UY)RN"%\GRO,)Z\`XXJOI_AO5M=AAMX]?MX0S;=J$;P!U)_6G*\G:UWWNM
M1QM%7;T_(CU"'3]-MGB2Y(F)&`'&#[`=:M65\+.UCMVO[F.%XB'$,BG<>A!'
M&!CFJMMX1N'U6;2[>.>?R"QDG5-S[!WY/^<UJW>EV:PV[>&]%FCGC39.LBF3
MS9`>6`_A^E*$)MMVL5*<=%>Y`7T>6WSJ&CW<N\;;:X\T#8O8[0.<>E9]WK#Z
M/!_9=HKO;[V978D"7J`Y';CM6A;>(]5FU&/4;FUQ@>6DCI^[7MG`':H;R719
M[P1ZU=R7#C*I+&^%08XXZU4HJ4?==GYJPXNSU5T9[>*8)6$<=@JH'7>UKE';
M`_O>]7)-0O9)GDL)ID:4;%$K9<)C&-P`S42:==SG.E:;_J5)D;;A/KSQ46K6
M^KZ5>A=3N8U*@#S+5PPYZ8(K'EJ1NY:_UW-KTY-)&I-X5FT.U35=3T==1MI(
M<B6&Z^52W`.!SD'M59KNPTC44U#P;#$4=,-!>8&PXYX[UC7]YK,;20PSR1B,
MC]V7.<]<GW[UJZ/:^'O$5DMOXDNH[6=54":&(R,0!T(&!^/6JC)3ERQ5O7OZ
MDR3IJ\G?T_R.5MM9U#2)6FAC(+GASSSBH_MM]<0&>]MRT98G)XS4FI?\>EO]
M3_.G:W_QZ0_[G]*KE?<M<MMC+U&QFMG2;[.?+<G86.34MO/93<&$HRD99?2I
M+AF;3K3<Q/RGJ:H6?_'VG^\:RY4FRU)N-S52]=E:&.!SSP2,X%78XU,'F02>
M63ZGO6CIJ)E_E'_'J>U8C?\`'DOX_P`ZV458REN-O];N+>59[K]YMP'!/:M2
M?6?"^LVIEM;9+>98P$QV/]:PO$:K]CC^4?ZH=JHZ$J^2_P`H_P!6.WO6'._;
M\G2QK*G'D3.HTV]U+38DTR>!)XVD#%=O7K4^J17`FQ#;0ICHH/.*I%W\V+YC
M_J/7V-4H7<ZJ^6/4]ZTVBC!17,S9>^OI8A#=7+@$9`/0@5'/=Z?]I5K*)U4*
M`^XXY[XQ4\CO]EB^8_ZMN_O46G(DD\7F*&_>CJ,T/=(@D,=G)*\L4A''RH[9
M-&JRVZPI:O`J&.+))/!).<TEZB"67"@?O?3ZUEZJ[^6_S'IZTY)03L*.K02Z
MK;6VR.TGR[/\\:+T&/7O5_1=*T*\N2'EDZ!F+'EF/7-<TW_'VU:NF_ZS_@+_
M`,ZQI)<^NIO-.$=&;EMI5K%>7+-J\AMXTQ^Z8`M[8JF+Q8;@SV2R(H..N<CW
MS56V^ZO^\/YU<OE7^U[?Y1]T=O:MI6MHK$1>I;9=*OK>:^N+MUE4+Y:(0`S9
MY_2J$`L520W=U(HVDH4`X/:NC^RVH\*0D6T8_P!,D_@']VL?Q`JCPVV%'_'T
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MDN_*4+^Y/W1CO6YXA_X][/\`ZXFIC&RWV,W)6:L9[VEA*]M90%G=@S-)L^93
MZ>]074=]8WT=C(K1-(0<G/S$_P`6/I4DQ,=VOEG;R.G%,U!WENK?S&+?N#]X
MY[FM>6/,M#*[4K$NHWDME<2&XCEER_"R/EF.!SGJ*S=1AU/5+N2]N$/E[]JJ
M\@#=.`2,9JUHO[W6!YOS?[W/:J'B!F^WWGS'_6OW]ZQFES6\V:4_B^19M[K3
MM.L;M;R1X)4!(4*"JX[`=S]*DT2:_7R[VQBDD$Z`[6ZG/MV-9H^:PFW<_.>M
M:-F[K91[6(^7L?:M:>Z)GH33^'K;4]VH:I=^7B9$1>,L2>2?I5EM`\-6EN;6
M>2>"7RCEP,JQ]0",\UEVS,3-EB?WT?4U?\0N\FJ_O&+?,W4Y_AIQJ1YG[J,N
M>=K7%LAI5K;2:5=7#2+)PN%!VL>X.14`T""RN&9-1*1E57<J`[6/\+>WO5.[
M_P"/E/I_2H8&;[#<?,?N^OO5<]GL'*^YNWWAW4DT@DZG83E&+1F*3$@`./Q!
M]#4-U8N;&.WE0(\A#)@G`QW<]AUK'A=Q;QX8_G5HW-P-V)W'[GLQ]:V32CL8
MV<GJQT?]B"\ECU"[$ISM26WR,#U&?ZBG66AZ/<1W`OW.W:!;S1Y;G<,L1G/3
M-4KM5^PM\H_X^6[?[(I(698$VL1\_8^QJ827/L7*\%HS7T:'P]87LEG/Y,\4
M9)BNB"&5Q]TYP3SGI6'JEDCR2GS6&]B5P@.[\<#%;\"K_P`(1<_*/^0JG;_8
M:LZ;_D'0?[XK2<5R$QD^<S?#V@ZP9S.T6V(8C!+[25/UK5O-+M$B6PGG0VOE
M%RXMU,HD!^X3G]:OI_QZ2_\`7$_TKG;GGS\_\\S_`#J)04*>AM";E+4T'T/0
M)+]WT'S&A4_,SL>!Q@Y[GK^52K874#L]NQ=D3*G9NXZ<U/#;V\7AE;B*!%DW
M-^\50&Z#O4]Q_P`BG;S?Q[I?G[]%[T**O\@527,CFX;9)FE$DBQ."-LAS@'O
MGUSQ6SH6@>&FNY+CQ/??:`L1\N:V'RAL<`@C(YZFN=+-MD^8_P"M]?I71>!/
MWD5WYGS?NF^]SVKGIV]HE8TFY*+U.CBUKPT-#MO#VB>'EEE%RLIGV?O2V.@8
M=N^.E9-[INNW]\)II4,K,Q^S`@.,>WXU#HC-'>Q^6Q7G^$X[FMNZ5=LLVT;\
M#Y\<]1WKI^.&IA#W).QF7'B_.GR:5)8A978;Y=GS`CC\.@J)O$4:7B76FO,6
M\E5>*9%92X[X&!C&/QJEK'%^^./EJOI?^N_[;5Y_MJG.E<Z8PA;;<[+3+R]L
MM.9OMWG271R;?HJDD\D=!CVJ*]M?L$\FC:Q-)>JVW[.(I?ER2.<#J>V*KV")
MY+_*.GI[UVVJ6UM$=(\JW1?G/W4`_CKT?9QE2U.1R<9GGUZKZ==KH[^'O)EB
MD.\S#:S#L#GI4FJP7VG:<D%WK4<2S8+6<4NX$`<$^E=5XB59?#_B&:50SI/!
ML=ADK\K=#VKSG4/WMY%YOS?)_%SW-<<XJFW8WA)U)*_0UGTU8H(_LD1D:4!O
M,?';TK7.E276@B\OQ!"((]MNL(",3DMN?`RQ/2N:A9AJB88CYAWK;UEFR/F/
M1>_L*UHJ,T[HF?Q(KZ+J^H1%MDKQQ2$>?,%Y"^Q'2K&D:AJ:23IX?OEC9BV^
M67EF!ZX)_G77_!]5_M+58=HV;#\F..K]JY74$2);KRE"_O9/NC'\)JX1M%._
M?]!M1O)6[&9J/C76K>X4H%@#Q`2-'"-I(Z'TS5?4=9SI=WJ.BQ11&6()<3W#
M!G;(&=H[9QGCI6;<LS+'N8GGN?8U0T!F_P"$DA&X_?\`6O.J5JC:U.VG1@DF
M6=`\>^)Q'-IMK*P$EN8?,C7<,9STP>?IBH++49(]8:"-[EX@Q!FXP3]""*[-
M%6VL3-;J(W^TM\Z#![]Q7)^$.?"M_GGYXNO^]40E)\MW?<UDH\LFE;8Z@^#]
M,TO399;WQ(WG26WF1I/$VR1L<H&!SN^O%4%FOIM*_LO1UB63<!+)!'ND?'/8
L9Q5GXDNXTBT`8CYAW^E)X.9H-2/D,4_=G[AQ7HN,8U'"*LC@C*4XWD[G_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<TEXT>
begin 644 image_002.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_
MVP!#`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'_P``1"`#Y`9$#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#^='Q9_P`%
M=/VYDU_5;=?C-XA6.'4+Y%V78&0ES*J\R"5\8`($CM)_>=FR3RC_`/!6[]N1
MR2WQH\1`G.<3*>IR>>_UP/4`5^>7B?YO$>M9/_,2O\<+T^UR@9.WD^YY/-<]
MGV!_/^AK_=JGX?<%QITXQX0X:48TZ<8IY/E[LHTZ<4KRP\I/2*UE*4G:[E)M
MM_FM7%U_:3M7K+]Y4VG+^>?FC]*V_P""M/[<#``_&;Q#P`,^8N3CUSQ^G7GK
M4?\`P]B_;>//_"Y?$G//$J8_#Y*_-C(]!^O^-)5_Z@<&?]$CPU_X9LN?_NJC
M+ZWB/^@BM_X,FO\`VYGZ5C_@K+^W"!@?&GQ4`.`!?3*![!5<*H'8*``.``.*
M=_P]G_;A_P"BT>*?_`ZX_P#CE?FE11_Q#_@S_HDN&O\`PS9=_P#,P?6\1_S_
M`*W_`(,G_F?I4?\`@K+^W`23_P`+H\5<_P#3]/\`_'*7_A[-^W%V^-7BO_P-
ME_\`BJ_-2BC_`(A_P9_T27#7_AFR[_YF#ZWB/^?];_P9/_,_2O\`X>R_MP_]
M%H\4G_M]F_\`BZ/^'LO[<'_1:/%/_@;-_P#%U^:E%'_$/^#/^B2X:_\`#-EW
M_P`S!];Q'_/^M_X,G_F?I7_P]E_;@_Z+1XI_\#9O_BZ/^'LO[<'_`$6CQ3_X
M&S?_`!=?FI11_P`0_P"#/^B2X:_\,V7?_,P?6\1_S_K?^#)_YGZ5_P##V7]N
M#_HM'BG_`,#9O_BZ/^'LO[<'_1:/%/\`X&S?_%U^:E%'_$/^#/\`HDN&O_#-
MEW_S,'UO$?\`/^M_X,G_`)GZ5_\`#V7]N#_HM'BG_P`#9O\`XNC_`(>R_MP?
M]%H\4_\`@;-_\77YJ44?\0_X,_Z)+AK_`,,V7?\`S,'UO$?\_P"M_P"#)_YG
MZ5_\/9?VX/\`HM'BG_P-F_\`BZ3_`(>S?MP_]%G\3?CJ4H/XCG'TR<5^:M.W
M'T7_`+Y4_P`Q1_J!P9_T2/#7_AFR[_YF#ZWB/^?];_P9/_,_2C_A[-^W#_T6
M?Q-_X,I*/^'LW[</_19_$W_@RDK\U]Q]%_[X3_XFC<?1?^^$_P#B:/\`4#@S
M_HD>&O\`PS9=_P#,P?6\1_T$5O\`P9,_2C_A[-^W#_T6?Q-_X,I*/^'LW[</
M_19_$W_@RDK\U]Q]%_[X3_XFC<?1?^^$_P#B:/\`4#@S_HD>&O\`PS9=_P#,
MP?6\1_T$5O\`P9,_2C_A[-^W#_T6?Q-_X,I*/^'LW[</_19_$W_@RDK\U]Q]
M%_[X3_XFC<?1?^^$_P#B:/\`4#@S_HD>&O\`PS9=_P#,P?6\1_T$5O\`P9,_
M2C_A[-^W#_T6?Q-_X,I*/^'LW[</_19_$W_@RDK\U]Q]%_[X3_XFC<?1?^^$
M_P#B:/\`4#@S_HD>&O\`PS9=_P#,P?6\1_T$5O\`P9,_2C_A[-^W#_T6?Q-_
MX,I*/^'LW[</_19_$W_@RDK\U]Q]%_[X3_XFC<?1?^^$_P#B:/\`4#@S_HD>
M&O\`PS9=_P#,P?6\1_T$5O\`P9,_2C_A[-^W#_T6?Q-_X,I*/^'LW[</_19_
M$W_@RDK\U]Q]%_[X3_XFC<?1?^^$_P#B:/\`4#@S_HD>&O\`PS9=_P#,P?6\
M1_T$5O\`P9,_2C_A[-^W#_T6?Q-_X,I*/^'LW[</_19_$W_@RDK\U]Q]%_[X
M3_XFC<?1?^^$_P#B:/\`4#@S_HD>&O\`PS9=_P#,P?6\1_T$5O\`P9,_2G_A
M[-^W!_T6?Q3^%[,1^>\9^N!FC_A[+^W!_P!%H\4_^!LW_P`77YJ?Y]/Y44?\
M0_X,_P"B2X:_\,V7?_,P?6\1_P`_ZW_@R?\`F?I7_P`/9?VX/^BT>*?_``-F
M_P#BZ/\`A[+^W!_T6CQ3_P"!LW_Q=?FI11_Q#_@S_HDN&O\`PS9=_P#,P?6\
M1_S_`*W_`(,G_F?I7_P]E_;@_P"BT>*?_`V;_P"+H_X>R_MP?]%H\4_^!LW_
M`,77YJ44?\0_X,_Z)+AK_P`,V7?_`#,'UO$?\_ZW_@R?^9^E?_#V7]N#_HM'
MBG_P-F_^+H_X>R_MP?\`1:/%/_@;-_\`%U^:E%'_`!#_`(,_Z)+AK_PS9=_\
MS!];Q'_/^M_X,G_F?I7_`,/9?VX/^BT>*?\`P-F_^+H_X>R_MP?]%H\4_P#@
M;-_\77YJ44?\0_X,_P"B2X:_\,V7?_,P?6\1_P`_ZW_@R?\`F?I7_P`/9?VX
M/^BT>*?_``-F_P#BZ/\`A[+^W!_T6CQ3_P"!LW_Q=?FI11_Q#_@S_HDN&O\`
MPS9=_P#,P?6\1_S_`*W_`(,G_F?I7_P]E_;@_P"BT>*?_`V;_P"+H_X>R_MP
M?]%H\4_^!LW_`,77YJ44?\0_X,_Z)+AK_P`,V7?_`#,'UO$?\_ZW_@R?^9^E
M?_#V7]N#_HM'BG_P-F_^+I/^'LG[<'_1:/%7_@=/_P#'*_-6BC_B'_!G_1)<
M-?\`AFR[_P"9@^MXC_G_`%O_``9/_,_2O_A[1^W"./\`A=/B?CCF]GS^/[ZO
MKS]B#_@J3^V5XF_:-^&^B>(_B]XLU+0[WQ!IT-Y9S:G>F"6*:=!)&4-V$";2
M0H"A0O%?@SD>@_7_`!KZN_8NO#8?M"?#VY#;3%X@TQP<D`$7$9YP0<>V>@[]
M#\_Q9P'P=2X8X@J4^$^'*=2&3YE.G4AE&7QE"4,#BYQE&2PJ::E"$DT]XKIH
M]J&)KRK44ZU62=6FM9RV<DFOBZK1G^F;_P`-*>*/^@SJ7_@8_P#\717Y5?\`
M"Q[C_GXB_P"^IO\`Y)HK_)OV%/\`Z!\)_P"$>"_^8C[;V<.S_P#`I_\`R9_G
M\^)/^1BUG_L(WW_I7+7/5T/B0`>(M9`Y`U&^`)ZD"[EZ]/Y"N>K_`&UA\$/\
M$/\`TF)^>U/XE3_KY4_].3"BBBJ("BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`KZ3_90./C?X'))4+K>G$%>#GSD[^@'45\V
M5]'?LK.1\;?!&,?\AK3>>?\`GL@]?2OG.+_^25XB_P"Q+FG_`*K\8;X;^/1_
MZ^TO_2T?U[_VA+_ST/YC_&BN>\U_7]3_`(T5_CD?H)_%WXC_`.1AUC_L(7W_
M`*52US]=EK&G->>)=1B65(O.U:=#/(,V\2374N7<J=Q$.',S#/E[2&7@D?7G
MAK]C.'4],M;[4?&RE[ZVCNK;^S+;=;^7/"DT1,LD,WF*RL&#IL#*1M'.3_J%
MXP_2(\(O`/+\FQWBEQ3+A^GGLZM#**.'RC.,ZQ6.J83V4,<J='*<#7C3>!=2
MD\9#$8K#UZ,*E.HL-6I355_H/@1]%;QT^DWFO$.6^#'!D>*JW#%*AB^(*U?/
MN'\CPF4T,PJ8Z&7RQ-;.,SH5)_7JN"Q6'PLL)@L92GB:,Z%2O0J>Z?"-%?>1
M_8HG8ED\;1!"24#:>Y8*>5#$;06`QDA5!.>!TJ2V_8IQ*/MGC8&WS\QM[$K(
M!GGF19%!QWVGZ5^)S_:)_1#C"4X^*<ZKC"4W3I<'\92JVC'F<5"634E*;^%1
M4[N2:3ZO^B*?[*;Z=]2K3IOP2=*-2<8*O6XXX#AAXJ3LJDZBX@JRA2M:3FZ+
M:BTW!.\5\$T5]L>.?V.M8TG3UO\`P5J\GB)U8B:RNUBMI\8ZQ2".-&()&<J,
M]]N:\+N_@+\4[)/.N/!NL)`TK0J8TAG;<IVC)61%92>0ZGE>0M?J7`OTLOHY
M^(N40SGAWQ=X+H49594*F`XESG!<(9UAJT;M0Q.3<38K*\;!3@E4IU:7UJA.
M$H_[1&IS4H?C/B1]"#Z6'A3G=;(N*_`KQ!KUJ.&CC(YEPIP_F/&_#^(PS<8N
MKAL^X2P.<Y;4Y)S5.I1JRPF)IS3YL+R<M67C=%;VL^'-5\/7MWIFLV5SI^H6
MNUC;W,?EMY;':#SG.&RI921D'@<9PCP3@8&3P2"1ST)``/U``/7`K]]P&/P6
M:8+"YCEN+PV/R_'4*>*P>.P6(HXS!8O#U5)TZV%QF%JXC"8FG)1NJF&Q->%I
M0O-.7+'^8LSRS,<ES#&93F^!QF5YIEV(JX/,,MS'"XG`YA@,70GR5L+C<#C*
M&%Q>$Q%*2M.CB,/1J1>\4)11176<(44ORY'7&.3[X[<>M/\`+)4LJG;NQO+#
M:![C;G/3)R![=*-;V2E)V;2BKMI;V5ULM7JDEJV.VEVTD]%=V].CWV7=Z$=%
M2M&`?ED5P,9"\$]CM)X]P>GN>*C.,G&0,G`/7&>,XP,XZ\#FC75---.VMM=$
M[Q:E)..MKI[W5@LU9]'?7T;33[/3:VVHE%%%`@HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HJP8548;>9-D;K&``[B55=<IAO*18VW"5V/G*5:-!N(7VJ?]F[
MXXVOPDC^.]Y\+/&=C\(;B]33;3XA:GIDFE^&;R\E9/*33+Z^CA.L><C!XQ8Q
ME<.C>:4^9O$S?B7A[('ED,]SW)\DJ9WFN&R')*6<9KEF53SK/L:Y+!Y%DO\`
M:>8Y=#.,ZQ7)/ZOE.55,QS&LH3<,$_9U.3:EAL17]I["A6K>R@ZM5TJ52HJ=
M-)N52HX0ER0BDVY2Y59.U[:>&T4YP`S!0P`8@!QA@`3@,.,-CJ,#!S71>&_"
MVN>,-9TCPWX7T?4_$'B'7+^TTW2M&T:UN-1U/4KV]D6""TL[&VMWGDF:9E4E
M=ZJ&&<Y#'U,3BL)@\-B,;C,7A<)@<)AZN+Q.-Q->GA\)0PU&//4Q%7$5G2IT
MJ$:?-5E6K.C1ITHRG6JT%;FRC&4Y1A",ISG)0A&*<I2E)VC&,4FVV]$DKZ_=
MSP4%0V=OS;3N]L9(Q^/TJ?[*Y!=%FDA7#/-';RM"BGG#RD*%8#@D*RYZ$BOZ
MYOV0?^#6/QQ\1?A_X>\:_M7_`!CU#X0>(-7:"\N/AMX+T&S\0>(/#^EW$,=Q
M9IXAN]3*6D.J7,+A;FPCA5M,N`\-PTK1,*_8#X6?\&RO_!.'P.]I=>,[/XK?
M%2_LVCD#>)O&`TG3KIXPN\WNE^'M*TRS996!9[=6:./=L29U4$_XK^-G[?[]
MF[X-YQG608?Q*XV\6LZR''X_*\32\(O#W,.(\BQ689?/V-:C@.,<WSOAGA7'
MX1XA3I4\URBOG6`K.C6G"I.C&-:K^E9=X5<79A2I5I83!X"E5C"2ECL7&%7E
MG&,D_J]"-6I?EDG:<H--V:4DXK_.4*1Y.U_ER=O0\9XYRF>.^U<]=HZ`5!GY
MV4*>5.XDD=B1%'.5SZ%>.AYX'^I2G_!#7_@EQL3/[*7@QCM7+-J&O.6X')?^
MTAO)ZEL#<><#.*R]>_X(/?\`!+/7M,FTQ_V7O#^D&8$?VCH&N^)-(U2+(X:*
MZM]4QN'4-)%(V>22:_ENG_I0GT'Y5J<*O@W])W#P]HH5*W]A^&5>,*<I<E2K
M]7CQU"I5=.*=2G24X2<K1;NF>N_!CB'IF&4OO[V*7337V;Z^1_EW-;D?,P,<
M>,AGWD,#T(/E(0",$%D4X/(4\57.,G:<KDX(.01G@YP,Y'.<#Z"O]$SX@?\`
M!KW_`,$\O%,C'P=JOQD^'-Q(;IT>R\56.OP(Q=C"H36=+N&*)D`M+*\TBC+/
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M\/:E(9/M>F0^$/$.L^65'RI#=0:G:QOM;(9V3+`;O*3.!^[8O]M7^RXP>#AC
MJGTP?#^M2FX)4<'D/B3C<9'VD(33JX/#>'4J]%)32FZJCR34Z<K3A**\I^&_
M&ZM?A_&*_P#?PW:^O^TZ=?FG\_Y(:*_L^T?_`(-(+UM-T[^WOVP8$UATSJB:
M9\-Y_L".%`9;,W&K/,5#[L/-(=R%2`&)6K__`!"/1'D?MB/@\C/PW?.#TS_Q
M,_2OA*O[>C]E=2K5:+^DQ*HZ4Y0=2EX6>+%2C4Y92CST:O\`JE352G+EYHR4
M(7C*+<8\W+'L7A7QNTG_`&535TG9X[")JZ3LUS.S5[-7=FFKNUW_`!945_7U
M\1O^#2WXN:;#]I^&'[5'@CQ"46/S;'Q9X.U30I5<C]XXO;34KN'R0<["ULK$
M=03D";X:_P#!I?\`%&_,-Q\5?VJO!&BP,KO+IG@OPKJVKZB5278?)O=3DMK-
MUV]'%N^XE6";2<?2O]N!^RY7#TN(U]*SAR=!*5LHI\'>),^)IN.\8\/+@I8Z
M+:^"57$4J52Z4*KD[&/_`!#+C;VJI?V)4OUJ?6<+[%7VO4]M97_POSL?R`X'
M`PY8XP`O7//7/?MQ^9XI"""00002"#U!'8^XZ&O[Z])_X-1OV0;?0TT[6?CS
M\<+W75MV2\UJTL?"%K;K<>7MBDM[:7P_<D+OR\J"Y?()5#&`#7Y3_MW?\$.O
MV#_V%?"4^M_%+_@H1KWA[Q<VE:QK7A[X8W?@#2_$/C+QS#;&2/3M/T"RTBZL
MYM.+7'EI?:SJD4]G'$'E6V7@5X7A-^W'_9]>-G'6#\-_#GC'QAXEXPS?,%E^
M09)E7T>?%C.,;G,G6A0>(PF%X?RS/L;3P5.I4A4Q&88_"8#`8+"S6)S#$X&C
M2Q-7#Z8WPRXKR_#_`%G$X?`4Z23<YSS7!4XPM3E4M*5:5"+DU&48QC*<I35E
M&S4C^6NBIKE8DN)TMV9H%FE6%F979HE=A&S.@5&8H%)9%"L<E0`0*AK_`%Z3
M;2;C*+:3<964HMI-QDHRG%2BVXR49S2E&24YI*<OSYIIM/=-I[/5-IZIM/5/
M5-I]&U9LKZ,_97_Y+;X(_P"PUIO_`*/2OG.OHS]E?_DMO@C_`+#6F_\`H]*^
M=XP_Y)7B+_L2YI_ZK\8;X;^/1_Z^T_\`TI']:E%%%?XY'Z"?S9?!_P"!NKG5
M+CQ5XJ70FT+5+F:XAT'4;1YKZ6VGD>>UNX9DD2.%94D64^8KEBV=NXL*^U+6
M*'3H8K.QABM;6V0006\);R888U$<<48+$"..-52,#HJ@"OBSPIX_^)GA>RE\
M1^-_$VD>'O`JSRV>DPW=K]KUG5K:QWK:6.E6R3>9$KP1PHMS-%/&$^?:`1CH
M/"'[6/AK7_$3Z=KFF'P[I%Q/(ECJ]S>HX"[SY3WB^6J*TB%694*@-N0<C%?S
MO])_PA^E-XV\<\?<:T<+E7B;PUP9BLU>(J^%U?&XSAG(J668I81Y-A:&+HX2
MEQ)QGEF!>$AQ,N':/$6;X:NL7A<WQ\5A\%E]#_IX^A=X\_0K^CIX;>&/`6+Q
M>>>#_%_B/@\DJX:/C-A<LPO%O%&)SG`8+,JG$N(QF6U,56X1\.LWSBOCJW"4
M^+\1PMDV+I5,/F639<Z&(S+/,5];!\`#`X&.K_\`Q5&_V`]@7Q^K9Y[\U3T_
M4=+U6SCO]+U"WU2PE">7J-DX:U=G4,J@?,P+!@0-YX((+9JV1@D$8()!&<XP
M<8R.#]17^;>,PV-P.(KX3'4L1A<7AJ]7#XG"XJC6PV)H8BC.<*]&OAL1AL-7
MP]:C5C*G6H5Z-"O1J6A5H4VX\W^O^78S+,TPF%S#+,1A,=@<;AJ.+P>-P6(H
M8O"8O"XBG"KA\3A<7A,7B\+B</7I5(5:&(PV)Q&'K4Y*=*O4B^9O,C8..#@#
M.6)&.A`9BN?^`_3MAH9@`"S-C^\[XW=WP&"AB>?E`4'HH&`&T5RN<I))R;2;
M:6RBWORI)*-WJ^513=Y-.3<GW>S@K6BM/-__`"6KTW=W;2]M#A_&OPY\)>/+
M&_M]>TFT>]NK0V]MK0B4WUL_E-&NR0JR`(2#AHG?@G)[?E1\2_A5J_P\\0W>
MF745U)ITEZ\&DZG);20VMXK2R+`B3;&21]@CR%"$[BX0*K!?V2WMP%PJX`*@
M94D#EB&W?,QY."!DG``XK)U;1M)UV*&'6-/M=2BMITN;>.\B6=(+B,AEFC63
M<`^X9/5>2`H&`/[;^B;]-?C7Z->:XG`YA'-.-?#O,<)4HXCA'%9M7ME6-ITL
M1+`YEPY+'5<3A\LE3Q$J5/&9?2]A@,;AJN(G.A#%4L/5E_G#].+]G7P#]+G)
ML%FV2O(O#OQ8RC,'B<+QMALEH^RXAR[&8G"O-<GXPHY93PF)S-3H0JXG+<XO
MBLVP./H8>FZ]7`5\3AH?B9J_AC6-"DBCUC3+S2C<1+<6B7:,WVJWD`:.:.5(
MEBV.C*X)YVG)`K4\%^#;CQGXFTKPU:3"UFU:?R(KJ9HV@C9%W2C<C'S64!]B
MKM\PJ<$'('['>)/!_A?Q?`MMXDT+3M7A1!'&MS;J#%&HPJ1-"8BBJ,;0I`&!
M7E/AWX`>#O#_`(]E\7VUI:6=AIMM"^BZ59S7+1K>,FR:69)&EE,R@D$Q3HH)
MXCP,#_0C(?VK?"&?^'O%U/.>%<[X(\2\)PKG]?AO$X.G@>*>&,=Q'-2PG#6%
MHTL1]5S",_;XVCC<=#&X-X:&%R?&S5>M*HJ=3_+/B3]B7XA\*>)_`T\AXNX>
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M.IV5U<Z>!#?-"[*Q:UG,):/RPA\MD`R,5'"/BQ](GZ27!WA!D_@3XQ<4<+\>
M8'PHXDQWBEC>,>!K<,YWFM3-8Y+'.EQNN%J7#^%S;,J_UG"<&Y9EBQ6$P3R[
M%XG%XJEF%/%X7#\G''@E]&#Z)WB+X\9Q](_P"X/XV\,,=XR\+95X-X#@#Q/A
M+C3)<CCD=//:F4+PSQ'&-/B''9%@<.\%6XWS'/<9D]?$8G'8>EDE/-,CS7#Y
MDKWQP_9NB\"Z,GBSPO<SZEI%J_E:I9,JM>6H=@(KH&.&%%M><EF1R%.3(,%J
M^1Y8`'DR<G<Q4H2R[<D[A^[`8<9*A@0.^1S^SWPZ\867Q3\!6&O7-BDR:G;7
M&G:M8W$.8+J>SB2.Y2*,8)@,FXVW/F+$%+NS!C7Y9_%J#0;'QYKMKX?T/5-`
MLK>ZN8_LE]LCB\Y)9XI9[6)H$+V;R;#`5)9H!]YF*N/UCZ"OTD/$[C;.N.?`
M7QEP6.S#Q&\+\=F2S#BVIBLDK8>>"PV8U\KJY'F%'+J>$KYCFF#Q^%K0P&<X
M*CC*.98/$T,3B:6"EAZ>(J_CO[2+Z)7@UX;\/^%_TE?H_9CE>5^$GC5@\G64
M<#T,/Q.JE#$8O)(YO'B+)<9F7]H8?!91B\#4PKQV39WC,NQ679C2KTL!+-8U
M\3'#^1,`&8`Y`)`/(R`<`X.",]>>:2I)L>;+@;1YCX7T&XX'1>G3[J_0=*CK
M_2V+O&+LU=)V;4FKI.SDM)-7LVM&TVM&C_(G7JK/JM-'U6C:T=UHVM-&U9LH
MHHI@%%%%`!1110`445.L0/E@\,V2[E@$"LNY`/ER&`QOR2.PQV3?*KN]KQBO
M.<WRP@M=93:ERKKRS;<5%L:3;LET;;Z1C%7E*3L[1C=7=G:ZT=T045J6FE7-
M_<06EG$]S<W3Q0VL-O\`OY+B:4`HBH%7:7R652Q8#J"`6KK]:^&7C'PY9OJ6
MO>&]8TK3H76.:ZNK<1JLDA"QHAD$:N0Q'G'<JQYVAF*LP\#'\6<+93F669/F
MO$F099F^=5?8Y/E689WE&#S/-*KJ2I1AE^78C-:688U5*M.I3IU,)@<32E.G
M.'M(22YOH\KX-XOSS*<US_).%.)LYR+(8SGGF=93P_G6991DT:>%EC:G]K9I
M@LLQ&79:Z>$B\3../QN$E&BXU.5PDI'GE%3M'&))%61=H<JAE;R\@$@',27(
M?(QC;P>H..B^4`A9MI`9E!68`.<D`(KPJ_R?Q%U0OT"(WRCW8SC.W+=W@JMX
MVG:BYJFZSC3G.I&E&;Y9SG0IQA)--M\L9_.-6;3E'1N-^9-2:;7NM)MWM[KL
MD[K57T_4/_@FYX$_8P@NOB9^T7^VWXDO;OX<_`72](USPI\#M%L[F;6/C]\0
M+JXFM]%\&/KGV=[32[&&>.&ZO(7;8+(,LZ^6DLDO"_MY_P#!1;XV_MQ>+K3_
M`(2=;;X?_!KP1:Q:+\*?@'X/DDTWX??#W2;-4M;%;'2(9S!J6JQ:?;V]I<ZW
M=J\MTT1FABM%G:!?HWX,?MQ_LK7'_!.;Q-^PI^T)\`]=;6;#Q?<^//AU\=/A
M4/#5IXOM_%M[-<7=C;^*8M7L-2N[ZTM;N66S5K>:**\TO:BV\%T6<?$/[.7[
M#'[3_P"UU?\`BFP_9Q^$GBWXGR>#[>UOM;NM/M([..QTZ^.+"XNY+VZ$!N+Q
M-K_8(&DN+/>B323`AV_SQX7R;A.CXZ>.OTF/I6\-Y[X<YEX/\8/@?P4XH\:>
M,.`ZW@KP-X2U\ARC+L%Q_P"$6/P^-P?#O"W$7B7Q!F><+CK-.+<!0\2\JS&O
MEO!BXJPG#%>%'&_98BOB7E.59-D5:GBZ&+HRQ&80RS"XJ.9XC,'6][#YC*G"
M56IA\)&,:>!2JTZ-:'M:G))1Y7QW_#*/QZD^"7AS]HV/X:^)+OX.^,/B!_PK
M'PUXVM8X+BQU_P`=R;F3PQIUG:RWFI_VB_ES&`W%NHNPF84+Y0_N[_P0I_9:
MM/AY^TCX-^-_[2/[/W[6VD:EX6^(5AH'P9\:^'/AY/+\+K?QNUK-97VE_$6#
M5X(]7L+&!);B:22SBMS;W>QC=1$21K^_W["'[`?B;Q__`,$EM+_9&^.'P9UK
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M6Y'%_L<D"".-&!.Q1Q(YN/WA!W.[S!C<.6.XO,K`L`X1234B1A``&<^N6X;Z
MH`(U!/.V-$5>BJJX`(>8HCE#F-.8W:6,_*.4D<!Y$/57<!G7#,,DU)7_`!E5
M:M5SG&4Y+EJU&HWTA)SFI<K^)6M;XY7Y5=MZO]Z5MTD[J_,HI-IZIW23L[W2
MO97T2#IP``.P`P![`#@#V%%%%8#(_*3YLA26).XQQ;ER2<!@@/<\DDGN<TBQ
M(I!7Y2&=OE5$R7_O%%4MM_A).XY)9F/-2T5?M)VMS.UDK::).Z2TTU[/Y@]5
M9ZJZ=GK9K9J][?)K[M!@C4`+EMH'W2Q.3G)8L?G+$\DEB"><9YIV!@CL1SC@
M^YW##[CW;=GC.<\TM%3=WO?7Y?Y-?@.[&[%QCN.`Q^9@!T&YLD\=VRQZDD\T
M;1VP!V`"X`]!QT%.JI/=16J/+=2Q06\:2S2W,Q2&U@AB8*1/<2RK&CDG()PN
MU6)`P,[TE7KSC3IN4INT813]Z3E*RC%1BY3DY-)12G)MI1BWHE;R6S;;C"R2
MU;;:5E\^_FR<1A69U.R1L!I$5$D*K]U2RH"0.@SEN3\V>:^2OC]^US\,_@ZG
MQ*\(:5X@\+>+?CQX+^$'B;XO6/P8N/%5CI'B#5O#VA6\M[/=S/J$LD-E`\1@
MFMXW$<]S$2+>/9-"8NF\7_MA?LN^`?%&F^"_&/Q_^$/AWQ3JUMJ%Y8:'JOCW
MP_:WLMII);^TIV'VV183:B.3]Q-Y<TS+L103D?YKO_!6+XOZ#\;_`/@IG^T;
MXX^`OCN^\:>&?&OC*Q\.>&?$FB:MJ4=IK@ATW1M&O=%TJY%S&\GAVY\007*)
M;"06$UHX\N.(;9$_V`_95?LR<[^G!XR<6</^*:XZ\,?#O@?PPI^*E+B?,^`.
M(I\)<3U\'QKPO@,-P_F&=9EAN%L#1RC-\EP?&SQ=?)L[AFF(PN#Q:P&/RV65
MU<?4^&XRXPI\-X/#SP<,-F.,Q&-CA%AJ>*P\JE/GHSDIRI4IU)RYIRI1C%J*
MYM]G%_Z2G[.G[5'PV_:,_9I^'_[4.BZIIV@>`O&?@FT\8ZJVK:E9RV_A@?8(
M+G6-(U34T-K:M)H5Q)+:370A17$!?[/&9`!_$U_P<27O_!.#Q9XVT'XE_L_?
M$6;X@_M/>.[YM6^(;>#/%4OB_P"'J^$K5YD@FU![F&==&O[BZN)[FTM?#^H:
M;;2!V+VC0;XU_1K_`(*`?\$S_P!I3P'_`,$=OV8O@O\`L[)J!\0_L_:9?_$_
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M8A$C!)8DD)&J(@)Y"(B(O154``1TK,69F8Y9B68^I)R3^)-)7_6+&*C&,5>T
M8QBKVO:*45>VE[15[:7O;2Q^";:=O*WX=/3IMT"OHS]E?_DMO@C_`+#6F_\`
MH]*^<Z^C/V5_^2V^"/\`L-:;_P"CTKYWC#_DE>(O^Q+FG_JOQAOAOX]'_K[3
M_P#2D?UJ4445_CD?H)_&SXR\0:KJ?B"\%[=/<)87-S:V44I:6*UMX7DMX8H8
MY6=$2.(84`<G#-N*1[./%TV&#10.6QEG0DAA_&,,!NSR,@J#T4#BM;Q'_P`C
M#K'_`&$+[_TJEKGZ_P!HL%EV`P.$P^$P6"PN#PM"E"%'#86A2P^'IPYJE9PA
M1HPI4E"=;$XBM4CR.-:K7K5:ZKU*M2<OA\QS+,<QQN(QF88_&X[&5JLY5L7C
M,5B,5B:LHPHX6+JXC$5:U:HXX;!8/#1YZLE##X3"T(*G1P]&E3^V?V1/&NIQ
M^+)/!][/-+H][:R745K+(7CCG6,,C6X#JJ?>&U"K;0`"=V[/Z($DDDYR22<]
M<^^._KCO7XI_#_7=2\->)]&U72;V#3KM+B%//N_-:+;+.(6+K%+$QB"8(`<?
M,%)X!!_9V.^LK*RLIM5U&W#2VUN6N7N+:&&Y\R*,B^BD\R8F*X+>:L+1(RJX
M4R@@U_S[?M3_``I_U?\`&KAWCK)L#E]'!>(_#>&4\!E>`JT<;7SWAIU<#FN8
M8JA@<`L%5KX_#XW*.>NY?VGC)X3VN(HSIX:.*J_]2'[%OQQ7$?T>.+O#CB7,
M<=*OX2<3U*F'S;.<SPO]E8/A?B_V6-R7*:&)S+-X8K#4\OQV#SE4J4Z6%RC"
MT<73P>"K?6*_U&G>HIZ>3+'YD$T=S$P1;>YMY$GANY9%#HD:Q[MA$9!<&63D
M;58YR&D8)&0<$C(Z''<>U?Y9UJ-2A4G2JQ<*E.<Z52#NI0J4Y.-2$DXP<9PD
MK2C*,91<HIQB^:-/_:JAB*6(A&I1FJE.<(U(3BX2A*$XQE"49PJ5(3C.,HRA
M.$YTYQ:E"I.+C*24445D;%#6]6TOP[I%QK>L7D-AIUK#-+/<3R*JH85)6/!`
MR]P<"%<@_,.&&2/A?QM^V/?R3BW\!:+%8V\1D"W>L1FYF=22HF0VDEH%9AB1
M=Z''`;?@UW_[6NB>)K_PYHMQI<E_=Z3#<-+J6FV%G=3*Q1LQW%\8)/F2W(!A
MV!,$'?M(#+^;[^9%(9/+9(R[I&>"R%,A5=9/,&Y5!#)G(.1SBO\`:[]GU]#G
MP,\1?#>GXM^(N'P7B-G6+SC,,OI<)XBOC:>0\)X?`<N">'XBR;"8S+\5F6:9
ME+$+&T\;C*V%R>AAY8-Y96Q=669SH_\`.Q^U)^GW])#PJ\7L1X'^%F)S+PJX
M<R[(\LS"MQKA<'@ZG$?&V*S2+QOUOAC/<1@\PP>49+EM."RFMA,#3Q6<5\=2
MS&IFD<%1GE>'E]8W/C#P;XU\%ZUJ'C=M9OO%6H6CWMEXQU>T!TW1=9\R,MH7
MAN&((8K>63,-S)<->1S@R,GD1,((^#\"6'P?M](>+XB6GBZ+6[[4K)+%=,A^
MRV<%B0OF3"XNH+II$E$A=L2([QR!HO*51MY;X=^#/$'Q$UNRT+3T-Y#%<P2W
M8:[9([>R,RS2R+;R.8O-"LQ#QPE0`5**29#^I7C7P!X6UCP/=Z!>V5C;1:9H
MDHT_41`BW%FNFVICL721$R\NV*/S"X82LK\#.*_7?'_Q9\/_`*+6;Y5X28;B
M7Q'5/Q&XUP_$F=8?PX\0,+D.?>$7#^"H8;(L@PO#^"EDF9X7)\'FM;%Y;6QW
M!N6X/*<MQ65\(X7$Y7B:6,S#,<7F7\^?1D\#/%?Z9F0<1>.5;A+PCJ8GP@X$
MQO#F18OQ:\-\7GW#OCIQ=C99IGW$KXHS2GQ/EN(SG-LAI8#$8>CQ[FN/SW-<
MLS?B]87.\)6R[!9)A.&[_P!GMO#/@`KX&M(H;>RT!-0\/:<N8_ML$%G$R^3N
M92TGE>6;@L[&1FZ@L`/@_P"*GQB\"_$CP%;VFJ^'9Q\2[;R5FU.SMO(AM5MX
MQYL&6=Y&MT<,@\Z5G*@`.'!->:0_$WXCQ^'-1\+IJ&H:EI6@2B.RUB$SB33;
M9=UL\=K=`,L5I<)$,PW)E=07"NI;`\0NKAIKBXD!`,LLK.Z,X,GF2,S$_.5P
MY.2J@)_=51Q7T'T:/H(87@/BGB+B_P`0>+5Q1Q7E/B+@N,^$>+^%>(\\RKBF
MMA:E+,\5]3XQJTL;4^OX#BS`9O@<SS;(\]R^EF%#-<-F-1XO&Y/F&45Z_A?2
M_P#VE..\3N#N&N`O"_@F?!W!.<^%.*X#XYX&XTX8X<S7@JGC\/BL!E]/,N`L
M)3P5%9=FW!N8</9KD^1\39'FF)RYY-BLJHPPF`S;`9KAZD$S%II68$,TLC$'
M.02Q)!R6.<^K,?4D\U'2DY))ZDD]SU]SD_F2:2O]/?DEY)62\DNB6R71)+H?
MX[NUW965W9.UTKNR?*E&Z5D^5*-UHDK)%%%%`C;TK0=3UN\L]+T;3-4U?5-1
M&W3].TVRN;W4+V4\;;;3[*"[N98XW67,J*?,C`=43#"J[Z7=K=W%F;2[6ZM[
MB>UDLUAFDO8[F%GW6[VS007/F1"-UGW6\;0LK&6.,J8Z^COV._C'H?[/W[2W
MP3^,OBRVUFY\/_#GQWH/B74+;P_=_9=7NM/TN]-[/9QQ'B]L[T2/%>6L@"W,
M+;(IHF49_L6^-'_!<+_@CKI7@B+XJ_#C]FO0OB=\;-9M?$D6G^%+WX.^'-!U
M30=7UZPN8=2OO%WB"\L9+6[AN[BX:?4I(A/J%S,;E[>Y1V20?P!]*SZ6'TB?
M`/Q,\/."/"?Z#WBO]*/(/$3)ZU+#<8^&O$V19#E?!_&,,W^I?V3QSC>*<%4R
M;*,KEEW+GG]KXO'X'"8/!QK87%5[U*'M?L,@X>RG-\!B<7CN)LNR2IAJSC+#
MXRE.I5JT>124Z2A*+E)RO&*@FVUW5G_":ZJ2P173:6)61U<JH/0LJHK,!@%@
M`&/S``<"(XR<=.V>N/>NM\<>)+;Q7XT\4^*+'P_H_A6RU[7]9U6S\,Z$L@T7
M0+/4M1NKRVT;3!)+*_V#2X+A+&S)D.;>WBZ\YY*O[SP%;$XG!8+%8W"2R[%X
MG!8.OBLMEB*&+>7XFOA,)B,3@IXO#1CAL54P6(KXC`U,3AHQPV)G@I8G#QC0
MQ%",?E*T:<*E2%.:JPA4J0C54)056$*DXPJJ$FY152$8U%&3<HJHHR;E&05Z
M-\-_`^J>/_%>C^'=+A\YKV>W>[5VRL-C"R&YG=EC^5?+0E5(8[6`RQ4FLKP;
MX+U7QQKVG>'=%B,U[?N-T@/[FWC.TM++\N56)3^\.X\\_+G%?J9\&O@EIOPD
MM+F1[J#5_$UZD<$]^FYEM8$P9+>TD`38A8-DDN&^\N-QK^._IC_2QX4^CKP+
MFF783-<+B/%[B'),7'@;AB--8S$866/IU<LI\59O2@ZE'!Y5E;Q>(Q6&CC*M
M&KFU?"U*&"I2A0JXN']^_0*^@_QS]*WQ*R3,<9D^.P'@APSQ#@Y>(O&$Y/"8
M7$X?`.AFU?A+(ZK4:F/SO.:>&PV`JSP$<13R7#X^IB\?.E4>&PM3NM!\!^"O
M"]K!;6&@:+;+I\-NAO7L[=)?/BB15NS=-&K"XE*^8\B%0S.6"C(%?=?[$GQ"
M^$?@GX^>#M0^-?PMT7XV^`/$3CPO?>$]6T^QURP74]?N(['2]:BAU>*^LK@6
M4DJW%U!Y),JAEC6%,`?EC\;OB+;W.H'X+:)IUV_B;Q*VF6B:H\DEK9Z:;U(9
M8F60!998X8&8NP<_/N^8@9;Z8^!UA-\&)?`LFA/)J][X,U[2-<1IKGSUOM4M
M+Z&>:*0S1B24:C=(WV5(A'Y:/C8X`Q_SG>,?AGQ56\),)QOXB\9<3T>./%C#
M9OC>#,FQ>>9Q@^*,RX'Q&!QL<-XD87C'"Y[2S/AG"8GBRCALHR>E3JY5F.*C
M1Q.-P>'PF3485:W_`$R8+.?#GQ3QOC/]&7PV\/>'I^&'!/A_FG`_B'Q#PU7H
M\)97E/B/CZ6*P6$\+*67Y?D>5U,RS+!Y1A<%G.?9]1QF9X'+:-?"8;$XK,\3
MF>.I4?Z/_P!J;]G3_@A7IWC7QU\+?VK/@AI'[)VN:/>-)H?Q+O\`3_$?PZ\,
M>.],O].CU:/7/AYXL\/G5/#5TB&9DET1M.LKNV?RK:*UB?%O'\.?L=?\$?O@
MI\?;S]KGPY\-/@]JE_\`L:?&[PE:']EC]KGXH20GXB^%/$>D+`L$_A+PG$;"
MXU[PAJ\QEDM?$FIVEA<ZMIJV]ZSQ75S-'%_1'\0_V4?@7_P4Q^$/[,WC[]IC
MX9:W9W'AB?3OBGX?\#7]\]K;6FK7^E6K7^E^*-.CB:WU31[]\336=PL5T957
M;>K&SPR?H9X9\+>'_!VA:3X9\+:39>'_``YH=A:Z;HV@Z5;6]CI>E6-JQ:&U
ML[.UBB@BB5"L)15V")`$5&+L_P#DK/\`:9<>^#?@5AN`?#GQ?^E'F?C1Q!*A
ME'B-D?BGXS<0\?>$'A'GWAQQEDN;</<;>#%;$YOBN,LXXOXDS3@_*LQQV'XH
MXFQ_A[P[E%7B?@K$<)\=97G6!K9;_P`LV8<#2H\2YIAL^RS):4\DS#&Y=*>!
MH8%XS%UJ$L;EV9X'&5L#"655L'"O2Q-*&(P:E*O/"T<10Q,*-:G.I^1/P(_X
M(S_L[?"#X#?!#X0:KH/P\\2:Y\./$>A>(/B-\18_A9X97Q!\8'\-7<M[I6E>
M(;O4;/5[M+1)V6.^ALKV)VAC"?:'E#W,_P"L'A'X;?#[P#;/:>!O`_A/P7;2
M+&&M_"GAO1?#2$1J%"31Z)8V*W`XRRW(G7<,J`0I'9K$J+&D9,:Q*$B5,(D:
M#`VI&H$:#``^5!M&`I7"X>`%`4<!0`!DG``P.223QW))/<DU_FKXN_2-\:?'
M#,LPS7Q,\3>,.+Z^:\1<5<48W"YIG.;3RVIG/&6=+B#/L8LJEF^(RN,<1F,,
M-3P.%C@I8;)\LRW*\HRJAEN59;EF78+W,%E>7Y=!0P6$P^'2I4*//2HPA4G3
MPU*-&CSSC%2DXTXZOF3E*4Y2<I2YC#U739-2TS4[.UOKO3+K4+"]TN/5;...
M>?3MR316\R6\B&!VM6DD>(RQ/AY7!8JZX^8_V6?V9+[]GO3OB3<>*?BUXY^.
M7C3XJ^.KKQIXH\;_`!!&E_VB%2V&FZ+I-M'I.DZ18P66B:/';Z;910V2-#!#
M''N9%4#ZV,:EMY+%L$!@Q1@O904VG`[9R?4D\T%`=P+.5.S",[,BE.A522,]
M"2<[B!G/.?A,L\0.)LGX5XIX,R[,WA>'^-:N1UN)\+#+LIGB<U?#>-J9EDV&
MGFE7+:N;X;+L+F-3Z_5R[`YG@<#CL92PV)S#!9C6P>`G@.J=&G4JTJ\XJ56C
MS^RG>:E#VD>2HXVJ15YQ]V3<9-KJGJ/_`!+>Y.2?<GN3USWHHHKXB3O*3;NW
M)MO75MMWUUUO?77776YJ%%%%(`HHHH`***Y_6/$VC>'8X;CQ!JVE:+;7%R;6
MWFU.^ALX;J9Y"D45M<3LJ27+#;NM0A<.2H?`W'?#X:OBJD:.'I5*U67PTJ4*
ME2I*RE)\M.E3JSE90DWRP=DK[7M4(3JSC3IPG4J3?+"G3A.I.3M*5HPIPG)Z
M0DW:.R.@K^5__@Z&_:R\1?"/]G[X1_`3P)XCUKP[XI^,/CBY\4:OJ?A[5;W2
MM0M?"/@[31IKZ>38W=M=I;:KK6I6?GN^^*YC2X%N8V8,G]2R7"R1QNC))YJJ
MR>7AD96Y$@EW>7@J01&&+`G`9@=U?@M_P5+_`."'/A?_`(*/?$&S^,0^.7C/
MP)\1M.LO#?AG2=.U"RT_5_`FG>$=(NI9=<CLM+B@MM2M]7U<3O+%=2ZJ8?,M
MK(RVLFR43?Z'?LK>/?H[>$7TX_!GQ0^E1Q%5X7\*N`,RS;B*>*_U7QW%F&K\
M8X;)<UP'!M'.,LP&$Q^(PV2X+.LUJ9UF6.K9;F&&H?V/E]*MEV,E6IT(_+\8
M87-\;P]F&"R6'-C\5!8:_P!86&J4:,Y?[3*$WK&M&G%04)1A)JI5Y91E"5O\
MW+4=6O\`5+JXO-0NKO4Y[MV)N=2EDU.]E(<N7>^O7GO-S%R<K/E]V'!6M+P[
MK-QX>\0Z!X@M$C%UH>IZ7X@M+9MT7VF72-5BN&L6,.Q8HKF.W_T@(BR`;C$T
M88"OZ;_V\O\`@@3X/_9M\6Z#X"^$OQ+UOQ=KWQ\CU/2?V=-)\2Z=;V6IZM\4
M_!&@)XJ\0_#/5M0@@M--AN_%NC&>/P5<K':1I>0&QOI+^Y)5?YBO$?A_6O#'
MB'6/#GB#2[K1=>T#5K[2M5T+48+BTU/2-9T^X>VOM/O;:X"SI+%+$\<T65;S
M!D';M!_]$GZ,_P!*[Z/OTQN`X<1>"7$"X@X;Q641JT\FS+*J_".>1X:S2EF?
M#]?$4<DQT\/Q!A\FPF;8?,^$JN,P&'JX')^(<K_L'$RPV)GAJ6-_DS.,CS7A
M[$QAF5&6&Q'M7*,X5'6@\11]E5C>JKQ<^2M1Q%/F;=2C4A53:=H_ZG?[!/[9
M_P`&_P#@H7^QI9>-O#6LVND(G@J7P+\8/#UQ<&UU+X=:^WAFXTO7X[E;]EN'
MTF_19K[2K^>\N8[G*W`NKJ%&8?Y>'QH\+Z/X,^+_`,4/"&@SWESHOACX@^,]
M`TN>_N+:ZO9M/T;Q+J6FV4EU<VBBVGN9+:VB>>:`>3)*S/$2C+7U-^Q%^WO\
M5_V)]4^)UGX-DN=;\"?&;X:>(_A[\0_`=Y=R+INK6>L:?/::/XAA#R,EGK&A
M13G['=6S*4B9X98Y44`_"$LI::1]WFY9OG>0S&0;CAVE)S*S?>,A^^3N(YK^
M*OV<?[.#,_H$_2'^FIF_#?$5?%^`WC+F_AWGGA%P]7]A5QF50A4XVS[B'*\]
MQ+C'%U\TX(QG$D>#\OQ23P^:\.XC)<=7<<WP>9+$_2\6\7T.)LAX<P]6C;-<
MMA7I8VM)RYI<M.G1I2BG)IQQ4:4<34FK<M:#@HI:N$XR<=,G'TI***_U_6RZ
MZ;]_,_.PKZ,_97_Y+;X(_P"PUIO_`*/2OG.OHS]E?_DMO@C_`+#6F_\`H]*^
M<XP_Y)7B+_L2YI_ZK\8;X;^/1_Z^T_\`TI']:E%%%?XY'Z"?Q?\`B/\`Y&'6
M/^PA??\`I5+7/UT'B/\`Y&'6/^PA??\`I5+7/U_M=#X(?X(?^DQ/SJI_$J?]
M?*G_`*<F=GX3ATNZUS2(-5S]F$T#3#SA'NC#+*D0D,92,2,65A(N"K*F6(R_
M]\O_``00^&'[(7Q<^`7CSQG>>#_!OC7XRZ?XKNO"WCRV\6Z'I.KR>%_"CAI_
M#%AI&DZ]9W"2V$6G+';W?B&#STU$K+=V@M([B&)/X-/ACX.OO'_C#1=!L[42
MK<7%O]J;=*&2RM/)-R<AS@/&CJ,_(/.&U<",)^N^@>$=`\)Q7,/A>VN-`^V1
M6T%Y=:+J%_I%Y?Q6<8AM?M]UIES:2WIBB&T?:3(K98NK%C7^`?[<'AKA7Q6X
M1X*\)7XF\<\!\;XW!X;/L)B.$Z>#S#+\JX>H<0RIXN/$6!IYOD6=UUQ;2PL:
MV%>'S>G6JU>&<,ZM=Y?@Z>!/];OV?_T3_&3Z2OA)XE8/@O-N%>"N"</QUP]6
MSC/.)L+Q#.OQMG>2\-9I_9W#N'>3PY:N6\*XC.(9ECXUL9++Z6:9G@I5,JQ6
M.<<7AOT8_P""EWA3X1>`_P!M[XH:#\"+31=)\$067A*XU+1_#/V?_A'M)\>W
M5@6UJVTN&$/#;0F4R_;8(I&1+E?]'^SPJL"_!C8W-@8&3@>@SP/PH0K'MV(,
MC&YGDFFDE9$$<#2RS2R2R-;Q*(X27^5`%.[`PE?Y#9)@L1E'#?#.0XO-,7GN
M)X>X=R3(<1GN8*7]HYY6R?`+`SS?'RJ5<15EB\PES8K$.OBL7B'5G_M&,Q=:
M,\36_P"F_P"CIX3YIX(>#W!'AAF_%.,XRQO">4U<#7S_`!LZ\I8B=?-,SS&&
M$P4<77Q6,H9/E.'Q^'R?)<+BL17K8?+,LPT)U&Y1IX<IR`,"3P`<?J1U/^>:
M;5?4[M+#3+V\8Q*+6WDDS+)Y2,YB1XSRK$QPNV;I@?E0;AY8!QZN'HRQ%:E0
M@O?K5:5&&DI>_6J0I02C",YSDYU(J,81;<FO*_['F..P^68+%YABIN&%P.$Q
M>-Q$U?W:&#PM?%UI::^[1PU622NVTHI-R2=\[`)(]WF+-$(RC\B5)5'F1F)X
MY%`0$JI.!,H!B`)P/A']IOX*>%=&TR[\?Z)<)H]RUZ$N=(<""'4Y[B1_,G@@
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M1QM"5;_'3BSQ=\)OVE7!?C#X%95X4U*7'G#_``?Q%Q3X,\0\<X[#1PT<SP5>
MCE&`XB>;9%3EFG"&.>-Q5"4LKK5<VP6,R_$4*&9RGB*.,P>$^(OV4OA7>6Y3
MXH7TGDVLT&I6FBZ>LKBX\V*X>TG>\`"K+"5AWP[%B^5@02#S]QRK%,'C=%F@
MDCDB>.4;EGBDR/WHXW$AB3C:,D_+CBLCPUX;T_P?H6E^'M+1DT_2[%+&V+.)
M)2BHJ-)*Z+%')-)MW/(D,:LQ8B->`L>M^*/#WAU&?6=2CMY"#(MM`KW-PL62
M1.\<09A&`"2#@@=6R#7Z=](#Q=XK^DKXU\0\986AF>9U,;C*F4<&9=A,MK/,
M\%PAE.)Q]#AS`RPV7QQ-6.-C@:]*OCZL%3C/,,3.K*M1]G3G'^WOHO>!G`_T
M0OH[\)^'^9XC)\HC@<LI9SXA9SF&:49Y3F/'>>9?ETN+L;#&YE+#7RVMC<)5
MP67X65*:EEF#HT8X;$0=2*YCQ1X*TEO`_BO1O#N@:=;76HZ;(L4=G;11S3S^
M7\I+2K(&(8<$`?>).3BOQ^U[PWJ7AJ_O--UW3[G3M0M95C>UF81MECS(A,#*
M\.#E&!'RJ6P>0O["P?%?X:W.F2:I_P`)CI$5O%-<Q^=+<"*>'[+O7RI+4L)F
MDG*CR44A_GP<E2:^'OVGO%WAGQG>^%]5T+3YDG:*Y6YN;RTFMKN[M695LIA*
MYCBFMWA=980(1(BD,TC+O4_Z'_LW>/\`QDX2\1>(?#/C+@CB^OD7'^8U\PS;
MBOB>CG^#SG(>)\@X::P:KU.)?8_VA@L9E&$G@ZM#`U,PJX3$5<AQN*Q&$RV&
M`I8W_*+]K7X<_1WX]\+.$_%SPZ\3O#C"\4^&N7PR?(N`^#\?P?B\IXIX3XFX
MSIPS!X3"<(UL14RW-,IXBQZQ=*6-IX'`8R"S_`3PM;,56EA_CAAM9ESG:Q&1
MT.#C(^O6FTK`!B!G`)`SUP#@9]_7WI*_W*_K>_XZ7];*^]E>R_YQOZU5G]W3
MTZ;=`HHHH`D63;_`AR`"2&+$`8P'W;T![^6R>@P,"GF=CNW*')544EI08T7@
M(H210Z[<*?.$K$#))8EC!12:335DE+E4E%<BGRN\>?DY.=KO-S;3<9.46XL_
MK[O6_P#EY&G;6:W,T*E)(XYV.95,<<,>5=BJHP8[(SL.0Q_=@@#<RA?0/%WP
MKUWP7I^D:WJZ0-H^O00W>F36]]&\YM[F,3P^=$;;?YGD21,_EQD!MXP`01^U
MW_!(3_@E]^S_`/MR_!O]I+XI_&_XB^*_A\?A%IDEOH.I2KHVD^`(;N;1+G48
M-4U/7=3\^2]31Y+9'U?3+5+6?R+FWCAN;:5VD;XGTOX=7'Q;^$FI:$;C3-43
M0-9U72?A?KD#[+F]TS0)YM/BN-58.%$5W:VJ/%&!#(B$"66X.3+_`)U^(GT]
MN`LA\8>*^`.'LXQN'R_P$\1^!^`_I'5,]X3KX/`9<_%CAC&9GP?5X%XDK4ZF
M59K4X=Q'U7'<81PU>%;+\EE/$4<'#&8)X*O_`&I]&?Z,E+Q\R;Q$X<P.&S',
M/%7$>'&=<=>$&7Y/B9RPL\1P5F.`QF?X?C+"2P\J/]G<4Y14J\.\(5Z6)YH\
M;5,#E>8TJ.'SS"X["_*'P$\::)\.?B%;:_K\M['I-O#>VA-I:2S23-*NW:\1
MW.`^!N"K%M/#$,#G[[^'GQ]T/X@^+-1\+6>FS:>D5JEQHEU/($N==4*WFQ0Q
MO$%1XE4.T1+NJJR"21E)'PAX,^!_C#Q9XG\1Z!816-E)X6N&@UC4=2OGCLX;
MR&8PR106]M!<7%S)!<K*I598HBP#,BH/+/VQ)^S]K&KW?P_NV\>OX<U#POIE
MMH\VJ:5X>MY;:WN[IH;&>_AAC>SO+B)+8S2S?:'$\DC-M2`GRE_`_IV_\2A\
M3<88C&<6<;T*7B5Q!X?QR?!9W@LVXGS++.!*67Y#B.*N`>(<3PKD>15:N:TN
M)ZV;2R:=+'XR6*P&0YE#-<!@I8G$82B?Z+?LYL5].W@7P[AA>`_#S,Z_@]P;
MXH5^)<SX;K<-\-Y;G?BEB,5G]3@[Q.X4ROC#BCBO"1RC%<%87)JF<X&A@N'L
M)A\SXORO^R:^<8G#8?,:4/"OVI;]-%^)7AO4/#,+6OB>'2+6[.K6\[7<TLD]
M_);6=H;00R*+U8/*$2[B!&'C*.P^3^G'_@EG_P`$RO!_[8/P*\'?&GXN_&?X
ML?#/XE>&O&$-SXR^%K>'?#FAV:6NAZ@DWAG4XY]:TR[N[[1?%-G%'<;%>&4P
MSD%K5S&K_7W[&?\`P;J?LC>&5^#'[07C[XK>//V@-?ANM$^),"70L])\#^(?
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M*JQL\<2HJ[$6-C&JG:"P`(O@D@$\$@$CT)Z_K7Y\?L+^&/VGO!GAG6/#?QSM
MS!X>TX06_AE-9U)=0\16D<*+$EN][#(+:6SMX42-&%L78(K/<RN0S?H.HPJC
M<&P`-PP0W'W@1D$'J,$BO^5CQH\/\+X7>)'%7`V`XZX2\2L!D.:5:.$XVX%S
M.GFW"^?4*\(XJEB\%BJ4ZL*>(<*SIX["JOB7A\51K4_K6(456J_!X#%2QN"P
M^*GAL3@Y58R<L/C.;ZS3E&3@XS<W.<DU&ZG.<I3YN>3<IR;6JWVA0S*2ORL5
M(;>DA_N^7&4/F@]F5@I'(P*6:8VZ2RR[1#$K2O(`S%(8X?-?*`[G?Y6"[<#D
M?*2#G^2O]OC_`(*K?M*/\:_B;\,O@QXQF^&OP_\`"'B%_#^GWVEZ;:_\)3JU
MSIT2F[N[B_OEO(H+2[N5=K:"*QMYH;<K'+++*#*WN>!W@/QCX[\0YAP_PK/*
ML''*LOIYEFV:YSB*U#`Y?AJF+I8.E=87#XG%UL16KUH1IX?#TN:4%.I.I"G!
M\W]!_1]^COQW])'BW,.$>!JN38&ME&4O/,VS7/\`%XC"9;@,O6-H8&$G]4P>
M-Q>*KU\37C3IX;#TH5)QA4FJL%"TOZTQ,PQO&PMPH,<@.02#GD@GC[BGKP&/
M!/Q;\4/^"AO[)GP9\<:I\-_B+\6]'T+QGHTMK#J.D_8-2N3;27T7VB!99K>*
M6!)$ARL\'FF6.8%'".#&/Y$K3_@I9^W):22.?VB/&]R'AG@\J\;2YDC6?=EU
M*Z=&YE0ME)'9OF`9@QKXZ\5>+O$OCGQ%J_BWQCK6H>)/$NO7MQJ>KZSJES+-
M>WVI74SW$]]*R-&B3/-([B.%([:/=LB@2,*@_N+@3]G).&8Y@_$SC7"U\I^I
MJ.64^!UB:.8/'NM%NIC*O$.6/#PPM.A>T*4)5ZM5VDX4]7_HYX:_LEL^>=9A
M_P`1>\0<J7#T,O2RE>'57%O-J^:SJP7/F$N)LFCAZ.7T*'M7[.@I8C$5ITE*
M5*G2ES_Z"WP;_:3^#/Q\\.GQ5\*O'FA>*]'C>;[5]EN4@U2QCC&X37^CW#K?
M65H8RK"^N4CA;D!%P=OKMEJ\6HV]M=V,]G>VEQ*-MY9SQ7%D\)9@K6]U%.\5
MQD;,/&<N#O2%E8;?\XO0/%WBGPHUU)X8\1:YX=EOX)+74)=$U;4-,DO[:0$-
M;W;6=Q#YL6"0$P.#SFONO]D/_@I)^T%^R7=1Z7I.LKX]^&\KNUS\.?&%_=WM
MA'/(`KWNDWDMW%?6%R,(4'VN6S0K'FU*KM;DX\_9RX_#83.,?X<\:X?.*]&I
M&KDW#?$&71R_&8S#^SE*MAZN?T*_U"GBH32]A.M@Z.'JQTFZ,TD_%\3_`-DU
MQ?E.!S_-_"WQ%P/$CP]6.(R'A/B++EE&<8C!1C*5?!5>(J>(Q62XG,^9*.%E
MB,MP>%Q<7[*53!XCV51?W/Q.7BC=AM+QHY!&""R@D$;FQ@G&-S8_O'J8S*V_
M'RQJ"1N<(^\@XVKMG4JQXQO7V//%?AM\&O\`@N?\%?&U[IF@_$/X8>.?`VN7
MT]C8(^G/9>)--GNY[>-I)4F@>"2&W,[-Y?GC?Y;*6)();K/'_P"WC\4[_P`9
MZK<>`[BPT'PA;EHM'T[4=%M;F[U*-IF$.H7DC2,\33Q;)C$L@,;-LW/C)_CW
M$?1@\8LJSJODW$W"\N%:M.A5Q-+%9SB<,\NQ<(5734<#B\!B,PIXMR;BUR\G
M+3:J5%"_*O\`/W/OHS^-7".<K(N,^"<9PABZN&JXK"XC/J^'IY=C:%"JJ52K
MEV99?B\TPN,BI:-PJ*44TJD(5E4IQ_5+7OC/\-?"WB6W\'>(_&.B:-XFND6>
M#2-0N!!.UM(Q$4K.6,2>8NU@2VWG.2"#74P>-/"MU+';VWB?PY/<RM^YBMM8
ML;IYP<[5B6.X0ER-O')R<;>E?SH?$_XC>)_BMXJD\6>+I;&;7%M8=/-SI]G'
M;IY-J-BF,N9Y%+D%GV2K&<_(B+@#CHKN[BF@N8;V^@GMRKV\D%[=PM`X`VM&
M8ID(9<#!;=TYS7Z#2^C%E];+\OG5XEQ6!S1X&+S*E'!8;'8)9A^\<OJE15,/
M4>%:=**]HG/24KIW1[E'P`HSP6#J5N(<1ALP>#C]=I_5<-B\&\<U4;>&G"5&
M?U:,722<USSDG.2C=Q7]/=WJ5II]N;N_N+:RM@"6GOKF"QA0#D@RW$@5R!W&
MU6X*G!%?F5_P4$U_P/KOA3P(EIX@TW5M<MO$4ABT[3-8CF_T2ZC\Z&XECMF>
M&-XSM:.<*LP!YDD"AA^;VN^//''B>"VM?$/B_P`1ZO:VD$-M;V]YJMT\4<$"
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MC_;9BTBYAFCP`SVKR+<&8N!D1&3+J>!U/\\:`Q@!6=2$6-75C&RQJ-H0>7L!
M`&`2P8G'))R3JZ+9:??ZQINGZQJIT72K_4;%+W6-KWNGV489-TEU:*ZQPN@/
M^DW%T98RP=BG\(^KXV\%>%.,L55S>E6QF09FE"ICZ^5X?#3P^-PU&HY5JE;+
ME0:J8R490Y9T(2J3J^]]6Q4WR3]KB[PGX:S^M6S>-;$9+C%253&3P6&PLL-7
MA1C.M7J3PT514<2Z<:D5B(24>?WY0DIW?W7_`,%F/#GA;QA^P1XA_:`T3Q18
M:1XM_9YUKP5^T/\`!OQC%>-%]L\1>#]<M]6L-'@N08Y[:V\2P3363_8);2\G
MMS%;B\BC,N[^';_@JKXOT_\`:?\`B'X._;N\)O\`#NP\._M(Z';WFI?#OPE>
MVB^-?AWXY\)6D.F>+[7QSI$6^Y>[US7&O]2MM9S&FHP-Y[('`>7^CG_@X!_;
M9^`WA;]A;2OV+OAE\8O"WCGXH>+=6\%:9KVD^#;FSUB.P\'^&!'=WUQX@O\`
M3Y!I^C3ZA=P11?V>N9((R]G)&DD)N)/YG?V&/@9\`?$WP]^)WQ=_:OETC2?@
MO#)!X2T75+/6;I/%.G^,GMGO+%K"TL[I'$,L)6(/=VEU;.6)G63EJ_Z0_P!C
M7P!F7T7OH<Y/]+;Q1P/B-@*_#?C=XB\%^$W!5/@/&8KCKQ$\(?%&IP/@*W!O
M"'"V:3X=S'&SXM\4N%<N\3<CK8;+<SSBMF'`G&N7<,X/"X/B3-I8G_-OBS*G
MQQQYB.!N'L7E<,/5R_$XNOG6;XV.!P.61R>MC:]/,,UQL)>RP]*.`]EAL7*7
M)"E*O&G*%248>Q_*]S)%B,,I>"0CY<MAQA)`K/NRC[>5/RXZ*`0*C)W$MM5-
MQ)VJ`JKDYVJH``4=``````!BO1_BFOP__P"%@^,$^&$6IP^`XM>U:'P>VLR0
MR:E<Z1#?SBPDO9(;:UB:1[,1L-D$)&?GW$@GSE\;WP"!N;`)!(&3@$@*"<=2
M``>P'2O^IC(L=#-LIRO-HX#,<K_M+*,IQRRW-\-]5S?+:>/P&'QM'`9M0E4K
M2PV:X6G75#,<+[>LJ6*HU4ZE11I.'\VXW#O"8O%81U*%:6$Q6(PTJ^%J*OA:
M\Z%:M2E5PM>+<:V'G*FYT:D6XSI3IS3:FG)M%%%>P<@5]&?LK_\`);?!'_8:
MTW_T>E?.=?1G[*__`"6WP1_V&M-_]'I7SG&'_)*\1?\`8ES3_P!5^,-\-_'H
M_P#7VG_Z4C^M2BBBO\<C]!/XO_$?_(PZQ_V$+[_TJEKGZZ#Q'_R,.L?]A"^_
M]*I:R8(%E9$(DW.70*F"V\PI)`,;>1,S84#)8'`Y4D_[70UC32M>2IQ5W&*;
MDJ:LYSE3IQM%SJR<ZD$J-#$U+M47&?YU5TJ57T52I?R]^H?=?[%^A2&Z\5>)
MVCC$5K9VUC#*49IDE89D>)@1MWAL,-IX!Z]:^]&78S(/X25_[Y./;T]!7Z)?
M\$^O^"`GQS\4_LP0_''7_B_H_@[Q'\4_!EKXP^'/PUN-%N[BWBBGLTO-/A\8
M:T)/+MY+\2"!8[**%H6^9V9`S5\%>*?#FK^#_%?BOP3XA6WC\5>"O$NK^%?$
ML%G.+JR@US0M\&L06MTH5;F&'48KB.*X`42PJC>6N[=7_(O]+'Z0_A5](GZ4
MWCGF?A5XDY)XB8/@G/<JX4S"63X7.,&LGP^1Y;3R"%*G'.,%@WF.!H9_EW$6
M55LZRM2RC%YQAJL<,I<\,7C?^M/]D;XQ^%-?Z/'!O@?E-7,<G\3.',OXAXLX
MGR/.<#3PL\X_MKB:IBL5Q%DF-IR5',,MAAL9D-.IAY^SS#+:,Z/MZ5:A5HUH
MX-%*VW<=N=N3MW$%MN>,D``G'4@`9Z"DK\!/]>4[I.S5TG9JS5TG9J[LU>S5
MW9IJ[M=E+,B>21-&DD307,1B=5D1DNXU69F5]PW%5!'0`EA@@X"4N<@J0"#V
M/-73G*G4A.,I0<9*2E3E*%1-.,DX3BU*$DXIJ<91DFE9HSK4H5J<J<X4YQE&
M47&K!5*;YHN-IP>DXN[4HM-2BY1DG&33S/`G[3_[77A[2_B%\*_@Q\;_`(H?
M"SX.:9;ZSI\?@?2+FVMM'\0>)+I9DOX="N[RTNKO3["8!S<):7<:@D_9OLR_
M*O[$_P#!)G_@D_9_MC_LRVGQS_:1^*GC33+C6?$'B;1?"6@>#;W1S<:?9Z1=
MS67V_P`0:]J$.HWFHWHN%4&RN9DD`3R[@R3%Y*_(:Y1;JUDLG!CMY(&A*0,\
M15G"![A71@WGLB["S%D",0L8(0I](_L_?MX?M`_L)^$];TGX+?$K0?!WP_U*
MYFUC4/#?C'0+;Q9X>L=0D!ENIM`L]18365[?RNTVHN9[O[3,P*QIRK?6^,O$
M7B#XF>%><>'?T<\JX$\+O$[/.*_#7&93G^&X'R:OQ/G.#X:R7-<GXCAG/'F7
M\#YUGV:\2\8YYG5/B+-,XSOAKBG,LPEA<!P[#-LMRW!8"M4_QF^DG]![Q!X(
MRW,/%'P!XSK<*\79CFG&V=^+^99/QM1\'<NXJR+B+B;"YYEV!A2P^88/AKAW
M(>`<%@LMAAL+'/>&<#B\+E^9YEBZ68<0YIC\34C_`&O?V>)OV1OVA/B/\!K[
MQ0OBO3?!\/A[5M#\77IBTN?4?#_B&R:_MX=7M1YT-IK.GVX2/4)XYC92W3'[
M-%Y94G\^]<\?_#S7)M:\-^']5DO_`!!/I\\%SKMC9PWECI$")L$]QK,T,UBD
M*(06A$#.J''F9(8_.W[4O[</QI_:5^)7Q1\=>/O%<'B;5/'FH6XU'5O[,CL&
MFT?3C+#IND6-K;M';:?I5E:R1065O;P)/!"B1O<2,A)^+8M6U&S^U0VMY<V\
M-RHBN8H)Y8H[A4^4F98W7S"_)<-E,LP5%7"C_63Z,G[+_C^'`.0\3>.?'=#*
M/%"?"W!6+A@^$L-4CE%?B!Y=E699KF_%E"O0RS$SE',Z->GB>#\'E^!R[$XR
M@HYKB,/@*V-P"_ASBG]KCQ'PUP'X?>%%/(\'XL9KP[EV<\/^*_B-Q-*#QF?5
M<)C>),FH8;@#$Y=B89=4J5,@Q.4X27B=65+-*^(P^/SG)<ICBL?@\?5]'OYK
M?P/XV,L5UX;\<)97%Q=?:',TFCZG<L[%99(K5[<R;F!GC4,NTM^\W)P?0_&O
MQPA^(O@G^Q/$OAS3[/Q'93&:PUC2T2VBCL5`\C3BCR2.R+'A"D84C;A2`>?F
M=IW8L2$.6+8*Y`).3C.3U&>2<]\T>>V&&U<NYDD.7^=VY9V7?L#,V6.Q%`).
M`!@#_73,/!/@_/LTX#XGXFIXS/N./#NEE"X=XVABL3PUF>%J9;456<:&0\-X
M^/!>7X+&J%+#YEDV7Y`LLS"C2H_69XR.%P.&P7^5&6?2'\0.&<E\2.#N"L;0
MX7\._%*6;QXFX!GA,'Q5E%>AF:I*@\1G'$^65>+LRS#*%3E/),[S#B-YEDU>
MMB\5EV'PV+Q^88C'LD"K)(JG*J[!3NW94,0#N(&[(_BP,]<#.*92DEB6)R6)
M)/J2<D_G25^OI))**2BDE%*]DDDDE=R=DDDKRD[)7E)WE+\(;NV]KMNU[VNV
M[7LKVO:]E?>RO9%%%%,04444`=CIWC7Q?I6AWOAS3?$FOV7A_4,'4M"L->UR
MQT>^2:...X2^T:TNK?3+[[=`D4%T]S;7#SQ(B)*NU6'UI\#H=2^(%C:>'(?B
MMK'A*YL(R7\*Z=HL-E'<V\<6RXFBN0KN+F[56>YGW1J[,Y6VB8[1][_\$7/V
M(OV1/VWO$GQ,\!_M/O\`$S3]=%OX;M/A=JG@.ZGMH9=5N[MH+NUU4K97\<L2
M6Z#R(X19S*1F6:2/$8_HTM_^#9/]ECP%K>H>._`OQ^^*WA"33+._NXH/$ECH
M.IZ-8Z7&&:\NM2FF@TFX\J.W3S2SWUNR1JTLS,WF-7^&O[17]I%]$;P.X@X[
M^C]XA5_$'PX\<<CR_"<8\%9Z_H^9-QGP?QMGN:Y=@UEU7`YMF^#XEPV,CC</
MBO['QV?SX=EFV6X[`4\-@L=5K?5\'+^S_H;9^^`O%3@_B;BQRQ_A1G>9X3A_
MQ!P>"XOXVX=Q^$X8Q..YLQQ^&?`F?<.\05L7E7LYYAALHIYF\KS24L10S'+,
M;&M1E0^!/^"4?_!-#P#^V%'\2'\5>(/%/@[X?_#+5?#^G72^"KK3X/%'CC7=
M;L!>7DVK:I=VDCZ;%8R`^=.D`DEF,FV5P%>NC_;(_P""87Q#^`OQ\3X;?`:V
M\3_&KPMK?P^U7XJ:9%)!8W7C+PGHNA7[6.I:!JTL*Q1Z[;O$5N]-\0*!?SV\
M12^M;N]833_GM\6_^"@>L_\`!,/]J/QKX=_8.^.6C_%S2(M-/AGXB^*-3\/W
M$W@CQ#KNGW,MK+8+I+R-:W6L>&KJVDLAK-AJ%QI\J(2CWD/ELWT?\#/^"PGQ
M03XKZ_KO_!2S1/%&A_#+]LOX*1^"?!OQA^'^DZGX3UGX4>!;ZYDM]0O_`(:Z
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MD7^S%^V;^T=^P'H7@6Z\8_&;X??MX_\`!,;QCXNTOX?>"/VKM!\;Q/\`$3X&
MS^)?$)L='@^*=EK;PZO?W.AZ5-9OXAT.:*VU"WEFENFU`MYBGIO^"H_Q[^"G
M@#XR^)?&GB>_T?PGH\&GZ#9V=YI=S!>+X]O-2@%W!JEA-IUQ<Z7JTUU&1,+N
M.WD\JVE,MRTQW2U_*/"'T,<1XT?2XQO!/C!P;PSXC>$W%'"_&O%OA?QIX"X6
MOP3B,VS_`(#S'(LNSSA?Q&R_-N#LH\;.'_$/!5^((9#QAX6<891P]Q9PUG^(
M6/S3#XWAR&#SW$_SY](SZ46;>,^.S7BW$<)<!>'U7^V</B:^6<.<(9!A<;0H
MUL'7=2>-XKPE.GF'%OUE4_K;S&O5GA76FI4L+0Q$VH?M?\,_^"@OP&\1^'/A
MDGQ+\;^#_A%\1OBMJ5[HO@/X:^*_$>G1^)?%FHVDD8@@T&S@DN9KBPNPYL],
MU*XCMDU6>!Y[:&-)$@7K?`'[<?P8^)G[3_Q+_9$\'_\`"5:C\6O@_ICZQ\1)
M)_#LMAX5\-:>9GALVNM;GNBLK:DR#^S6AA(NUDCD,<"MQ_F_?M(:1\6?VA/V
MA=3^+7@V]OM*T&SET'_A%M72\_L^\\'VVBA1I(T*XM$@NH8M-D5-1AN]/DA:
M>\9KC<(O*BCV/!^F?M@?!/XJ_P#"]?@]^T/XBO/BB+E;F^\17&N:N^H^($CE
M>1;37Y]:O]0A\0V!+GRX-6BN?+4J\!B=4=?W7C?]BG]"VM1S_&Y'],CACACC
M;C;@3B/,.!_#_BV'$5#A_P`-/$7'<3Y9F/".3\5<1Y/@>(LQEPKDO`T\=PWF
MN#XLJX3/<9Q+6H<1X7%/),J>28K^'9?2LX*P&-P.79MG654YNOAHXBI3Q$*M
M66'A2JPQ'UE*E4P^`Q52MR550KXG#U)46IJ$86;_`-2<M'^\EEE"IN,BF1&5
MHX4M@9D=&R!A0Q9"&(!;."`*_P`_3_@JY^T=\#?%'[>?Q`\-_LR>&_$'B'4K
M?4-0L/C3#<V+:'I.C>/_``_<OIOB<Z'Y\*M?13I`\IO`S6]S?%WM0(&CMT_1
M[]@K_@K7^VIXM\<?#SX9_&_5_`EYXA\<>*+72]0UG4KU9=*L9+H!XXS:P)'/
M9236P<W*?;9HTNQB%U3:A^??^#BW]A:Q^$7BBR_X**_!'Q1H6C-XGUSPOX4^
M*O@O2)[:WCO/%5[%]HMO%6F1VH=IH-=C;S-=BNA)),6AEC%D,)-^!?L^?HF\
M"?1\^FW4\"_'KC?@?C?BKQD\.>+>$_H]9SX=<:<8X[PESSQ8PV/IT\JR;Q"I
M91P;E?$]7!9O&AF#X&Q."S'#82MQ;DF#GFE>629A4IU?Z_\`HY_2UQW`N=4/
M%;PDXNSW!\,99G6"X;\4\9PIEF1YIG-;A">*R[-,ZP&44N+L%5X;JYHJ&'PF
M,PM7$T)I8+%8JK@L5AL36PM:'YHSQB*0[RD2EV0*9`P+HVUQ',JLDD88X20`
M@C!YR,Q@#(+`[&)"D%2!Z98XSCN=J@C!&,XK)_9_^)W]J^!]#\9ZK:Z5JVM?
MV?=VUS>BW>YTL:IA`C7&EN'NHYI59I)6$UM$TQ+1PV\?[I?J;0?&GP6U[3H]
M/\=?#NZTJX#*EWXC\-7G[ZXO-H%U?O8OYQ\JYE#SB&WBA5`XC0*%"C^S<W\+
MZV0<3\1\%9_Q%D.2\4\*\2YQPWF^!Q?]H0R[ZSE6,Q.#JRP&>+#+!XN56MA5
M/"4EA\/[;`XBEBU75)QB_P#6#&_Z0?\`0VP7&RX5HY)XHXG*HX&C2Q'$F893
ME'#DL!Q%2S7'8',LCQF5Y[F"H3='`X;!YK@LPP6?8C#8^CC705++J]*-&O\`
M-S*%)7)W`D'T!'!_7T)'O3P<HNX)Y8<J?DBW,W&-CSLFY@<@QJ`"W`D(&:^N
MA^SOX)\;64>K_"KQ])<P7<MREOI.O:9/%>QO;LWFPJ5CMBJIC9&LOF2``"26
M1@6;[7_87USX7_"J^\6:!K_[.6@^)_BO:VUU8ZAXS^)]H_B;PK?Z(Y:*S_X1
M;1+NSCL-,O?)57NYG-]*'(\IX]M?EGBU@N(?"/A;&<3X_(*/$2IQP,LOP.3<
M2\,WS"ECZWLH9C2Q$\TQ%2GE=!TZW/BY974YJL%AXT74FIK^I,1^UF^B]G>4
M\%?\0YJ<;<>\5<?8G%X#AWAN/"6>\-Y='-<+E^#S6G@L]XWS;*\;P?E4<QR_
M$8C%9+7H9CFM#-/J-94ZV`O0C7Y#]D'P;X>M/A:-<@AL]6NO$>M.TIU/1[%;
MC2KS35\J:.*62"281HP=2\5U(KE<QR;2,_7";%4"((%9<,R`@2H1P,,6VIC[
MJILVC@=!4TGV1+FY>PTO2=&LY;V\O(-)T6TCLM(L'O)I)GBT^VA6,1VT9<QP
M(>%B5%VC&*B`P`!T`P.W3Z<?E7^=G$V?UN)<[S/.JJKTEF&,J8JGA:V(6(6$
MISC35/#QG"-.BU0C'V2E2H4X34%-1?,F?R#X@<98KC[C#B#BW$+%THYYFF)S
M##X/&8R6-K9?A:L,)'#8*6(M3HUHT(1J0A*CAL-"-.$(^R7,E!GEJ.%&T#@*
M"2`.P!;+$`<#))]23S3QP`/2BBOG]]>Y\<VWN_Z^204444"/#?CI^T'\/?V?
M](\.:EXVNYFNO%?B;3_">@Z38&":[O-1U",3F\NF:5/[+TZR@):>:YBD$Q&Z
M.1%QEFF_&7X9?%KX?_%VX^&7B-_'T7A;1M;\/>+K#PIY;WGVR\TRX8:7#,LY
MWZA97BFU6YMHW!\L.H8E6'CG[6?[+/P`^*\,_P`:OC#X2\;>*[KX:^#]8N9=
M#\':O>:?=^*;6UMWM=*B6SBCN(9;G2V2.W2:UAMYI+=`+AII"TK?RO?#[XP:
M[\&OC':^)O",GBGPAX8TCQU9:O/X,34M2L+B/2-*ORL>CZ[:I-#_`&A>VMB/
MLER]^DMQ-,I:X=WD=F_V*^AM]`;PG^F'X+9GG?AAQAX@91XY>&:P&<<5OB+A
MO)Z?AMFN?UL]EG&3\$955P'%V*XMQ52IP]PWA<'A^(,%PUEV#PF=\5T,;F&.
MQV(P$.'J?\I^+?CCQ)X4\8X'+^)<JX=Q'!/$_M,!ET\!CLPGGF`R]X&IE>-S
MW,56RK#X":GF.8?7IY;'&XF6'H99]4PL?95ZF*?D'BRVOH_%&NVVH:9JFFWB
MZYJ5M<:9J@N7UO3G6[F>6UU<S^7.UW8L!!+YZH[O$6GW,SLWW]_P3*\'>$_B
M?\=KWX:_$3P%<^._A_K_`(/UZ\UZU>\NH=/T)[+1[FZM_$B6$)$$NLQ%`--\
MPD)('0PS9<CH?CCXA^$O[9G[8&H?$[X<>"/'$GPU.A:#X@^*.G:#;Z9:>)I;
MRTTY#XINM)L%CC,B7VJO=.^LFVN(Q#(+B2V0JM?1_A/]OC]G?]D;PKK?A7]G
MO]GZXLO%VMW4OVR_\1^);#Q"L>F7NG21Z?+?^)+"TLIX[\6[HU[HUJD<=M>^
M;;I*JQ[:_P!TO'SQD\7/$?Z/&6^%/A9X`^)4/I%^*/A/PCB<=P]@.*LBX9I?
M1[SS.*&#4,?Q?XB?ZQY3GV4YMP]+AO$Y_D-7"Y)A,3C\KIY95JY@\MK9QDV)
M_B_@/A3A7(?$+%<8\1\></\`^H?#W$^<4Z>8ULMS?,9\>82E*K-X?+<GAEE?
M!U<-F:S5X7$O&8GZG3KX6OAGAH^UPU:E^+OQ(LO#>D^.O&.E^$5U/_A%=.\1
M:Q8Z`NM@+J\&F6NIW$%D+U5B@"7GV18ENEDB#K.'#8.<<*_WFQTW'ITZFNC\
M7^)KWQ?XJ\2^*M1@M;>_\2ZWJFMWUO:)*EK%=ZI?37UPMNLLDLJH)IG"B21S
MC&XD\US5?Z1\.8?&X+AW(,%F<\16S+"9%D>'S+$8O'+,\57S/#Y/EF&S*KB,
MQ6'P?U^K5QN'Q%2IC)83#/%5)5,2L/AEB7A:'\XYG.A5S/,JF%Y/JU3,,=4P
MWLZ'U2E]6J8S%SH>SPC;>%@Z4Z3AAVV\/!PP]W["[****]DX0KZ,_97_`.2V
M^"/^PUIO_H]*^<Z^C/V5_P#DMO@C_L-:;_Z/2OG.,/\`DE>(O^Q+FG_JOQAO
MAOX]'_K[3_\`2D?UJ4445_CD?H)_%_XC_P"1AUC_`+"%]_Z52UBQSO$Z2+]]
M&#AB6SN156(G##!AV*8BN"&'.X$BMKQ'_P`C#K'_`&$+[_TJEKGZ_P!KH).-
M-M*5HQ:4HQG&_)%>]":G3EHVK3IS5G)6M*2E^=5/CJKI*=1-=U[2IO\`TC^I
MW]D+_@YA^+7P!_9U\!_`WQ[\'-)^*/B7P#HD7A3P[\19?$-UI"KX?MQL\/KK
M^AQDKJMUH5MY%G)/:RV(N(+>-64R%I6^1+OXNZ5\2_B9XGU/Q%-,/%?Q)EOO
MB]=:_;!8=&\17_BM!J6O:=H\8MR$O;34+U_-B#,L(5E,:KM"_A&)Y`,!F'"A
M2))04VJJ_(=^4W;02%P`?NA1Q7W9\-OB,#\)_#7B2;2HKS6/@1XKM;@V4%UF
M\U'PGXCA5+FXVL99VBM955Y-DD80J%D^4-C_`!,^D)^S!^C5X7U<_P#$?P(\
M,'P9Q1XQ\89KEO'-3*,^S#^RUQ?QA5SO.?#W,:.6YKB*V39)PNO$^-;*<TR'
M"U,NR:G+Q/6:5L?AI9#E-$^JROZ0_P!(CP4SSAWC?P3\6.*>`^),JPN+X7P^
M(RM97B,OQ5#-:-/^Q\-Q#E.:Y9FN7<090\WRO+<JQ679EA7"&"S*>-IXVEB,
MLPD*WZ)+I]BUG*#?,=5C<.T<46ZU:-U+B.-06D>1!^[=Q-@/C,2YP,B6&6$K
MYT3P!P&1905=T895@,#&X$'!!ZXR>M4=&UK3]:TG3-=TJ<76GZG;0WMM-:2E
MHW^UP17"1Q,,`74`D"WP8-$)5D6*"!0JB;Q)K]EH_AK7=?\`$-_'%#H>F2RP
M32NB+<W"1E[>",[1Q("J`@%N!D[NO^..'X;SC'9]2X7HY3CO]9J^=4^'J>3+
M"5*6-6=5<=_9L,LG@9P5=8WZ_"IA*M&R<*\*L;<L.9_Z8?L]?V^_B7B/$?+_
M``@^FS7RK.<IXYXUS'"9?XSTL!EW"-3PR5;)J]/+.'\\X/X;RB.!SGAR?$^7
M4L.\VCB\)F^38?.%#V>;X.%-X694!5B6*LKD>48V+,N>"IR,Y&"&"E6[#!!I
MP$2AYIA(MM$&EE>-D<Q0Q<2F9SL$4@8,"I1A%D;]V#G\C?%7[17Q0U_71JL6
MNG1Q:.T5M:Z/]HM[3RHI#Y>]9[BY:1O+`4G>J$9*QJQ7&'J_QN^(FNZA;ZI>
M>(;R":"VL[$M837%JC16<T<QD>W$[6TT]Q)$KW+SQ2"8[@%4.X/^G>1_LE/&
MG%TLKK9[QSX?Y,\7EM?%YK@J"SS-\;D^.I3H-95'V.#P-#,*E;"U<2UC<-4A
MAL)C,-&E4I5H2C5?^EW%7[<GP"P,L[H<+>&?BKQ%+!YC'"Y)C<14X;X>P&?9
M=.G7]KF[6)Q689IDSHU(4(T,LQ>&K8O$TZSKK%822G3A_3_\+?\`@F'^VK\9
M?@Y9_'+P+\.O#\_A+6[8:GX1T+5_%4&F^,_&>AM:?:H=8T+2Q:W-LMM=(/,L
M4O[NUENXV0*D<A*C\`/VF/BUXAU#6O$?PGU3PI+X8F\(:]<Z+KUEK*O_`&[:
MZMHT\EIJ-K*+:X:U@$5W;31RQ,)L'<D4S@"0_P!7_P"R-_P<G?L^^`_V/_!F
M@?%;X7^/[CXK?"OP1I?@F;3/!VEZ2?"WB>;0M,2PT/48KQ]3M)=%M+THCZA`
MUK>S0H3YLTLXD9_XP_CO\4)?C+\9/B=\5Y]*BTJ?X@^-_$?BR;2PQE336UK5
M[S4$LTD0JLCVR7(CEE54BED5GCBBC98D^%_93?1_^D?5^DM]('$?2O\`HT8+
M@/A[P5SC#Y;X-\75*6:X#"8GBO"<1YG['&8%RXAS:CQE3Q'`E')^*,+G[PF!
MP>&K<24X2PW,Z&693_EG])#]HO\`25\6>`,PX+S/Q"CA^"O%&68X[-,@P7!6
M2Y+5J\(8FK/!1X>R_-YY=7Q=3AZ&+PGU+&1]OF&-Q&/R_$3EG=-N=)^132-)
M*\C@%V>1G.`-S.<EF"[5SG)^554$G"@8`C)R2<`9).!T&>P]J&;>S-_>);\S
MG^M)7_2"K.\E?WWSMMN3;DEJW)R;=E&[;U:;:NY.7^84I2E*3D[MMMO35MR;
M>RW<I/97;NU=W"BBBF2%%%%`!1110`445MZ5H5[K=]9Z7I5O=:AJ=[-!;P6-
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M]GWP)/\`%'XE:#%8_%+Q:+-K&RU*ULKK5?`6B2VL;V8M8I[0W4&JZC%,J:L8
M9B+:XW1(L8A&/U59Y<(I,D+Q,2@$I>2!S]]?-R?-<G(DED\QY6R[,2<U_P`>
M_P"T?^D]]%CQ!^F;6X_X;^C9X8>-^=>$=/+.%<!XF\><6>)6+R#/^*>&,\K9
M_5SG(>%.!^,^%^%LSX?R'B&&'P&75L\>:3SJ64RS)/"4%A<+BO\`2GP:^C)F
M%7P_PN)XOXEXBX>QG$$5CWP]E>#RS"U<MR[&4*L*.'S+$YIE^*QL,RQ%*+KU
MH4L/1GA:%>E0G3552E'^7W0?^"0/[6&LZ-9W6IZ_\/M`F56$>BW_`(DG@FMH
MY(T\TSQ6]HEO"ZX?SH]CJK[HPY10M?+?[0_P)\4_L_7OA[2OB!\0-%^(]QX7
MO=*\/67A5[G4-4T6TTS3KP:C>:!I6I7EQ<&PTXW$<UI(-*DTQ9+0M($A+D'^
MR0G<-KCS$9)XY4<L1,EQGS!(5*OQD[?+9,>]?C!^VA\'?A[:>/IK"Z\(V-QI
M>LZ:->:WU#S[B%]3N"RW5W`S2AXF=YC.`CC#DE2$!C/ZY]'S]L+X_<9^+V20
M\;)<+YEP%A*^;9GB^&_#WPYX2R/-WA<=@ZN!S.CEG$N=X_-,YRV2PV,A6K3R
M[%Y;F6:5<)A_K&<*I3I3H_@/TT?"#A[Z/WAGPMXB\$X/-*V59=Q=E>3\>5\5
MFLL?FN(R[-,!F&`R:&$P5?+Z>60PT\ZI4\5CZ\,3AL3A*-+#X?`4N7$8NA+\
M3/CA^U#>_$K2+KP5X#^'_AWX(_"BZURQ\7ZM\*?`FI:U-X-O?'EOH<7A^Y\2
MC2=8U+4XEEFT^!;;R0[6PB2-T3S09#6U/]HO6_&OP0\+_`[Q9;:;J3^$?$CZ
MWX<^(WB+4=:U'5]"MHH!;IX>TZ!I)+6&Q6$?95AN+>]2.)%2W:!`H'M7C?\`
M8TTJYN;B_P#!GB:2Q$LUNRZ;K4'F^9%(^]U@OH([=V7!&V60N[J%=V+L6KW+
MPC^QC\*/'5WX.\#:A>77@S6;A(;74O&EA=W-_OOE5;>:-;5Q+;LDLJR,NR`2
M$,/WASS_`*T/Z<7T'>">$^`:V3/B&M@L+GN+XAFZ'#N<9IQGP5G%7+54S'B?
MC7$9[F"XEXDQ.+PV$HX'-90XDX]KYY1R_+%B\QQN'RS+XT/X5R[QIX8XFS7A
M;)LJS/%9IF'%V:Y?PWE^7>PAA?[/K9CB*&#P5/,</BZE##97@98O,885U,/*
M<*-2I5J.$X+VM3P+PM^UWH6C^'-!T?6/#]]JVM>';:UT<ZG;WD5MI\VGVMK%
M:6MPD12(NWE0K(!<!FYPT1.*]K^%WQ??XE>+/%6E7&E6MAI.A:;87FFZG:W3
MW<UQ)=(&>.]>-_LL;<X,$$,)B?,9+$8'W+HG_!$7X0V>H"Z\0_&?QYX@TB&R
MU*1]/T3P]86=U=-:I(!+#<WMO=*B6@7)CEB,MR%_=/&S`#"^!7[*?PM\&^+-
M3^'GP-^+'A[XG:G>R7&O^(/#'BC3GT/Q+HN@^&M1:PU:?5;1G@NYAI=Y"VGW
M.C0,EW>RQ27%G<PVS*(_\Y_&3QJ_9L<4^'OB[G7T?^'>/.*?$.I@X9O/B+'<
M)>(^!X1X,J<0<14LRS+.IX[-*6(X?X8PN7J.;82C@\?ALORROB^(J.!P>-<E
M@L)2_;.,/V>'$."X:XPQT^'<JR[B/$9;F5;A_+\NXEPW$G$.9YU4X@X<H4\H
MX<X6P^88-8JNJ>;9_G,Z>'YYX?+,HS2O&"K3IU#SS2[^[TF_MM3L+V6WU#2;
MR&ZL[FUE-I<6]Y9RATN(B-TIE&PQ,R.-T9./FP]?K4=&\)?MH_L]CPS\6C%K
MMKXA66[UNPLKV^MIO#^L::XAM];B)O+FY2]RNZVDO#=*`4W)(P;._P"./V9O
MA9XTL'$?AZU\*ZNEH!87FA1R+!#<[!A"TQN?M%LC_*CX#R1JK,[$YKXH\<?#
M_P#:<_9,TD_$GX0:#8_&.,3WD/B?PG8ZK-!+_P`(_!'+<7&IWMDDD9)LPBO)
M'!B6,+LVD(RM_E%P]G\/&+B7@G"^'O%&7^'/BYE'%.!Q'`&>\4<1Y1P?'+L_
MI59XW`_5N.L7/#Y1DBK8W!T%A<;CL7@\(\SQ&#PR59YA[&O^K>`/T>O'_P"A
MIXA9I@.)N%Z/C;X!^(F4U<OXVQG`=3Z[AN&?8UL#"KQ3C.#\ZHTLZJ5LKRV6
M*P.*P^`>(QF*R'%5,1E=26+P&"G/ZU_9P_8_^"O[,_A[5-%\$:5>:[)K5Y#?
MWVK^,9K'7-6F,=N+<6R%-.L+*.UDC`+J]B]T7^9KK>2:VO&/[,7PG\6WNF:L
M-'3P]<6%ZLUS!H;"R&HA)1(4O8I8KJ&2)V4[EMTM@`65-BG;7G_[,?[;OP:_
M:,\"Z)K=WXM\-^"?B``\/BOP/JVIPZ5J-A=6ENOV_4+"TO9997T<W0F-K++.
M\K6X0NJR%E7Z_P!.U"PUG3[;7='O8?$&@WL<EQIWB#1I8[S3;ZVMRL5PMM,R
M0Q"X29@RR&66)HF4@'[]?E_C13^DEPEXK\;8WQPQ'B%EWBG+B'&8+B[-^*Y9
MI]9S7.(4YX3VD,VJ97A>'\ZPV+RW"4L=D^-RJ6(P&89''#9QE,9X-RQ-'_2K
M#^''@+XE\'Y5E<>!O#WBCA/ZM#-,KP4<EX<Q=7!1I8G`XJ=5^SA2S_+*T,=E
MV$6.G6Q6`JSQ>`J4ZWUJ=.OAZE+3O#N@:-#:VVCZ18:?!80Q6]B+>UB1X(H(
MUB1@Q4LTKQJOFO(7+MEN"2:VB[GJ[Y'^K97:-HL_>$;1E"`_\2L64=%51C#D
M@G=$D,5RP0/]K9;;S(TP#ME:X218XT<_,0J3K@X21@,F)2&56#*P(!#(<HP(
MSN0D`E3U4X&1@XK\$Q.)QU6?-B<;6Q4X-TO:3Q=7%\GLIUG&G"M.K6C[-2G5
MJTX4ZGLFJKJPIKGYS]APF!PN$P]&A@L%A<'A:-*%+#X?#X+#X;#4Z"HX>G"E
M0I4L#A\,J,:5##PC3ITXPC[*,XTHN3JU%X[#`[#+'`],L68X]68L>I)/-%%%
M<1L%%,)?)P!CM_G-/'09Z]Z!N+5F^H444PE\G`&.W^<T`DWL/B)AD$B,V0Y.
MUSYD9B=-LUL8Y-R-;7#9DFC923(<HR+A1_+]_P`%@/@RW@SX]:?\1-(\):9X
M;\+_`!!\.P2BZTJZC5=2\2V`8ZUJ%Q:J/W%QJ%UON)T53\\DB!DP@']0L"&0
MSYR\=FAN[UT`B-MIT5J;FZNG6<JGE6H!#SB8JZC<(AD`?R??\%2?VE]/^._Q
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MPU+`SQ.(J8'#U<16PV#JU93P]"IB>15ZM+#N4J%&M7C2I>WG1IP<Y0NWU:DD
MDD]223P!R>3P``/H``.P`I***]+;0Y@HHHH`*^C/V5_^2V^"/^PUIO\`Z/2O
MG.OHS]E?_DMO@C_L-:;_`.CTKYSC#_DE>(O^Q+FG_JOQAOAOX]'_`*^T_P#T
MI']:E%%%?XY'Z"?Q?^(_^1AUC_L(7W_I5+7/UT'B/_D8=8_["%]_Z52US]?[
M70^"'^"'_I,3\ZJ?Q*G_`%\J?^G)A6[I?B35]%CO8]*NFLAJ-A)IM\8<YNK.
M1]SQ2ABR-GE0P0%5)VX8[JPJ*RQ6%PN.H3PN-PV'QF%J\OM<-BZ%'$X>KRRI
MU(>TH8BG6HU.2I2I5(>TI3Y*E*E5AR5*=.I#-I25I)25X2M))KFIU(5:<K-.
MTH5:<*D)*SC.$9)IH_2G]C7Q$=1\*Z_X9N=5CFNM-N5OM(T^2;$MNDX5KEX(
MY&9I%D.XLJ853N5-H"JOM_QX\.W.N_"?Q?I]IY<EQ:VAU/RUE,;1FPE&V-(F
M#.Y14"N@W%CNP5!`K\@=&\0ZSX>O;;4M%U"YT[4;1RT-[:RO%/MP`L+[6$;Q
M*%4*C(3P-Q:OM+P9^V7>6&F6NG>.?#,7B&:"P:R.HV,T=M/<Q.J[3?)<B>)Y
MF;)D*HJL69@`2,?Y`_29^A=XNY=](#"?2;\"L/DO%^.EQSPMQMBO#^2R[(\U
MP6=9+'*:N/K8.OC\5ALJSK!9K7R[$K&3YL)F.'KYG6S&K"I0I.I4_F_CGPMX
MDI<:T./^$51S&=/-<!F6)R6+H82O&MAY4XU)4:];]S46(49J=H*HI3<KMJ,E
M\>^'_#.H^*=?L/#^E03SZIJEXUO&A1XUBRY7S;DO'E47.Z5NR\8W'GU#XI?!
M<_"#4O#^G>)O$=GJ=QJ&+G5=.T:(_:]-MOD._P`Z1YX7,R/F!C$05&2IZ'[N
M^$?Q:^$?CZXNI]-T?0O!7C:1+N&.UGCMX;FY6Y!+ZA#J,B?93-*S^8L20`([
M';N4(6\=^)W[)'Q0UV+QO\2+#5IO%MAH5C/K-ZQCN6DM=!M;1;D&34LI9.UL
M&$0A@AB7"*0B;P!^Q9?],O-*WCSA>!_&*'_$KO#F4Y9A,JJ\*<>X">=9_P"(
M_%O$^+H95D.(X=X^RG`XSA3+^'\FJ8O!U:E;#8['O/,RQE"$\3"C@<TP\/ML
MIX\SG-N.(Y!FN6XSA.EAL%4FLCQF68O-\RX@QV*3<L5EV:9+@L=@,+E>5*+G
M5JU7"T)N>+K890JS7SSH?AGX3^*+B72-,\0:_P"#M2N&5=-N?%=EI>HZ-J4P
M*F*R?4+5K&YTJ>5F5);EBMKYA(6%(PL-<7\1/AAXD^'>KP:;K4=B9-0B^V64
MNDZG;ZU836K_`#+F\M))2DA1T95E#,0WS%L,XX:TO(;*_6Z>UMKQ8FQY-Q$9
M(IPIP#<1NP+,_#2'(8MG)!XKUSX;?&'4/ASXHN/&-AX8\-ZUJ4EPDVFVVO13
M2:1I:6LGFI%907%[):RJH*PM9O"_[M5B1EQM'];YID?B5P9B,RSO@_.LRX_R
MVGDF*G#PUXKQO#^'S#'9_2^KT<#5R?Q+QN`RK'<,X.JFJ^=X7.>'^+\(IT5'
M*XX*#K8>?Z3*AF>'Q+KT,?+&X5J$*F5XFGAW)5IU<-1EB<+FJ?/3H4L/]9K2
MPE6E4A6J4X>PK1J8CF?CLUH\7+P3P;SE(Y3$^U.[R2HP(5>>3`N0,X%4R`"0
MK*P!(#*2589X920I*D<@E5)!Y`Z5],_M&?M+>(_VD-8T77O%'@WX=>%]2T>V
M^R0S^`O"6F^$S>P,%&_4TT\^9>W#8#O-<22RO)NDE>20EZ^9B`I(!R`2`3C)
M`.`3CC\N/2OT'@C-.*\ZX8RG,N-N%L%P7Q1B*%3^V^&<MXKRWC;!9/C(UIQC
MAJ/$V4Y1D.!S+VE",<0Y4<JPWL545&=YPFCZ3-L/EF&Q^(HY1F%7-,OA*"PV
M-KX&MEM>M&5*$Y^TP5>MB*E-TZCG2YW5:J<BG&,8S224445]6>:%%%%`!111
M0!(%&%P&8G`(![M]T#Y3R?3UZ=:_I&_X)@?LO6'PJ^&EO^T=XQT[2X_B5XY&
MFI\,AJ]O;:I/X?\`"DSB.YUJ"PFCDM[>;5K589;:[GC>6#S(]FUEVK_.;HVD
MZCKFIZ;HVBV5UJ6LZG?65EI^FZ=&US=W^H75Q%!I]K:Q*"?/G>1$*$/F7@;0
M>/[7_A9^RU^T;\%?V7/@MJ?QA^&6N^%XK3P7I&EZD2UOJFI6<$]S'=Q6&I6,
M$GF:-+IMN\5NR7"`VWEO%,'9"1_F=^TPXNR/_B'GAQX1YUXL\'^'>`\5^.</
M3XAX6SOB+*\DXB\5^$N%J,<YS/@'(H8WBGAS%3R?/,SIY=E_%M:C1S.G4RV-
M?)ZE&G]8QD,1^O>#^<QX:SG-,_H\-8OB#-L%D^)PW#^)P\INED&=9DGA,-G<
M\/3P..J8O%X*G5E/+H4L.ZM#%Q6(I-5.2=/H5\6ZCJ.LZ3J%Q=36LL$ZQ;H&
M;=;QSL/-7_2&G60W&3YS3B7YB3"(L@#W.0H9',8"QEV**"2`F3M`)))`7`R2
M2>Y)KYN32->FN$M$T.^6=[RU:25;9OLWE0,NYK:7>RNC`;EDWR(RD,I(.:^C
M3^[50X$8DEABAEED2-4<8BEM7C.7FN9+G]S;M&R)DC*/U/\`S`_3AROPNPG%
M/A_3\*L5P5++J'"V<87'Y?P9B\BJX/!5<+Q#4JTG7ADF,Q]&.+Q4<3B\4Z$L
M3B*W*JE/#>UHT8QI_P"DGT9\7QKB.'.+9\<U>(:^8KB'"5J6,XDIYE1Q>)H2
MR>$:N)I?VI1PK6&DZ4:LZLHT(\SLW.K[2,F.X5-RR1,H<AY6/EHAR<P")B9)
M)D^Z65MKD$J@!%?/'QR_9)^)W[1[V>O_``F\.ZYXQU[0[";3I-#L[.5(YH#S
MY<4EW:V,:W<;84/]LFMR`0`P(DK];_V/?@%;^,_'6OWOQ/\`!.K)IOA;3K74
M-/LM;M)+*WGOI9U1H)&>+;=)`-V\P^4[E"^['%?LEIFB:1HEK%8Z+IMGI]A;
MHD,%K911V\*)$HCC6-MH+1JJJ$Y*%>G%?Y?<4_21J^#_`!-2CPKEN'S;/\#0
MH3JXK&8BA+)%3Q])SG@J]/`U:F-Q/M:,(PJ_5Z^$E0GR.5:[L>-])JOP-XD<
M&<2^#?$N3XW.\!G6$P-3$X[#9DLOIY7F-"I#'Y3FN5XC*ZE:6*Q>6U8NK3I5
M*T\)4E5J4\?A:M.3IQ_@V\;_`/!/O]L_X<>%;CQMXL_9W\?:7X;LD,VH7,*6
M&JWFFP!2S27NBZ?J.IWHAA'#7<8AA(4LEO$N$7YW^&2^?\2/"5JC%;Z+Q'I.
MG):+',UTNIW%Y&]M%-;,MG)'/<84-#(CO&Q"N7(:O]%V6TMYD9+BV1DE_=R1
MLL921"2&65E`>5&!PRR.T;\_*0:^8?'G[$?[+OQ(\:^&_B)XI^$'A6;QCX7\
M26'BK3]:TVQBT:>?5M-C*6;ZE'I2VD%_'&V)F,T1N))U\R2X8LX?]!X5_:1P
MQ6"S;+_$;P_5&IC,)F%#!9AP5BY.C2=7`8VCA\+C\GSZI5=:A+%5:$:N)P^:
M*=.FYXBG@IU8MU/\E\;]!W+,GXCX7XFX'XSQT*F1Y[D&;X[+N*,+1Q2QRRK/
M,KS:O]6Q^5QPT:$JU/+_`&4*5;+W3C)N:J-SE`_&.Z^$GQ2EN97D^&GB^4&X
MDE<'1[DK/('8QRR/"8][(<,#$8XY2,RQR*2#^./_``4#_8G^/7PV\;:9^W=\
M`/AKXST_QU\.KVQ\7?&*RL]*GL(KS2=*,5BVJ"Q@MV2ZCUBTC:X\01P1RP2&
M6:?[(LB+&?[T]G^VX]@1@?3Y:\_^)2^''\`>.;3Q?=Q67A>[\+^(K'Q!<SB*
M2"'1M3T>ZLKY5CFBD2\DF$A=K1B"9VV(0A2)OFOHN_M"^/?`_P`7<AXIR#@C
M*L^R[-E/@KC7@;$X_/L7E7B-X?<85*/#_%O`^;Y7@L-.KF*SK*LRG#*8X>G+
M$X+B*ADF,P47*G*"_P!1_$/Q/J>('#F+R7'\/8'!8BE5699!G.%S+-9YAPYG
M>#KPQ^7YKELJL'&C6PU7"0A)QJ481P[J4DU2DZ3_`)$?V0_VGM#_`&L_A8WQ
M%L-&C\&:QI.M2>&O%/AC[=]NM=.U%P9+&\L421IHM*NHU/DF>:9@"G[WA@?J
M1GW"1"BF*2*6`Q/''@V]Q"8+F&4HBF47,;,;CS"^]V8KL7"C^:'2O%FK?\$P
M?VQO%&F^%[?6?'G[//CJXAEL/MD=SHT>I^#M8NF;2;O?<22V5GXET))X8<W"
M%&C5HFM7D`D7]C8/VVO`1TS4[R[\+^)3?V[2?V?!;-;&QU)&9O)N#J+H8;2(
M+MDG602$#<%8$9K_`%8^G#]#/-?!?Q0PF?>#V09GC/`OQBR_!<=^$<I5_P#A
M;R/*<VPV4XC-.`\_PF/QO^L.!SK@C.<PGE684LTC"<,.\MC5JXK%8'%SCT\%
M_3(\(\!PKE5#QE\0<AX.XTIT<UP69PSNCBL)3XAGDT95:N;82MA,JQ5/'+.<
M/5IQPN72DZM?&1J8##X7&8C$TXQ\&\6_\$GO@+XO^,-Q\2I]3U;PQX8O+YM3
MG\`^'8([6SU75;JX:[OR;\-+J$%K=S2.#;PW=M;QHPCA@MT547YT_;D\,>+_
M`-@[3O#/Q`_9J^./B?P9X?\`%?B2_@3X':MJ`UK2-(-K,WVA_#MAK5M>I!HP
M,;_:+-9[HD'%K<I$D:5VOQ0_X*L_\*M\0VC'0=`\36<L%ZLG@WPY?VET8U4.
M(-1UC7)Q,D33X#26<-M%="1G0,"I(_%']KC]K?X@_M9>.5\3>+DM]-\.:+!]
MA\(>%K&64Z7H-LIV`V;/.\\\\L2QK/<R3&*=HQ-'!`',=?Z3?03\#?I\^.O'
M_A1Q'](O.\TS_P"BQPOPO4RS%\,^*U+AKB_ACCOAS+:&(PV$X6R_@SB'A[&8
MVOC*N80P,H^)&(AA<?E6#RVJ^&^,\RG*KE<OQ/B_QX^CCG/A_P`59SX-9;G.
M4\7YMQ'4629[3X?XAX'S.KCX5:4L5Q?EN(Q>*HUO[#BWB<-1P$,'ELLQK8CZ
MS_9>&C1=673ZG_P4._:XUWQUI?CG5/BUK=S=Z5?07']B6`CTOP[<6MO*)%LG
MTBU\J-[1X_W8B=F98U14=,%C^_OP;_X*8?!;QY\,OAEK?BG5A_PMGQEXBTGP
M9K_P\T.U:/5-/U[5+H6O_"0K:2RW7D^&)9`\J2&61L,NR101$O\`)"S<D$`D
M'`)SD`<`<-C@<<@XKKO"'B*[\,>)?#GB*P#PW_A_6M&UJSEMY)(Y5?1[Z#4`
MZ2AS(9RT1C"R.UMY;&)K=E5-G^G?TG?V9?T9OI!<&<+Y/@.`<I\-<ZX`PV/7
M"^+\+\GX9X.GFV'>19^L'PGGD\%DU..(R3%9Y/*,QJ8B7UG.:6,P=5X+,IRS
M&M2A^0^&WTD/$7@/.,RQ&)SS'<1X//ZM&&8TN(\;BLTAA,14QV#5;.<''$UY
MQACZ&#6+I63IX6O3J2]K1]K&C4?]ZV0'`WI(A^[+'D)(IZ/&6YVN,,N1G!&1
MGBG,8XUEGFFAALXH;VY:YN9%M;>.#3;=YKS[3=RDPVC*T;+"THVS@94`GCQ'
M]G;XX^&/VB_A!X+^*OAZZGG75]-MXO$5JZQ+>6/B2VM;<:U9.(8TA21=0-RL
M82$1E5!C4I@G\,O^"I/[;OCW6O'.M_LX^`+K5?!7ASPQ?Q:9XZN(KE[>^\77
MZV@6WMY;JWEB5-(A@9&B2VMK:=OD6XNK@K,#_P`J'T:OH0^+WTCOI#YO]'?+
M<'A^$^(^$,PSFAXD9AG\*BH<"Y?P[G/]AYQBL5A(RH8O'8VMF,Z&79!@\-"2
MS7&X_`U9U\'@54Q4O]._$3QCX3X`X"P_'V)J?VI@LVPV$>18/+9R]KF^)S7"
M?6<+AL/B*D:M#!QH\T*F-Q.+DZV#P]'$4Z4:V.J\M/Z1^*?_``66\#^&?%5W
MX5\!_#6^UJ+1O$$NC:QXFUW5X[?37M+#5I--O]3T?3[.%+F^MIHX7NM/D:\B
M62)XV=6!(/ZV?#3XH>`_C%X4TWQM\./$>F^)M!U2"'Y[.YC^T:9J%S`ES'I^
MHH`_EW$22"*9,1GSE;!4?+7\'K73%_,55#!)(U>0&6012-N"DRE]I1?D4H$*
MKE1BOT3_`&/?^"@7C#]D7P9XJ\(^&O!^@>*3XOUW2M?2;7[W4(++2I--BBL[
M@0Q6TD+G[3"I,V)B3=*TB@1?*?\`;WZ7/[%?P]J>#G#53Z)'#^9Q\6^&\=EV
M$S#`YWQC&>!\2<LS>>58?-\]SC->*\:L'P_BLAJ4L5F>5Y?D.&I82I@\R>7S
MH8SZM'$U/XR\+/IAYW/B[-*?BEC<&N%,RHUZN%K8#*ZM&OP[6PLF\)0R^EE_
MM*V81QD:]/#XEYA-1Y<*\9*4:LJE)_UU*Q+@$;0<9&<D9&<9P`<=,[1GK@=*
M_.C]H#]OF?X8?M`^%OV=_AU\-CX[\774]E=>*;KQ%KL'@?1K73)K6>\N++1M
M7U)'LY[^*R2.^;5)?.L(4+6CV4EP2\?U_P#"3XP^#?BOX0^'OB#2_$/A^;Q'
MXY\!6?C:'PO9:Q;W&IR![6UFU*.UMG2%VMM.FG>&28L[R;`XCCY0?._[>?[*
M?@#]HOX/^+-6O+&UL_B1X`\,:_J?@OQ99D07+(\:W>H>']4(MY9;O29DMS.7
M+PR_:V<1W*6+K8K_`(4_1QX>\)N$?'W"<(_2HX'SO%<*YK_;_`U)5(9Q0P?"
MG&F;9ACN$>&N-,[R3+\7PMFW%_"N2<1X;$/$Y?DG$.3PQD:-7,<-F>.I9%C\
MHG_;7B%C.*,VX%KYOX7YS@J>94(X/.VZ:I8BMF>2T<)_;&+R;`8J&'S7#97G
M&999.%;`XC%8+$PA3PV,@Z5.>L?Y^OVG/^"B7[2_Q5UCQ7X&N_%D'AKPAI_B
M;6X;+3/`EU=6426EO?75F((]<2^N;S4;"Y@51(QG-I=*1+!;PQ.L:_GUI]E=
M:O?6EA86YN+V^OX8;>$L<SW,J*J1@DAC*TDF6;.W=N^7Y@*S+B8O/.YC12[O
ME`"H0%R=H56"J%Z`*`H`P`!Q77_#WQ#I_A;QCH'B#5;)]1LM*O[:]>TCD$<A
M:#&&B)R-P"@X8,"P4@<$'_M\X#\).!/`'PYQ?#7@GX=<+9+2RS)<5CL#D7">
M483(J?%.?Y9P]4AEU7'8NA*>.QM;-,?@L-S5<PS7'UY1S2I&GB*<I5*M7_$_
MC?C+B?BS'9OGF;YCFF>9C*688K`X;,L?6Q:IU*GUBM3P&'IS]AA,+2<UA\/)
M8/`Y?2DJ+K>PA*<D8&KZ%J.@:I<Z+K-K/8:G8736E[:SX$L<B!]X^[@D,H&<
M$'/&:Q020">"0"1Z''-?1/QLO?#GC_7M3^)7A?64D36;YY;[0+]/+U30Y`6`
M,VU8DN8)&RL<T2IYC98'HH^>&&&8#)`)&3U//?(!S]0/I7V'AWQ+F/%?!_#^
M;YWE5?(.(Z^49=+BKAW&8:O@<7P]Q-++LN6<Y+4P>-:Q?U?!9C''1P6-A];P
M..PTH5\-F>+E*I"E\GEN)KXS+L#B<7AWA,;6PM"IC,+*,HO#8ITZ?UBBN;XH
MPK^VC"=_?A&$UI-"4445]N=H4444`%?1G[*__);?!'_8:TW_`-'I7SG7T9^R
MO_R6WP1_V&M-_P#1Z5\YQA_R2O$7_8ES3_U7XPWPW\>C_P!?:?\`Z4C^M2BB
MBO\`'(_03^+_`,1_\C#K'_80OO\`TJEKGZZ#Q'_R,.L?]A"^_P#2J6N?K_:Z
M'P0_P0_])B?G53^)4_Z^5/\`TY,****H@*?O.UDPH5P@(P/X,=">?F(RW7)Z
M8'%,HHULU=I/>S:NNSLU==TW9[--:!_7]7)UN'0JR8C9&1XWC:1'CD3!$B.C
MAPV1G&[8#RJ+@8_8']CK]NKPWIGP5^(7[+'QRU#48-$^(^F:CX?T#QU";0)X
M4M]6T[_7:M/<0W-Q,T=TB16C`+;Q0MY<L<KE&7\=ZE64JNT*O*[7.7S)@DHS
M_/@M'D!"``%`4AE+`_D7C/X'^'/CQPOA.%_$7AS+\[PV3Y]E/%G#V-JT*2S7
MA_BGA_%+'9)G>38WV4:E'%8+'QH8BMAJV)AE^8X?#SP>.H5XU*$\+[_#O%7$
M7"..Q.9\,YOB\ES#%9;C\HK8O!.$*E3+LRH2P^-PE1N#<L/B*4G"K3BX<\6U
MS1NY/Z>N?V7_`!-=Z_I_A[0_%?A3Q%KOBB['_"(6>GW\9E\36MQ)OAO+==Y6
MU>>!EF:UG99("YC?+1L*_4+2?^"?_A#X*?!#0O%?Q!\+2Z]\5]8>>Q\576H7
ML=_X6\#VEW"%AACTE($(UN!F:`Z@+N2&26-I$@5&"CXL_8(_94^.7QZ^)>A?
M$?P1HGB*U^'GPMUFRUGQG\0DTS4YM#\/+#)O.GP2QV\XN;_4W#0>3:Y6%9I'
M*PIY7F_TQZW-8:Q)?VNJZ;%>Z7=W<AN-`U,32B4^:QL_M-L4M)\VPVK&K,KJ
M5`E+L":_A7Z2'BCXGY/"MX7Y#X]9=GW$N%P_UKB[/^#\LR3ASB/AK.7*&*RW
M`YS@N'N*<ZH83#YA@,5@.(<1EF.I0X@PE6M7ECH83)\PR7`TN#+N&LUQN0YO
M3Q.<UL)F>986MALHSJGE.'P]/`5L53JNAC,/0JNK[6>%E3A&3O-5XSK*%G)2
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MK+Q,PO"F,SJMG?"6`JY/F&?\0XG*%1H?V-F^'S&I4JY6\?A\'/'S6*I0PSIX
M/%UW@<0[U*7L*,9U/\U6\TR\L;J[L+NTN[6^LKB>UO+6:&1+C3[BTE:"ZMM0
MMYHX);>X@F1XI8V"F.56C;YE(K.;;N.P[DR=K'@E<_*2.V1@U_=%_P`%0O\`
M@COKWQG\5_M)_&#X:?LN6EQXRN8)9_`1\!:M9:2FL:G=I%>1ZQ+H\%VD5S=S
MW]U<2ZTI"%_FC1;8AF/\G?[;G[!_Q<_8)\?^#?AM\:KG0YO%7B_P)X9\</IN
M@7R7EYH']OPK)=:!K=M$LOV35-)F<VERX=H)9HI7A5HMK5_NS]$O]HE]''Z6
MF3\!X;A3C[@O+?%/C;AJAGE?PDP_''#G$_$N2XK`<%</<7<68%T\A;K1P7#$
M<_GAL;FN;X/)U7JT:6#<%FN7YGEU']OS_A#.,AK8V5;"UY9?A:BC#'RIJE2J
M4ZE6=.DWSS2<WRI-4^9.-ZBC&$DH_$%%3O!Y8&\N"0,/Y9$;,1DJ&W$J?4,,
MCN*A88)'H2.H/0^HP#]0`#7]XQ?,F^6<;-1DIPE!QDXJ:BU))WY9*2<>>G):
MPJS33E\JTUO\O-=UW3Z/JFGU$HHHI@=!X<U_4?#&MZ'XCT:YFLM8\/:QIVM:
M?>6[M%<V]SIEW#>VLL+H5`9)H4)W!B0!SC-?UJ?`G_@MW^UM^T'X$L/ACX,E
MT*Y\6Q^$KFQ\>:3JVAV6M:OXGM7T>UL]1\26$NHW+1Q3R&*349%,5S<+<3LQ
M:3>)!_(=O.%Z!EZ.,AL#@#KC`[<9[9Q76^#?'OBWX>Z[9>)O!>M7OAW7+`3K
M;ZCI<\UK<!;H!;E)&CD42)<+E948%&!S@,$*_P`:?3)^A1X0_3)X+R_)_$#A
M7AO,>+.$UB\5P'Q3F^39=F..R/$UW2Q5?*H8S%X;$8S`Y+G6.P.75,WEELHX
MR-;"8?'4:>)KQK'?ALTSO"47@\JXHS_A6GBL=EE?%YEPW5PM'-*=+!8S#UYR
MPT\7AL33C4]C"<4U!56H1I4IT'6JUX?V=?LZ_&SQ!\3=-\2:5XMA\OQ+X9A-
MS"MO:7%I:7D=T2+6-HQ<3"UD.`&M]T*Q`CRXUC*5T.LS:^MU$FK2207L#&2.
MWGNC;_89X[\7\1M=T<@G>PF46]K,XE5K>-?,\YR9#_/+^SS_`,%4?&'P2\+:
M[87G@+2_&GB+6K.WLFU35M;NK2Q\RW@5%N[BVBLSJ#3.^6D:*^$1<G9\I$AO
M:[_P6(^/&KZ)JU@O@OP'8>([R:<:?XFCEU2^71+"1G:WM[6UN;F3S)[2,I$L
MDTTPD*!FCR2!_B[]'C]F5])+P]\9>/<;G_@[X<4>`,?0GEF2Y[FW$O#>9XF>
M*E0KX6>8\*973AF-7`9'F4L7C<+FV*QN$RW'1PLI4<)AX3G*E'^V_%+Q/X2H
M>%G"G!F5?2"XR\9.(<EJ8>M4XMK<*9WP'CL]R/,N?%4L%QUEN,S+$83$<8<,
MX9QRFM7R?-*F39EBZ-;-J.#ITL91HT_ZU/$/_!03]HK6M*\+Z;I^N6OA`:!I
MD>GZAK6FV8ENO$310QQ"[U`W+SQR7$[Q^<&A@M8]TC'RAN(KSN7]KC]J+QAJ
M^BZ?9_%KQ0]]=ZE;65A9V5OI]@M[>7#A(K86CVEQ,RJY"-<HT<#`;T1$(4?R
M9_!#_@I]\9_!GC.;5/B_=3?%/P?J22QZEI!:TT^_M)"6-O<:-)#';V]LIX9A
M=0765PJ*APM?V)?\$?/V@_V'/VF?AKKWQD?PY)X+^)OPBUK3].\:7OQ4U73+
M:STI]=A^UZ'=>'YI+JVM-1LC$K+$YA$\`$33$,=I^4^F+]%OP>_9\>$6<>+.
M.^AUP-QYD>`Q];+<'F?`_A[PSQ=E>'XBXTJYM#+'Q-F7%]'%Y_E>38_BC$X3
M+,37I91G;H4L15P&38'!RQ&"Q&`_#.%\RS;C?-<-E>!SC'PQ]?V<:6"57$U<
M77I4$HRH87!86,ZF+Q3HWA"="E+DE>M4;C*#E^^7P:M_'EO\,_!,'Q,F6?QK
M_P`(_I`\0E-Q:+4(],MA>"Y<M()+TW2R_:Y8]D,EPS-##"A$:^H#H.<\#D=#
M[]Z^2]=_;3_9YT;Q3\/?`UG\1=&\8^,?B?XDC\-^&?#WP^:'Q=J<MW+"]PU]
MJ<>FW1&EZ;!'M>\NY5>.+YQ&&&"/K1=NU=C*RX&UE.59<<,IR<J1@@Y/'<U_
MQE<?93Q-ALXQ.?\`$?"D^$/];LUS_/<ORV.3XK(LOC1KYWC_`*UALFRS&TZ.
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MX7^.@TU-$L+;2XW,&OZ`BSH]_JFFW\X(@9YOLLD&R:#@EF_H;Z%OA]F'$WC3
MPOGV+X+S/B;A3AO,5B,TQU+#82>39)FSP]2>09AF]7,*E#"UZ67YG]5S&6!P
ME7%9D_J]'%T<'46!=*M^(?22XUP_"?A9Q/A\+QAD_"?%&<97BL-P[+,<95H8
MS'5J<J3QN&RZAA8UL6L37P4J]"AC)X>.%P\ZZJSJ_P`GXR07VA^(--U+P/\`
M$S3(_$_@#7;.\AU?3]6D;5+K2H_-9-.U[2-6E9[Z*72[[R[I%AF,;11_-"QY
M'G&E?\$W/CGXUDA5/VG_``[=>"1-'8>&+[2KJ^OKN^T!X-]N\UK975M]DO!8
M^2=2@NH;AX9C*CDNI%>M^`?A[K'Q%\1KX>T064<ZK/=-)*[-'9VMK/Y4H6W4
MAF253Y]Q&S,AF),8BC_=CJ?V@?B%X%_8<\):IJ.E>,-.\5?&[7;>?3O`'ADR
MRII^BK<QFUU77]4M+"XLQ;7'SM/!)=R"*:7&("#Y=?\`7Y]#[C;Q]Q&/P?!O
M">2Y?Q=D>=\2R_L;'<:Y5E7%L^#LVH8>C@<US/AVEQ3@,]>1J>&^IT,ZQ&`C
ME%*>(P=".(KUW]7IU/X,^C]B^+LZR^-3B/(O]8.#</F&8/+N)\YS:E5QV3XR
M-&$<1@<!+%4\?C\92J2]C3]G#ZNHU_WM+$^_&*_$W]J[X0>#/@1\3I/AEX4\
M9S^/+[1=(TM?%6NO!'%IB>);JW26[MM,98H?]!202A8[TW=RB@>=<2/N-?,+
M2$MNVJ""Y`[`L2<[5V1@J3\H2-$R!\@``&MXAU[5O$FM:SKFN7LVI:QK>I7F
MI:MJ-Q(TEQ?:A>7<MW/=2D;(@[2RN$6*&*&.,[(H8UXK%9MS,Q`!8EB`,`9.
M<`=@.P]*_P"BWAG+LVRS(,IP&?YK//,ZP^`PM+-<UG%4_KV.5.,\5-4X4Z%.
MG1H5KX;!TZ.'PU"G@L/A:5+#484HQ7]`5ZE.=6;I4HT:?,XTZ<8I*-.-U%/1
MMRTO*4G*<I-N4V[B?4D^YY)]S[TXMD890<8VY+93@`[<,,;L?-G(ST`XIM%>
MZXQDN645*-K.,DI1:TM>,KQE;E37-%M-733NWBFUJG;_`(/R\S]F?^"6/[;G
M@_\`9[N/&'P\^+VJKHOPXUFWN?%7A[5&@N;E+3Q7HNF.][I)B%P52VU:W>)H
MR(@[:EF1IPCI`?AO]K31O&UU\4-0^*GC33M33P_\:[R?XB?#_5KQP9-1\#:U
MJ=U-I?E.JA1?65B]K:N7C,4:*P>)]X$?RBMQ(F-H7(\L$LN_<(WW!2&)`#KB
M*0*%W1`+P26/;>*?B?X\\;:;X5T;Q7XEU'7-*\$:5_8?A2QOI`\&AZ4+@W"V
M5D%566%'VHJNS@1HB=B3_)_#_P!%WA[@'Z4/%_TE.`,-E.$S;QERG"Y#XSX#
M.(XF2JX3A_)76R+..!(9?3]EEN?YUQ=@,FK<9U<SE]5Q6182FLK]GFKQ54_4
ML=XFYAGGAGE?ASGD\55PO">+GCN$L1A)4XWJ8RO)8O!YXZTE+$9?A,#.I3RB
MGAXNKAL76JU:DI4G",>$;.YL@*=QR`<@'/(!/)`Z`^E6UPR)O)9_+6*!?M$J
M2("?,=E=G\A%/.%,14`\[F&138EF9CU8DGKU)SW)/YDGU)KH-!N[2SU739[_
M`$^+5;.VU+3+V[TR:7[)%J-C;/&UW9&ZVL8S=1J\.Y<E3)O",1@?U1BYU:6$
MKU*.&KYA5A1K2HX.DJ-*OC,53PV*KX6E3Y9T\-3Q.(KX:.'PT).G@(8S&4)5
ML3A,)A55E^98>*GB*,'4A0A4K4X3JS4IPH4ZDU"=>44U*I3P\).K4C\<X0:C
M%S:2^X?$=A\3$_9W^"?QQ^'7C&/^S?AO-J_@75+;PK<:E;^*O`&L:E='6/MF
MOM:(TLNEZE("EI<.Z6+Q!(4MVCN&(^IOBA_P5<\;^+/V6/#?PZTJ\?3?B]X@
MM;SPU\5/&5O8R1K;>%8?+BTLZ8K3NIUK6+=<:I.?/@C$DJQVEK)L`^E/V0=-
M^&OB!_%_QF_9VLM4G^#'C'PU/X+_`&K_`-EV^W7^M^&[&ZC9=+\9>"6G3;K6
MEZ2\I,+V"0S65E'B1II?G'XO?M1_#/PS\+OC1XW\.>!;QKOP%_:]Y?\`@;49
M6E2.3P_=Q+>11M'<AKPR6RSBUS>2/+)^ZP0[AC_D-X;8;P$^D_X[9AX4>,GA
M11QO&'T?..<\\9_#O,.)^%LGR'B;*IYYF.:Y[Q/X+^,>5TL)5GFF<\#<7<03
MXRPU;*L5Q!P?XL<(U>"O$[(<;"K@.(<#A/ZRXHQ'''AOP/3XMX7XBJX3*./\
MDPG!^?T\'F.+Q675XX/`*EE?%7"6*G4@X87.<KPE7+\5AWA*&9Y!FT<=DV+C
M.%?"8FM\WS"266>:1&:4RO)<*I5`AD9F+#*$;=Q.``....M6K>.W6*5[JW:9
M#;2&WEW[0L\<@0!8V1/M2#`$BPR*T75G)4@_?_[*7_!.?XW?M,M8^)H=.A\'
M_#*74+>.Y\5>)/,LIM4M+<J\\'AG26Q=:\[1*<20O%%;!O,D>8IL/Z/_`/!4
MOX"?#?X/?LG_``:T[P-X&\.VL_@768/"L'C"WACCUQ(9K6$7DM[<V26D5]=:
MQ)"9YI9[5P#([QI&^&3^F/$+Z>O@7PO](KPF^BOD.98;Q$\0?$GC&MP7Q-A^
M$N(<O>$\+(X7`9EB\/\`ZTY@J6(RW%9YB\7E'U9\,Y9F-7.J*IPHXJEEN)K4
M<!4_-LE\!^-\R\/N,/$?,\'7R#(>',IAFV`_M7`XJEB.(U.OAHSC@H\]+$4<
M-3IXKVSQE:C"E4?)3@JDI-O\7OA7\*-#^)[B+7/&^E>%[BSL+TRZ>X)U>YBL
M+=1IZRQ<01V?EQ1*+V6.1VCVLY?AJ^?M7LO[-U;5-.-S#>G3]1O;+[9;2+-;
MW?V6YE@^TP2HJK+#/Y?FQ2*JJZ.K!0"!737/A7QGHUC<:Q-X>US2=-CAM6GO
M+BROX8H+74(T^R2/<"W#-#>0M&8F,GERA@ZJ1@GEO(#R."'5^OEHWG.Q;I)A
M88RJD\^6R[E'#.",U_4/"6`SI<5<79V_$:AQ=PKF5#)\-D?">7Y5DL,OX-S#
M#U<RQ69RH9_E6.QV(S!9Q'&05'`YY6P>,R^CESI8;!R=:<9_A']F9M@<PQE?
M'8W$/!8NCAIY?E>)RZAA/JL:7M(5\51QTU2Q>*I8CW.:.(BJ<-*L)<[<"C15
MF2#RB`Z3+EW4NP41X!(0;ANPQ`RP/0G&,`FJY&"0>H)'7/0XZC@_4=:_2K:7
M5VMK\LXV=KI6J0IRUC:<6H.$H2C*,W>RZ6M+W35[733Z7Z?T]U=--I1112$%
M?1G[*_\`R6WP1_V&M-_]'I7SG7T9^RO_`,EM\$?]AK3?_1Z5\YQA_P`DKQ%_
MV)<T_P#5?C#?#?QZ/_7VG_Z4C^M2BBBO\<C]!/XO_$?_`",.L?\`80OO_2J6
MN?KH/$?_`",.L?\`80OO_2J6N?K_`&NA\$/\$/\`TF)^=5/XE3_KY4_].3"B
MBBJ("BBB@`HHHH`_OP_X(-?M,_"CX"?\$OM,D\8Z-907Z?$/Q4T'AW2=3@UC
MQ/XVGU"Y=EOM0TV1)!8::K`2P"96CM8G"!"$(;0^+?B[7_VK_C,;WX;_``U&
MEW>IPPZ=I?AGPY;6]^\J6[[/[7UN_LHX$@N+A=LT\OEH#([L5YQ7\L?_``2]
M_:-E\$_$J;X,>*];MK7P5\0--DA\//?7*6UKH/C&-A)`\%U(0\)UA2\=S"[2
M0M*JF)8MQ!_KB_8D^/W@+]GCXB^(M7^(6C7<L?B"VLM'T_6;-(GD\/A62.<R
MK`D,%Q:!`T;3B+?(O[S><X/_`"__`$J/HDTOHD^-7TLOI5^&/!'$OB]](+Q-
MQG%?B)PCD=;/<VI9%F&$XU>6^WX?RW(L%F."IYA4R.OEV,S+-:V.JYWGF9T,
M%B,IR:61TL90=/\`;<ASY9_EV19'CJU#!Y;@Z5#!8F:I0593P\9U(SG6Y;PA
M)N"4DXKF;O=\S?[F?LP_#[5_AM\"_A]X+\2&Z_MW2]'CN-6M;ZX6]:SU%YFO
M+FQ24QKBVL;J62UM54#;;PQJ6=@9#]!H@1=JEL;0IW,7)P,9RQ)W'N1CGM7R
MAJ/[9O[.]KHUIJUG\1=,U]M0U6S\.V%CI*23:I?ZEJ,L<02.!C^Z6WD<BZFE
M`CC*-@G@GZJCN!(JL`NU]NV1I%C0E@"%BYD\_@_+(I19!\R@`@5_QO>,63>+
M$N*,^XX\3N#^(.#L?XA\8\8Y_4I9WP[FG"6&QV>5\U_M;B##Y;E.;8/+L5&E
ME5;B++X3IO`N&$I8_+XU,77G5EB:W]`8&>!EAZ-'`8BAB:.&IPIPE2K0J<D5
M"%';F]QR5-7E&,>9MKR)5C53D!<[&C!\N$$([^85RL8)YP,DECM#,6<L[?E?
M^U;_`,$<?V(/VQ_B##\3OB[X"U:?QO/K5MJOB7Q+I'BCQ!8:QXGM+`3"R\.Z
M@\UY=V4'AV,SOFRTFSTNX8*H^VF,%#^J?Z?Y]J:4&7.6!?;DACQM'&T9P/4X
M')KS/"KQO\8O`OBF?&O@YXG\<>&'%[R_%91/B3@7B7-.',YJ9;B^:.)P,\QR
MFM1KU,)4E:LZ,Y3I.O3P^)A%8C#X;$4'C,#@LQH_5\?A:&,H<RFZ.)IQK4W)
M?:<9W3?K=>1_('^U'_P:I?#OQAXNTO5OV4?C1_PJCPJ]O)#K/ACXCV5_XOD^
MUH2!-I-YIZ:5)';[AA1=_:I3&REI)2/./\_G[=/_``0Z_;2_8B.I^([_`,(W
M'QB^$^G6TM]/\4?AM9S7UA86T<0+MKGA[,^JZ0$F)WS.\\(A5Y&V;0&_U`,8
M)()4D8)&.1Z<@X'KC&>]?GU_P4C_`&W_`(2_L'_LQ^._BQ\38K#7[N[LYO"_
M@CX=3RVWV[X@^+-9M+B#3M$AL)TD\_1[=)FOM9OI(9K2"VA:&5HI62O]Q_H.
M?MSOVE^#\3_";P=5?`_2QPF<YQE7!64^'W%O#&'CQUQ)4SO.LMIK$1\2>&<+
M@.(X9CE>'GC\2\WS_`8G(<#EF%QE7/J7]E8.MCJ/YQQ)X;<'5<)CL?*/]B2I
MT:M>>+H5I1PU'V<93O+#59.$G4;<8TZ34I/EA!+W3_)QD54ED0,&57=0RDD,
M%8@,I9(V((`(+1HQ')13\HC/4XZ=JW_%>N7'B?Q/XC\1W<-G;76OZ]K&MW-O
MI\,5O807&JZA<7\T-E;P*D,%G%).R6T,*)%%"$2-510!@5_WRX26)GA<+/&X
M;ZEC)X7#3QF"^LT\9]2QD\-AYXO!?6Z5.E2Q?U/%3Q6$^MTJ=.EBOJOUFG3I
MT\33IP_ENI&$:E2-.?M*<:E2-.IRN/M(1J3C"IRMMQ]I",)\K;<>?E;;BVRB
MBBN@@E,K$+D`E``I+.<!0`/E+E`0!@848'O@TK3NWWL$`E@H:10&/\0V.OS<
M]22:AHJ7"#<FX0O.W.^2/OV22<]+3DDDE*2<K)+FLDD^9V4;^ZFVEI9-[M::
M-]UKTO;0D,A8Y<!SR"6W$L",8<A@6P.A)W>K'`Q^D?[%/CZUU232?@?#I^K#
M6O%6N+_8EEH$3W=SK]^\#W$44UCYF+R\W[ULTE8A(F8QIN'R?FQ78>$M?U7P
MUXC\/ZYH%Y?:5KVEZIIM_I&J:;<W-C>6E[;2*JO9WEK)#=P3,H56:"X0M)NV
MA`37X1])/P3R3Q]\(^)?#[-Y_5L15H5,YX:S)U:U+#93Q?D^`S3$<+YEF5'#
M.-7-,LPN:>Q6/RB;]EC,)7Q')5PF+P^#Q4?V+P-\:?$7P)XVEQEX7\14>%>*
M<?D>;<(0S^KP[E'%-;*<!Q1'!X#%YKEN49W1JX"KG>42AALWR2K4E3]EFF7X
M.-1U,+6Q>&Q'^@C_`,$B/^"?7C+PQXPF_:<^-W@W6?`VO^$VFT?X3>#/$!@T
M75S/)`UKKGB3Q79Q1WEUH\9*G^RK=VCCNX[AF6/R]L9_I,AGWA?+V-&$#;E4
MQX1AF,"-MI!VXR@`P1@`=!_GY?LZ?MQ_M-?`_5]*^(WA#XE^(K[7M4\,6UMJ
MEGXTU36/%6E7PO[")GDU#3=4U)TFN[620O;NSJL,JAC&V,'^BW_@E#^W[K/Q
MGM/%/P__`&@OC&GB/XMZ[XG+>`?#5_I]M9WEUHD6F)J-Q'IHL;6WM_*MC(T,
M*O+$J6Z1J!)*@+_^=K]-/Z/'C-F&=<8^*O$F>9#Q)EW#*P&54LKR'#\0.ME&
M!PF-S++LPP^!P&*CCZL<NRS%8/&YSFN=YACKYA+,*V+J4\-'#)+_`%<X_P#V
M:?B-]&WPRSKQ&R_BG+/$OA;%/"\?<2<2X;+,VP_''$N>\>UZ_$O$_$N></8#
M+L3A,#1P-;.GF.:X^-?#Y5A<'B'0P&6X'"X:K3C]\?M[>'O#?Q(^&?@WX*^)
M[+5KO3OC-\5?"7@]QH>K_P!C3.ADFGN9[F]$;BV6R*`"V8N+F10CB1C@?CUI
M/_!OI/H^D_'*ZO?V@[_6=?UOQG)J?P#LKRR>WT3PQX,@^T3:7X3\7VWD1OJ>
MH-9&TLS>Z9+I<,<\4DTL$@(0_P!%WQ)^&?A'XN^';?P_XPMYY[*WU+1_$6D7
M=FWV/5='UC2+M;_3]2T^Y".]M=1OB.7S$D$D):)U+$M7*:Q\>_A?X1\>R?"K
MQ1XMM-"\5V7@B+QHEUKMY:Z;I^H:.-4?3+N>'4;L&";5E>,375C%;?(\LB0+
M&B@C\<\(OI&>+'`GAC'PQ\`_K6%S?&5\[SWQ-P%#@O`\58_-,)DG%O"_$7#F
M<Y'B\7EW$..R/"Y?3HKACB;"\/X7!XS-\LS&>$S#&X[)\UHT<H_SSXT\-.!.
M-L17K\<</Y1FR66RRG#XG,'3IUL/1J>TE4A1JSJP]C6HXJ2Q>"KQO5P^*7M*
M=50C[%_YWG[2GQ<^*/[!/CWQ3\-M3\.3:)\=H=,U+1+JSO8O.M-$TVYFD@;Q
M!;W,,L`O(;LPF?1Y02LD!CDF$V\&OQ'\7>-/$GCS7]6\4^+=7NO$'B#7;A[G
M5M8OY9)KJ_D>59E9MS^7!&CJ#%%:1V\:+\FS;Q7]$/\`P<Q:9X,UG]M_P=\1
M_`&O^'/$>F_$#X4:)!<7.@:F]U+_`&KX<NWTBY\X&:1$B(N-/>VC!P=MVTC2
MJ4$?\WI228O((W)D*X&5+-+/^\4;`H.-A^90,AN,_P`-?^@9^RWX9X97T,O!
M#Q*H<.XK*^-/%3@G!\8\<0S;+\70S+!<2XO$9C@<ZR#`X7,L!A\QRO)\GQ62
MTXPR_$V]I+'X?%5ZN*KSFL+_`"-AN"<M\./KW!V28K%8K*LOS?,\5A*N)Q,,
M55G'-*\,5[U:$(RJ\E/ZO1YIRFW+#^U2A.I*4XF8NS.V-S,6.``,L23@```9
M/```'0#%-IY"!G`8L`3L(XW#/!Y'`(P1P.M,K_1E.Z3UU75MM^;;<FV]VW*3
M;;;E)MR>P4444P"BBB@`IY?*[,#;\O')Y7DGYB2-YR6`P.3M"\8912:4E*+U
M4ERR6JYHMIN+LTW&5DI1ORS2Y9QG&\6?\!_=M_7WW/OG_@GY^U!=?LU_'31-
M4U*_N++P!XN>#PYX\LH&;[/<:?<S%=/GN'E=Y8K>R,HDE6WEB\V%2LP>*-$7
M['_X*U_L]^'/#'BSPW^TK\/_`!#IFJ^&OB\;:SBMM-6`:3%K"0Q:A:ZU;70)
MLI(=6M8TN/[$L[:W>P:1K:65D$BM^(JS%1@*I!`#@F3$FW&TN!(.4P"I7;M/
M(P>:^D/A7^T/>>$;WPO8?$WP]IGQL^'?AA;U-(^&GC?6=9BT#2GU(XN=1TE;
M&XMEM-46+,5M,_VB.!2!Y1^5A_#?BM]&;/,%])7A'Z7WA%FLLMXIR;@W,>!O
M&/PWP6'R3#4O'?@>A@L1_8.78;.,]Q64Y'P_QKD^,>!P^5YSG5?V%;*\)0P<
M,SR[$T*=+$?N'"?B3EU;PXSCPEXOPWM,JQ>;8;/.$N))SKU'P3GTIJ&)Q=;#
M8>%7,,7DM:#K5<9EV7N$J^*JPQ$XOV,9+^B']C+_`(*,_!_QO\&_"VE?&GQ[
MX4\#_$72[ZT\)Q^'(M.N+"*^L;."#3])U734>&.'1Y[Y(TGOY+>^:.5W99`V
M&S\T_P#!0/X[Z-\7?VH?@1^S+9Z_H=]\-M$\4^&/$'C'5]-9=3MM5U6_G69[
M2\%K.+1_LEI&UNMLL*M'-+\\DP``^&;[XE?\$XO&O@GQ':W?P*^*OPD\<78N
M[C0KKPKXP'BS0X[P%Y+.!YM<-^T.GHY$1B%O"PB&"5!K\XUUW4-.UE=4TF_N
MK>[L+XW.GZBLI%\CP7#R6MRTRNZB=5*Y\MO*.,!6!);^-/`K]G+X5_\`$?/$
MCQZX6X+\;_!3/L'@?$BGPCX=^*O"'!V'X-X3XW\3.&LTPF1\;^%W$W!_&G%N
M%S7*>"\7GW$6*P.#Q%?,<;@,;C<)BJ>,AB,!E5;#_KG'?T@>)(\`<.\#8S.>
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M:W2:*\169%GB#*EPH)3S-DPD=3(JABJE"`>0O(K_`$T\$."\G\/O#;+/!&7%
MO^N&>^'_``YA<AXESFA"I@<]J5,YP.9/)\SS;-<!@:&8_P"LN(RW&UUALWE*
MIGM2KEU',ZU+**>(H8:7\X<:YSBL^XHQ7&E/*'EF`SW,\1F62Y?B)TL3A*%+
M`XFC;#TJ56K5H2P=.5.4:]&5&E1J>TJTXQDI6C^N5U^Q'\)_VL?B)X,E_8[\
M3>'?"F@:SX'LO$/Q7\,:[XEBUF]^%NN3V<4\]DFEN;2^U.P>\D>SMI;2YD)2
M/S6&00WC'[3'_!,_XX_LV:99>(-1NM!\<Z!?27D:7?A>ZVWD!M%=F:?3;@/,
M.(V9HD9G3_5Y)!>OA?PKXQ\4>!-<T[Q#X3U?4?#6JZ5<V]Q:ZMH<TUI=0.LT
M<JI+/`8GNH%D0$VMV]S!(@$6PQ!5']`_Q;_;4^$'Q1_9P^!OB#5_B5I?B#XH
M^']->/XGZ?):'2-6&OW5K;"=XM.$A6_62Y:=Y)E'EW#-YD'E1L$7_/GZ0G$W
MTZ?HB<7>"%/PLXGQ/TA/`_-<RQ7`V8\*<2^%V<<2^)N68N,\VS[`UN+_`!!R
M+ZSBL=3S6..APQD7$_U;)>2KD.3X'-,HS'-)X_.,U_L/Z,W`OT;?I&<7YCPQ
MXKXBEX.8_%4\?G.8\:99Q5EF2<-Y;E^#R/'5:U?*<GSE_P!FX=X7%Y=A\PQ>
M5XFMF%;&4<7BJ.!K87ZQAJ.&_G0GMO*FDB"3;HW:-HI%9)P4)!=D,0VKD?=8
M*PY!QBM*70+R+3TU4(T]E(ZQK+:C[0BRD9,,\J[5@F'"^6RLP?Y>37V5\9;'
MPAX[TR/XF?#'3K748M!OQ!XI6.W:VE'FR8CGN],#)/MDD(EN)ED$)4M(ABC&
M]?D/Q#XLU#7+DB6WL;*R@'DP:7IL<]KIT?EY59C"+AFEN6`4O/,[N[#=@;G#
M?Z#>$OB[G_B]D.29U@N#Z_!N-R[-<QR;Q1X8XLQE.CGW!N?Y73HJOPS_`&53
MP^&SN.88O#XS+L]R?,,?AHY+B<GQ<*F-JRJUH4:'XSXX>!?#_@9Q1Q!D./XY
MPO'N5YCE>79YX1<8<&997EPQXA\.9K*O&AQ;A\XQ&)Q&2QRK+,7@LRX?S_*<
M#7Q&<X;B+`8G!85X>6$Q,9<JZ[7=<%=K,NUB&9<$C!*_*2,8)7@GD<5]%?LK
M_P#);?!'_8:TW_T>E?.S*WWB`-WS#```W8(P.`!SQC@=*^B?V5_^2V^"/^PU
MIO\`Z/2OUCBZ_P#JGQ!=QE+^Q,S4G#X>=9=B^;EOJES<S2>JC9/5,_F^C%QQ
M-*ZLG7@TFN5V<[I\O1--65W;:[M=_P!:E%%%?XYGWQ_%_P"(_P#D8=8_["%]
M_P"E4M<_70>(_P#D8=8_["%]_P"E4M<_7^UT/@A_@A_Z3$_.JG\2I_U\J?\`
MIR844451`4444`%%%%`%JVO)[6:">WD:">UEAGMIX28YK>ZMYEGANX9%(9;B
M)U78^2%`&%W`,/Z+?V7_`/@I)\'/%_@SP5X+^,FKZIX*^(]E;:1X6.M-ITFI
M^'_$[VUG:Z;;7%Q=[F.D7&H2HLUS/>23Q)+,1L'`K^<DG..G`Q3UE91A"4&5
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M\9V-MI'A2#5/`5]')--=:N^I02WEW"X+&&TEB^S0PK>[AYHN%F<!SM8L"#_S
MI^/=#P>XFRKQ1\)O'3(<BXG7#6=\8\'8G*ZN%H9EFF(EE693R?!YOPGFF88'
M%8_*<ZG1K83,9UL'C<&Z>-P\)?7*]#"TZ%;_`$(X\^B#X_\`!_".3^+?A9X:
M>)WBWX:YEX5^'WBCA,ZX(X7AF.=SCQ1PM1SG.,BCPQ@<PQ688[%\/YQ2S?+L
M6LKP>;1KY72RW-:N`P]6IB(1_N[^&'Q.\*?%OP9IOCCP3J']I:#J<,AMY)+>
M6WGMYHI%1[2Z21WS/;!O*GV.0TJEE8`[1Z.""`1R",@XQD?3M]*_E[_X)E?\
M%0O"GPH\.?#_`/9F^,6EWUC;7OB+74LOB;/?0W.F:?/K6I9T'0;BSA7[7=3.
MDL-J;T,%C<&24.P*U_3S)=16UK+=74\,,-O;R74]U*XCM([6!?,GNI)V(C2!
M8P93(S*JH=S856K_`(_OI'>">9>#?B;G?#V&R?.<-PAF6=YU6\.\=F\\/C<Q
MS?A:EFU?#99/&5\MI.C6S6%*=&ECJ*PV'QD*JHU*V`H?7Z,)_DGAYX@9'XA9
M(LPRS$N.9X!QP'$F28NC5P&=<.9Y052&89/G>4XRA@\?EV88'$TZV%Q5/$8*
MA2>)PV)IT*E7V%6-"T,\YQUX^E?YY?\`P=&>(=;N_P#@H!H'AVXUV_U#0-#^
M#GA:[L=`EO3/8>'Y-6>__M8V%D/W%J^J,+&_NY)HYKLS3N4GCA$,,/\`1Y^T
MU_P<8_L%_L[?$/Q/\+K(_$+XL^)?"&KZKH'B/4/`FA63>$='U?2C<6DEG+XB
MO]3A.H!]5MGM6N-*TZZBC0[QYO!;^!3]MG]J_P`6_MG?M-?%G]H?Q;!+IUQ\
M0?%&HWFE>'WN9[FU\+^%DN4B\/\`AFR:>::7R=.TJUM(;J0R8N;S[5/#';0R
M16T'_2!_H]7[/?Z4'AE]*/$_2=\9O!KB'PS\-<O\$>(</P/CO$3)J&59CQGG
M'B++AZAE-7AC*\76Q6=9?3PN083$YGCLUS/*^'HK*\WH82"KK-)4CXWQ5XIR
M;%Y)_8N7YA1QF,GF-'ZS3PU3GC0IX5U75CB'%I->U7LU!.3]I!M_#K\FNI1W
M0[<JS*=F=F5)!VY).WCY<DG&.33:5CDD^I)_,TE?]H*BHI13YE%**ERQCS**
M45+E@HPCS**ERPC&$;\L(J,8I?SKKUU?5]WU?WW"BBBF`4444`%>Q?!:TTO5
M?B1X-LM:\J*QAOXI7\T@13.A=X4!;</,DE=`>QVL``1FO':U;"^GL+FVNXG"
M2VDUI/"T997C:*02!PP88?.,_P`)/!!&0?D^.\BQG$W!7%W#N79G5R7,<^X8
MS_)LOSBC&4JF5XS-,HQ^#P^.A&#4W5PU2JJ]!P]Z%:"DMC[/PYXDP7!OB!P/
MQ;F644.(,OX7XQX6XBQV1XIP6&SC"9)G^4YEB,MKN:<52QM+!2PTW)."C4;J
M1E#FB_W6D4))(BHD2H[*L:<)&%8@(G)^1`-J\G@#FOWI_P""./QL_96^#.F>
M-I_C'K&@>%?B9K?BVR'@KQ)XAT:">2STM]&^QZG!IFKSI+/9BX=5\PI*L6&=
M4C`(5?Y[/AWJY\4>"_".MW,CQS:KH]A+=2R*V#.885N9R6).QI"TO+LS*V=W
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MZW#0:A/IJ6T<`NKZ.RCGF@11:I<W,RI'YMAME+S/`PEO90PE:X\UE9<5QG_!
M4C7+SPG\,O@EX'\._$738="BL;[2_$O@7P_?M#<:FX\N6'6=4B@F\Y/,\IE%
MO='[DQ2[$\REC^W?LY?H%>%;\2<@R+A6EG/#?%>6YCDF;2\7\#F.<4>,:=7`
M8YX_.>&,;7RJMALGH\)\595AZN49]PX\NIY7F>!KX"&+S)2PZC#_`#L^F'PC
MX.<&_1>^BKXD\!\'^*O`W'/C!D><YYQ#PCXOX6OEW$5+)H9-A)UL?G?#M3`8
M3`8+'9;Q3CL/A^$<=DL\'@\ZX4QN5YS++84L;0C'XH_X**_&7PU\:/VA[NZ\
M"ZW9^(?!/AC0M.\,>'=1T6W9K.]N[427&H?9E#@NUQJER\7VF/$4UO#:A(#(
MDCR_:G[(O_!-6\\-WOA+XZ_'6\TO_A&;#1YO%,?P[BA:\O)H;GPZ;^*#6D=W
M^6VAGV.D3P,EXAW3.%`K\4O#&E'7O$>@Z,3(AUO5M)TD&VVK,L=[J%K!<31N
MFQ(I(@&:-GC8H`SR,Y&X?T__`+<?QDT/]F[]E^/PE!=N?&/B_P`&0^!O"L1N
MFN+PZ?):0QWNJ2W5G<I(DZ0JRVDSDB.V(6YCN9<R'_I,\8\5Q5P!D7@[X&^&
M&/Q^'EQ1?AS%XE87GS>>3Y7/*J..QM/'T'*CDW-6Q.>8S$5L,GS.I4C!U*:P
M]6G_`):X%T,76S+,\;!SE3;J482J)0A4J2FX*::C*<81]G"-MG%.R6A_,S\4
MKSPCJGQ#\=:IX#LKW3/!USXGUNZ\/:?J)A^U6VF76JW<UC:A88842.VM'BB2
M,H7C2,*\CGYJ\^88)&",$C!ZC!Z'IR._%.8D,1C`4D!2=P&,@#(^\5[-GGKS
M32222>I))^IK^R,OP:R_`X'`1K5:\<#@L+@E6KS=6O76$P^'PT*]:M+WISG3
MPT+N2YY-RG4E*<YR?SU249RE))+FE*6E[>]*4K*_3WM/)+T$HHHKL("BBB@`
MHHHH`*G2YE0!5=@F`"F]RIP,9P7.,]?D*@=@!@""BA:---J2O:2;4HW5FXR5
MI1=M+Q::Z-/4$VMFUYK1_)JS7R:)WN'D;++']T*%5`J\?Q'&"['JS2%RQR6R
M2<P$Y)/`R<\``<^@```]```.@&*V=,T2_P!8F^SZ98W^H3E$98K*UDN'R54N
M&V#&`=V.F.,DX->\^"_V8/B/XHD@N;_2I/#VCM.HGN=4G@MK[[,1N:6UT]P;
MFY)7F,K$$<$<@\5^<<=^+7AAX7X*KF/'_'/"_"E*G1J553S?.LOIYGB*<:=?
M$*.#RJ.,Q.=XV5=X:JZ%+"Y=5=:LXM0C*K[67ZSX9^!OC#XR9E0ROPP\-.-N
M.L36K4\.ZW#W#>;YAEN%E*OA\/4J9CG=/`PR7`4,+/$TI8VOC<XIQPE+VE2K
M%JE."\O\%>!?%GCV\CTGPQ8S7CSA1.X$4=C`(550]PTCHJR`'.^1278EHQ+N
M)'T-\./V7-?U?Q5JZ^.8)=-T/P].1=M!)%'-K;.TBQKIC-!+$0-HDG!C=0%9
M5";U*?>?@?P9H_@'P_I^@:/'&YLK&TLY]4-ND%[J#VMO%;O=3%55D:X:(S-$
MV?+:1E/(S78&0DJ2`3&#Y62W[HEMS,@W8+.<EB^_DDJ`>:_P_P#&K]J;XF<2
M9CQID/A1EV6\(<(8_"5LCR#B#$4,3BN-:<*>,K4I\3TL16FL)EN/S#+Z4<-A
M,(L-4J9-A,:L2JF,SS#IX?\`Z-?H\_L7?"CA3*O#[B?QOSK-N.N.,MS##\1\
M3<*87$X?"^'U6-7+</5PO!F(PD%5QV:8+)LWK3Q>;YI1S/#4>**^"E@883+<
MCQ#EB/S?^/GP6^'WP[L4N=&N->6]O7D:.W"(VGVOEME7O)O)B)^U'!@CC<,5
M8;0U>=^`?A7=^-?`OC3Q':VS_P!H^'IK&:T1@I2Y$2.EY%(CQM.$CA8`+%+"
MXG3>690JC]3=?T73?%&BZEH>KVL5_9:C"8+F&X17W8!"21MC?')%P8C&54<!
ME8$@\_X%\!Z#\/O#DOAW1(&$<T5_),TYCEGN9+@%$BN72*)'15/(6-&W$MN[
M#GX'_:/\3<.>`^&X9QF8\69]XT9;Q]PECJ/$W$N:4<QR?.>#\#G.&S/-<OQ<
MJ.6Y95RJA5PF&7#&-RJG_:;S3!YI4SRIF<*F%Q^"J;^(G[)3@_B;Z3.*XMR_
M*N!N'/H]9UX:<9Y=B>$N%LGQ>39WD/'&89-7R3(L1A*53-LYI9SB(9CCX<4X
M;.?;9/#`5,J7#_\`8TZ5?!XU?CQHOB[7_"=Q=C0=1N--,EO)ILXB+E+NS!V>
M3=PS&2*4%$`+O%YH))W@\CE99&EDDE?&^5WD;`P-SL6;`[#).!7>?$31KK3/
M&OB:UN[&XL)DUC4[@0R1F&.6"XO)IK<V@9`/**,PC.YPZJH&T@@\'(NR1T'`
M5V7!(8C:Q'+`*&Z=0H!ZX'2O]X.$5POFF`P?&?#^69'AZW%V1Y!F&)S7*J.5
MSQ&:8-9;AJV74,;FV74E+-8Y1#&ULOPTL77K5,)"C4H4H86E)X6C_P`SG%W^
MMV28S%\!\1YCQ!*AP5GN?Y=ALBSBMFE*CDN8+,<3@\UGA<ES*?+D^(S*IE-+
M$8ZGA<-AXXBI&E.M+$SITL35>TS,BH50!5"@@$'@8R?F()/?CZ`5]#?LK_\`
M);?!'_8:TW_T>E?.=?1G[*__`"6WP1_V&M-_]'I75Q;&,.%.(HQ2BO[&S65E
M>UW@,:V]6]VWUZ['R]&I.IB:$IR<FJE**;MLI)):);));?,_K4HHHK_'0^^/
MXO\`Q'_R,.L?]A"^_P#2J6N?KH/$?_(PZQ_V$+[_`-*I:Y^O]KH?!#_!#_TF
M)^=5/XE3_KY4_P#3DPHHHJB`HHHH`****`"BBG`#/S9`(X/3^='5+OUZ+U?3
M_,:3>Q^LG[*\T$WP?T5$*^9!>ZC%<E"P<"2=BJG#$#Y%1L[>I8=\+]"LW^M5
M0OEN%79C*KL/#HS$R*QP,G>1[#)S\M?LC:9?V'PUN[N[#"SU'4C)IZDGYE`!
M=AGJ&8AAM&,9!)(KZD8Y9C@#+$X'09/0>P[5_P`DOTN*&%P7TF/'3#8#'T,R
MPJ\3>*:L<;AG>$ZF*QM'&8JA&2DU+ZIC:U?!2E&WOY>MG=/_`+DOH(8G'9I]
M#OZ-M?.,HQ&4XR'A'PIA)8+%.LY^QP%''8'`XQQJ<C4,UR_!8/-5"47!1Q]%
M1CR.FU]<_L>?!]OVB?C+X)^%Z^/O"?POEBU*#Q#:>*_$EW';D3:9J$-S-IVB
MBZ:2SO==U$AUMK6X@E*W+`1["H6OZY/V]OC+\-/V3/V#OC#XA^*'BB[71-$^
M$^I>`M-N;J]-MXF\4^*=8TEM'T+3[&*(Q&XU?4&9+ZZALD46BI,0WE@8_@V\
M8_$"3X9:/_PEO]G:M?C39HI(9-`D)U#2Y5N%F3408U1K=H''G+)&RLI!+N2%
M8?.G[<?_``4N^.W[:7A'X1?##QQXGU'4O`'P1M+VW\*P7S3IJ6M:A<I';1^(
M_%$DMS.^J:W9V$26=C<S)'Y$$CK.EU<EKEOQ7@+]F=XN_3M\=?`OBW$YZ\F^
MCGX>\4U<T\0<WHX+*J>/RN7#^*ROB',<%D>9T,1B,SS'B;C'&97D.14\-G^#
MPU#+,+7Q>=X/^TL#@5S_`.-_[5WA'PA\(N*,?Q%P)C_#SAKCKCS,I\2\8^&^
M5\)5N'^+^*^(^)*%?+\1XI9SQ)A\OD^,\-4P^3T\MQ$,3FM)9'+#4\/@\+AI
MYACIX[\V;VZDFN[J3.XO-.RRRA9YU:25G>8W$PDF>>0DEY'=_F9F0(2,5)',
MA8M_$Q8@$D<G.,L2Q^K,S=R2>:1L;FP"HR<*225&>`2>20.,GD]Z2O\`M#Y8
MJ+IQBHTK*,:46O9PA"ZITX1C&G",*<+4X*$(1C3A"G"%.C"E0H_\_P`Y2E)S
M;;E)N3DW>3<FY-RE:\FY-RDW\4G*3]Z3;/I1113VT6RT^[0D****`"BBB@`I
M^\C=@`;E53C/10`".>IQD]LDX`IE%#UM?HU)>J4DGZI2DOF]'T/^&_%/\TG\
MC])/V2?B5>ZUHE_X*U6_MWET2VB&@P,)/M;V4K%YHI"\K1201#Y;=4BA>-``
M7DQFOM3[?<K(S07DL<WV=;1HUG=2;1$\J.$C&!&$&`!Z`9/%?B[\*OB/=_#3
MQ(OB+3M)L=4NULFM%@OYKF"!4DC5)''D2*S2X4D,V4!+$(0<#VB^_;`^);?:
M8K.TT:Q#;XHF^SSS201!ML86;[3&)71`!YC0J),;S$F=H_P\^E5^SS\5_$?Q
M\XLXL\'N'N&,'P3Q92RO.\57S?/\!D6&PO$F,IU*7$]*A@*>!QN,=/%8S"X?
M.:V)C1IK$XK,\:Z3A*$Z<_\`HA^AW^TQ^CQX??1M\.^%?I(U\XXG\2O#;$<1
M</\`#-;#\`XGC?-\-PE[+"4LAK4>(\ZC#!Y7CIY4_P#5NI2R?,*4X9+DF3X3
M'5*U.%-4?T8\2_$W0?@YI6E>/I]20:EIUS<-9Z+<6`C>YOH(Q;PQQ22,\=U#
MMR8)2L:RK^]!)V`?C+\1O&^J_$+QOXK\8:S+-+?>(]<U75'>XF>:6$7VH7%V
M8D8R/!'CSB'6V1+<-N^SQQ1E5#?&'Q&\6^.KLW?B?5)M2=6+11223BWMSAEQ
M!`)A'&-K,#M7G.3D@8XAY&<DMC)8L2!CDY)_G7]R_0P^B!A?HQ\-YIC<]SBE
MG_B!Q92HQSZ>7UL6^'LHP5"HJN'R7*J.*H4JF+K4ZGM*F/S^M.-;,)3A0PV"
MR[!894\3_F=].;Z8\OI8\9Y35R_)IX7A/@V>=X/AO/>(LEX:P?B%GF79EG>9
MYGAJ&?8SAFEA\MP.09/1Q6%P7#?#&!I3>%IX>><<19CG7%>.S''$HN98WC>%
MC"T)S"\#/$\;B02"5)(V5UE#`;7#<8&!D`UM:UXN\4>)&M6\0^(=:UTV49BL
M_P"V-3OM3%JA&"L`O9YQ&,8&%QP`.G%<[17]LRH8>=>EBIX?#SQ-!35#$3P]
M"=?#JIS<\</7G1E5H1ES24E0J45*_O)]/X1<Y._O2LW=J]D[:*Z5D[)+=->0
M@&`!DG``R>IQW/O2T45HDHI)*R222[)))+5MZ)):MO35MZN0HHHI@%%%%`!1
M110`4444`?>/[&.@>;?^)O$$R_+:Q6-C`IPT:M-%YC2A7#,'(=<E6"Y)79@\
M??`+@DL[.YSEW.]MQ&&9"^?+SR0(PJCHH```^(_V+1,MEXP=S(MLPTTPR29-
MN]QY4BM"`$!$B+$@7Y^2=WW64#[@5$;(5V(4?,$1Y#'DX"N2L2EE!`<KD9!Q
MQBO^7G]HCC,?F'TM/%*.)Q"Q<,!/AG+L&J<)*."RZ'"^55</@*JO.$,11Q%?
M&RQ55SH.K6K+GHT:D%2J_P#9=^RERW*,L^@WX-SPF`J82KFCXTSC,)5^5O'Y
MMB>-,ZH8S'4%&G14J%6CEV"AA?=J*%"BU#$5HRE.G%]22?4DDGW)/))[D\DT
M54O-1TW3RJ7^I:?9.7V*+F]MXV<YQGRV8&,\9*EWVYP6)!JRCQ2Q+<PRQW%M
M(PV2V\BR(5."#O4LK9!SD8R.0,8S_$\\%C*=*%>KAJ].C5DXTJU2A7IT*LTG
M-QI8BIAZ>&J2:NU&&(E)I-J-K-_Z)4<TRVO6JX3#X[!UL3AE'ZQA*&+P=;%8
M5.RC]9PM'&U\5AULKUL/!:K5MV)`V""`./K@_7GFD8[B3@*6&,KP0.^,DXSC
MGMZ`4$8)`YP2,_0TE<W,[WOK:U]'HKI=&K:O9>>NC7=RQ=[J]]]^WJK.W:S6
M]T]3XL_;%\)RW&F>'_&4$9N#8D:9<PQQ*-JR@"&6Z>*,2,D:*%C)=0H)+$X-
M?G8X"NX!R`S`'U`)`/X]:_8;]HC4-/T_X2>)1<B*.?4;*WM+%[IDC)U#SE1!
M;825[O?$RCRDCB:-F4RS%%P?R"DMSO/)4,TA#/@I@,=H,B\;F!!R5&<[MHZ5
M_P!)O[+_`(SS[BGZ-T<FS;"UUA.!>+<SX9R#,*EE3Q^58RC0SVAAJ',J*;RK
M$XW&Y9*L_:4L2WAH4L7.O3GA8_\`(=^V0\/^&^"OI?8G.<@QE"6*\1^"LDXT
MXDRJFH>URO/H5\7PY7KUG&I.5L]PN2X/-J=-TZ/LG#$-TW+$.K.I7T9^RO\`
M\EM\$?\`8:TW_P!'I7SGP>@('8$@D#T)&`2.Y``/:OHS]E?_`)+;X(_[#6F_
M^CTK^]^+VGPKQ"T[IY+FC35[-/+\8TU=1=FFFKI.SU2=TO\`*G#?[Q1_Z_4_
M_2S^M2BBBO\`'(_03^+_`,1_\C#K'_80OO\`TJEKGZZ#Q'_R,.L?]A"^_P#2
MJ6N?K_:Z'P0_P0_])B?G53^)4_Z^5/\`TY,****H@****`"BBB@`I2Q(`XXI
M**.C71JS\T--K9V/US_9G\26FN_"?PW:0"W2?05;3;BW@F5V?[.D:"XG@&7$
MSE78D.!\X&Q>WK?B+Q%I'A32[C6==FEMM/@1R\L<+RE6"LR92-695;&,`'G@
ML!\U?%_[&*ZD[^);]L?V1:VEM:I#$L<8^V'[TS[5#,S#!9BVYB7;))&/;?VC
MO%>L^'O!-UI6C^'M0U!M;@>WO]4MX?.L=%@B`,=U<[@Q#7@`,;%@@W$[1QM_
MYA_'?P3R[%_3IXB\*LFQE',LNXL\1\NS'%>TS7"9-_9D.-:N&XHX@R^MG.91
ME@L/7RJIFN-I0GB(8A3EBL#A:4:U:O1@?]A_T;?I%YKE?[-+A7QKSG`8C*<V
MX$\)LWR?+H4LFS#B".>8SP]I5^$^%\?2R+)U_:&(P>?SR;)J=:%*>!IX#"4\
MUS#,,;@L%AL5C#Y%^)/[3GB[Q59ZQX:TTVNG:+?3S6WVVVAE@N[G3TE=("2T
M\JI'+!L+(\3R8.&?<-]?*<CXE<J%!WL<J7()#'YAN8]>HR,>PHD=_.E=AME:
M1V?[P.\L2^1G@[LY``P>PP*C)))).2223ZD\DU_T7^&'A%X>>#?#W^J_AWPG
MEG"N6RQ%'&8^E@H3J8C-,UI8'#8"KFV:8O$?[1B<QJ0PTH3E.%.E0]I7AA*.
M$HR6'C_RD>,7CAXI^/7%/^N'BMQOG?&V<T,/B,NRW$9O6A.GE63U<RQ^94LI
MRRA2IT:6$R^C6QTW3H1ISDU"BZ^)Q=2E&L!))))R222?4GDFDHHK])VT[:?=
MIUN_O;?=MW;_`"8****`"BBB@`HHHH`****`+$5R\)!1(R1C[Z;P2.^&)'X#
M`]JCDE,LAD=5)8DE1E4Y.<!58!0.@"XP.*CHJ7"#?,X1<K6<G%2DUV<FFVET
M3;2Z)`M-59.UFTDI-=G))2:[)O1[`>23@#)Z#.![#))P/<D^I-%%%4`4444`
M%%%%`!1110`4444`%%%%`!1110![[\-OC]XL^&?A^]T'2;:PF@N9/M$$MQ`7
MDA8KC.Z.:%CR2<DLP(&".035_P!I;XM:SINIZ3?:]&;;46`:2"![:YM40_*E
MI-;SQ[5`PI,RSLP`)8GFO!-QR,C(&/E);!QCKSGMS@CC@8%(3DD@!023@9P,
MGH,DG`Z#))QU)-?BF(^CCX$8WB?-N-,R\(O#[,^*\[S>CGN9Y_F?#N$S3,L5
MG%"49T\PC5S&.)IT*O-&$JOLL/#ZQ6@I8F&)IQI1A_0.%^E7])'+>#LC\/LI
M\</$W)^"N',EQ7#N3\-9/Q5CLGRG!Y'C566)RQT,K6"GB<//ZSB%36)Q.(EA
MX5IK"UL).<Y/7O?$&M:D_F7^J7]W("6#W%Y<RLI8Y)4O*QS[G+>I)KZ_^`7Q
MUMO"FG0^$O$4^H7L^I7^FQ:9-)YL\%K;W.R(QNAQ(QBX,;)*(]K!0,C%?%%:
M%AJ=WIMS:7=FRQ3V5S#=PN%!/G02&1&;)Z9.&"["0.H8LQ7C7X%<">-7ASF/
MA]Q#D6`C@'*GF63_`-G8;+\HG@,\RZ&+JY55I5<'EE%4,++%5X4L?3I1I*O@
MG*A)2IQC3AK]'SZ27B;]'SQ5ROQ2X2XDS%YM3C+*\\69XC&YW1S;A[,Z^`I9
MUAL5ALQS2HL7BU@</7J977K5W/!X^4<13J1FW(_=EN&(SNP3S@C//7!Y&>N#
MR.E-GFM;.VGO+N7R[6T@DN+N?($=O$B[BSDYX49W=,E6`.0<?$G@_P#;"L)X
M+.U\8>'[B.^2VC^V:CI4FZWN)A"I+I:3>;/$\S_.5,LBCS$56Y4GS_XU?M,R
M^,M&?PSX4L[O1M)O<+J-Y<OLU"YA4@K"?+=$BBD48DB>!W`)`D5P&K_GPX2_
M9W_28S?Q%P'!G$/`6+X>R*>8TZ6;\>3QV58_A3`Y-#,JN%Q>;8+,\NS&O3S'
M$3HX+$K+LLITJ6+K8C$X>.,PV"I4JTH?]3/'/[5KZ(&1^$^/\0>%/$W"\5\0
MTLIKU,B\.:67YWEG&&9\0SRNC5P639E@,PRNG2RW#4<;C</#-\SJ8_$X.A2P
MV+JX"OF4HTW+^Q7_`((9_LS?LC?M0?"7XC_&GQ]X1\(?&#QII7Q$UKP?IEEX
MG;^U+;PEX8L=&M88KNT\.*TODG7;N6Z+ZE-'*T\(1[5;62-V?^=__@O=^S;^
MS?\`LP?MU:KX%_9PT[2/#'A76/`_A_7O$WA30-1-]I_A7Q7J6KWJ7^FV\<ID
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MP4JT\/3I48SI8>A5G7G5Y20$.X*E"'8%#U0@G*G(!RIXY`Z=*^BOV5_^2V^"
M/^PUIO\`Z/2OG,DDDDDDG)).22>I)[DGDFOL/]E_P<Z^+_`/C:UN)+E1XVM=
M)OK=8"4MQ':07D>#E3YA=R&<LT;(``BODU_K+XCY]E>1\,8R.9XF6&_MUXCA
M[*W*$ZKQ.<9CE6=U\!@7*FG:OBX9=BX4+Q?M\336'I1G7KX>C5_+>'>'<YX@
MJ9K4R?!3QRX=R;$\39O&E4HQJ8;),MQ>483'X^-.K5I3K4L)5SO+98A4N>=#
M#UY8JLJ>&H8BO1_J=HJ_]D_Z9S_^.45_DA[&/_07@/\`PNPW_P`F>]]<PO\`
MS^?_`(38_P#^=Q_%AXC_`.1AUC_L(7W_`*52US];_B(YU_5V&=K7]\RG'WE-
MS*RD<]",<_I6&(V.#M.#SQZ5_M/#X(:/X(=OY(>?F?"U(OVE3_KY4_\`2Y^0
MRBI-B]RP]MA./;.>:-B_WF_[X/\`C5:]G^'_`,D1ROR^_P#X!'14FQ?[S?\`
M?!_QHV+_`'F_[X/^-&O9_P#DO_R0<K\OO_X!'14FQ?[S?]\'_&C8O]YO^^#_
M`(T:]G_Y+_\`)!ROR^__`(!'14FQ?[S?]\'_`!HV+_>;_O@_XT:]G_Y+_P#)
M!ROR^_\`X!]0?LQ?$5/!/C1-*OIE&B>)DM;">(.X$=[(I\J;!(0,9&"2,5?J
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M4FQ?[S?]\'_&C8O]YO\`O@_XUIKV?_DO_P`D9<K\OO\`^`1T5)L7^\W_`'P?
M\:-B_P!YO^^#_C1KV?\`Y+_\D'*_+[_^`1T5)L7^\W_?!_QHV+_>;_O@_P"-
M&O9_^2__`"0<K\OO_P"`1T5)L7^\W_?!_P`:-B_WF_[X/^-&O9_^2_\`R0<K
M\OO_`.`1T5)L7^\W_?!_QHV+_>;_`+X/^-&O9_\`DO\`\D'*_+[_`/@$=%2;
M%_O-_P!\'_&C8O\`>;_O@_XT:]G_`.2__)!ROR^__@$=%2;%_O-_WP?\:-B_
MWF_[X/\`C1KV?_DO_P`D'*_+[_\`@$=%2;%_O-_WP?\`&C8O]YO^^#_C1KV?
M_DO_`,D'*_+[_P#@$=%2;%_O-_WP?\:-B_WF_P"^#_C1KV?_`)+_`/)!ROR^
M_P#X!'14FQ?[S?\`?!_QHV+_`'F_[X/^-&O9_P#DO_R0<K\OO_X!'14FQ?[S
M?]\'_&C8O]YO^^#_`(T:]G_Y+_\`)!ROR^__`(!'14FQ?[S?]\'_`!HV+_>;
M_O@_XT:]G_Y+_P#)!ROR^_\`X!'14FQ?[S?]\'_&C8O]YO\`O@_XT:]G_P"2
M_P#R0<K\OO\`^`1T5)L7^\W_`'P?\:-B_P!YO^^#_C1KV?\`Y+_\D'*_+[_^
M`1UW7P[\`ZW\3?&GA#P!X9A%UXD\<^)]!\)Z!;M*D44FH^(-2BTNWEGD=<)!
M;W#.TXR)'CVF($CYN)V+_>;_`+X/^-;GAWQ%K'A/7-&\2>'[^?2=;\/:MI^N
M:1J=IYD=S9ZKI-S%=Z9>Q-YV%FL[J)9XBJJ"Y;S`ZG:/&XBIYW6R#/*/#6(P
MN#XDK9+G-+AW&9A1^LY;@N(*F4YI'(L;F>%A.,\9EF%SEY55Q^#ISIU,3A%B
M80J1:UTI)1J1=36GS0]HHOWI4_:4W44':T*CIJI[.;NHRM=-.Q_9[XM_X-?=
M&\&_LWZSXET'XZW&O_%_2/`$WB6[\.^+_"<.E^$HM8M=$34=5TNSU33;@ZK+
M+"T4]I;SS-$`Z1R2QQ1AXQ_%IJMK<:;J.J:9=1)%=65]=6-T@+YBGL[B2"5%
M+%3\LL;#+("<<@<BOZ/O'?\`P<U?MK^/O@!>?!@^"OAIHWBS5_!R^$/$'QCT
M>/5W\2ZG;7.F+I^J:FVGW.H+I-AJ^HAKAYW@CD:)YG422R9E;^;N\FDO+NZO
M+F>:>XNKB>YGFE5WEFFGE:6661GDD=I)'9G=FD=BQ)9V)+'_`"P_9<>&7[2;
M@*CX_P"8_M#.+^'N+<1Q5QEEF-\,8X#B#(^*,=AZ=&7$'^L>+PN)X?R_+\FR
MKA/$TL1DU#A_)?J[S7!U,/5JXN="3K4I?H/'G$F4YU0X8R[(%6IY=D&4U<!&
M.)R[+\+C&ZF(IU81KYE0PU'-,RC2@JE.$<PQ.+HT%*2PKI0FZ;J$Y))ZDDG'
M3DYJ140XRQ7(7ENFXYR>@X`&0/PR3U38O]YO^^#_`(U]6?"#]G(^--";QIXI
MUF#1_"4<4DF8IK=K^7RU)#()$E2$85GVO"S!5(+!AAO]'_%3Q;X"\%^%*G&'
MB%G+R?*/KF%RO`TZ.%Q>89GG&;XZI"C@,GR7+,OIXC'9EFF+G*,:&$P]/F<5
M.I4JT:,)U5ZG@QX'^)?C]QI2X#\+>'EG^?/`XK-L=+$8_+LIRG),DP7(LPS[
M/LWS7$X3+\JRC`>UI?6,9B*DE&=2G3IT*U2I&F?--CH\U^MPT$%[,EK&DMQ+
M;P?:$CCWJKR-L.55@P9,Y*JP+`A&S^H?P`_X0+X<V_P[\'O<)XFUGQCXGL-9
M\FW=XKNP%W;P);R31ELVTB6YB6>)U)2577Y0N#\M^*?B1\/?!'A;4O`GPET^
M[_M&])M];\7ZE'%)=7"0."\5HZQP&,3NA$8"-#&IVKAE4G)_9EO[[6/C[X-N
M;JXN+V>37+$^:8SOVFX7&`S%H\Y/R'H<@`'-?SGQED'&GTBLCPF=<3Y1Q?X2
M>'W!'%V*XOR7AG'XG^S>.O$5<-Y+3Q7"V9<18*&&4N!<KP'$4JV94,)@,XQN
M>X_"NA#,\+E^-GBJ=#^@<+Q)P#]%C#\8\.\%9[P+XX^*'B+X58K@//\`C7*\
M%_;'A]X42XRQN(PW%>7\$X[&5:.#\2<XQ7"F%P^2YAG.*RG`\/Y9F=:6)R#&
M9C2PV&^L?UD_V=-_SX6__@5<_P#R116C_9S?\^MW_P!\M_\`%T5_$WL<5_S]
MH_\`ACR3_(_G'V]+_H7XG_Q*L^_^4G%^/?\`@V!OK&\O;V+Q=<W,LTD\[1);
M+(5>21G92\5I&K%22-\:HK8RJHI`'S%KW_!N=XJTJ1U74=9F15)7RM-E)(&<
M8/EX*XY'`X^G/^@UXE_X^;S_`'I?YM7SAXJ_X^)/H]?01^DQXQJ,5_K1>T8J
M\L#A92=HQ5Y2]DN:3M>3LKR<G97LLWDF72;DZ&LFV_>ENVV_M=VS^"B]_P""
M!GBJR+"34-4A56*YFL7'"DCD>4"#QT))'O6+)_P0JU>'_7^(I(<=3)$5Z=?E
M,.1[`DGMSR1_:?XZ_P!7/_OR?^AM7RKXO^Y)]6_]GJ/^)G?&9:?ZSTO_``VX
M7_(7]AY;_P`^/_)I?_)'\I4G_!#VXB8B3QE9J`3]Z3:P&3@%3`<-ZCUXJ$_\
M$1MO+>.=/`Z\RC./^_'7_.*_H[UCK)_OM_,UP=WT/U'\S1_Q,[XS?]%/2_\`
M#;A?\@_L/+?^?'_DTO\`Y(_`#_AR3!W\?Z0#W!O44CV(-KD$=P>AXJ$_\$4+
M($@_$70P02"#J^D*00<$%9+N.0$=P\<;CHR*V5'[P/\`?;_>;^9KH8/]1#_U
MRC_]`6C_`(F=\9O^BGI?^&W"_P"0?V'EO_/C_P`FE_\`)'\_O_#E&Q_Z*-H7
M_@XT7_Y-H_X<HV/_`$4;0O\`P<:+_P#)M?T#T4?\3.^,W_13TO\`PVX7_(/[
M#RW_`)\?^32_^2/Y^/\`ARC8_P#11M"_\'&B_P#R;3V_X(JVK*J?\+(T,(,`
MH-7T0!@.S?Z9D^^"#7]`E%"^D_XT*_+Q5&%U:7)@:-/F76,N24.>+ZQES1?6
M+'_8>6=<-%[VYK3M?2ZYU+E?]Z-I+I)'\_)_X(I6);<?B+H6-H0)_;.C[0H[
M`?;\^W6D'_!%&Q`P/B+H6!P/^)QHQ_4WQ)^I)/K7]`]%'_$SWC/M_K12^>78
M5VZ:73LK):*R5M$@_L3+79>P5HKE5I-65[VT:OKK=W;ZR9_/Q_PY1L?^BC:%
M_P"#C1?_`)-H_P"'*-C_`-%&T+_P<:+_`/)M?T#T4?\`$SOC-_T4]+_PVX7_
M`"%_8>6_\^/_`":7_P`D?S\?\.4;'_HHVA?^#C1?_DVC_ARC8_\`11M"_P#!
MQHO_`,FU_0/11_Q,[XS?]%/2_P##;A?\@_L/+?\`GQ_Y-+_Y(_GX_P"'*-C_
M`-%&T+_P<:+_`/)M'_#E&Q_Z*-H7_@XT7_Y-K^@>BC_B9WQF_P"BGI?^&W"_
MY!_8>6_\^/\`R:7_`,D?S\?\.4;'_HHVA?\`@XT7_P"3:/\`ARC8_P#11M"_
M\'&B_P#R;7]`]%'_`!,[XS?]%/2_\-N%_P`@_L/+?^?'_DTO_DC^?C_ARC8_
M]%&T+_P<:+_\FT?\.4;'_HHVA?\`@XT7_P"3:_H'HH_XF=\9O^BGI?\`AMPO
M^0?V'EO_`#X_\FE_\D?S\?\`#E&Q_P"BC:%_X.-%_P#DVC_ARC8_]%&T+_P<
M:+_\FU_0/11_Q,[XS?\`13TO_#;A?\@_L/+?^?'_`)-+_P"2/Y^/^'*-C_T4
M;0O_``<:+_\`)M'_``Y1L?\`HHVA?^#C1?\`Y-K^@>BC_B9WQF_Z*>E_X;<+
M_D']AY;_`,^/_)I?_)'\_'_#E&Q_Z*-H7_@XT7_Y-H_X<HV/_11M"_\`!QHO
M_P`FU_0/11_Q,[XS?]%/2_\`#;A?\@_L/+?^?'_DTO\`Y(_GX_X<HV/_`$4;
M0O\`P<:+_P#)M'_#E&Q_Z*-H7_@XT7_Y-K^@>BC_`(F=\9O^BGI?^&W"_P"0
M?V'EO_/C_P`FE_\`)'\_'_#E&Q_Z*-H7_@XT7_Y-H_X<HV/_`$4;0O\`P<:+
M_P#)M?T#T4?\3.^,W_13TO\`PVX7_(/[#RW_`)\?^32_^2/Y^/\`ARC8_P#1
M1M"_\'&B_P#R;1_PY1L?^BC:%_X.-%_^3:_H'HH_XF=\9O\`HIZ7_AMPO^0?
MV'EO_/C_`,FE_P#)'\_'_#E&Q_Z*-H7_`(.-%_\`DVC_`(<HV/\`T4;0O_!Q
MHO\`\FU_0/11_P`3.^,W_13TO_#;A?\`(/[#RW_GQ_Y-+_Y(_GX_X<HV/_11
MM"_\'&B__)M'_#E&Q_Z*-H7_`(.-%_\`DVOZ!Z*/^)G?&;_HIZ7_`(;<+_D'
M]AY;_P`^/_)I?_)'\_'_``Y1L?\`HHVA?^#C1?\`Y-H_X<HV/_11M"_\'&B_
M_)M?T#T4?\3.^,W_`$4]+_PVX7_(/[#RW_GQ_P"32_\`DC^?C_ARC8_]%&T+
M_P`'&B__`";0W_!%&P8`'XB:",=QJ^C9^O\`Q_=?\^M?T#T4+Z3WC.MN**2O
M_P!2W"__`"+#^P\M_P"?'_DTO_DC^?H_\$5+0JJ'XD:*50#8KZYI4J*0,`K#
M-J$D(_W?+V#H%`XIO_#E*R/+?$?0B3R3_:VAIDGJ=L=XB+D\[414'154``?T
M#T4O^)G?&9RYGQ/2<K*/,\MPKERIW45)IR4$]5!-13U44]0_L/+?^?'_`)-+
M_P"2/Y^/^'*-C_T4;0O_``<:+_\`)M;=M_P1NU2SLCIUE\5+*WTY][/9PZLO
MV68RCYG>-(9H&+9R3$[1L26#.#N/[V5RMQ_Q\3_]=I?_`$-JY\3])+Q;QL*5
M/&YYE^,IT<3A\91IXS(\KQ=.EB\)-U<+BJ=/%X3%0IXG#57[;#UX0A6H5E"M
M1JTZM.G4I]F#P<,NG6J9=7QN7U<1AJ^"KU<!C\;@:M;!XF,8XG"5:N"QF$JS
MPV)A",,1AY594:]-.G6I5:<I0E^%\?\`P1,24`/\0]*8X7#_`&]`05&%;Y;4
M!B!_>#`GKUP?9O@E_P`$;[/P-\0/#_B^?XA:24TS48+J5#?1[YC#(K;L+:+P
MY!9@N.O&!7ZYV_3\/Z+72Z;_`,?$'^['_)*TK_21\7\PP^)P.)XFA+#8JA7P
M]:$,OPL.:GB*;I5+6BTKQ=M$OD<KR;+U^\5)WIOVB7/*TI75I2U]Z44DHRES
M2C&,:<6J:5-;W_"@-#_Z&W0__`F7_P"+HK>HK\B_M7-O^@V'_A'1_P#EIKRT
+OY)?^!__`&I__]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
